
<html lang="en"     class="pb-page"  data-request-id="3e416b15-cf50-41b0-a616-ae213cf39f7e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b02092"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design" /></meta><meta name="dc.Creator" content="Lewis D.  Pennington" /></meta><meta name="dc.Creator" content="Brian M.  Aquila" /></meta><meta name="dc.Creator" content="Younggi  Choi" /></meta><meta name="dc.Creator" content="Roman A.  Valiulin" /></meta><meta name="dc.Creator" content="Ingo  Muegge" /></meta><meta name="dc.Description" content="Minimizing the number and duration of design cycles needed to optimize hit or lead compounds into high-quality chemical probes or drug candidates is an ongoing challenge in biomedical research. Sma..." /></meta><meta name="Description" content="Minimizing the number and duration of design cycles needed to optimize hit or lead compounds into high-quality chemical probes or drug candidates is an ongoing challenge in biomedical research. Sma..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 24, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02092" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02092" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02092" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02092" /></link>
        
    
    

<title>Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02092" /></meta><meta property="og:title" content="Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0019.jpeg" /></meta><meta property="og:description" content="Minimizing the number and duration of design cycles needed to optimize hit or lead compounds into high-quality chemical probes or drug candidates is an ongoing challenge in biomedical research. Small structure modifications to hit or lead compounds can have meaningful impacts on pharmacological profiles due to significant effects on molecular and physicochemical properties and intra- and intermolecular interactions. Rapid pharmacological profiling of an efficiently prepared series of positional analogues stemming from the systematic exchange of methine groups with heteroatoms or other substituents in aromatic or heteroaromatic ring-containing hit or lead compounds is one approach toward minimizing design cycles (e.g., exchange of aromatic or heteroaromatic CH groups with N atoms or CF, CMe, or COH groups). In this Perspective, positional analogue scanning is shown to be an effective strategy for multiparameter optimization in drug design, whereby substantial improvements in a variety of pharmacological parameters can be achieved." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02092"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02092">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02092&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02092&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02092&amp;href=/doi/10.1021/acs.jmedchem.9b02092" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 8956-8976</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b02075" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00491" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Lewis D. Pennington</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lewis D. Pennington</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</div></div><span class="conrtib-corresp"><strong>*</strong>L.D.P.: phone, +1-781-609-6868; email, <a href="/cdn-cgi/l/email-protection#1c70796b756f326c79727275727b6873725c7d7077796e71796f327f7371"><span class="__cf_email__" data-cfemail="eb878e9c8298c59b8e858582858c9f8485ab8a87808e99868e98c5888486">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lewis+D.++Pennington">Lewis D. Pennington</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8337-1891" title="Orcid link">http://orcid.org/0000-0001-8337-1891</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brian M. Aquila</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian M. Aquila</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+M.++Aquila">Brian M. Aquila</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Younggi Choi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Younggi Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Synthetic Chemistry, Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Younggi++Choi">Younggi Choi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Roman A. Valiulin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roman A. Valiulin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roman+A.++Valiulin">Roman A. Valiulin</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Ingo Muegge</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ingo Muegge</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Modeling and Informatics, Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</div></div><span class="conrtib-corresp"><strong>*</strong>I.M.: phone, +1 781-296-8693; email, <a href="/cdn-cgi/l/email-protection#335a5d545c1d5e4654545673525f5856415e56401d505c5e"><span class="__cf_email__" data-cfemail="bfd6d1d8d091d2cad8d8daffded3d4dacdd2dacc91dcd0d2">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ingo++Muegge">Ingo Muegge</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3294-1852" title="Orcid link">http://orcid.org/0000-0003-3294-1852</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02092&amp;href=/doi/10.1021%2Facs.jmedchem.9b02092" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 8956â8976</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 24, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 December 2019</li><li><span class="item_label"><b>Published</b> online</span>24 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02092</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8956%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLewis%2BD.%2BPennington%252C%2BBrian%2BM.%2BAquila%252C%2BYounggi%2BChoi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.9b02092%26title%3DPositional%2BAnalogue%2BScanning%253A%2BAn%2BEffective%2BStrategy%2Bfor%2BMultiparameter%2BOptimization%2Bin%2BDrug%2BDesign%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8976%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02092"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5042</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02092" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lewis&quot;,&quot;last_name&quot;:&quot;D. Pennington&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;M. Aquila&quot;},{&quot;first_name&quot;:&quot;Younggi&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Roman&quot;,&quot;last_name&quot;:&quot;A. Valiulin&quot;},{&quot;first_name&quot;:&quot;Ingo&quot;,&quot;last_name&quot;:&quot;Muegge&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;8956-8976&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02092&quot;},&quot;abstract&quot;:&quot;Minimizing the number and duration of design cycles needed to optimize hit or lead compounds into high-quality chemical probes or drug candidates is an ongoing challenge in biomedical research. Small structure modifications to hit or lead compounds can have meaningful impacts on pharmacological profiles due to significant effects on molecular and physicochemical properties and intra- and intermolecular interactions. Rapid pharmacological profiling of an efficiently prepared series of positional analogues stemming from the systematic exchange of methine groups with heteroatoms or other substituents in aromatic or heteroaromatic ring-containing hit or lead compounds is one approach toward minimizing design cycles (e.g., exchange of aromatic or heteroaromatic CH groups with N atoms or CF, CMe, or COH groups). In this Perspective, positional analogue scanning is shown to be an effective strategy for multiparameter optimization in drug design, whereby substantial improvements in a variety of pharmacological parame&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02092&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02092" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02092&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02092" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02092&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02092" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02092&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02092&amp;href=/doi/10.1021/acs.jmedchem.9b02092" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02092" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02092" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02092%26sid%3Dliteratum%253Aachs%26pmid%3D32330036%26genre%3Darticle%26aulast%3DPennington%26date%3D2020%26atitle%3DPositional%2BAnalogue%2BScanning%253A%2BAn%2BEffective%2BStrategy%2Bfor%2BMultiparameter%2BOptimization%2Bin%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D8956%26epage%3D8976%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0019.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Minimizing the number and duration of design cycles needed to optimize hit or lead compounds into high-quality chemical probes or drug candidates is an ongoing challenge in biomedical research. Small structure modifications to hit or lead compounds can have meaningful impacts on pharmacological profiles due to significant effects on molecular and physicochemical properties and intra- and intermolecular interactions. Rapid pharmacological profiling of an efficiently prepared series of positional analogues stemming from the systematic exchange of methine groups with heteroatoms or other substituents in aromatic or heteroaromatic ring-containing hit or lead compounds is one approach toward minimizing design cycles (e.g., exchange of aromatic or heteroaromatic CH groups with N atoms or CF, CMe, or COH groups). In this Perspective, positional analogue scanning is shown to be an effective strategy for multiparameter optimization in drug design, whereby substantial improvements in a variety of pharmacological parameters can be achieved.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Minimizing the number and duration of design cycles needed to optimize hit or lead compounds into high-quality chemical probes or drug candidates remains a challenge for biomedical research.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Following the seminal statistical analysis of the potency effects of common structure modifications by Hajduk and Sauer 12 years ago,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> it has become increasingly appreciated that minor structure modifications to hit or lead compounds can have meaningful impacts on pharmacological profiles due to significant effects on molecular and physicochemical properties and intra- and intermolecular interactions.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4â6)</a> Despite numerous advances in structural biology and computational chemistry over the past 30 years,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the complexity of biological systems and the variability of bioassay data continue to complicate computational predictions of the impacts of small structure modifications on multiple pharmacological parameters.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For example, having structural information at atomic resolution not only for the desired target but also for multiple antitargets as well as having predictive models for all relevant optimization parameters is still impracticable for many drug discovery programs.</div><div class="NLM_p">Brown and co-workers recently suggested that one way to identify better hit compounds is by having more balanced distributions of positional analogues in corporate compound collections and improving the use of multiparameter decision trees and statistics.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Similarly, rapid pharmacological profiling of an efficiently prepared series of positional analogues stemming from the systematic exchange of methine groups with heteroatoms or other substituents in aromatic or heteroaromatic ring-containing hit or lead compounds can be an effective strategy for multiparameter optimization (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). This approach, termed positional analogue scanning in this Perspective, leverages the beneficial effects that minor structure modifications can have on molecular and physicochemical properties and intra- and intermolecular interactions,<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4â6)</a> which can lead to substantial improvements in a variety of pharmacological parameters to streamline multiparameter optimization efforts.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Surprisingly, despite myriad manifestations of positional analogue scanning being reported in the medicinal chemistry literature for decades, no review has been published to inspire and guide the effective use of this strategy for multiparameter optimization in drug design.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Positional analogue scanning for multiparameter optimization of aromatic or heteroaromatic ring-containing hit or lead compounds leverages the beneficial effects that minor structure modifications can have on molecular and physicochemical properties and intra- and intermolecular interactions (CH â X: exchange of aromatic or heteroaromatic CH groups with N atoms or CF, CMe, or COH groups, etc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Positional analogue scanning for multiparameter optimization of aromatic or heteroaromatic ring-containing hit or lead compounds is distinct from the Topliss method for potency optimization of aromatic ring-containing hit or lead compounds (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The method of Topliss is a systematic approach for iteratively selecting ring substituents and analyzing structureâactivity relationships (SARs) resulting from the properties and patterns of ring substituents, which considers the effects of ring substituents on hydrophobic (Ï), electronic (Ï), and steric (<i>E</i><sub>s</sub>) parameters developed by Hansch.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Positional analogue scanning leverages the beneficial effects that minor structure modifications can have on molecular and physicochemical properties such as molecular weight (MW), hydrogen bond donors (HBDs), hydrogen bond acceptors (HBAs), polar surface area (PSA), acidity/basicity (p<i>K</i><sub>a</sub>), lipophilicity (logÂ <i>P</i> and logÂ <i>D</i><sub>pH</sub>), and aqueous solubility (<i>S</i><sub>H2O</sub>), as well as intra- and intermolecular interactions that can affect ligand conformation and receptor binding. Positional analogue scanning is intended to optimize pharmacological parameters such as binding affinity and kinetics, functional activity and potency, target selectivity, passive permeability, active transport, protein binding, metabolic stability, pharmacokinetics, and safety. Positional analogue scanning is ideally suited for simultaneous multiparameter optimization and sophisticated data analysis.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The Topliss method for potency optimization of aromatic ring-containing hit or lead compounds considers effects on hydrophobic (Ï), electronic (Ï), and steric (<i>E</i><sub>s</sub>) Hansch parameters (L = less active, E = equiactive, M = more active; descending lines indicate sequence; square brackets indicate alternates; â , compared to 4-H compound). Figure is adapted from J. G. Topliss.<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various manifestations of positional analogue scanning have been reported in the literature for decades, variably described as an atom or substituent scan, transposition, shift, walk, dance, or shuffle, generally constituting a partial scan of a single aromatic or heteroaromatic ring of a polycyclic drug molecule, and typically focused on a single pharmacological parameter, such as potency.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> It is recommended in this Perspective that a generic term, positional analogue scanning, be used to describe this general strategy, as positional analogue scanning in small molecule drug discovery is analogous to alanine scanning in polypeptide biochemical studies and both are intended to be systematic and complete.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> The maximal value of positional analogue scanning can be realized by assessment of negative, neutral, or positive impacts across multiple pharmacological parameters, exploring all possible positional analogues in situations where predictive modeling is not available.<a onclick="showRef(event, 'ref9 ref17'); return false;" href="javascript:void(0);" class="ref ref9 ref17">(9,17)</a> Additionally, positional analogue scanning can provide opportunities to identify activity cliffs and nonadditive SAR that may elucidate ligand binding conformations and receptor binding modes.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The modern need in chemical biology and drug discovery for rapid and simultaneous multiparameter optimization justifies the synthesis investment that may be required to enable full positional analogue scanning.</div><div class="NLM_p">An example of full, iterative nitrogen scanning is shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As part of a program seeking selective agonists of the class A GPCR sphingosine-1-phosphate-1 receptor (S1P<sub>1</sub>), early lead compound <b>1</b> was identified. Though <b>1</b> displays moderate potency toward S1P<sub>1</sub> and good stability in rat liver microsomes (S1P<sub>1</sub> EC<sub>50</sub>, <i>E</i><sub>max</sub> = 70 nM, 110%; RLM CL<sub>int</sub> < 14 Î¼L min<sup>â1</sup> mg<sup>â1</sup>), it also exhibits undesired activity against S1P<sub>3</sub> (S1P<sub>3</sub> EC<sub>50</sub>, <i>E</i><sub>max</sub> = 1.5 Î¼M, 92%), low solubility in aqueous media (<i>S</i><sub>pHâ¯7.4</sub>, PBS < 1.0 Î¼g/mL), and poor cell permeability (LLC-PK1 <i>P</i><sub>app</sub> A â B, ER = 1.2 Ã 10<sup>â6</sup> cm/s, 0.40). In the absence of X-ray crystal structures and predictive models for S1P<sub>1</sub> and S1P<sub>3</sub>, nitrogen scanning of <b>1</b> was undertaken to probe impacts on potency and selectivity and to tune molecular and physicochemical properties with minimal effect on molecular weight. Of the 11 monoaza-analogues of <b>1</b> prepared and tested (<b>2</b>â<b>12</b>), only positional analogues <b>2</b>, <b>5</b>, <b>8</b>, <b>10</b>, and <b>11</b> displayed similar or improved physicochemical and pharmacological properties compared to <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). When <b>1</b> or positional analogue <b>2</b>, <b>5</b>, <b>8</b>, <b>10</b>, or <b>11</b> was dosed orally in female Lewis rats in a single-dose screening assay (1.0 mg/kg), only positional analogue <b>10</b> achieved an unbound plasma concentration sufficient to elicit reduction of peripheral lymphocyte count (<i>C</i><sub>u,plasma</sub> = 66 nM; PLC POC = â64%). A second iteration of nitrogen scanning, combining the favored positional analogue <b>10</b> in ring system C/Câ² with the favored positional analogue <b>2</b> or <b>5</b> in ring system A or B, respectively, sought potentially additive benefits of multiple nitrogen atoms. This effort resulted in the identification of diaza-analogue <b>13</b>, which compared to <b>1</b> exhibits improved potency toward S1P<sub>1</sub> and selectivity against S1P<sub>3</sub> (S1P<sub>1</sub> EC<sub>50</sub>, <i>E</i><sub>max</sub> = 20 nM, 120%; S1P<sub>3</sub> EC<sub>50</sub>, <i>E</i><sub>max</sub> = inactive), enhanced solubility in aqueous media (<i>S</i><sub>pHÂ 7.4</sub>, PBS = 2.4 Î¼g/mL), and better cell permeability (LLC-PK1 <i>P</i><sub>app</sub> A â B, ER = 6.7 Ã 10<sup>â6</sup> cm/s, 1.0) while maintaining good stability in rat liver microsomes (RLM CL<sub>int</sub> < 14 Î¼L min<sup>â1</sup> mg<sup>â1</sup>). When <b>13</b> was dosed orally in female Lewis rats in a single-dose screening assay (1.0 mg/kg), it elicited reduction of peripheral lymphocyte count at a lower unbound plasma concentration versus <b>10</b> (<i>C</i><sub>u,plasma</sub> = 6.1 nM; PLC POC = â64%). It is interesting to note the observation of numerous activity cliffs in transforming <b>1</b> to monoaza-analogues <b>2</b>â<b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), as well as unfavorable nonadditive SAR when combining positional analogues <b>2</b> and <b>10</b> to give the corresponding diaza-analogue (not shown; S1P<sub>1</sub> EC<sub>50</sub> = 70, 60, 24, and 200 nM, for <b>1</b>, <b>2</b>, <b>10</b>, and the corresponding diaza-analogue, respectively). It is also worth noting that the observed impacts on solubility, permeability, and metabolic stability upon positional analogue scanning do not correlate with changes in cLogP. While the probabilistic analyses and predictions discussed below will help to guide positional analogue scanning, this example illustrates the value of full rather than partial positional analogue scanning to maximize the chances of success.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. An example of full, iterative nitrogen scanning, which contributed to the identification of a lead compound (<b>13</b>) with an improved pharmacological profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of partial, tandem fluorine and nitrogen scanning is illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In a program searching for dual inhibitors of rapidly accelerated fibrosarcoma kinase (Raf) and mitogen-activated protein kinase kinase (MEK), lead compound <b>14</b> was discovered. Compound <b>14</b> exhibits modest potency toward C-Raf and MEK1 (C-Raf and MEK1 IC<sub>50</sub> = 530 and 230 nM, respectively), moderate solubility in fasted-state simulated intestinal fluid (<i>S</i><sub>FaSSIF</sub> = 32 Î¼g/mL), favorable parallel artificial membrane permeability (PAMPA <i>P</i><sub>app</sub> = 6.0 Ã 10<sup>â6</sup> cm/s), and good stability in human liver microsomes (HLM CL<sub>int</sub> = 6.0 Î¼L min<sup>â1</sup> mg<sup>â1</sup>). To exploit the unique properties of fluorine in drug-like molecules,<a onclick="showRef(event, 'cit5c'); return false;" href="javascript:void(0);" class="ref cit5c">(5c)</a> fluorine scanning of <b>14</b> was undertaken to probe impacts on potency while minimizing effects on molecular and physicochemical properties. Of the five monofluoro-analogues of <b>14</b> that were synthetically accessible by nonselective late-stage fluorination (<b>15</b>â<b>19</b>), positional analogue <b>17</b> displays the best balance of physicochemical and pharmacological properties (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). To capitalize on the favorable properties often imparted by aromatic nitrogen atoms in drug-like molecules,<a onclick="showRef(event, 'cit4a cit4b'); return false;" href="javascript:void(0);" class="ref cit4a cit4b">(4a,b)</a> a parallel nitrogen scanning effort on an <i>N</i>-methyl derivative of <b>14</b> (<b>20</b>) was initiated to interrogate impacts on potency and to tune molecular and physicochemical properties. Of the four monoaza-analogues of <b>20</b> that were readily synthetically accessible (<b>21</b>â<b>24</b>), positional analogue <b>24</b> exhibits the best balance of physicochemical and pharmacological properties (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compound <b>25</b> arose from combining the favored positional analogues <b>17</b> and <b>24</b> from the fluorine and nitrogen scanning efforts, respectively, and exchanging the metabolically labile <i>N</i>,<i>N</i>-dimethylcarbamate group with the more stable 2-pyrimidinyl ring. Compound <b>25</b> displays favorable potency toward C-Raf and MEK1 (C-Raf and MEK1 IC<sub>50</sub> = 56 and 160 nM, respectively), good solubility in fasted-state simulated intestinal fluid (<i>S</i><sub>FaSSIF</sub> = 160 Î¼g/mL), and excellent stability in human liver microsomes (HLM CL<sub>int</sub> = 0.50 Î¼L min<sup>â1</sup> mg<sup>â1</sup>), as well as no inhibition of cytochrome P450 3A4 (CYP 3A4 IC<sub>50</sub> > 100 Î¼M). Compound <b>25</b> was advanced into clinical trials. As with the case study summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, several activity cliffs were observed in converting <b>14</b> to monofluoro-analogues <b>15</b>â<b>19</b> and <b>20</b> to monoaza-analogues <b>21</b>â<b>24</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. An example of partial, tandem fluorine and nitrogen scanning, which contributed to the identification of clinical candidate <b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although positional analogue scanning can be rendered more efficient today than 30 years ago by exploiting numerous advances in chemical synthesis and building block availability,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> more progress is needed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Positional analogue scanning for the case studies in this Perspective generally relied on <i>de novo</i> syntheses of each positional analogue using common intermediates and commercially available building blocks; thus the syntheses for the CH group progenitors and their positional analogues were usually similar in length and yield. Positional analogue scanning could be made even more efficient by late-stage functionalization of the CH progenitors to afford all positional analogues either simultaneously or in parallel. Recent advances in CH group activation, photoredox catalysis, electrochemistry, and biotransformation offer the potential to increase the efficiency of fluorine, methyl, and hydroxyl scanning.<a onclick="showRef(event, 'cit20a ref24'); return false;" href="javascript:void(0);" class="ref cit20a ref24">(20a,24)</a> Numerous synthetic methods to introduce fluorine atoms, methyl groups, or hydroxyl groups on aromatic and heteroaromatic ring systems in pharmaceutical and agrochemical compounds have been reported.<a onclick="showRef(event, 'cit5a ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref cit5a ref25 ref26 ref27">(5a,25â27)</a> While a limited number of synthetic methods allow direct, nonselective CH functionalization to prepare multiple positional analogues simultaneously at late-stages of synthesis,<a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> most synthetic methods aim to provide selectively a single positional analogue. An increased variety of commercially available building blocks would be a particularly important advancement for nitrogen scanning.<a onclick="showRef(event, 'cit19a ref21'); return false;" href="javascript:void(0);" class="ref cit19a ref21">(19a,21)</a> Recent advances in Minisci-type reactions may facilitate the synthesis of functionalized aza-heteroaromatic building blocks that could be used for <i>de novo</i> syntheses of positional analogues for nitrogen scanning.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">For this Perspective, comprehensive matched molecular pair (MMP) and positional analogue analyses were performed to provide probabilistic expectations and further substantiation that small structure modifications to hit or lead compounds can have meaningful impacts on a variety of pharmacological parameters.<a onclick="showRef(event, 'ref4 ref5 ref6 ref9 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref9 ref17 ref18">(4â6,9,17,18)</a> Additionally, several case studies of positional analogue scanning published over the past 12 years have been highlighted to demonstrate the effectiveness of this strategy for multiparameter optimization in drug design. Because Young and Leeson recently suggested four structure modifications (the exchange of CH groups with N atoms or CF, CMe, or COH groups) as privileged transformations for multiparameter optimization,<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> these structure modifications were selected to be represented in the MMP and positional analogue analyses, as well as the case studies; however, other common structure modifications are also amenable to positional analogue scanning (e.g., exchange of CH groups with CCN, CCl, CCF<sub>3</sub>, or COMe groups).<a onclick="showRef(event, 'cit5d ref9'); return false;" href="javascript:void(0);" class="ref cit5d ref9">(5d,9)</a> These structure modifications effectively scan molecular and physicochemical property space: N atoms and CCN groups add polarity and HBAs, CF and CCl groups increase van der Waals radii, CMe and CCF<sub>3</sub> groups increase lipophilicity, and COH and COMe groups add polarity and HBDs and/or HBAs. These structure modifications may also impart beneficial or informative conformational effects. It should be noted that in contrast to the two case studies discussed above that embody the full spectrum of partial, full, iterative, and/or tandem positional analogue scanning with broad pharmacological profiling, many of the case studies detailed below exemplify targeted positional analogue scanning on selected rings with narrow pharmacological profiling, as is common in the biomedical research literature.</div><div class="NLM_p last">Most of the case studies of positional analogue scanning described below were executed during late-stages of multiparameter optimization; however, positional analogue scanning can also have meaningful impacts during early stages of multiparameter optimization. When structure-based drug design is not an option due to a lack of structural information for the desired target and key antitargets and a lack of predictive models for the parameters that need to be optimized, positional analogue scanning can be considered as a systematic version of scaffold-hopping and focused library design for multiparameter optimization. On the other hand, if target structures are available, binding and functional activity parameters can be predicted using small molecule docking and scoring approaches<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or more sophisticated approaches to calculate binding free energies such as free energy perturbation (FEP). In fact, the appendage of methyl groups has been exhaustively studied using FEP.<a onclick="showRef(event, 'cit5b'); return false;" href="javascript:void(0);" class="ref cit5b">(5b)</a> Additionally, combinations of MMPs and quantitative structureâactivity relationship (QSAR) models have been explored to aid the optimization process.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Another concept employed in hit-to-lead optimization couples virtual screening with focused library design and diversity-oriented synthesis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> These computer-aided optimization methods, including docking, FEP, QSAR, and diversity approaches, focus mostly on improving binding free energies, paying less attention to multiparameter optimization challenges. In the following <a class="ref internalNav" href="#sec2" aria-label="Discussion">Discussion</a> section, we provide MMP analyses of 13 parameters relevant to drug design. It is hoped that the statistical analyses presented here may afford quantitative guidance on how positional analogue scanning can impact multiple pharmacological parameters. Finally, we also present several case studies of how positional analogue scanning has been leveraged to overcome multiparameter optimization challenges for the identification of advanced leads, preclinical candidates, and clinical candidates, which may serve to inspire and guide the effective use of this strategy in drug design.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> MMP Analyses</h3><div class="NLM_p">As an initial step toward providing probabilistic expectations for the impacts of positional analogue scanning on a variety of pharmacological parameters, comprehensive MMP analyses were performed on ChEMBL24 data,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> focusing on exchanges of aromatic and heteroaromatic CH groups with N atoms or CF, CMe, or COH groups (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). These MMP analyses were extracted from â¼1.8 million compounds with â¼15 million activity data from more than 1.0 million assays stored in the ChEMBL database. Assays included in the MMP analyses were selected either by assay type (e.g., âBâ for binding and âFâ for functional) or by text-appropriate searches in the assay description field of the ChEMBL database; the MMPs were included for all assay types irrespective of the measure or unit. Because these MMP analyses incorporate high structural diversity for aromatic and heteroaromatic ring systems, it is believed these MMP analyses are the most comprehensive to date for the above four structure modifications, going beyond previously reported MMP analyses for isolated five- and six-membered aromatic and heteroaromatic rings, as well as fluorine-substituted phenyl rings.<a onclick="showRef(event, 'ref9 ref17'); return false;" href="javascript:void(0);" class="ref ref9 ref17">(9,17)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MMP analyses. The percentages of MMPs derived from ChEMBL24 with â¥3-fold decreases (blue), <3-fold changes (gray), and â¥3-fold increases (orange) are depicted. For exact values, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Tables S1âS4)</a>. The number of MMP occurrences is noted in the upper left corner for each graph. The statistical significances of the differences between the â¥3-fold decrease and â¥3-fold increase bins are indicated by one, two, or three asterisks corresponding to Ï<sup>2</sup><i>p</i>-values of <0.05, <0.01, and <0.001, respectively. The number of MMPs represents the total number of MMPs associated with unique assay data extracted from ChEMBL24. The number of unique MMPs lists the number of structurally unique MMPs. The number of assays refers to the number of unique ChEMBL24 assays associated with the respective MMPs. Interpretations of property increases for each parameter are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S5)</a>. A list of measures and units associated with the assays for each property for CH group â N atom exchanges is given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S6)</a>. The statistics for ring diversity among unique MMPs for CH group â N atom exchanges is provided as <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S7)</a>. An overview of targets associated with ChEMBL24 assays is also available in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Figure S1)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The MMP analyses for the four structure modifications and 13 pharmacological parameters are summarized in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. To aid the visualization and interpretation of the MMP analyses, the statistical data for the impacts of the four structure modifications on each of the pharmacological parameters are presented in three bins: â¥3-fold decreases (blue), <3-fold changes (gray), or â¥3-fold increases (orange). For exact values, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Tables S1âS4)</a>. The 3-fold threshold for bin assignments was chosen on one hand to maximize the number of instances observed in each bin and on the other hand to ensure the recording of meaningful impacts beyond potential experimental variability.<a onclick="showRef(event, 'cit8a cit18a cit18b'); return false;" href="javascript:void(0);" class="ref cit8a cit18a cit18b">(8a,18a,b)</a> The statistical significances of the differences between the â¥3-fold decreases and â¥3-fold increases have been calculated as Ï<sup>2</sup><i>p</i>-values and marked in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. It is important to note that observing â¥3-fold changes is not equally achievable for all pharmacological parameters. Impacts on binding affinity or functional activity are often observed across multiple orders of magnitude, restricted only by the wall of the assay at low concentrations, or perhaps formulation or reagent restrictions at high concentrations. In contrast, measurement ranges for in vitro clearance parameters can be limited to as little as 1.0 order of magnitude due to limited incubation times in microsomal or hepatocyte stability assays, making it much harder to observe a â¥3-fold change.</div><div class="NLM_p last">The MMP analyses in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> illustrate how likely it is to see a meaningful impact on a pharmacological parameter of interest. For example, the likelihood of seeing a â¥3-fold change (either increase or decrease) in binding affinity for CH group â N atom exchanges is â¼42%. In addition, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> illustrates that the chance of observing â¥3-fold decreases in binding affinity for CH group â N atom exchanges is significantly higher than for observing â¥3-fold increases (27% versus 15%, respectively; <i>p</i>-value of <0.001). Several observations provide statistical quantification for general trends that have been widely known. For instance, CH group â N atom or COH group exchanges have a â¼38% probability of significantly increasing solubility â¥3-fold while CH group â CF or CMe group exchanges have an â¼18â23% chance of decreasing solubility â¥3-fold. Other findings may be less expected. For example, the impacts of CH group â CF group exchanges are minimal for microsomal stability, clearance, or half-life, while the impacts are more pronounced for binding affinity and functional activity. Other less expected findings include CH group â COH group exchanges having a 19% chance of increasing cytotoxicity â¥3-fold. In summary, these four structure modifications afford a reasonable chance of having meaningful impacts on a variety of pharmacological parameters commonly encountered during multiparameter optimization.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Positional Analogue Analyses</h3><div class="NLM_p">To unmask effects that may rely on specific positional analogues as the next step to providing probabilistic expectations for the impacts of positional analogue scanning on a variety of pharmacological parameters, positional analogue analyses were performed by dissection of the above MMP analyses for individual positional analogues (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Positional analogue designations in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> are assigned relative to the nearest ring substituent or ring fusion; illustrative examples are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S8)</a>. Because of the wide variety of substitutions contained in each of the three different subsets of positional analogue designations, the differences between the designated subsets may not always be easy to interpret. However, in some cases the positional analogue analysis reveals marked differences that are compelling. For instance, the MMP analyses in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> for CH group â N atom exchanges suggest the likelihood of â¥3-fold decreases is much greater than the likelihood of â¥3-fold increases in CYP inhibition (33% versus 11%, respectively), even though CH group â N atom exchanges leading to 4-aza-analogues would be expected to result in a greater likelihood for increases in CYP inhibition. This perhaps unexpected observation may be due to the MMP analyses masking positional analogue differences (i.e., 2-aza- versus 3-aza- versus 4-aza-analogues). <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> suggests that this is indeed the case. 2-Aza-analogues from CH group â N atom exchanges exhibit a 40% chance of decreasing CYP inhibition â¥3-fold while 4-aza-analogues afford a 40% chance of increasing CYP inhibition â¥3-fold. Positional analogue dependencies were analyzed for the eight pharmacological parameters for which a sufficient number of MMPs could be extracted from the ChEMBL database. As with the MMP analyses in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, the positional analogue analyses in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> reveal both expected and unexpected findings. For instance, the greater likelihood for â¥3-fold increases in CYP inhibition for CH group â N atom exchanges leading to 4-aza-analogues is expected, while the greater likelihood for â¥3-fold decreases in CYP inhibition for CH group â N atom exchanges leading to 2-aza-analogues is perhaps unexpected. Similarly, the greater likelihood for â¥3-fold increases in permeability for CH group â CMe group exchanges leading to 2-methyl-analogues compared to other positional analogues may not be expected.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Positional analogue analyses. MMP statistics presented in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> are dissected here by positional analogues. Positional analogue designations are assigned relative to the nearest ring substituent or ring fusion. The percentages of MMPs with â¥3-fold decreases (blue), <3-fold changes (gray), or â¥3-fold increases (orange) are depicted. The number of MMP occurrences is noted in the upper left corner for each graph. The statistical significances of the differences between the â¥3-fold decrease and â¥3-fold increase bins are indicated by one, two, or three asterisks corresponding to Ï<sup>2</sup><i>p</i>-values of <0.05, <0.01, and <0.001, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Statistical significances for the differences between the likelihood of â¥3-fold decreases and â¥3-fold increases were achieved for 40% of the MMPs in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> (21/52) and for 43% of the positional analogues in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> (41/96). Moreover, for almost all parameters in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, differences between <3-fold changes and â¥3-fold changes were statistically significant (<i>p</i>-values not shown). Quantifying the probability of observing a change in a parameter is important as it varies greatly between parameters, even if it is unclear whether the result will be an increase or a decrease. While it would have been desirable to obtain MMPs for additional parameters of interest such as plasma protein binding or in vivo toxicity, they were not included in the analyses due to sparseness of data.</div><div class="NLM_p">Some additional insight into the positional analogue analyses can be gained from inspecting the different assay subsets included in the pharmacological parameter categories. For example, for the pharmacological parameter of clearance, both in vitro and in vivo assays were included to have sufficient data for a statistically meaningful analysis. Because of the greater likelihood of â¥3-fold decreases in clearance for CH group â CF group exchanges leading to 4-fluoro-analogues, a detailed analysis was undertaken of the rat clearance subset of the clearance data. It was found that 55 of the 218 MMPs are associated with 40 rat clearance studies. It was also found that 10 of the 55 MMPs are associated with â¥3-fold decreases in rat clearance (18%), while no cases were found with â¥3-fold increases in rat clearance. The statistical significance of the preference for â¥3-fold decreases in rat clearance (<i>p</i>-value = 0.002) is slightly stronger than that for all 218 MMPs associated with the clearance analysis for the 4-fluoro-analogues in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> (<i>p</i>-value = 0.009). The most favorable rat clearance result for 4-fluoro-analogues was found for a MMP of melanin concentrating hormone receptor 1 antagonists.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This MMP exhibits a 16-fold decrease in rat clearance along with an equally impressive increase in oral bioavailability (<i>F</i>: 35% â 93%). In contrast, the most unfavorable rat clearance result for 4-fluoro-analogues was observed for a MMP of ghrelin receptor agonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> This MMP displays a 2.6-fold increase in rat clearance. The distribution of fold-changes in rat clearance is available in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Figure S2)</a>.</div><div class="NLM_p">The diversity of assay subtypes included for each parameter is tremendous. On average, there are only three MMPs associated with the same assay (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Table S6 in the Supporting Information</a>). For instance, the 19â¯355 MMPs for CH group â N atom exchanges analyzed for changes in functional activities are associated with 7586 different assays. Combining data from different assays is possible because for each MMP the same assay was used and correlations between different assays are largely irrelevant when fold-differences of MMPs are analyzed. However, some bias is introduced from assays presenting different data ranges that render the measurement of a 3-fold change less or more difficult. For a few parameters, this bias can be particularly restrictive. For instance, for hepatic clearance, due to the upper limits of hepatic blood flow, a 3-fold change can practically be observed only between truly stable and unstable compounds. Because of the nonlinearity with which clearance contributes to the efficacious dose, a lower than 3-fold change would be meaningful to report for this parameter; however, due to the large variability between the tens of thousands of different assays analyzed here, it was decided not to provide assay-customized fold thresholds. While being a practical necessity, it is also a limitation of the MMP analyses presented here.</div><div class="NLM_p last">In addition to the rat clearance example discussed above, we provide a second example illustrating how a subset of assays behaves in comparison to the composite across all assays interrogated for a given parameter. <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Figure S3 in the Supporting Information</a> illustrates for CH group â N atom exchanges how the MMP statistics for a subset of 1163 MMPs associated with a subgroup of 792 antiproliferative assays differs from that of the entire set of functional activities for 19â¯335 MMPs derived from 7568 assays. In this example, the observed differences are small. A â¥3-fold decrease in functional activity is observed for 24% (22%) of the antiproliferative (all functional) assays, while the fraction of MMPs with â¥3-fold increased functional activity is unchanged. Additional detailed analyses could be performed for other pharmacological parameters and assay subsets; however, the vast number of assays in ChEMBL24 renders such analyses prohibitive and beyond the scope of this work. The examples discussed here are arbitrary; however, it remains to point out that each assay has its own potential for achieving the desired parameter changes by leveraging positional analogue scanning. In summary, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> illustrates that the four structure modifications highlighted in this Perspective have important positional analogue dependencies for impacts on an array of pharmacological parameters frequently encountered during multiparameter optimization.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Nitrogen Scanning Case Studies</h3><div class="NLM_p">An example of nitrogen scanning to improve potency is shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As part of a program to identify splicing modulators of survival motor neuron-2 premessenger ribonucleic acid (SMN2 pre-mRNA), compound <b>26</b> was screened along with diaza-analogues <b>27</b>â<b>29</b>, of which only positional analogue <b>29</b> was found to increase SMN protein levels (SMN EC<sub>50</sub> = 0.60 nM, 2.5-fold increase, FI). Further optimization of <b>29</b> was undertaken to increase potency and reduce hERG binding (hERG IC<sub>50</sub> = 0.60 Î¼M), as well as to improve pharmacokinetic (PK) and neuroPK profiles. Exchange of the aniline NH group of <b>29</b> with an O atom and the 2-benzo[<i>b</i>]thiophenyl ring system of <b>29</b> with a 2-(5-(1<i>H</i>-pyrazol-4-yl))phenolyl ring system afforded clinical candidate <b>30</b> (SMN EC<sub>50</sub> = 0.020 nM, 3.6-fold increase; hERG IC<sub>50</sub> = 6.3 Î¼M). Interestingly, ortho-hydroxyl groups in several precursors of <b>30</b> were found to be critical for inducing planar conformations and high potencies, suggesting that a N â S interaction between the proximal N atom of the pyridazine ring of <b>29</b> and the adjacent S atom of the benzothiophene ring system of <b>29</b> may give rise to a planar conformation and the favorable activity cliff observed for <b>29</b> compared to <b>26</b>â<b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The finding that only one of the three positional analogues tested gave improved potency is in line with the MMP analysis-derived probability of 15% for achieving â¥3-fold increases in potency (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. An example of nitrogen scanning to improve potency, which contributed to the identification of clinical candidate <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of nitrogen scanning to increase microsomal stability is summarized in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In a program seeking potent, selective, and orally bioavailable inhibitors of cyclin-dependent kinase 8 (CDK8), lead compound <b>31</b> was identified. Though <b>31</b> displays excellent biochemical and cellular potency toward CDK8 (CDK8 and 7dF3 cell IC<sub>50</sub> = 1.4 and 0.60 nM, respectively), it also exhibits poor stability in human, rat, and mouse liver microsomes (HLM, RLM, and MLM CL<sub>int</sub> = 530, 79, and 240 Î¼L min<sup>â1</sup> mg<sup>â1</sup>, respectively). Nitrogen scanning of the indazole ring system of <b>31</b> was undertaken to reduce lipophilicity and probe impacts on potency and microsomal stability. Of the three monoaza-analogues of <b>31</b> prepared and tested (<b>32</b>â<b>34</b>), only positional analogue <b>34</b> retains favorable potency toward CDK8 (CDK8 and 7dF3 cell IC<sub>50</sub> = 2.6 and 6.5 nM, respectively) and displays markedly improved stability in human, rat, and mouse liver microsomes (HLM, RLM, and MLM CL<sub>int</sub> = 45, <10, and <10 Î¼L min<sup>â1</sup> mg<sup>â1</sup>, respectively). Compound <b>34</b> was selected as the preclinical candidate and advanced into in vivo efficacy and safety studies. As with the case studies discussed above, it is interesting to note the observation of several activity cliffs in converting <b>31</b> to monoaza-analogues <b>32</b>â<b>34</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Both the detrimental impact of some positional analogues on potency and the improved microsomal stability for most positional analogues are expected given the MMP analysis probability distributions for these pharmacological parameters in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, which suggests a higher propensity of increasing microsomal stability â¥3-fold and decreasing clearance â¥3-fold for CH group â N atom exchanges.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. An example of nitrogen scanning to increase microsomal stability, which contributed to the identification of preclinical candidate <b>34</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of iterative nitrogen scanning to increase microsomal stability, reduce CYP 3A4 inhibition, and ablate PXR activity is illustrated in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> As part of a program seeking palm site allosteric inhibitors of hepatitis C virus NS5B replicase (HCV NS5B replicase), lead compound <b>35</b> was identified. Though <b>35</b> displays excellent potency toward several HCV replicons (gt-1b, gt-1a, and gt-1bC316N EC<sub>50</sub> = 1.3, 2.1, and 35 nM, respectively), it also exhibits poor stability in human liver microsomes (HLM <i>t</i><sub>1/2</sub> = 11 min), as well as inhibition of CYP 3A4 (CYP 3A4 IC<sub>50</sub> = 2.1 Î¼M). Because a metabolite identification study on a precursor of <b>35</b> had identified the left-most phenyl ring as a metabolic soft-spot, nitrogen scanning of this ring of <b>35</b> was undertaken to increase polarity and potentially block metabolic sites. Of the three monoaza-analogues of <b>35</b> prepared and tested (<b>36</b>â<b>38</b>), only positional analogue <b>36</b> both retains favorable potency across HCV replicons (gt-1b, gt-1a, and gt-1bC316N EC<sub>50</sub> = 1.9, 2.8, and 55 nM, respectively) and displays markedly improved stability in human liver microsomes (HLM <i>t</i><sub>1/2</sub> = 110 min). Unfortunately, <b>36</b> also exhibits inhibition of CYP 3A4 and hERG (CYP 3A4 IC<sub>50</sub> = 4.1 Î¼M; hERG IC<sub>50</sub> = 5.8 Î¼M) and activation of PXR (PXR EC<sub>50</sub> = 1.6 Î¼M). A second iteration of nitrogen scanning of the left-most ring of <b>36</b> was initiated to further decrease lipophilicity and potentially reduce these off-target liabilities. Of the four diaza-analogues of <b>36</b> prepared and tested (<b>39</b>â<b>42</b>), only positional analogue <b>42</b> retains favorable potency across HCV replicons (gt-1b, gt-1a, and gt-1bC316N EC<sub>50</sub> = 1.0, 2.3, and 51 nM, respectively), displays excellent stability in human liver microsomes (HLM <i>t</i><sub>1/2</sub> > 120 min), exhibits reduced inhibition of CYP 3A4 (CYP 3A4 IC<sub>50</sub> = 11 Î¼M), and shows no activation of PXR (PXR EC<sub>50</sub> > 50 Î¼M). Unfortunately, <b>42</b> displays inhibition of hERG (hERG IC<sub>50</sub> = 4.8 Î¼M). Exchange of the C4 CH group of the benzofuran ring system of <b>42</b> with a CF group afforded <b>43</b>, which retains favorable potency across HCV replicons (gt-1b, gt-1a, and gt-1bC316N EC<sub>50</sub> = 4.0, 9.0, and 18 nM, respectively), exhibits excellent stability in human liver microsomes (HLM <i>t</i><sub>1/2</sub> > 120 min), displays reduced inhibition of CYP 3A4 and hERG (CYP 3A4 IC<sub>50</sub> > 13 Î¼M; hERG IC<sub>50</sub> = 24 Î¼M), and shows no activation of PXR (PXR EC<sub>50</sub> > 50 Î¼M). Compound <b>43</b> was advanced into clinical trials. As with the case studies discussed above, the observation of several activity cliffs in converting <b>35</b> to mono- and diaza-analogues <b>36</b>â<b>42</b> is notable (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Additionally, maintaining a low level of CYP 3A4 inhibition for 2-aza-analogue <b>36</b> while observing strong increases in CYP 3A4 inhibition for 4-aza-analogue <b>38</b> is in line with the positional analogue analysis in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, which suggests a 40% chance of decreasing CYP inhibition â¥3-fold for 2-aza-analogues and a 40% chance of increasing CYP inhibition â¥3-fold for 4-aza-analogues.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0018.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. An example of iterative nitrogen scanning to increase microsomal stability, reduce CYP 3A4 inhibition, and ablate PXR activity, which contributed to the identification of clinical candidate <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Fluorine Scanning Case Studies</h3><div class="NLM_p">An example of fluorine scanning to improve potency is shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In a program searching for selective ATP-competitive inhibitors of protein kinase B (PKB/Akt), racemic lead compound <b>44</b> was found to exhibit modest potency toward Akt, but with favorable lipophilicity (Akt IC<sub>50</sub> = 62 nM; cLogP = 1.7). Fluorine scanning of the readily modifiable phenyl ring of <b>44</b> was undertaken to probe impacts on potency with minimal effect on lipophilicity. Of the three monofluoro-analogues of <b>44</b> prepared and tested (<b>45</b>â<b>47</b>), positional analogue <b>47</b> exhibits the best balance of potency and lipophilicity (Akt IC<sub>50</sub> = 7.4 nM; cLogP = 2.0). Resolution of the enantiomers of <b>47</b>, exchange of the Me group with an Et group, and substitution of the ortho CH group of the phenyl ring with a CF group afforded clinical candidate <b>48</b> (Akt IC<sub>50</sub> = 0.50 nM; cLogP = 2.4). The positional analogue analyses in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> suggest that there are negligible differences in binding affinity or functional activity impacts between 2-, 3-, and 4-fluoro-analogues. Overall, the chances of observing â¥3-fold increases in potency versus â¥3-fold decreases in potency are higher for all positional analogues, although the chances are somewhat smaller for 4-fluoro-analogues. In that regard, the significant improvement in potency for 4-fluoro-analogue <b>47</b> is somewhat surprising.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. An example of fluorine scanning to improve potency, which contributed to the identification of clinical candidate <b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of fluorine scanning to increase microsomal stability and improve PK and neuroPK profiles is summarized in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> As part of a program seeking potent and selective inhibitors of phosphodiesterase 1 (PDE1), lead compound <b>49</b> was discovered. Though <b>49</b> displays excellent potency toward PDE1 and selectivity against PDE4A (PDE1 and PDE4A <i>K</i><sub>i</sub> = 0.085 and 240 nM, respectively), it also exhibits poor stability in human liver microsomes (HLM CL<sub>int</sub> = 190 mL min<sup>â1</sup> kg<sup>â1</sup>). Fluorine scanning of the pyridyl ring of <b>49</b> was undertaken to probe impacts on potency and microsomal stability. Of the four monofluoro-analogues of <b>49</b> prepared and tested (<b>50</b>â<b>53</b>), positional analogue <b>53</b> displays the best balance of potency and stability in human liver microsomes (PDE1 <i>K</i><sub>i</sub> = 0.058 nM; HLM CL<sub>int</sub> = 80 mL min<sup>â1</sup> kg<sup>â1</sup>). From comparison of the PK and neuroPK profiles of <b>49</b> and <b>53</b> after single 10 mg/kg oral doses in mice, <b>53</b> possesses superior profiles (<b>49</b>, <i>C</i><sub>max,plasma</sub> = 48 ng/mL, <i>C</i><sub>max,brain</sub> = 28 ng/mL, brain/plasma ratio = 0.32; <b>53</b>, <i>C</i><sub>max,plasma</sub> = 490 ng/mL, <i>C</i><sub>max,brain</sub> = 390 ng/mL, brain/plasma ratio = 0.71). Compound <b>53</b> was advanced into clinical trials. The increased brain/plasma ratio of compound <b>53</b> is not surprising given the 21% chance of achieving â¥3-fold increases in brain uptake for CH group â CF group exchanges versus the 7% chance of observing â¥3-fold decreases, as suggested by the MMP analysis in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. An example of fluorine scanning to increase microsomal stability and improve PK and neuroPK profiles, which contributed to the identification of clinical candidate <b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of fluorine scanning to increase oral bioavailability and avoid hERG and CYP 1A2 inhibition is illustrated in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In a program searching for selective antagonists of the class A GPCR orexin-2 receptor (OX<sub>2</sub>R), lead compound <b>54</b> was identified. Though <b>54</b> displays good potency toward OX<sub>2</sub>R and selectivity against OX<sub>1</sub>R (OX<sub>2</sub>R <i>K</i><sub>i</sub> = 12 nM; OX<sub>1</sub>R <i>K</i><sub>i</sub> = 1600 nM), it also exhibits poor stability in rat liver microsomes and low oral bioavailability in rat (RLM ER = 0.79; <i>F</i> = 8.0%). Fluorine scanning of the phenyl ring of <b>54</b> was undertaken to probe impacts on potency and PK properties, including oral bioavailability. Of the four monofluoro-analogues of <b>54</b> prepared and tested (<b>55</b>â<b>58</b>), positional analogue <b>55</b> displays the best balance of potency toward OX<sub>2</sub>R and selectivity against OX<sub>1</sub>R (OX<sub>2</sub>R <i>K</i><sub>i</sub> = 10 nM; OX<sub>1</sub>R <i>K</i><sub>i</sub> = 800 nM), oral bioavailability in rat (<i>F</i> = 24%), and no inhibition of hERG or CYP 1A2 (hERG IC<sub>50</sub> > 10 Î¼M; CYP 1A2 IC<sub>50</sub> > 10 Î¼M). Compound <b>55</b> was advanced into clinical trials.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. An example of fluorine scanning to increase oral bioavailability and avoid hERG and CYP 1A2 inhibition, which contributed to the identification of clinical candidate <b>55</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Methyl Scanning Case Studies</h3><div class="NLM_p">An example of methyl scanning to improve potency and cellular permeability is shown in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As part of a program targeting potent inhibitors of human immunodeficiency virus type 1 (HIV-1), lead compound <b>59</b> was identified. Although <b>59</b> possesses good potency toward HIV-1 and excellent stability in human liver microsomes (HIV-1 EC<sub>50</sub> = 0.58 nM; HLM <i>t</i><sub>1/2</sub> > 100 min), it also exhibits poor cellular permeability (Caco-2 <i>P</i><sub>c</sub> < 15 nm/s). Methyl scanning of the pyrazole ring of <b>59</b> was undertaken to probe the impacts on potency and permeability. Of the three monomethyl-analogues of <b>59</b> prepared and tested (<b>60</b>â<b>62</b>), positional analogue <b>60</b> displays the most improved potency toward HIV-1 with a significant increase in cellular permeability (HIV-1 EC<sub>50</sub> = 0.050 nM; Caco-2 <i>P</i><sub>c</sub> = 260 nm/s), albeit with somewhat diminished stability in human liver microsomes (HLM %R at 10 min = 80). Compound <b>63</b> arose from CH group â N atom exchange and was shown to have good potency toward HIV-1, excellent stability in human liver microsomes, and favorable cellular permeability (HIV-1 EC<sub>50</sub> = 0.10 nM; HLM %R at 10 min = 98; Caco-2 <i>P</i><sub>c</sub> = 180 nm/s). Compound <b>63</b> was advanced into clinical trials; however, the azaindole NH group of <b>63</b> was subsequently linked to a phosphonooxymethyl prodrug moiety to improve pharmaceutical properties and oral bioavailability. The increased permeabilities observed for the CH group â CMe group exchanges are concordant with the greater likelihood of â¥3-fold increases suggested by the MMP analysis in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. An example of methyl scanning to improve potency and cellular permeability, which contributed to the identification of clinical candidate <b>63</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example of methyl scanning to improve potency and membrane permeability is summarized in <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In a program seeking potent agonists of peroxisome proliferator-activated receptor Î³ (PPARÎ³), lead compound <b>64</b> was identified. Compound <b>64</b> exhibits poor potency toward PPARÎ³ in a cell assay, which was proposed to be due to low lipophilicity and modest membrane permeability (PPARÎ³ EC<sub>50</sub>, <i>E</i><sub>max</sub> = 1100 nM, 74%; logÂ <i>D</i><sub>7.4</sub> = 0.40; PAMPA <i>P</i><sub>app</sub> = 2.2 Ã 10<sup>â6</sup> cm/s). Methyl scanning of the pyridine ring of <b>64</b> was undertaken to interrogate impacts on potency, lipophilicity, and membrane permeability. Of the four monomethyl-analogues of <b>64</b> prepared and tested (<b>65</b>â<b>68</b>), positional analogues <b>66</b> and <b>68</b> display the best balance of potency, lipophilicity, and permeability (<b>66</b>, PPARÎ³ EC<sub>50</sub>, <i>E</i><sub>max</sub> = 130 nM, 42%; log <i>D</i><sub>7.4</sub> = 0.90; PAMPA <i>P</i><sub>app</sub> = 4.8 Ã 10<sup>â6</sup> cm/s; <b>68</b>, PPARÎ³ EC<sub>50</sub>, <i>E</i><sub>max</sub> = 350 nM, 83%; logÂ <i>D</i><sub>7.4</sub> = 0.90; PAMPA <i>P</i><sub>app</sub> = 6.0 Ã 10<sup>â6</sup> cm/s). Combining favored positional analogues <b>66</b> and <b>68</b> afforded clinical candidate <b>69</b> (PPARÎ³ EC<sub>50</sub>, <i>E</i><sub>max</sub> = 41 nM, 68%; logÂ <i>D</i><sub>7.4</sub> = 1.4; PAMPA <i>P</i><sub>app</sub> = 13 Ã 10<sup>â6</sup> cm/s). The favorable additive SAR for potency, lipophilicity, and membrane permeability is notable and in line with observed probabilities from the MMP analyses (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The higher impacts of 2-methyl-analogues <b>68</b> and <b>69</b> on permeability are also in agreement with the significantly higher chance of 2-methyl-analogues compared to 3- or 4-methyl-analogues improving permeability â¥3-fold, as observed in the positional analogue analyses (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0006.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. An example of methyl scanning to improve potency and membrane permeability, which contributed to the identification of clinical candidate <b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of methyl scanning to reduce hERG inhibition is illustrated in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As part of a program targeting potent inhibitors of integrin receptor Î±<sub>v</sub>Î²<sub>6</sub> (Î±<sub>v</sub>Î²<sub>6</sub>), lead compound <b>70</b> was identified. Although <b>70</b> displays desirable potency toward Î±<sub>v</sub>Î²<sub>6</sub> (Î±<sub>v</sub>Î²<sub>6</sub> pIC<sub>50</sub> = 8.6), it also exhibits undesirable inhibition of hERG (hERG pIC<sub>50</sub> = 6.1). Methyl scanning of the pyrazole ring of <b>70</b> was investigated to probe impacts on potency and hERG activity. Of the three monomethyl-analogues of <b>70</b> prepared and tested (<b>71</b>â<b>73</b>), positional analogues <b>71</b> and <b>73</b> provided the desired potency toward Î±<sub>v</sub>Î²<sub>6</sub> as well as reduced inhibition of hERG (<b>71</b>, Î±<sub>v</sub>Î²<sub>6</sub> pIC<sub>50</sub> = 8.4, hERG pIC<sub>50</sub> = 5.0; <b>73</b>, Î±<sub>v</sub>Î²<sub>6</sub> pIC<sub>50</sub> = 8.8, hERG pIC<sub>50</sub> = 4.6). Combining favored positional analogues <b>71</b> and <b>73</b> gave clinical candidate <b>74</b> (Î±<sub>v</sub>Î²<sub>6</sub> pIC<sub>50</sub> = 8.4; hERG pIC<sub>50</sub> = 4.9). The observation of reduced hERG inhibition upon increased methyl substitution and greater lipophilicity is unexpected, both intuitively and based on the MMP analysis in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0007.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. An example of methyl scanning to reduce hERG inhibition, which contributed to the identification of clinical candidate <b>74</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Hydroxyl Scanning Case Studies</h3><div class="NLM_p">An example of hydroxyl scanning to improve potency and membrane permeability is shown in <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In a program pursuing inhibitors of phosphodiesterase 4D (PDE4D) and self-induced aggregation of Î²-amyloid 1â42 (AÎ²<sub>1â42</sub>), early lead compound <b>75</b> was identified. Compound <b>75</b> displays poor potency toward PDE4D and self-induced aggregation of AÎ²<sub>1â42</sub> (PDE4D2 IC<sub>50</sub> = 3.1 Î¼M; AÎ²<sub>1â42</sub> SIA = 19%), as well as limited membrane permeability (PAMPA <i>P</i><sub>e</sub> = 2.6 Ã 10<sup>â6</sup> cm/s). Hydroxyl scanning of the benzofuran ring system of <b>75</b> was initiated to interrogate impacts on potency and permeability. Of the three monohydroxy-analogues of <b>75</b> prepared and tested (<b>76</b>â<b>78</b>), positional analogue <b>78</b> exhibits improved potency toward PDE4D and self-induced aggregation of AÎ²<sub>1â42</sub> (PDE4D2 IC<sub>50</sub> = 0.96 nM; AÎ²<sub>1â42</sub> SIA = 59%), as well as improved membrane permeability (PAMPA <i>P</i><sub>e</sub> = 21 Ã 10<sup>â6</sup> cm/s). Compound <b>79</b> arose from Cl atom â I atom exchange on the quinoline ring system of <b>78</b> and was selected as an advanced lead compound (PDE4D2 IC<sub>50</sub> = 0.32 Î¼M; AÎ²<sub>1â42</sub> SIA = 68%; PAMPA <i>P</i><sub>e</sub> = 19 Ã 10<sup>â6</sup> cm/s). The finding of improved membrane permeability upon increased hydroxyl substitution is unexpected, although the preference for â¥3-fold decreases versus â¥3-fold increases in permeability observed in the MMP analysis in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> is not statistically significant.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0008.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. An example of hydroxyl scanning to improve potency and membrane permeability, which contributed to the identification of advanced lead <b>79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of hydroxyl scanning to reduce inhibition of hERG and CYP 2D6 is summarized in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> As part of a program seeking potent agonists of the Î´-opioid receptor (DOR), lead compound <b>80</b> was identified. Though <b>80</b> possesses good potency toward DOR (DOR EC<sub>50</sub> = 19 nM), it also displays undesirable inhibition of hERG and CYP 2D6 (hERG IC<sub>50</sub> = 7.9 Î¼M; CYP 2D6 IC<sub>50</sub> = 4.3 Î¼M). Hydroxyl scanning of <b>80</b> was undertaken to probe impacts on potency toward DOR and inhibition of hERG and CYP 2D6. Of the six monohydroxy-analogues of <b>80</b> prepared and tested (<b>81</b>â<b>86</b>), positional analogues <b>81</b> and <b>85</b> exhibit a favorable balance of potency toward DOR and decreased inhibition of hERG and CYP 2D6 (<b>81</b>, DOR EC<sub>50</sub> = 20 nM, hERG IC<sub>50</sub> = 78 Î¼M, CYP 2D6 IC<sub>50</sub> = NR; <b>85</b>, DOR EC<sub>50</sub> = 94 nM, hERG IC<sub>50</sub> = 57 Î¼M, CYP 2D6 IC<sub>50</sub> = 43 Î¼M). Compounds <b>81</b> and <b>85</b> were advanced into clinical trials. The 10-fold decrease in CYP 2D6 inhibition observed in going from <b>80</b> to <b>85</b> is in line with the MMP analysis in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, which suggests a 27% chance of decreasing CYP inhibition â¥3-fold versus a 10% chance of increasing CYP inhibition â¥3-fold for CH group â COH group exchanges.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0009.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. An example of hydroxyl scanning to reduce inhibition of hERG and CYP 2D6, which contributed to the identification of clinical candidates <b>81</b> and <b>85</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this Perspective, positional analogue scanning has been shown to be an effective strategy for multiparameter optimization in drug design, whereby substantial improvements in a variety of pharmacological parameters can be achieved with minimal structure modifications. When rational drug design is not sufficiently supported by structural information on the target and key antitargets and predictive models for key optimization parameters are unavailable, positional analogue scanning allows for the systematic exploration of alternative scaffolds and the preparation of focused libraries in the pursuit of multiparameter optimization. Positional analogue scanning can be considered when a high-value hit has been identified and systematic hit expansion is desired. Furthermore, if an advanced lead has been obtained and other, less synthesis-intensive multiparameter optimization approaches have been exhausted, positional analogue scanning can provide an attractive optimization strategy. As Poongavanam, Liu, Zhan, and coauthors stated in a recent Perspective on strategic advances in medicinal chemistry, âno single strategy is likely to be a universal panaceaâ; for context, a list of medicinal chemistry strategies including their general merits and drawbacks is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S9)</a>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">For high-value hits or early lead compounds, when the primary goals are to identify issues and assess feasibility for multiparameter optimization, full positional analogue scanning using diverse structure modifications is recommended (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). One may consider beginning with privileged structure modifications (exchange of CH groups with N atoms or CF, CMe, or COH groups) and then extending to other common structure modifications as the SAR suggests (e.g., exchange of CH groups with CCN, CCl, CCF<sub>3</sub>, or COMe groups). For advanced lead compounds, when the primary goals are to address issues and optimize profiles, targeted positional analogue scanning on selected rings using specific structure modifications is recommended (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). What form of positional analogue scanning to use and what extent of pharmacological profiling to perform depend on the optimization challenges encountered or anticipated. For example, to improve potency, solubility, and CYP inhibition, one may consider nitrogen or hydroxyl scanning; to improve potency and permeability, one may consider fluorine or methyl scanning. Sequential positional analogue scanning may be considered to seek the potentially additive benefits of each structure modification (e.g., nitrogen scanning followed by fluorine scanning, etc.). If no meaningful improvements in pharmacological profiles have been realized by positional analogue scanning using the four privileged structure modifications, then other optimization approaches may be considered.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0010.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. General guidance for leveraging positional analogue scanning for multiparameter optimization in drug design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Matched molecular pair and positional analogue analyses performed on ChEMBL data provide probabilities for observing significant impacts on a variety of pharmacological parameters upon positional analogue scanning (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The probability to observe these impacts varies across pharmacological parameters, structure modifications, and positional analogues. In many cases, meaningful improvements in targeted pharmacological parameters can be achieved, often in line with probabilistic expectations. However, some of the case studies also demonstrate that impacts can be serendipitous. Importantly, the impacts evoked by a single positional analogue across multiple pharmacological parameters could not be reasonably predicted here because covariate pharmacological parameter dependencies were not elucidated in the MMP analyses. It is also important to note that the impacts on multiple parameters that arise from specific positional analogues are often insular and uncorrelated, making it difficult to assess whether maximal progress has been made toward the desired goal and when to stop; hence, full positional analogue scanning is recommended whenever feasible.</div><div class="NLM_p last">Although the impacts of positional analogue scanning generally cannot be predicted with high confidence for each individual case, the modern need in chemical biology and drug discovery for rapid and simultaneous multiparameter optimization justifies the synthesis investment that may be required for positional analogue scanning. To this end, it is important to render positional analogue scanning more efficient by the development of more synthetic methods that enable all positional analogues to be generated simultaneously or in parallel by late-stage functionalization or by an increased variety of commercially available building blocks that allow expedient synthetic routes for <i>de novo</i> syntheses of all positional analogues. Finally, it is hoped that the MMP analyses and case studies of how positional analogue scanning has been leveraged to overcome multiparameter optimization challenges for the identification of advanced leads, preclinical candidates, and clinical candidates will serve to inspire and guide the effective use of this strategy in drug design.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02092" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02092?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02092</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Statistics for MMPs from CH group â N atom or CF, CMe, or COH group exchanges, property increase definitions, diversity of assay data for MMPs from CH group â N atom exchanges, statistics for ring diversity among unique MMPs in ChEMBL24 from CH group â N atom exchanges, relative positional analogue designation examples, medicinal chemistry strategies, target distribution in the ChEMBL24 database, distribution of fold-increases and fold-decreases in rat clearance for 4-fluoro analogues from CH group â CF group exchanges, and distribution of functional activities for all CH group â N atom exchanges and for a subset of antiproliferative assays (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf">jm9b02092_si_001.pdf (319.83 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02092" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lewis D. Pennington</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8337-1891" title="Orcid link">http://orcid.org/0000-0001-8337-1891</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cfa3aab8a6bce1bfaaa1a1a6a1a8bba0a18faea3a4aabda2aabce1aca0a2"><span class="__cf_email__" data-cfemail="a5c9c0d2ccd68bd5c0cbcbcccbc2d1cacbe5c4c9cec0d7c8c0d68bc6cac8">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingo Muegge</span> - <span class="hlFld-Affiliation affiliation">Modeling and Informatics, , and , Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3294-1852" title="Orcid link">http://orcid.org/0000-0003-3294-1852</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dfb6b1b8b0f1b2aab8b8ba9fbeb3b4baadb2baacf1bcb0b2"><span class="__cf_email__" data-cfemail="a8c1c6cfc786c5ddcfcfcde8c9c4c3cddac5cddb86cbc7c5">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian M. Aquila</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Younggi Choi</span> - <span class="hlFld-Affiliation affiliation">Synthetic Chemistry, , and , Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roman A. Valiulin</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Alkermes, Inc., 852 Winter Street, Waltham, Massachusetts 02451-1420, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Lewis D. Pennington</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=BIO-d7e2286-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lewis D. Pennington</b> is a Research Fellow in Medicinal Chemistry at Alkermes in Waltham, Massachusetts. His research interests include drug discovery and defining strategies and tactics for multiparameter optimization in drug design. He previously served a variety of roles as a synthetic and medicinal chemist at Amgen in Thousand Oaks, California, Array BioPharma in Longmont, Colorado, and Eli Lilly & Co. in Indianapolis, Indiana. He earned a B.S. in Chemistry (with Highest Honors in Chemistry) under the guidance of Professor Masato Koreeda at the University of Michigan in Ann Arbor, Michigan, and a Ph.D. in Chemistry under the mentorship of Professor Larry Overman at the University of California in Irvine, California.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Brian M. Aquila</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=BIO-d7e2291-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Brian M. Aquila</b> is an Executive Director and Head of Medicinal Chemistry at Alkermes in Waltham, Massachusetts. His research interests include drug discovery and designing molecules through harmonization of computational, medicinal, and synthetic chemistry. He previously served a variety of roles from bench to leadership in medicinal chemistry at Sepracor in Marlborough, Massachusetts, and AstraZeneca in Waltham, Massachusetts. He earned a B.S. and M.S. in Chemistry under the guidance of Professor Nick Baumgartner at John Carroll University in University Heights, Ohio, and a Ph.D. in Chemistry under the direction of Professor Matthew Platz at The Ohio State University in Columbus, Ohio. He completed postdoctoral studies with Professor Dale Boger at Scripps Research Institute in La Jolla, California.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Younggi Choi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=BIO-d7e2296-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Younggi Choi</b> is a Research Fellow in Synthetic Chemistry at Alkermes in Waltham, Massachusetts. His research interests include drug discovery and collaborations with academic groups and process chemistry teams to expand the synthesis toolbox for medicinal chemistry. He previously served a variety of roles in the High Throughput Chemistry and Medicinal Chemistry groups at Boehringer Ingelheim in Ridgefield, Connecticut, and the DNA Encoded Libraries group at Forma Therapeutics in Branford, Connecticut. He earned a Ph.D. in Chemistry under the mentorship of Professor James White at Oregon State University in Corvallis, Oregon, and completed postdoctoral research with Professor Dale Boger at Scripps Research Institute in La Jolla, California.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Roman A. Valiulin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=BIO-d7e2301-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Roman A. Valiulin</b> is a Senior Scientist in Medicinal Chemistry at Alkermes in Waltham, Massachusetts. His research interests include drug discovery, organic synthesis, photochemistry, structure elucidation, and teaching. He previously supported synthetic efforts emphasizing physical organic chemistry and NMR techniques in synthetic chemistry and contributed to the Formulation Development and Pharmaceutical Sciences groups at Alkermes. He earned a M.S. in Chemistry at Lomonosov Moscow State University in Moscow, Russia, and a Ph.D. in Chemistry under the supervision of Professor Andrei Kutateladze at the University of Denver in Denver, Colorado. He completed postdoctoral studies with Professor K. C. Nicolaou at Scripps Research Institute in La Jolla, California, and with Professor M. G. Finn at the Georgia Institute of Technology in Atlanta, Georgia.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Ingo Muegge</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=BIO-d7e2306-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ingo Muegge</b> is a Senior Research Fellow and Head of Modeling & Informatics at Alkermes in Waltham, Massachusetts. His research interests include drug discovery, in silico drug design techniques, predictive modeling, and cheminformatics. He previously served a variety of leadership roles in computational chemistry at Boehringer Ingelheim in Ridgefield, Connecticut, and Bayer in West Haven, Connecticut. He earned a Diploma in Physics at Humboldt University in Berlin, Germany, and a Doctorate in Computational Chemistry at Free University in Berlin, Germany. He completed postdoctoral studies at the University of Southern California in Los Angeles, California, and Abbott Laboratories in Abbott Park, Illinois.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Alkermes colleagues Markus Haeberlein, Franco Lombardo, Michael Hale, JÃ¶rg Bentzien, Michael Hewitt, Nathan Fuller, Brian Raymer, Hoan Huynh, James Woods, and Jonathan Lehmann for helpful suggestions during review of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">p<i>K</i><sub>a</sub></td><td class="NLM_def"><p class="first last">negative logarithm of the acid dissociation constant</p></td></tr><tr><td class="NLM_term">logÂ <i>P</i></td><td class="NLM_def"><p class="first last">logarithm of the octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">calculated logÂ <i>P</i></p></td></tr><tr><td class="NLM_term">logÂ <i>D</i><sub>pH</sub></td><td class="NLM_def"><p class="first last">logarithm of the octanol/water distribution coefficient at a specified pH</p></td></tr><tr><td class="NLM_term"><i>S</i><sub>H2O</sub></td><td class="NLM_def"><p class="first last">solubility in water</p></td></tr><tr><td class="NLM_term"><i>S</i><sub>SBF</sub></td><td class="NLM_def"><p class="first last">solubility in a simulated biological fluid</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio or extraction ratio</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">not reported or not reportable</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>max</sub></td><td class="NLM_def"><p class="first last">percent maximal activation versus basal or a reference standard</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">LLC-PK1</td><td class="NLM_def"><p class="first last">porcine proximal tubule cells</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>u,plasma</sub></td><td class="NLM_def"><p class="first last">unbound compound concentration in plasma</p></td></tr><tr><td class="NLM_term">PLC</td><td class="NLM_def"><p class="first last">peripheral lymphocyte count</p></td></tr><tr><td class="NLM_term">POC</td><td class="NLM_def"><p class="first last">percent-of-control</p></td></tr><tr><td class="NLM_term"><i>S</i><sub>FaSSIF</sub></td><td class="NLM_def"><p class="first last">solubility in fasted-state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matched molecular pair</p></td></tr><tr><td class="NLM_term">FI</td><td class="NLM_def"><p class="first last">fold increase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>maxâ¯plasma</sub></td><td class="NLM_def"><p class="first last">maximal compound concentration in plasma</p></td></tr><tr><td class="NLM_term">Caco-2</td><td class="NLM_def"><p class="first last">Caucasian colon adenocarcinoma cells</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub>, <i>P</i><sub>c</sub>, or <i>P</i><sub>e</sub></td><td class="NLM_def"><p class="first last">membrane permeability</p></td></tr><tr><td class="NLM_term">%R</td><td class="NLM_def"><p class="first last">percent remaining</p></td></tr><tr><td class="NLM_term">SIA</td><td class="NLM_def"><p class="first last">self-induced aggregation</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E. R.</span></span> <span> </span><span class="NLM_article-title">The impact of chemical probes in drug discovery: a pharmaceutical industry perspective</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">10</span>â <span class="NLM_lpage">16</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2015.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.chembiol.2015.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=26933732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=10-16&author=R.+M.+Garbaccioauthor=E.+R.+Parmee&title=The+impact+of+chemical+probes+in+drug+discovery%3A+a+pharmaceutical+industry+perspective&doi=10.1016%2Fj.chembiol.2015.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective</span></div><div class="casAuthors">Garbaccio, Robert M.; Parmee, Emma R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-17</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Chem. probes represent an important component of both academic and pharmaceutical drug discovery research.  As a complement to prior reviews that have defined this scientific field, we aim to provide an industry perspective on the value of having high-quality chem. probes throughout the course of preclin. research.  By studying examples from the internal Merck pipeline, we recognize that these probes require significant collaborative investment to realize their potential impact in clarifying the tractability and translation of a given therapeutic target.  This perspective concludes with recommendations for chem. probe discovery aimed toward maximizing their potential to identify targets that result in the successful delivery of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwf2z0pWI1rVg90H21EOLACvtfcHk0lh8hctfPQLyRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqsLk%253D&md5=7cb4cb2533a5f52281d34fa51c684105</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DThe%2520impact%2520of%2520chemical%2520probes%2520in%2520drug%2520discovery%253A%2520a%2520pharmaceutical%2520industry%2520perspective%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D10%26epage%3D16%26doi%3D10.1016%2Fj.chembiol.2015.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâHagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SundstrÃ¶m, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%99Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0lh8hctfPQLyRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug design: an update on recent applications of efficiency metrics, strategies for replacing problematic elements, and compounds in nontraditional drug space</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">564</span>â <span class="NLM_lpage">616</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrestox.6b00043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=564-616&author=N.+A.+Meanwell&title=Improving+drug+design%3A+an+update+on+recent+applications+of+efficiency+metrics%2C+strategies+for+replacing+problematic+elements%2C+and+compounds+in+nontraditional+drug+space&doi=10.1021%2Facs.chemrestox.6b00043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-616</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery and development is a complex and lengthy enterprise that suffers from high rates of candidate attrition at all stages of the process.  The phys., biol., and toxicol. properties of a drug candidate are inextricably linked to its structure, and once a mol. has been synthesized, all subsequent studies along the development path are focused only on assessing and understanding its properties in greater detail.  Unfortunately, a full prediction of the biol. properties of a mol. from an anal. of its 2- or 3-dimensional structure is currently beyond our expertise.  This backdrop mandates that considerable care be taken at the design stage if a mol. is to be successful in testing a mechanistic concept underlying a disease process and to progress into late stage clin. trials and, ultimately, marketing approval.  While there are multiple potential causes of candidate attrition, an introspective anal. of drug design practices over the past decade has focused attention on the perception that contemporary mols. are unnecessarily obese, burdened by high mol. wt. and excessive lipophilicity.  This practice is believed to have its roots in the singular pursuit of enhancing potency during lead optimization rather than adopting a more holistic approach to drug design that gives broader consideration to how structural features affect developability properties.  In an effort to provide the medicinal chem. community with practical guideposts to enhancing compd. quality in the drug design phase and which can readily be applied, a series of efficiency indexes have been proposed that attempt to define aspects of compd. quality in the context of a series of physicochem. parameters.  Of these metrics, lipophilic ligand efficiency (LLE or LipE), which provides an index of the dependence of the potency of a mol. on its intrinsic lipophilicity, has been characterized as the most robust metric that has potential for broad-based application.  In this review, after describing the background literature behind the derivation of efficiency metrics and approaches to assessing compd. aesthetics, synopses of some recent practical application in lead optimization campaigns are presented.  However, mols. that fall into space beyond that assocd. with traditional drug-like properties are an important part of the current and future landscape, exemplified by the summary of direct acting hepatitis C virus NS3 and NS5A inhibitors that have transformed clin. therapy for this chronic disease.  While drug development in nontraditional drug-like space is more challenging and the rules for compd. quality will be different with much still to be understood, careful and disciplined drug design practices will be an essential element of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotJb_EhGoW7Vg90H21EOLACvtfcHk0libv1UpnlwGrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D&md5=aef48399fb698b5f958c1cc11e1d25aa</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520design%253A%2520an%2520update%2520on%2520recent%2520applications%2520of%2520efficiency%2520metrics%252C%2520strategies%2520for%2520replacing%2520problematic%2520elements%252C%2520and%2520compounds%2520in%2520nontraditional%2520drug%2520space%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2016%26volume%3D29%26spage%3D564%26epage%3D616%26doi%3D10.1021%2Facs.chemrestox.6b00043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abou-Gharbia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childers, W. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of innovative therapeutics: todayâs realities and tomorrowâs vision. 2. Pharmaâs challenges and their commitment to innovation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5525</span>â <span class="NLM_lpage">5553</span>, <span class="refDoi">Â DOI: 10.1021/jm401564r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401564r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5525-5553&author=M.+Abou-Gharbiaauthor=W.+E.+Childers&title=Discovery+of+innovative+therapeutics%3A+today%E2%80%99s+realities+and+tomorrow%E2%80%99s+vision.+2.+Pharma%E2%80%99s+challenges+and+their+commitment+to+innovation&doi=10.1021%2Fjm401564r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision. 2. Pharma's Challenges and Their Commitment to Innovation</span></div><div class="casAuthors">Abou-Gharbia, Magid; Childers, Wayne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is facing enormous challenges, including reduced efficiency, stagnant success rate, patent expirations for key drugs, fierce price competition from generics, high regulatory hurdles, and the industry's perceived tarnished image.  Pharma has responded by embarking on a range of initiatives.  Other sectors, including NIH, have also responded.  Academic drug discovery groups have appeared to support the transition of innovative academic discoveries and ideas into attractive drug discovery opportunities.  Part 1 of this two-part series discussed the criticisms that have been leveled at the pharmaceutical industry over the past 3 decades and summarized the supporting data for and against these criticisms.  This second installment will focus on the current challenges facing the pharmaceutical industry and Pharma's responses, focusing on the industry's changing perspective and new business models for coping with the loss of talent and declining clin. pipelines as well as presenting some examples of recent drug discovery successes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4lpJv0KTwLVg90H21EOLACvtfcHk0libv1UpnlwGrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D&md5=81598458e7db3879f2e5bb67d5b40eb3</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fjm401564r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401564r%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26atitle%3DDiscovery%2520of%2520innovative%2520therapeutics%253A%2520today%25E2%2580%2599s%2520realities%2520and%2520tomorrow%25E2%2580%2599s%2520vision.%25202.%2520Pharma%25E2%2580%2599s%2520challenges%2520and%2520their%2520commitment%2520to%2520innovation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5525%26epage%3D5553%26doi%3D10.1021%2Fjm401564r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mytelka, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunwiddie, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persinger, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munos, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindborg, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schacht, A. L.</span></span> <span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industryâs grand challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">203</span>â <span class="NLM_lpage">214</span>, <span class="refDoi">Â DOI: 10.1038/nrd3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge&doi=10.1038%2Fnrd3078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0libv1UpnlwGrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214%26doi%3D10.1038%2Fnrd3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D. R.</span></span> <span> </span><span class="NLM_article-title">Statistical analysis of the effects of common chemical substituents on ligand potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">564</span>, <span class="refDoi">Â DOI: 10.1021/jm070838y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070838y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ejtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=553-564&author=P.+J.+Hajdukauthor=D.+R.+Sauer&title=Statistical+analysis+of+the+effects+of+common+chemical+substituents+on+ligand+potency&doi=10.1021%2Fjm070838y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Statistical Analysis of the Effects of Common Chemical Substituents on Ligand Potency</span></div><div class="casAuthors">Hajduk, Philip J.; Sauer, Daryl R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The results of a statistical anal. of more than 84000 compds. from lead optimization programs against 30 different protein targets is presented, with a focus on the effects that different chem. substituents have on compd. potency.  It is obsd. that the potency changes induced by most chem. groups follows a nearly normal distribution centered near zero (i.e., no effect on potency).  However, the widths of the distributions vary significantly between different substituents, and these effects cannot be rationalized by simple physicochem. parameters.  In addn., certain substituents consistently bias the distribution toward higher or lower potency, suggesting the existence of preferred and nonpreferred chem. groups for lead optimization.  The implications of these results for understanding protein-ligand recognition and for enhancing the efficiency and speed of lead optimization will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9sbNYA_Mzl7Vg90H21EOLACvtfcHk0lj6qSJafwCdlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ejtQ%253D%253D&md5=396d02789aece9be31fe3508fbabca7d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm070838y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070838y%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DSauer%26aufirst%3DD.%2BR.%26atitle%3DStatistical%2520analysis%2520of%2520the%2520effects%2520of%2520common%2520chemical%2520substituents%2520on%2520ligand%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D553%26epage%3D564%26doi%3D10.1021%2Fjm070838y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Leveraging the Necessary Nitrogen Atom in Chemical Biology and Drug Discovery</span>. Presented at the 258th National Meeting of the American Chemical Society, San Diego Convention Center, San Diego, CA, August 27, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=L.+D.+Pennington&title=Leveraging+the+Necessary+Nitrogen+Atom+in+Chemical+Biology+and+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DLeveraging%2520the%2520Necessary%2520Nitrogen%2520Atom%2520in%2520Chemical%2520Biology%2520and%2520Drug%2520Discovery%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3552</span>â <span class="NLM_lpage">3579</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+necessary+nitrogen+atom%3A+a+versatile+high-impact+design+element+for+multiparameter+optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein â¥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0lj6qSJafwCdlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520necessary%2520nitrogen%2520atom%253A%2520a%2520versatile%2520high-impact%2520design%2520element%2520for%2520multiparameter%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">The difference a single atom can make: synthesis and design at the chemistryâbiology interface</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">11961</span>â <span class="NLM_lpage">11980</span>, <span class="refDoi">Â DOI: 10.1021/acs.joc.7b02088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b02088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGhs7%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=11961-11980&author=D.+L.+Boger&title=The+difference+a+single+atom+can+make%3A+synthesis+and+design+at+the+chemistry%E2%80%93biology+interface&doi=10.1021%2Facs.joc.7b02088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface</span></div><div class="casAuthors">Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11961-11980</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A Perspective of work in our lab. on the examn. of biol. active compds., esp. natural products, is presented.  In the context of individual programs and along with a summary of our work, selected cases are presented that illustrate the impact single atom changes can have on the biol. properties of the compds.  The examples were chosen to highlight single heavy atom changes that improve activity, rather than those that involve informative alterations that reduce or abolish activity.  The examples were also chosen to illustrate that the impact of such single-atom changes can originate from steric, electronic, conformational, or H-bonding effects, from changes in functional reactivity, from fundamental intermol. interactions with a biol. target, from introduction of a new or altered functionalization site, or from features as simple as improvements in stability or phys. properties.  Nearly all the examples highlighted represent not only unusual instances of productive deep-seated natural product modifications and were introduced through total synthesis but are also remarkable in that they are derived from only a single heavy atom change in the structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX_eF-VHK7ZbVg90H21EOLACvtfcHk0lj6qSJafwCdlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGhs7%252FE&md5=1ed0b2ee9315842d41e6efec8f97ed2c</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b02088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b02088%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DThe%2520difference%2520a%2520single%2520atom%2520can%2520make%253A%2520synthesis%2520and%2520design%2520at%2520the%2520chemistry%25E2%2580%2593biology%2520interface%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D11961%26epage%3D11980%26doi%3D10.1021%2Facs.joc.7b02088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">SchÃ¶nherr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Profound methyl effects in drug discovery and a call for new CâH methylation reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12256</span>â <span class="NLM_lpage">12267</span>, <span class="refDoi">Â DOI: 10.1002/anie.201303207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201303207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12256-12267&author=H.+Sch%C3%B6nherrauthor=T.+Cernak&title=Profound+methyl+effects+in+drug+discovery+and+a+call+for+new+C%E2%80%93H+methylation+reactions&doi=10.1002%2Fanie.201303207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Profound methyl effects in drug discovery and a call for new C-H methylation reactions</span></div><div class="casAuthors">Schonherr Heike; Cernak Tim</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12256-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The methyl group is one of the most commonly occurring carbon fragments in small-molecule drugs.  This simplest alkyl fragment appears in more than 67 % of the top-selling drugs of 2011 and can modulate both the biological and physical properties of a molecule.  This Review focuses on so-called magic methyl effects on binding potency, where the seemingly mundane change of C H to C Me improves the IC50  value of a drug candidate more than 100-fold.  This discussion is followed by a survey of recent advances in synthetic chemistry that allow the direct methylation of C(sp(2) ) H and C(sp(3) ) H bonds.  It is our hope that the relevance of the meager methyl group to drug discovery as presented herein will inspire reports on new C H methylation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyoLZDDgvsMh0LsK7uFuY7fW6udTcc2eYsYKy0oPjwubntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D&md5=ef08f80e55b2c530b49e4306da024902</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303207%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DH.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DProfound%2520methyl%2520effects%2520in%2520drug%2520discovery%2520and%2520a%2520call%2520for%2520new%2520C%25E2%2580%2593H%2520methylation%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12256%26epage%3D12267%26doi%3D10.1002%2Fanie.201303207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Methyl effects on proteinâligand binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4489</span>â <span class="NLM_lpage">4500</span>, <span class="refDoi">Â DOI: 10.1021/jm3003697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4489-4500&author=C.+S.+Leungauthor=S.+S.+F.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Methyl+effects+on+protein%E2%80%93ligand+binding&doi=10.1021%2Fjm3003697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Effects on Protein-Ligand Binding</span></div><div class="casAuthors">Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4489-4500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of addn. of a Me group to a lead compd. on biol. activity are examd.  A literature anal. of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event.  Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water mols., and changes in conformational energetics.  The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calcns. for Me replacements in inhibitor series for p38Î± MAP kinase, ACK1, PTP1B, and thrombin.  Me substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change.  The greatest improvements in activity arise from coupling the conformational gain with the burial of the Me group in a hydrophobic region of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0Czyhgy6KbVg90H21EOLACvtfcHk0ljyz965UoFdtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D&md5=0ea58d9c1bf845d383931b6a017f9b37</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm3003697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003697%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BS.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DMethyl%2520effects%2520on%2520protein%25E2%2580%2593ligand%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4489%26epage%3D4500%26doi%3D10.1021%2Fjm3003697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5822</span>â <span class="NLM_lpage">5880</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5822-5880&author=N.+A.+Meanwell&title=Fluorine+and+fluorinated+motifs+in+the+design+and+application+of+bioisosteres+for+drug+design&doi=10.1021%2Facs.jmedchem.7b01788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5822-5880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the Me group while also acting as a functional mimetic of the carbonyl, carbinol, andnitrile moieties.  In this context, fluorine substitution can influence the potency, conformation, metab., membrane permeability, and P-gp recognition of a mol. and temper inhibition of the hERG channel by basic amines.  However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated mol. construction that broadens biol. mimesis.  In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a mol. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoQvY950L3LVg90H21EOLACvtfcHk0ljyz965UoFdtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D&md5=2d0ce3326c7ff932da8d7d26972ced14</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DFluorine%2520and%2520fluorinated%2520motifs%2520in%2520the%2520design%2520and%2520application%2520of%2520bioisosteres%2520for%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5822%26epage%3D5880%26doi%3D10.1021%2Facs.jmedchem.7b01788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span> <span> </span><span class="NLM_article-title">A survey of the role of nitrile groups in proteinâligand interactions</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2713</span>â <span class="NLM_lpage">2728</span>, <span class="refDoi">Â DOI: 10.4155/fmc-2018-0252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.4155%2Ffmc-2018-0252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30518255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWrt7nE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=2713-2728&author=Y.+Wangauthor=Y.+Duauthor=N.+Huang&title=A+survey+of+the+role+of+nitrile+groups+in+protein%E2%80%93ligand+interactions&doi=10.4155%2Ffmc-2018-0252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">A survey of the role of nitrile groups in protein-ligand interactions</span></div><div class="casAuthors">Wang, Yuanxun; Du, Yunfei; Huang, Niu</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2713-2728</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In classical medicinal chem., nitrile groups were commonly considered as bioisosteres of carbonyl, hydroxyl and carboxyl groups, as well as halogen atoms.  However, there is a lack of in-depth understanding about the structural and energetic characteristics of nitrile groups in protein-ligand interactions.  Here, we have surveyed the Protein Data Bank and ChEMBL databases with the goal of characterizing such protein-ligand interactions for nitrile-contg. compds.  We discuss the versatile roles of nitrile groups in improving binding affinities, and give special attention to examples of displacing and mimicking binding-site waters by nitrile groups.  We expect that this review article will further inspire medicinal chemists to exploit nitrile groups rationally in structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWBvAO21DSLVg90H21EOLACvtfcHk0ljyz965UoFdtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWrt7nE&md5=0317a874050467a6f60b5134aa909d8f</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0252%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DN.%26atitle%3DA%2520survey%2520of%2520the%2520role%2520of%2520nitrile%2520groups%2520in%2520protein%25E2%2580%2593ligand%2520interactions%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D2713%26epage%3D2728%26doi%3D10.4155%2Ffmc-2018-0252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sager, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">Hydroxyl groups in synthetic and natural-product-derived therapeutics: a perspective on a common functional group</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8915</span>â <span class="NLM_lpage">8930</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOjsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8915-8930&author=J.+Cramerauthor=C.+P.+Sagerauthor=B.+Ernst&title=Hydroxyl+groups+in+synthetic+and+natural-product-derived+therapeutics%3A+a+perspective+on+a+common+functional+group&doi=10.1021%2Facs.jmedchem.9b00179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group</span></div><div class="casAuthors">Cramer, Jonathan; Sager, Christoph P.; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8915-8930</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  By forming extended hydrogen bond networks, the contribution of hydroxyl groups to affinity can reach several orders of magnitude.  However, because of the high directionality of their interactions, a maximal affinity gain can only be achieved when the ligand scaffold allows a perfect spatial fit with the binding site.  In contrast to the broad potential of hydroxyl groups for mol. recognition is their exceptionally high desolvation penalty, which can equally reduce binding affinity.  As a consequence, alcs. are rarely present in synthetic drugs, but predominantly found in therapeutics derived directly or inspired from natural products, which were shaped under evolutionary pressure.  In this perspective, advantages as well as drawbacks influencing the use of OH groups in medicinal chem. are discussed and illustrated with four exemplary case studies.  Addnl., guidelines for drug design are derived from common features found in existing therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Ay8IcfLbF7Vg90H21EOLACvtfcHk0ljqOtTJuVWt9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOjsLY%253D&md5=5fff184a72d160ae211d4bc3d8dfba47</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00179%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DJ.%26aulast%3DSager%26aufirst%3DC.%2BP.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DHydroxyl%2520groups%2520in%2520synthetic%2520and%2520natural-product-derived%2520therapeutics%253A%2520a%2520perspective%2520on%2520a%2520common%2520functional%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8915%26epage%3D8930%26doi%3D10.1021%2Facs.jmedchem.9b00179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency as an important metric in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6401</span>â <span class="NLM_lpage">6420</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6401-6420&author=T.+W.+Johnsonauthor=R.+A.+Gallegoauthor=M.+P.+Edwards&title=Lipophilic+efficiency+as+an+important+metric+in+drug+design&doi=10.1021%2Facs.jmedchem.8b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic Efficiency as an Important Metric in Drug Design</span></div><div class="casAuthors">Johnson, Ted W.; Gallego, Rebecca A.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6401-6420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chem. lead optimization programs.  In this perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chem. lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, esp. when guided by physiochem. property-based optimization (PPBO).  Also highlighted are examples of small structural modifications such as addn. of single atoms, small functional groups, and cyclizations that produce large increases in LipE.  Understanding the factors that may contribute to LipE changes through anal. of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed.  Herein we advocate for use of LipE anal. coupled with PPBO and SBDD as an efficient mechanism for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ8DOcOj6GrVg90H21EOLACvtfcHk0ljqOtTJuVWt9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D&md5=29f38880914fa75c33be3a640ace4309</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DGallego%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DLipophilic%2520efficiency%2520as%2520an%2520important%2520metric%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6401%26epage%3D6420%26doi%3D10.1021%2Facs.jmedchem.8b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the efficiency and physicochemical trajectories of successful optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6421</span>â <span class="NLM_lpage">6467</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6421-6467&author=R.+J.+Youngauthor=P.+D.+Leeson&title=Mapping+the+efficiency+and+physicochemical+trajectories+of+successful+optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></div><div class="casAuthors">Young, Robert J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6421-6467</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The practices and tactics employed in successful optimizations are examd., judged from the trajectories of ligand efficiency and property evolution.  A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technol.) and types of mols., including those beyond the rule of five.  The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable.  What is clear is that while targets are different, successful mols. are almost invariably among the most efficient for their target, even at the extremes.  Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQtcLKSk7q7Vg90H21EOLACvtfcHk0ljqOtTJuVWt9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D&md5=f040ef02d161e070bb5021fde1585e66</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMapping%2520the%2520efficiency%2520and%2520physicochemical%2520trajectories%2520of%2520successful%2520optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6421%26epage%3D6467%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Practical application of ligand efficiency metrics in lead optimization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3006</span>â <span class="NLM_lpage">3015</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2018.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmc.2018.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29655612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVent7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3006-3015&author=J.+S.+Scottauthor=M.+J.+Waring&title=Practical+application+of+ligand+efficiency+metrics+in+lead+optimization&doi=10.1016%2Fj.bmc.2018.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Practical application of ligand efficiency metrics in lead optimisation</span></div><div class="casAuthors">Scott, James S.; Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3006-3015</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The use of composite metrics that normalize biol. potency values in relation to markers of physicochem. properties, such as size or lipophilicity, has gained a significant amt. of traction with many medicinal chemists in recent years.  However, there is no consensus on best practice in the area and their application has attracted some criticism.  Here we present our approach to their application in lead optimization projects, provide an objective discussion of the principles we consider important and illustrate how our use of lipophilic ligand efficiency enabled the progression of a no. of our successful drug discovery projects.  We derive, from this and some recent literature highlights, a set of heuristic guidelines for lipophilicity based optimization that we believe are generally applicable across chem. series and protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNrcXUmwxG8rVg90H21EOLACvtfcHk0ljqOtTJuVWt9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVent7g%253D&md5=50bba76316f6f2ec3c89e06f6717c388</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DPractical%2520application%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3006%26epage%3D3015%26doi%3D10.1016%2Fj.bmc.2018.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, Y. C.</span></span> <i>Quantitative Drug Design: A Critical Introduction</i>; <span class="NLM_publisher-name">CRC Press/Taylor & Francis Group</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1201%2F9781420071009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+C.+Martin&title=Quantitative+Drug+Design%3A+A+Critical+Introduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1201%2F9781420071009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420071009%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DY.%2BC.%26btitle%3DQuantitative%2520Drug%2520Design%253A%2520A%2520Critical%2520Introduction%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%2520Group%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">The many roles of computation in drug discovery</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1813</span>â <span class="NLM_lpage">1818</span>, <span class="refDoi">Â DOI: 10.1126/science.1096361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1126%2Fscience.1096361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=15031495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFehu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1813-1818&author=W.+L.+Jorgensen&title=The+many+roles+of+computation+in+drug+discovery&doi=10.1126%2Fscience.1096361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles of Computation in Drug Discovery</span></div><div class="casAuthors">Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5665</span>),
    <span class="NLM_cas:pages">1813-1818</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  An overview is given on the diverse uses of computational chem. in drug discovery.  Particular emphasis is placed on virtual screening, de novo design, evaluation of drug-likeness, and advanced methods for detg. protein-ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPr2xRlx_bxbVg90H21EOLACvtfcHk0liGS-AUOjTxJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFehu7w%253D&md5=77b2fac63e750ca7cdc7e4f35654549a</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096361%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DThe%2520many%2520roles%2520of%2520computation%2520in%2520drug%2520discovery%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1813%26epage%3D1818%26doi%3D10.1126%2Fscience.1096361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Van Drie, J. H.</span></span> <span> </span><span class="NLM_article-title">Computer-aided drug design: the next 20 years</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">591</span>â <span class="NLM_lpage">601</span>, <span class="refDoi">Â DOI: 10.1007/s10822-007-9142-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1007%2Fs10822-007-9142-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=17989929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BD2sjitVWntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=591-601&author=J.+H.+Van+Drie&title=Computer-aided+drug+design%3A+the+next+20+years&doi=10.1007%2Fs10822-007-9142-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided drug design: the next 20 years</span></div><div class="casAuthors">Van Drie John H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10-11</span>),
    <span class="NLM_cas:pages">591-601</span>
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    </div><div class="casAbstract">This perspectives article has been taken from a talk the author gave at the symposium in honor of Yvonne C.  Martin's retirement, held at the American Chemical Society spring meeting in Chicago on March 25, 2007.  The talk was intended as a somewhat lighthearted attempt to gaze into the future; inevitably, in print, things will come across more seriously than was intended.  As we all know-the past is rarely predictive of the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1OlneT5VFUBOk4JA3soTqfW6udTcc2eZmEbPvk2J6Drntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjitVWntw%253D%253D&md5=01bb0b716a58f96beb7dc0fd525abe3e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1007%2Fs10822-007-9142-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-007-9142-y%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26atitle%3DComputer-aided%2520drug%2520design%253A%2520the%2520next%252020%2520years%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2007%26volume%3D21%26spage%3D591%26epage%3D601%26doi%3D10.1007%2Fs10822-007-9142-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Computer-aided drug discovery</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">630</span>, (F1000 Faculty Rev) <span class="refDoi">Â DOI: 10.12688/f1000research.6653.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.12688%2Ff1000research.6653.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=630&author=J.+Bajorath&title=Computer-aided+drug+discovery&doi=10.12688%2Ff1000research.6653.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided drug discovery [version 1; referees: 3 approved]</span></div><div class="casAuthors">Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">630/1-630/8</span>CODEN:
                <span class="NLM_cas:coden">FRESJL</span>;
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    
            (<span class="NLM_cas:orgname">F1000 Research Ltd.</span>)
        </div><div class="casAbstract">Computational approaches are an integral part of interdisciplinary drug discovery research.  Understanding the science behind computational tools, their opportunities, and limitations is essential to make a true impact on drug discovery at different levels.  If applied in a scientifically meaningful way, computational methods improve the ability to identify and evaluate potential drug mols., but there remain weaknesses in the methods that preclude na.ovrddot.ive applications.  Herein, current trends in computer-aided drug discovery are reviewed, and selected computational areas are discussed.  Approaches are highlighted that aid in the identification and optimization of new drug candidates.  Emphasis is put on the presentation and discussion of computational concepts and methods, rather than case studies or application examples.  As such, this contribution aims to provide an overview of the current methodol. spectrum of computational drug discovery for a broad audience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8_WWMna927Vg90H21EOLACvtfcHk0liGS-AUOjTxJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D&md5=8766cd816d41aa01356ffce757026720</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.6653.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.6653.1%26sid%3Dliteratum%253Aachs%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputer-aided%2520drug%2520discovery%26jtitle%3DF1000Research%26date%3D2015%26volume%3D4%26spage%3D630%26doi%3D10.12688%2Ff1000research.6653.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Segall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusof, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champness, E. J.</span></span> <span> </span><span class="NLM_article-title">Avoiding missed opportunities by analyzing the sensitivity of our decisions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4267</span>â <span class="NLM_lpage">4277</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01921</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01921" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFGmu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4267-4277&author=M.+D.+Segallauthor=I.+Yusofauthor=E.+J.+Champness&title=Avoiding+missed+opportunities+by+analyzing+the+sensitivity+of+our+decisions&doi=10.1021%2Facs.jmedchem.5b01921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Avoiding Missed Opportunities by Analyzing the Sensitivity of Our Decisions</span></div><div class="casAuthors">Segall, Matthew D.; Yusof, Iskander; Champness, Edmund J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4267-4277</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery is a multiparameter optimization process in which the goal of a project is to identify compds. that meet multiple property criteria required to achieve a therapeutic objective.  However, once a profile of property criteria has been chosen, the impact of these criteria on the decisions made regarding progression of compds. or chem. series should be carefully considered.  In some cases the decision is very sensitive to a specific property criterion, and such a criterion may artificially distort the direction of the project; any uncertainty in the "correct" value or the importance of this criterion may lead to valuable opportunities being missed.  In this paper, we describe a method for analyzing the sensitivity of the prioritization of compds. to a multiparameter profile of property criteria.  We show how the results can be easily interpreted and illustrate how this anal. can highlight new avenues for exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUZozwQLjSAbVg90H21EOLACvtfcHk0ljQCR6Kd8AqKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFGmu7c%253D&md5=ee3d2630efd9eb85c1a576a9dc70bbff</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01921%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26aulast%3DYusof%26aufirst%3DI.%26aulast%3DChampness%26aufirst%3DE.%2BJ.%26atitle%3DAvoiding%2520missed%2520opportunities%2520by%2520analyzing%2520the%2520sensitivity%2520of%2520our%2520decisions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4267%26epage%3D4277%26doi%3D10.1021%2Facs.jmedchem.5b01921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissantz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶rner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidhart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz-Gasch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">A real-world perspective on molecular design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4087</span>â <span class="NLM_lpage">4102</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyjtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4087-4102&author=B.+Kuhnauthor=W.+Gubaauthor=J.+Hertauthor=D.+W.+Bannerauthor=C.+Bissantzauthor=S.+M.+Ceccarelliauthor=W.+Haapauthor=M.+K%C3%B6rnerauthor=A.+Kuglstatterauthor=C.+D.+Lernerauthor=P.+Matteiauthor=W.+Neidhartauthor=E.+Pinardauthor=M.+G.+Rudolphauthor=T.+Schulz-Gaschauthor=T.+J.+Wolteringauthor=M.+Stahl&title=A+real-world+perspective+on+molecular+design&doi=10.1021%2Facs.jmedchem.5b01875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A Real-World Perspective on Molecular Design</span></div><div class="casAuthors">Kuhn, Bernd; Guba, Wolfgang; Hert, Jerome; Banner, David; Bissantz, Caterina; Ceccarelli, Simona; Haap, Wolfgang; Korner, Matthias; Kuglstatter, Andreas; Lerner, Christian; Mattei, Patrizio; Neidhart, Werner; Pinard, Emmanuel; Rudolph, Markus G.; Schulz-Gasch, Tanja; Woltering, Thomas; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4087-4102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a series of small mol. drug discovery case studies where computational methods were prospectively employed to impact Roche research projects, with the aim of highlighting those methods that provide real added value.  Our brief accounts encompass a broad range of methods and techniques applied to a variety of enzymes and receptors.  Most of these are based on judicious application of knowledge about mol. conformations and interactions: filling of lipophilic pockets to gain affinity or selectivity, addn. of polar substituents, scaffold hopping, transfer of SAR, conformation anal., and mol. overlays.  A case study of sequence-driven focused screening is presented to illustrate how appropriate preprocessing of information enables effective exploitation of prior knowledge.  We conclude that qual. statements enabling chemists to focus on promising regions of chem. space are often more impactful than quant. prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxOLDuNAX5U7Vg90H21EOLACvtfcHk0ljQCR6Kd8AqKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyjtb0%253D&md5=0b81f2a0e9996c5dae44e61e5488ba79</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01875%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DK%25C3%25B6rner%26aufirst%3DM.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLerner%26aufirst%3DC.%2BD.%26aulast%3DMattei%26aufirst%3DP.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520real-world%2520perspective%2520on%2520molecular%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4087%26epage%3D4102%26doi%3D10.1021%2Facs.jmedchem.5b01875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muresan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Chemical predictive modeling to improve compound quality</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">948</span>â <span class="NLM_lpage">962</span>, <span class="refDoi">Â DOI: 10.1038/nrd4128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnrd4128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=24287782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=948-962&author=J.+G.+Cummingauthor=A.+M.+Davisauthor=S.+Muresanauthor=M.+Haeberleinauthor=H.+Chen&title=Chemical+predictive+modeling+to+improve+compound+quality&doi=10.1038%2Fnrd4128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical predictive modelling to improve compound quality</span></div><div class="casAuthors">Cumming, John G.; Davis, Andrew M.; Muresan, Sorel; Haeberlein, Markus; Chen, Hongming</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">948-962</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'quality' of small-mol. drug candidates, encompassing aspects including their potency, selectivity and ADMET (absorption, distribution, metab., excretion and toxicity) characteristics, is a key factor influencing the chances of success in clin. trials.  Importantly, such characteristics are under the control of chemists during the identification and optimization of lead compds.  Here, we discuss the application of computational methods, particularly quant. structure-activity relationships (QSARs), in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their use and impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XwzW0wcxYbVg90H21EOLACvtfcHk0ljQCR6Kd8AqKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF&md5=e0a4265bb306ae5544d00f3c9e3e4050</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1038%2Fnrd4128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4128%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DHaeberlein%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DChemical%2520predictive%2520modeling%2520to%2520improve%2520compound%2520quality%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D948%26epage%3D962%26doi%3D10.1038%2Fnrd4128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BostrÃ¶m, J.</span></span> <span> </span><span class="NLM_article-title">Understanding our love affair with <i>p</i>-chlorophenyl: present day implications from historical biases of reagent selection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2390</span>â <span class="NLM_lpage">2405</span>, <span class="refDoi">Â DOI: 10.1021/jm501894t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501894t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Snsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2390-2405&author=D.+G.+Brownauthor=M.+M.+Gagnonauthor=J.+Bostr%C3%B6m&title=Understanding+our+love+affair+with+p-chlorophenyl%3A+present+day+implications+from+historical+biases+of+reagent+selection&doi=10.1021%2Fjm501894t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Our Love Affair with p-Chlorophenyl: Present Day Implications from Historical Biases of Reagent Selection</span></div><div class="casAuthors">Brown, Dean G.; Gagnon, Moriah M.; Bostrom, Jonas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2390-2405</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with further theor. anal. We report here an unexpectedly strong preference toward para substitution in Ph rings within drug discovery programs.  A population anal. of arom. rings in various drug databases demonstrated that para substitution is favored over meta and ortho regioisomers, with p-chlorophenyl (p-ClPh) being one of the most predominant examples.  We speculate that the frequency of p-ClPh is traced back to historical models of medicinal chem. where para-substituted regioisomers were perhaps more easily accessed, and further reinforced by Topliss in 1972 that if Ph was active, the p-ClPh should be made because of ease of synthesis and hydrophobicity driven potency effects.  On the basis of our anal., the para bias has become useful conventional wisdom but perhaps so much so that a perception has been created that druglike space favors a linear arom. structure.  It is hoped this anal. will catalyze a new look at design of reagent databases and screening collections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZxc2KY5KeHrVg90H21EOLACvtfcHk0ljQCR6Kd8AqKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Snsr0%253D&md5=7f8a3a4eff01600299e04d59341a34dd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501894t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501894t%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DGagnon%26aufirst%3DM.%2BM.%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26atitle%3DUnderstanding%2520our%2520love%2520affair%2520with%2520p-chlorophenyl%253A%2520present%2520day%2520implications%2520from%2520historical%2520biases%2520of%2520reagent%2520selection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2390%26epage%3D2405%26doi%3D10.1021%2Fjm501894t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Segall, M. D.</span></span> <span> </span><span class="NLM_article-title">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1292</span>â <span class="NLM_lpage">1310</span>, <span class="refDoi">Â DOI: 10.2174/138161212799436430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.2174%2F138161212799436430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=22316157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1292-1310&author=M.+D.+Segall&title=Multi-parameter+optimization%3A+identifying+high+quality+compounds+with+a+balance+of+properties&doi=10.2174%2F138161212799436430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span></div><div class="casAuthors">Segall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1292-1310</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metab., and elimination (ADME) properties and an acceptable safety profile.  Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery.  Approaches to simultaneously optimizing many factors in a design are broadly described under the term "multi-parameter optimization" (MPO).  In this review, we will describe how MPO can be applied to efficiently design and select high quality compds. and describe the range of methods that have been employed in drug discovery, including; simple "rules of thumb" such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and exptl. variability.  We will explore how these methods have been applied to predicted and exptl. data to reduce attrition and improve the productivity of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPFOVyg2ehWbVg90H21EOLACvtfcHk0lgGZ_0oc0HyAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D&md5=43f90ad751fd2c0bc47715f465ef31b3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161212799436430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436430%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26atitle%3DMulti-parameter%2520optimization%253A%2520identifying%2520high%2520quality%2520compounds%2520with%2520a%2520balance%2520of%2520properties%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1292%26epage%3D1310%26doi%3D10.2174%2F138161212799436430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">Utilization of operational schemes for analog synthesis in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1006</span>â <span class="NLM_lpage">1011</span>, <span class="refDoi">Â DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006-1011&author=J.+G.+Topliss&title=Utilization+of+operational+schemes+for+analog+synthesis+in+drug+design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0lgGZ_0oc0HyAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520operational%2520schemes%2520for%2520analog%2520synthesis%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26epage%3D1011%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">A manual method for applying the Hansch approach to drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">463</span>â <span class="NLM_lpage">469</span>, <span class="refDoi">Â DOI: 10.1021/jm00214a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00214a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=463-469&author=J.+G.+Topliss&title=A+manual+method+for+applying+the+Hansch+approach+to+drug+design&doi=10.1021%2Fjm00214a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">A manual method for applying the Hansch approach to drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A procedure is described in which an initial small group of compds. is selected, tested, and ordered according to potency.  The potency order in the group is then compared to the tabulated potency order calcd. for various parameter dependencies relating to hydrophobic, electronic, and steric effects.  From this activity pattern anal. the probable operative parameters can be deduced and a new substituent selection made for the synthesis of potentially more potent analogs.  Application of the method is illustrated with a series of examples.  It differs from a previously described decision tree, single compd. stepwise approach in that it involves the batchwise anal. of small groups of compds., usually the preferred procedure for logistical reasons if the compds. are relatively easy to synthesize.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpILt0RoFSjlbVg90H21EOLACvtfcHk0lgGZ_0oc0HyAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D&md5=74658b807e3e45cbee88855eda203bdb</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm00214a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00214a001%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DA%2520manual%2520method%2520for%2520applying%2520the%2520Hansch%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D463%26epage%3D469%26doi%3D10.1021%2Fjm00214a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span></span> <span> </span><span class="NLM_article-title">A quantitative approach to biochemical structureâactivity relationships</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">232</span>â <span class="NLM_lpage">239</span>, <span class="refDoi">Â DOI: 10.1021/ar50020a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar50020a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOnu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1969&pages=232-239&author=C.+Hansch&title=A+quantitative+approach+to+biochemical+structure%E2%80%93activity+relationships&doi=10.1021%2Far50020a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative approach to biochemical structure-activity relationships</span></div><div class="casAuthors">Hansch, Corwin</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">232-9</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    </div><div class="casAbstract">The quant. approach to the biochem.-structure-activity relation has been discussed and reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6L7IpLGnFLVg90H21EOLACvtfcHk0lh2THHCBASPFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOnu74%253D&md5=1516684273e1f31a590fa3ab6ddee4d1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Far50020a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far50020a002%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520approach%2520to%2520biochemical%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1969%26volume%3D2%26spage%3D232%26epage%3D239%26doi%3D10.1021%2Far50020a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obst Sander, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâArcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for CâFÂ·Â·Â·C = O interactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2507</span>â <span class="NLM_lpage">2511</span>, <span class="refDoi">Â DOI: 10.1002/anie.200351268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.200351268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2507-2511&author=J.+A.+Olsenauthor=D.+W.+Bannerauthor=P.+Seilerauthor=U.+Obst+Sanderauthor=A.+D%E2%80%99Arcyauthor=M.+Stihleauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=A+fluorine+scan+of+thrombin+inhibitors+to+map+the+fluorophilicity%2Ffluorophobicity+of+an+enzyme+active+site%3A+evidence+for+C%E2%80%93F%C2%B7%C2%B7%C2%B7C+%3D+O+interactions&doi=10.1002%2Fanie.200351268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: Evidence for C-FÂ·Â·Â·C=O interactions</span></div><div class="casAuthors">Olsen, Jacob A.; Banner, David W.; Seiler, Paul; Sander, Ulrike Obst; D'Arcy, Allan; Stihle, Martine; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2507-2511</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly fluorophilic environment comprising the H-CÎ±-C=O unit of Asn 98 in the active site of thrombin was identified by X-ray crystallog. of a complex formed between the enzyme and a synthetic inhibitor (see partial X-ray structure, distances are in Angstroms).  Short C-FÂ·Â·Â·H-CÎ± and C-FÂ·Â·Â·C=O contacts involving H-CÎ±-C=O fragments were also frequently obsd. in small-mol. X-ray crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojeeRuEw83aLVg90H21EOLACvtfcHk0lh2THHCBASPFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D&md5=f9851cb27f3e9d10152ad10abcd5c965</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351268%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DObst%2BSander%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DA%2520fluorine%2520scan%2520of%2520thrombin%2520inhibitors%2520to%2520map%2520the%2520fluorophilicity%252Ffluorophobicity%2520of%2520an%2520enzyme%2520active%2520site%253A%2520evidence%2520for%2520C%25E2%2580%2593F%25C2%25B7%25C2%25B7%25C2%25B7C%2520%253D%2520O%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2507%26epage%3D2511%26doi%3D10.1002%2Fanie.200351268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pirrung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halstead, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, N. J. G.</span></span> <span> </span><span class="NLM_article-title">Methyl scanning: total synthesis of demethylasterriquinone B1 and derivatives for identification of sites of interaction with and isolation of its receptor(s)</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">4609</span>â <span class="NLM_lpage">4626</span>, <span class="refDoi">Â DOI: 10.1021/ja044325h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja044325h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Krtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=4609-4626&author=M.+Pirrungauthor=Y.+Liuauthor=L.+Dengauthor=D.+K.+Halsteadauthor=Z.+Liauthor=J.+F.+Mayauthor=M.+Wedelauthor=D.+A.+Austinauthor=N.+J.+G.+Webster&title=Methyl+scanning%3A+total+synthesis+of+demethylasterriquinone+B1+and+derivatives+for+identification+of+sites+of+interaction+with+and+isolation+of+its+receptor%28s%29&doi=10.1021%2Fja044325h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Scanning: Total Synthesis of Demethylasterriquinone B1 and Derivatives for Identification of Sites of Interaction with and Isolation of Its Receptor(s)</span></div><div class="casAuthors">Pirrung, Michael C.; Liu, Yufa; Deng, Liu; Halstead, Diana K.; Li, Zhitao; May, John F.; Wedel, Michael; Austin, Darrell A.; Webster, Nicholas J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4609-4624</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The principle of Me scanning is proposed for detn. of the sites of interaction between biol. active small mols. and their macromol. target(s).  It involves the systematic prepn. of a family of methylated derivs. of a compd. and their biol. testing.  As a functional assay, the method can identify the regions of a mol. that are important (and unimportant) for biol. activity against even unknown targets, and thus provides an excellent complement to structural biol.  Me scanning was applied to demethylasterriquinone B1, a small-mol. mimetic of insulin.  A new, optimal total synthesis of this natural product was developed that enables the family of Me scan derivs. to be concisely prepd. for evaluation in a cellular assay.  The results of this expt. were used to design a biotin-demethylasterriquinone conjugate for use as an affinity reagent.  This compd. was prepd. in tens of milligram quantities in a four-step synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFivtvsdHSBLVg90H21EOLACvtfcHk0lh2THHCBASPFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Krtrw%253D&md5=0556ce71c359790203c641280d133dbf</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja044325h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja044325h%26sid%3Dliteratum%253Aachs%26aulast%3DPirrung%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DHalstead%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMay%26aufirst%3DJ.%2BF.%26aulast%3DWedel%26aufirst%3DM.%26aulast%3DAustin%26aufirst%3DD.%2BA.%26aulast%3DWebster%26aufirst%3DN.%2BJ.%2BG.%26atitle%3DMethyl%2520scanning%253A%2520total%2520synthesis%2520of%2520demethylasterriquinone%2520B1%2520and%2520derivatives%2520for%2520identification%2520of%2520sites%2520of%2520interaction%2520with%2520and%2520isolation%2520of%2520its%2520receptor%2528s%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D4609%26epage%3D4626%26doi%3D10.1021%2Fja044325h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">In praise of remarkably powerful centamolecular therapeutic agents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1094</span>â <span class="NLM_lpage">1097</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.9b00286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1094-1097&author=N.+A.+Meanwellauthor=W.+R.+Ewing&title=In+praise+of+remarkably+powerful+centamolecular+therapeutic+agents&doi=10.1021%2Facsmedchemlett.9b00286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In Praise of Remarkably Powerful Centamolecular Therapeutic Agents</span></div><div class="casAuthors">Meanwell, Nicholas A.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1094-1097</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  While biol. medications have addressed many challenging therapeutic targets, the pharmacopeia is still dominated by centamols.  In this viewpoint, we illustrate the impact of centamol. drugs on mortality and morbidity due to chronic viral infections and present select examples from other disease areas that highlight some of their remarkably powerful biochem. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRNASt4Snv7Vg90H21EOLACvtfcHk0lirhmnvbUgbLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F&md5=16a78cfdc956392783a087a86bec8888</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00286%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DIn%2520praise%2520of%2520remarkably%2520powerful%2520centamolecular%2520therapeutic%2520agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D1094%26epage%3D1097%26doi%3D10.1021%2Facsmedchemlett.9b00286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">1081</span>â <span class="NLM_lpage">1085</span>, <span class="refDoi">Â DOI: 10.1126/science.2471267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1126%2Fscience.2471267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=2471267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=1081-1085&author=B.+C.+Cunninghamauthor=J.+A.+Wells&title=High-resolution+epitope+mapping+of+hGH-receptor+interactions+by+alanine-scanning+mutagenesis&doi=10.1126%2Fscience.2471267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis</span></div><div class="casAuthors">Cunningham, Brian C.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4908</span>),
    <span class="NLM_cas:pages">1081-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A strategy, called alanine-scanning mutagenesis, was used to identify specific side chains in human growth hormone (hGH) that strongly modulate binding to the hGH receptor cloned from human liver.  Single alanine mutations (62 in total) were introduced at every residue contained within the 3 discontinuous segments of hGH (residues 2-19, 54-74, and 167-191) that have been implicated in receptor recognition.  The alanine scan revealed a cluster of a dozen large side chains that when mutated to alanine each showed >4-fold lower binding affinity to the hGH receptor.  Many of these residues that promote binding to the hGH receptor are altered in homologs of hGH (such as placental lactogens and prolactins) that do not bind tightly to the hGH receptor.  The overall folding of these mutant proteins was indistinguishable from that of the wild-type hGH, as detd. by strong cross-reactivities with 7 different conformationally sensitive monoclonal antibodies.  The alanine scan also identified at least one side chain, Glu174, that hindered binding because when it was mutated to alanine the receptor affinity increased by >4-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zoDe8YESIrVg90H21EOLACvtfcHk0lirhmnvbUgbLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D&md5=b88aa28886f1716c85f8beb76e7e7100</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.2471267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2471267%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DB.%2BC.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DHigh-resolution%2520epitope%2520mapping%2520of%2520hGH-receptor%2520interactions%2520by%2520alanine-scanning%2520mutagenesis%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D1081%26epage%3D1085%26doi%3D10.1126%2Fscience.2471267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montague, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossetter, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, E. J.</span></span> <span> </span><span class="NLM_article-title">Learning medicinal chemistry absorption, distribution, metabolism, excretion, and toxicity (ADMET) rules from cross-company matched molecular pairs analysis (MMPA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3277</span>â <span class="NLM_lpage">3292</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKmsbvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3277-3292&author=C.+Kramerauthor=A.+Tingauthor=H.+Zhengauthor=J.+Hertauthor=T.+Schindlerauthor=M.+Stahlauthor=G.+Robbauthor=J.+J.+Crawfordauthor=J.+Blaneyauthor=S.+Montagueauthor=A.+G.+Leachauthor=A.+G.+Dossetterauthor=E.+J.+Griffen&title=Learning+medicinal+chemistry+absorption%2C+distribution%2C+metabolism%2C+excretion%2C+and+toxicity+%28ADMET%29+rules+from+cross-company+matched+molecular+pairs+analysis+%28MMPA%29&doi=10.1021%2Facs.jmedchem.7b00935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA)</span></div><div class="casAuthors">Kramer, Christian; Ting, Attilla; Zheng, Hao; Hert, Jerome; Schindler, Torsten; Stahl, Martin; Robb, Graeme; Crawford, James J.; Blaney, Jeff; Montague, Shane; Leach, Andrew G.; Dossetter, Al G.; Griffen, Ed J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3277-3292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The first large scale anal. of in vitro absorption, distribution, metab., excretion, and toxicity (ADMET) data shared across multiple major pharma has been performed.  Using advanced matched mol. pair anal. (MMPA), the authors combined data from three pharmaceutical companies and generated ADMET rules, avoiding the need to disclose the full chem. structures.  On top of the very large exchange of knowledge, all companies involved synergistically gained approx. 20% more rules from the shared transformations.  There is good quant. agreement between the rules based on shared data compared to both individual companies' rules and rules published in the literature.  Known correlations between log D, soly., in vitro clearance, and plasma protein binding also hold in transformation space, but there are also interesting exceptions.  Data pools such as this allow focusing on particular functional groups and characterizing their ADMET profile.  Finally the role of a corpus of robustly tested medicinal chem. knowledge in the training of medicinal chem. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGR-l9JlU2p7Vg90H21EOLACvtfcHk0lirhmnvbUgbLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKmsbvK&md5=5c17d88815192fd481e84e24921095ac</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00935%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DTing%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DRobb%26aufirst%3DG.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DBlaney%26aufirst%3DJ.%26aulast%3DMontague%26aufirst%3DS.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DLearning%2520medicinal%2520chemistry%2520absorption%252C%2520distribution%252C%2520metabolism%252C%2520excretion%252C%2520and%2520toxicity%2520%2528ADMET%2529%2520rules%2520from%2520cross-company%2520matched%2520molecular%2520pairs%2520analysis%2520%2528MMPA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3277%26epage%3D3292%26doi%3D10.1021%2Facs.jmedchem.7b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, C. E.</span></span> <span> </span><span class="NLM_article-title">A multi-endpoint matched molecular pair (MMP) analysis of 6-membered heterocycles</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">381</span>â <span class="NLM_lpage">388</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2016.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmc.2016.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=27840138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=381-388&author=G.+Changauthor=K.+Huardauthor=G.+W.+Kauffmanauthor=A.+F.+Stepanauthor=C.+E.+Keefer&title=A+multi-endpoint+matched+molecular+pair+%28MMP%29+analysis+of+6-membered+heterocycles&doi=10.1016%2Fj.bmc.2016.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">A multi-endpoint matched molecular pair (MMP) analysis of 6-membered heterocycles</span></div><div class="casAuthors">Chang, George; Huard, Kim; Kauffman, Gregory W.; Stepan, Antonia F.; Keefer, Christopher E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-388</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Arom. rings, ubiquitous in pharmaceutical compds., are often exchanged with another ring during the optimization process of drug discovery.  Inevitably, the preferred ring system for one endpoint may prove detrimental to another, thus necessitating a holistic, multiple endpoint optimization approach for finding the ideal replacement.  Accordingly, we conducted an extensive matched mol. pair (MMP) anal. of common 6-membered arom. rings across 4 endpoints crit. for drug discovery (log D lipophilicity, microsomal metab., P-gp efflux and passive permeability).  We also investigated the effect of context by considering the connecting atom.  Heat maps were created as a simple yet comprehensive way to view and analyze the vast amt. of interrelated data.  Paired difference statistical tests were used to identify transforms with changes that were significantly different from zero.  We conclude that the heat maps of transforms provide a unique and powerful approach for multiparameter optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4S5NvQKzOjLVg90H21EOLACvtfcHk0lhGdYe1LHxa6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL7J&md5=88d8b910b84e6d40388885cc28d336c8</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuard%26aufirst%3DK.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKeefer%26aufirst%3DC.%2BE.%26atitle%3DA%2520multi-endpoint%2520matched%2520molecular%2520pair%2520%2528MMP%2529%2520analysis%2520of%25206-membered%2520heterocycles%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D381%26epage%3D388%26doi%3D10.1016%2Fj.bmc.2016.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic replacements for benzene: maximising ADME benefits by considering individual ring isomers</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">1057</span>â <span class="NLM_lpage">1068</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.ejmech.2016.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=27783976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=1057-1068&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=Heterocyclic+replacements+for+benzene%3A+maximising+ADME+benefits+by+considering+individual+ring+isomers&doi=10.1016%2Fj.ejmech.2016.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic replacements for benzene: Maximizing ADME benefits by considering individual ring isomers</span></div><div class="casAuthors">Ritchie, Timothy J.; Macdonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1057-1068</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The impact of replacing a monosubstituted benzene (phenyl) ring with thirty three arom. and nine aliph. heterocycles on nine ADME-related screens (soly., lipophilicity, permeability, protein binding CYP450 inhibition and metabolic clearance) was assessed using matched mol. pair anal.  The results indicate that the influence on the ADME profile can differ significantly depending on the ring identity and importantly on the individual regioisomers that are possible for some rings.  This information enables the medicinal chemist to make an informed choice about which rings and regioisomers to employ as monosubstituted benzene replacements, based upon the knowledge of how such replacements are likely to influence ADME-related parameters, for example to target higher soly. while avoiding CYP450 liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWSOM3yUz8kbVg90H21EOLACvtfcHk0lhGdYe1LHxa6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP&md5=127e1316b7bff0db030226548f96045c</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DHeterocyclic%2520replacements%2520for%2520benzene%253A%2520maximising%2520ADME%2520benefits%2520by%2520considering%2520individual%2520ring%2520isomers%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D1057%26epage%3D1068%26doi%3D10.1016%2Fj.ejmech.2016.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpfe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Evolving concept of activity cliffs</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">14360</span>â <span class="NLM_lpage">14368</span>, <span class="refDoi">Â DOI: 10.1021/acsomega.9b02221</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b02221" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1aksb%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=14360-14368&author=D.+Stumpfeauthor=H.+Huauthor=J.+Bajorath&title=Evolving+concept+of+activity+cliffs&doi=10.1021%2Facsomega.9b02221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving Concept of Activity Cliffs</span></div><div class="casAuthors">Stumpfe, Dagmar; Hu, Huabin; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">14360-14368</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Activity cliffs (ACs) are generally defined as pairs or groups of structurally similar compds. that are active against the same target but have large differences in potency.  Accordingly, ACs capture chem. modifications that strongly influence biol. activity.  Therefore, they are of particular interest in structure-activity relationship (SAR) anal. and compd. optimization.  The AC concept is much more complex than it may appear at a first glance, esp. if one aims to represent ACs computationally and identify them systematically.  To these ends, mol. similarity and potency difference criteria must be carefully considered for AC assessment.  Furthermore, ACs are often perceived differently in medicinal and computational chem., depending on whether they are studied on a case-by-case basis or systematically.  For practical applications, intuitive access to AC information plays a major role.  Over the years, the AC concept has been further refined and extended.  Herein, we review the evolution of the AC concept, emphasizing new anal. schemes and findings that help to better understand ACs and ext. SAR knowledge from them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47Gyaq-vbgbVg90H21EOLACvtfcHk0lhGdYe1LHxa6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1aksb%252FL&md5=1c25c816cfe3ca0b3ad61023d2bd8a3f</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b02221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b02221%26sid%3Dliteratum%253Aachs%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DEvolving%2520concept%2520of%2520activity%2520cliffs%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26spage%3D14360%26epage%3D14368%26doi%3D10.1021%2Facsomega.9b02221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, C.</span></span> <span> </span><span class="NLM_article-title">Nonadditivity analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4034</span>â <span class="NLM_lpage">4042</span>, <span class="refDoi">Â DOI: 10.1021/acs.jcim.9b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.9b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslektr%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=4034-4042&author=C.+Kramer&title=Nonadditivity+analysis&doi=10.1021%2Facs.jcim.9b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonadditivity Analysis</span></div><div class="casAuthors">Kramer, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4034-4042</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We introduce the statistics behind a novel type of SAR anal. named "nonadditivity anal.".  On the basis of all pairs of matched pairs within a given data set, the approach analyzes whether the same transformations between related mols. have the same effect, i.e., whether they are additive.  Assuming that the exptl. uncertainty is normally distributed, the additivities can be analyzed with statistical rigor and sets of compds. can be found that show significant nonadditivity.  Nonadditivity anal. can not only detect nonadditivity, potential SAR outliers, and sets of key compds. but also allow estg. an upper limit of the exptl. uncertainty in the data set.  We demonstrate how complex SAR features that inform medicinal chem. can be found in large SAR data sets.  Finally, we show how the upper limit of exptl. uncertainty for a given biochem. assay can be estd. without the need for repeated measurements of the same protein-ligand system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnH9UtiNjinrVg90H21EOLACvtfcHk0li98PZvZeJ2kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslektr%252FF&md5=af972caed1cdca9dda8f58f2f64340b4</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.9b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.9b00631%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26atitle%3DNonadditivity%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D4034%26epage%3D4042%26doi%3D10.1021%2Facs.jcim.9b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span> <span> </span><span class="NLM_article-title">Decision making in medicinal chemistry: the power of our intuition</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">956</span>â <span class="NLM_lpage">958</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Orur7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=956-958&author=L.+Gomez&title=Decision+making+in+medicinal+chemistry%3A+the+power+of+our+intuition&doi=10.1021%2Facsmedchemlett.8b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Decision Making in Medicinal Chemistry: The Power of Our Intuition</span></div><div class="casAuthors">Gomez, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">956-958</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Medicinal chemists rely on their intuition to make decisions regarding the course of a medicinal chem. program.  Our ability to accurately and efficiently process large data sets routinely requires that we reduce the vol. of information to manageable proportions.  This prioritization process, however, can be affected by intuitive biases.  One such situation is structure-activity relationship (SAR) anal. in nonadditive data sets in which attempts to intuitively predict the activity of compds. based on preliminary data can lead to erroneous conclusions.  Matrix anal. can be a useful tool to accurately det. the nature of the SAR and to improve our decision-making process during an analoging campaign.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNYEcXQuaZhrVg90H21EOLACvtfcHk0li98PZvZeJ2kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Orur7N&md5=e37470769559afca2691e0a0ee15bae2</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00359%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DL.%26atitle%3DDecision%2520making%2520in%2520medicinal%2520chemistry%253A%2520the%2520power%2520of%2520our%2520intuition%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D956%26epage%3D958%26doi%3D10.1021%2Facsmedchemlett.8b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wienen-Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, H.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Surprising non-additivity of methyl groups in drugâkinase interaction</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2585â</span>â <span class="NLM_lpage">2594</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00476</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00476" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVSqs73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=2585%E2%88%92-2594&author=B.+Wienen-Schmidtauthor=D.+Schmidtauthor=H.-D.+Gerberauthor=A.+Heineauthor=H.+Gohlkeauthor=G.+Klebe&title=Surprising+non-additivity+of+methyl+groups+in+drug%E2%80%93kinase+interaction&doi=10.1021%2Facschembio.9b00476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Surprising Non-Additivity of Methyl Groups in Drug-Kinase Interaction</span></div><div class="casAuthors">Wienen-Schmidt, Barbara; Schmidt, Denis; Gerber, Hans-Dieter; Heine, Andreas; Gohlke, Holger; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2585-2594</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug optimization is guided by biophys. methods with increasing popularity.  In the context of lead structure modifications, the introduction of Me groups is a simple but potentially powerful approach.  Hence, it is crucial to systematically investigate the influence of ligand methylation on biophys. characteristics such as thermodn.  Here, we investigate the influence of ligand methylation in different positions and combinations on the drug-kinase interaction.  Binding modes and complex structures were analyzed using protein crystallog.  Thermodn. signatures were measured via isothermal titrn. calorimetry (ITC).  An extensive computational anal. supported the understanding of the underlying mechanisms.  We found that not only position but also stereochem. of the Me group has an influence on binding potency as well as the thermodn. signature of ligand binding to the protein.  Strikingly, the combination of single Me groups does not lead to additive effects.  In our case, the merger of two Me groups in one ligand leads to an entirely new alternative ligand binding mode in the protein ligand complex.  Moreover, the combination of the two Me groups also resulted in a nonadditive thermodn. profile of ligand binding.  Mol. dynamics (MD) simulations revealed distinguished characteristic motions of the ligands in soln. explaining the pronounced thermodn. changes.  The unexpected drastic change in protein ligand interaction highlights the importance of crystallog. control even for minor modifications such as the introduction of a Me group.  For an in-depth understanding of ligand binding behavior, MD simulations have shown to be a powerful tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4CmV2t7zeK7Vg90H21EOLACvtfcHk0li98PZvZeJ2kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVSqs73M&md5=40a57540d8979628a9a8dae2ff0d0896</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00476%26sid%3Dliteratum%253Aachs%26aulast%3DWienen-Schmidt%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DGerber%26aufirst%3DH.-D.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DSurprising%2520non-additivity%2520of%2520methyl%2520groups%2520in%2520drug%25E2%2580%2593kinase%2520interaction%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26spage%3D2585%25E2%2588%2592%26epage%3D2594%26doi%3D10.1021%2Facschembio.9b00476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croghan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, K. K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickrell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnett, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span> <span> </span><span class="NLM_article-title">Quinolinone-based agonists of S1P<sub>1</sub>: use of a N-scan SAR strategy to optimize in vitro and in vivo activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">527</span>â <span class="NLM_lpage">531</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.10.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmcl.2011.10.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=22104144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVyksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=527-531&author=L.+D.+Penningtonauthor=M.+D.+Croghanauthor=K.+K.+C.+Shamauthor=A.+J.+Pickrellauthor=P.+E.+Harringtonauthor=M.+J.+Frohnauthor=B.+A.+Lanmanauthor=A.+B.+Reedauthor=M.+R.+Leeauthor=H.+Xuauthor=M.+McElvainauthor=Y.+Xuauthor=X.+Zhangauthor=M.+Fiorinoauthor=M.+Hornerauthor=H.+G.+Morrisonauthor=H.+A.+Arnettauthor=C.+Fotschauthor=A.+S.+Taskerauthor=M.+Wongauthor=V.+J.+Cee&title=Quinolinone-based+agonists+of+S1P1%3A+use+of+a+N-scan+SAR+strategy+to+optimize+in+vitro+and+in+vivo+activity&doi=10.1016%2Fj.bmcl.2011.10.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolinone-based agonists of S1P1: Use of a N-scan SAR strategy to optimize in vitro and in vivo activity</span></div><div class="casAuthors">Pennington, Lewis D.; Croghan, Michael D.; Sham, Kelvin K. C.; Pickrell, Alexander J.; Harrington, Paul E.; Frohn, Michael J.; Lanman, Brian A.; Reed, Anthony B.; Lee, Matthew R.; Xu, Han; McElvain, Michele; Xu, Yang; Zhang, Xuxia; Fiorino, Michael; Horner, Michelle; Morrison, Henry G.; Arnett, Heather A.; Fotsch, Christopher; Tasker, Andrew S.; Wong, Min; Cee, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">527-531</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We reveal how a N-scan SAR strategy (systematic substitution of each CH group with a N atom) was employed for quinolinone-based S1P1 agonist (I) to modulate physicochem. properties and optimize in vitro and in vivo activity.  The diaza-analog (II) displays improved potency (hS1P1 RI; II: EC50 = 0.020 Î¼M, 120% efficacy; I: EC50 = 0.070 Î¼M, 110% efficacy) and selectivity (hS1P3 Ca2+ flux; II: EC50 >25 Î¼M; I: EC50 = 1.5 Î¼M, 92% efficacy), as well as enhanced pharmacokinetics (II: CL = 0.15 L/h/kg, Vdss = 5.1 L/kg, T1/2 = 24 h, %F = 110; I: CL = 0.93 L/h/kg, Vdss = 11 L/kg, T1/2 = 15 h, %F = 60) and pharmacodynamics (II: 1.0 mg/kg po, 24 h PLC POC = -67%; I: 3 mg/kg po, 24 h PLC POC = -51%) in rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPwWWOfAvgLVg90H21EOLACvtfcHk0lgjzL4D6wQmRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVyksg%253D%253D&md5=819b9bdc99ca598ac65dcdf34370bfde</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.085%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DSham%26aufirst%3DK.%2BK.%2BC.%26aulast%3DPickrell%26aufirst%3DA.%2BJ.%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DFrohn%26aufirst%3DM.%2BJ.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFiorino%26aufirst%3DM.%26aulast%3DHorner%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DH.%2BG.%26aulast%3DArnett%26aufirst%3DH.%2BA.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3DQuinolinone-based%2520agonists%2520of%2520S1P1%253A%2520use%2520of%2520a%2520N-scan%2520SAR%2520strategy%2520to%2520optimize%2520in%2520vitro%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D527%26epage%3D531%26doi%3D10.1016%2Fj.bmcl.2011.10.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Strategic Use of the N Atom in Novel Agonists of S1P<sub>1</sub></span>. Presented at the Overman Symposium, Eli Lilly & Co., Indianapolis, IN, September 12, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+D.+Pennington&title=Strategic+Use+of+the+N+Atom+in+Novel+Agonists+of+S1P1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStrategic%2520Use%2520of%2520the%2520N%2520Atom%2520in%2520Novel%2520Agonists%2520of%2520S1P1%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Molecular Design in Ligand- and Structure-Based Drug Discovery</span>. Presented at the University of Michigan Department of Chemistry Seminar Series, University of Michigan, Ann Arbor, MI, November 25, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+D.+Pennington&title=Molecular+Design+in+Ligand-+and+Structure-Based+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DMolecular%2520Design%2520in%2520Ligand-%2520and%2520Structure-Based%2520Drug%2520Discovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hyohdoh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itezono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takanashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iikura, H.</span></span> <span> </span><span class="NLM_article-title">Fluorine scanning by nonselective fluorination: enhancing Raf/MEK inhibition while keeping physicochemical properties</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1059</span>â <span class="NLM_lpage">1063</span>, <span class="refDoi">Â DOI: 10.1021/ml4002419</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyrtLnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1059-1063&author=I.+Hyohdohauthor=N.+Furuichiauthor=T.+Aokiauthor=Y.+Itezonoauthor=H.+Shiraiauthor=S.+Ozawaauthor=F.+Watanabeauthor=M.+Matsushitaauthor=M.+Sakaitaniauthor=P.-S.+Hoauthor=K.+Takanashiauthor=N.+Haradaauthor=Y.+Tomiiauthor=K.+Yoshinariauthor=K.+Oriauthor=M.+Taboauthor=Y.+Aokiauthor=N.+Shimmaauthor=H.+Iikura&title=Fluorine+scanning+by+nonselective+fluorination%3A+enhancing+Raf%2FMEK+inhibition+while+keeping+physicochemical+properties&doi=10.1021%2Fml4002419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties</span></div><div class="casAuthors">Hyohdoh, Ikumi; Furuichi, Noriyuki; Aoki, Toshihiro; Itezono, Yoshiko; Shirai, Haruyoshi; Ozawa, Sawako; Watanabe, Fumio; Matsushita, Masayuki; Sakaitani, Masahiro; Ho, Pil-Su; Takanashi, Kenji; Harada, Naoki; Tomii, Yasushi; Yoshinari, Kiyoshi; Ori, Kazutomo; Tabo, Mitsuyasu; Aoki, Yuko; Shimma, Nobuo; Iikura, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1059-1063</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile methodol. effective in obtaining a set of compds. monofluorinated at various positions (fluorine scan) by chem. synthesis is reported.  Direct and nonselective fluorination reactions of our lead compd. I and key intermediate II worked efficiently to afford a total of six monofluorinated derivs.  All of the derivs. kept their physicochem. properties compared with the lead I and one of them had enhanced Raf/MEK inhibitory activity.  Keeping physicochem. properties could be considered a benefit of monofluorinated derivs. compared with chlorinated derivs., iodinated derivs., methylated derivs., etc.  This key finding led to the identification of compd. III, which had potent tumor growth inhibition in a xenograft model, excellent PK profiles in three animal species, and no crit. toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQO4W5X_AfQLVg90H21EOLACvtfcHk0lgjzL4D6wQmRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyrtLnK&md5=c2da121b1a697eeff67786f88225b811</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fml4002419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002419%26sid%3Dliteratum%253Aachs%26aulast%3DHyohdoh%26aufirst%3DI.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DItezono%26aufirst%3DY.%26aulast%3DShirai%26aufirst%3DH.%26aulast%3DOzawa%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DP.-S.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DTomii%26aufirst%3DY.%26aulast%3DYoshinari%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DK.%26aulast%3DTabo%26aufirst%3DM.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DIikura%26aufirst%3DH.%26atitle%3DFluorine%2520scanning%2520by%2520nonselective%2520fluorination%253A%2520enhancing%2520Raf%252FMEK%2520inhibition%2520while%2520keeping%2520physicochemical%2520properties%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1059%26epage%3D1063%26doi%3D10.1021%2Fml4002419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyohdoh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takanashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iikura, H.</span></span> <span> </span><span class="NLM_article-title">Optimizing the physicochemical properties of Raf/MEK inhibitors by nitrogen scanning</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">309</span>â <span class="NLM_lpage">314</span>, <span class="refDoi">Â DOI: 10.1021/ml400379x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400379x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eitLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=309-314&author=T.+Aokiauthor=I.+Hyohdohauthor=N.+Furuichiauthor=S.+Ozawaauthor=F.+Watanabeauthor=M.+Matsushitaauthor=M.+Sakaitaniauthor=K.+Morikamiauthor=K.+Takanashiauthor=N.+Haradaauthor=Y.+Tomiiauthor=K.+Shirakiauthor=K.+Furumotoauthor=M.+Taboauthor=K.+Yoshinariauthor=K.+Oriauthor=Y.+Aokiauthor=N.+Shimmaauthor=H.+Iikura&title=Optimizing+the+physicochemical+properties+of+Raf%2FMEK+inhibitors+by+nitrogen+scanning&doi=10.1021%2Fml400379x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning</span></div><div class="casAuthors">Aoki, Toshihiro; Hyohdoh, Ikumi; Furuichi, Noriyuki; Ozawa, Sawako; Watanabe, Fumio; Matsushita, Masayuki; Sakaitani, Masahiro; Morikami, Kenji; Takanashi, Kenji; Harada, Naoki; Tomii, Yasushi; Shiraki, Koji; Furumoto, Kentaro; Tabo, Mitsuyasu; Yoshinari, Kiyoshi; Ori, Kazutomo; Aoki, Yuko; Shimma, Nobuo; Iikura, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-314</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituting a carbon atom with a nitrogen atom (nitrogen substitution) on an arom. ring in our leads I and II (X8 = X9 = CH) by applying nitrogen scanning afforded a set of compds. that improved not only the soly. but also the metabolic stability.  The impact after nitrogen substitution on interactions between a deriv. and its on- and off-target proteins (Raf/MEK, CYPs, and hERG channel) was also detected with most of them contributing to weaker interactions.  After identifying the positions that kept inhibitory activity on HCT116 cell growth and Raf/MEK, compd. II (X8 = X9 = N) (CH5126766/RO5126766) was selected as a clin. compd.  A phase I clin. trial is ongoing for solid cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNIlM5ZKpyzLVg90H21EOLACvtfcHk0li7rCqH816lMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eitLc%253D&md5=0f69b4f9da08754bff72823f6455a7c5</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fml400379x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400379x%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DHyohdoh%26aufirst%3DI.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DOzawa%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DTomii%26aufirst%3DY.%26aulast%3DShiraki%26aufirst%3DK.%26aulast%3DFurumoto%26aufirst%3DK.%26aulast%3DTabo%26aufirst%3DM.%26aulast%3DYoshinari%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DIikura%26aufirst%3DH.%26atitle%3DOptimizing%2520the%2520physicochemical%2520properties%2520of%2520Raf%252FMEK%2520inhibitors%2520by%2520nitrogen%2520scanning%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D309%26epage%3D314%26doi%3D10.1021%2Fml400379x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmstrom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klug-McLeod, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakaryants, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S.</span></span> <span> </span><span class="NLM_article-title">Quick building blocks (QBB): an innovative and efficient business model to speed medicinal chemistry analog synthesis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1104</span>â <span class="NLM_lpage">1109</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.9b00205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlams7fM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1104-1109&author=C.+J.+Helalauthor=M.+Bundesmannauthor=S.+Hammondauthor=M.+Holmstromauthor=J.+Klug-McLeodauthor=B.+A.+Lefkerauthor=D.+McLeodauthor=C.+Subramanyamauthor=O.+Zakaryantsauthor=S.+Sakata&title=Quick+building+blocks+%28QBB%29%3A+an+innovative+and+efficient+business+model+to+speed+medicinal+chemistry+analog+synthesis&doi=10.1021%2Facsmedchemlett.9b00205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis</span></div><div class="casAuthors">Helal, Christopher J.; Bundesmann, Mark; Hammond, Susan; Holmstrom, Melissa; Klug-McLeod, Jacquelyn; Lefker, Bruce A.; McLeod, Dale; Subramanyam, Chakrapani; Zakaryants, Oleg; Sakata, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1104-1109</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many pharmaceutical companies have invested millions of dollars in establishing internal chem. stores to provide reliable access to large nos. of building blocks (BB) for the synthesis of new mols., esp. for the timely design and execution of parallel (library) synthesis.  Recognizing budget and logistical limitations, we required a more economically scalable process to provide diverse BB.  We disclose a novel business partnership that achieves the goals of just-in-time, economical access to com. BB that increases chem. space coverage and accelerates the synthesis of new drug candidates.  We believe that this model can be of benefit to companies of all sizes that are engaged in drug discovery by reducing cost, increasing diversity of analog mols. in a time-conscious manner, and reducing BB inventory.  More efficient use of BB by customers may allow com. vendors to devote a greater portion of their resources to prepg. novel BB that increase chem. diversity as opposed to resynthesizing out-of-stock compds. that are inaccessible within company compd. collections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4oiMXHzQZrbVg90H21EOLACvtfcHk0li7rCqH816lMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlams7fM&md5=5d1b97e977d63c8cdf51ad26257d15f3</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00205%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBundesmann%26aufirst%3DM.%26aulast%3DHammond%26aufirst%3DS.%26aulast%3DHolmstrom%26aufirst%3DM.%26aulast%3DKlug-McLeod%26aufirst%3DJ.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DMcLeod%26aufirst%3DD.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DZakaryants%26aufirst%3DO.%26aulast%3DSakata%26aufirst%3DS.%26atitle%3DQuick%2520building%2520blocks%2520%2528QBB%2529%253A%2520an%2520innovative%2520and%2520efficient%2520business%2520model%2520to%2520speed%2520medicinal%2520chemistry%2520analog%2520synthesis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D1104%26epage%3D1109%26doi%3D10.1021%2Facsmedchemlett.9b00205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span> <span> </span><span class="NLM_article-title">The next level in chemical space navigation: going far beyond enumerable compound libraries</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1148</span>â <span class="NLM_lpage">1156</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2019.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.drudis.2019.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30851414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslaksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=1148-1156&author=T.+Hoffmannauthor=M.+Gastreich&title=The+next+level+in+chemical+space+navigation%3A+going+far+beyond+enumerable+compound+libraries&doi=10.1016%2Fj.drudis.2019.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">The next level in chemical space navigation: going far beyond enumerable compound libraries</span></div><div class="casAuthors">Hoffmann, Torsten; Gastreich, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1148-1156</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Recent innovations have brought pharmacophore-driven methods for navigating virtual chem. spaces, the size of which can reach into the billions of mols., to the fingertips of every chemist.  There has been a paradigm shift in the underlying computational chem. that drives chem. space search applications, incorporating intelligent reaction knowledge into their core so that they can readily deliver com. available mols. as nearest neighbor hits from within giant virtual spaces.  These vast resources enable medicinal chemists to execute rapid scaffold-hopping expts., rapid hit expansion, and structure-activity relationship (SAR) exploitation in largely intellectual property (IP)-free territory and at unparalleled low cost.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodA_WnK9Z3jbVg90H21EOLACvtfcHk0li7rCqH816lMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslaksb4%253D&md5=d707299b8c6e0ace79f27172147517e3</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DGastreich%26aufirst%3DM.%26atitle%3DThe%2520next%2520level%2520in%2520chemical%2520space%2520navigation%253A%2520going%2520far%2520beyond%2520enumerable%2520compound%2520libraries%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2019%26volume%3D24%26spage%3D1148%26epage%3D1156%26doi%3D10.1016%2Fj.drudis.2019.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goble, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohri, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span> <span> </span><span class="NLM_article-title">Increased building block access through collaboration</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1458</span>â <span class="NLM_lpage">1462</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2018.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.drudis.2018.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29571837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC1MnktlOgug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1458-1462&author=C.+J.+Helalauthor=A.+Bartolozziauthor=S.+D.+Gobleauthor=N.+S.+Maniauthor=A.+Guzman-Perezauthor=A.+K.+Ohriauthor=Z.-C.+Shiauthor=C.+Subramanyam&title=Increased+building+block+access+through+collaboration&doi=10.1016%2Fj.drudis.2018.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Increased building block access through collaboration</span></div><div class="casAuthors">Helal Christopher J; Bartolozzi Alessandra; Goble Steven D; Shi Zhi-Cai; Mani Neelakanda S; Guzman-Perez Angel; Ohri Ajay K; Subramanyam Chakrapani</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1458-1462</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgt4Gd6-WlAP69nzq6467DfW6udTcc2eZfG6rEPWdk8rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnktlOgug%253D%253D&md5=f91f621ad61ce13c503c38c7e3959ac1</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBartolozzi%26aufirst%3DA.%26aulast%3DGoble%26aufirst%3DS.%2BD.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DOhri%26aufirst%3DA.%2BK.%26aulast%3DShi%26aufirst%3DZ.-C.%26aulast%3DSubramanyam%26aufirst%3DC.%26atitle%3DIncreased%2520building%2520block%2520access%2520through%2520collaboration%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D1458%26epage%3D1462%26doi%3D10.1016%2Fj.drudis.2018.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogej, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomkinson, N. P.</span></span> <span> </span><span class="NLM_article-title">Designing novel building blocks is an overlooked strategy to improve compound quality</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">11</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2014.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.drudis.2014.09.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=25281855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC2M7nt1aksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=11-17&author=F.+W.+Goldbergauthor=J.+G.+Kettleauthor=T.+Kogejauthor=M.+W.+D.+Perryauthor=N.+P.+Tomkinson&title=Designing+novel+building+blocks+is+an+overlooked+strategy+to+improve+compound+quality&doi=10.1016%2Fj.drudis.2014.09.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21dR"><div class="casContent"><span class="casTitleNuber">21d</span><div class="casTitle"><span class="NLM_cas:atitle">Designing novel building blocks is an overlooked strategy to improve compound quality</span></div><div class="casAuthors">Goldberg Frederick W; Kettle Jason G; Tomkinson Nick P; Kogej Thierry; Perry Matthew W D</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">One pragmatic way to improve compound quality, while enhancing and accelerating drug discovery projects, is the ability to access a high quality, novel, diverse building block collection.  Here, we outline general principles that should be applied to ensure that a building block collection has the greatest impact on drug discovery projects, by discussing design principles for novel reagents and what types of reagents are popular with medicinal chemists in general.  We initiated a program in 2009 to address this, which has already delivered three candidate drugs, and the success of that program provides evidence that focussing on building block design is a useful strategy for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPdgCfKmtVe0g6wdEZmT2rfW6udTcc2eZfG6rEPWdk8rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7nt1aksA%253D%253D&md5=6abab9b017e3d115c1ac7ac6b0483bb9</span></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DKogej%26aufirst%3DT.%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DTomkinson%26aufirst%3DN.%2BP.%26atitle%3DDesigning%2520novel%2520building%2520blocks%2520is%2520an%2520overlooked%2520strategy%2520to%2520improve%2520compound%2520quality%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.drudis.2014.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Grygorenko, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volochnyuk, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabukhin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, D. B.</span></span> <span> </span><span class="NLM_article-title">The symbiotic relationship between drug discovery and organic chemistry</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1196â</span>â <span class="NLM_lpage">1237</span>, <span class="refDoi">Â DOI: 10.1002/chem.201903232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fchem.201903232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=31429510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVOhu73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=1196%E2%88%92-1237&author=O.+O.+Grygorenkoauthor=D.+M.+Volochnyukauthor=S.+V.+Ryabukhinauthor=D.+B.+Judd&title=The+symbiotic+relationship+between+drug+discovery+and+organic+chemistry&doi=10.1002%2Fchem.201903232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">The Symbiotic Relationship Between Drug Discovery and Organic Chemistry</span></div><div class="casAuthors">Grygorenko, Oleksandr O.; Volochnyuk, Dmitriy M.; Ryabukhin, Sergey V.; Judd, Duncan B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1196-1237</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  All pharmaceutical products contain org. mols.; the source may be a natural product or a fully synthetic mol., or a combination of both.  Thus, it follows that org. chem. underpins both existing and upcoming pharmaceutical products.  The reverse relationship has also affected org. synthesis, changing its landscape towards increasingly complex targets.  This Review article sets out to give a concise appraisal of this symbiotic relationship between org. chem. and drug discovery, along with a discussion of the design concepts and highlighting key milestones along the journey.  In particular, criteria for a high-quality compd. library design enabling efficient virtual navigation of chem. space, as well as rise and fall of concepts for its synthetic exploration (such as combinatorial chem.; diversity-, biol.-, lead-, or fragment-oriented syntheses; and DNA-encoded libraries) are critically surveyed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Fk5uC_3_C7Vg90H21EOLACvtfcHk0lhWstXhtMh_eA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVOhu73M&md5=595516bf7865e5b1024348d426521d25</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201903232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201903232%26sid%3Dliteratum%253Aachs%26aulast%3DGrygorenko%26aufirst%3DO.%2BO.%26aulast%3DVolochnyuk%26aufirst%3DD.%2BM.%26aulast%3DRyabukhin%26aufirst%3DS.%2BV.%26aulast%3DJudd%26aufirst%3DD.%2BB.%26atitle%3DThe%2520symbiotic%2520relationship%2520between%2520drug%2520discovery%2520and%2520organic%2520chemistry%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2020%26volume%3D26%26spage%3D1196%25E2%2588%2592%26epage%3D1237%26doi%3D10.1002%2Fchem.201903232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreher, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillyer, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truppo, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E. R.</span></span> <span> </span><span class="NLM_article-title">The importance of synthetic chemistry in the pharmaceutical industry</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">eaat0805</span>, <span class="refDoi">Â DOI: 10.1126/science.aat0805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1126%2Fscience.aat0805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30655413" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2019&pages=eaat0805&author=K.+R.+Camposauthor=P.+J.+Colemanauthor=J.+C.+Alvarezauthor=S.+D.+Dreherauthor=R.+M.+Garbaccioauthor=N.+K.+Terrettauthor=R.+D.+Tillyerauthor=M.+D.+Truppoauthor=E.+R.+Parmee&title=The+importance+of+synthetic+chemistry+in+the+pharmaceutical+industry&doi=10.1126%2Fscience.aat0805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1126%2Fscience.aat0805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aat0805%26sid%3Dliteratum%253Aachs%26aulast%3DCampos%26aufirst%3DK.%2BR.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DAlvarez%26aufirst%3DJ.%2BC.%26aulast%3DDreher%26aufirst%3DS.%2BD.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26aulast%3DTillyer%26aufirst%3DR.%2BD.%26aulast%3DTruppo%26aufirst%3DM.%2BD.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DThe%2520importance%2520of%2520synthetic%2520chemistry%2520in%2520the%2520pharmaceutical%2520industry%26jtitle%3DScience%26date%3D2019%26volume%3D363%26spage%3Deaat0805%26doi%3D10.1126%2Fscience.aat0805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">BostrÃ¶m, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KeserÃ¼, G. M.</span></span> <span> </span><span class="NLM_article-title">Expanding the medicinal chemistry synthetic toolbox</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">709</span>â <span class="NLM_lpage">727</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2018.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnrd.2018.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30140018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=709-727&author=J.+Bostr%C3%B6mauthor=D.+G.+Brownauthor=R.+J.+Youngauthor=G.+M.+Keser%C3%BC&title=Expanding+the+medicinal+chemistry+synthetic+toolbox&doi=10.1038%2Fnrd.2018.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the medicinal chemistry synthetic toolbox</span></div><div class="casAuthors">Bostrom Jonas; Brown Dean G; Young Robert J; Keseru Gyorgy M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">709-727</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The key objectives of medicinal chemistry are to efficiently design and synthesize bioactive compounds that have the potential to become safe and efficacious drugs.  Most medicinal chemistry programmes rely on screening compound collections populated by a range of molecules derived from a set of known and robust chemistry reactions.  Analysis of the role of synthetic organic chemistry in subsequent hit and lead optimization efforts suggests that only a few reactions dominate.  Thus, the uptake of new synthetic methodologies in drug discovery is limited.  Starting from the known limitations of reaction parameters, synthesis design tools, synthetic strategies and innovative chemistries, here we highlight opportunities for the expansion of the medicinal chemists' synthetic toolbox.  More intense crosstalk between synthetic and medicinal chemists in industry and academia should enable enhanced impact of new methodologies in future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy8c_ueHSwcYMcDoIzZtNkfW6udTcc2eZM4RdSKKBVerntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D&md5=d87e988602808139597576ced56faa88</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.116%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DExpanding%2520the%2520medicinal%2520chemistry%2520synthetic%2520toolbox%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D709%26epage%3D727%26doi%3D10.1038%2Fnrd.2018.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Organic synthesis provides opportunities to transform drug discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">394</span>, <span class="refDoi">Â DOI: 10.1038/s41557-018-0021-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fs41557-018-0021-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29568051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=383-394&author=D.+C.+Blakemoreauthor=L.+Castroauthor=I.+Churcherauthor=D.+C.+Reesauthor=A.+W.+Thomasauthor=D.+M.+Wilsonauthor=A.+Wood&title=Organic+synthesis+provides+opportunities+to+transform+drug+discovery&doi=10.1038%2Fs41557-018-0021-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis provides opportunities to transform drug discovery</span></div><div class="casAuthors">Blakemore, David C.; Castro, Luis; Churcher, Ian; Rees, David C.; Thomas, Andrew W.; Wilson, David M.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite decades of ground-breaking research in academia, org. synthesis is still a rate-limiting factor in drug-discovery projects.  Here we present some current challenges in synthetic org. chem. from the perspective of the pharmaceutical industry and highlight problematic steps that, if overcome, would find extensive application in the discovery of transformational medicines.  Significant synthesis challenges arise from the fact that drug mols. typically contain amines and N-heterocycles, as well as unprotected polar groups.  There is also a need for new reactions that enable non-traditional disconnections, more C-H bond activation and late-stage functionalization, as well as stereoselectively substituted aliph. heterocyclic ring synthesis, C-X or C-C bond formation.  We also emphasize that syntheses compatible with biomacromols. will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.  We believe that increasing collaboration between academic and industrial chemists is crucial to address the challenges outlined here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqR_RxjClS7Vg90H21EOLACvtfcHk0liKpGmB0yjtDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D&md5=f6269ea8193e28416fd86fe8afbcea3f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0021-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0021-z%26sid%3Dliteratum%253Aachs%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOrganic%2520synthesis%2520provides%2520opportunities%2520to%2520transform%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D383%26epage%3D394%26doi%3D10.1038%2Fs41557-018-0021-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The medicinal chemistâs toolbox for late stage functionalization of drug-like molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">546</span>â <span class="NLM_lpage">576</span>, <span class="refDoi">Â DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=26507237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+medicinal+chemist%E2%80%99s+toolbox+for+late+stage+functionalization+of+drug-like+molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span></div><div class="casAuthors">Cernak, Tim; Dykstra, Kevin D.; Tyagarajan, Sriram; Vachal, Petr; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">546-576</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs.  LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the prepn. of biol. probes.  This review details a toolbox of intermol. C-H functionalization chemistries with proven applicability to drug-like mols., classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations.  In addn., a no. of examples illustrate how LSF approaches have been used to impact actual drug discovery and chem. biol. efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7N9sPaaVAQbVg90H21EOLACvtfcHk0liKpGmB0yjtDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN&md5=a52fc5692f5515e5cadab0f2746fd6f7</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520medicinal%2520chemist%25E2%2580%2599s%2520toolbox%2520for%2520late%2520stage%2520functionalization%2520of%2520drug-like%2520molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danon, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reekie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">An overview of late-stage functionalization in todayâs drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1137</span>â <span class="NLM_lpage">1149</span>, <span class="refDoi">Â DOI: 10.1080/17460441.2019.1653850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1080%2F17460441.2019.1653850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=31411499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjur7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1137-1149&author=M.+Moirauthor=J.+J.+Danonauthor=T.+A.+Reekieauthor=M.+Kassiou&title=An+overview+of+late-stage+functionalization+in+today%E2%80%99s+drug+discovery&doi=10.1080%2F17460441.2019.1653850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of late-stage functionalization in today's drug discovery</span></div><div class="casAuthors">Moir, Michael; Danon, Jonathon J.; Reekie, Tristan A.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1137-1149</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Late-stage functionalization (LSF) can introduce important chem. groups in the very last steps of the synthesis.  LSF has the potential to speed up the prepn. of novel chem. entities and diverse chem. libraries and have a major impact on drug discovery.  Functional group tolerance and mild conditions allows access to new mols. not easily accessible by conventional approaches without the need for laborious de novo chem. synthesis.: A historical overview of late-stage functionalization and its applicability to drug discovery is provided.  Pioneering methodologies that laid the foundations for the field are briefly covered and archetypal examples of their application to drug discovery are discussed.  Novel methodologies reported in the past few years mainly stemming from the recent renaissances of photoredox catalysis and radical chem. are reviewed and their application to drug discovery considered.: It is envisioned that late-stage functionalization will improve the efficiency and efficacy of drug discovery.  There is evidence of the widespread uptake of LSF by the medicinal chem. community and it is expected that the recent and continuing endeavors of many academic labs. and pharmaceutical companies will soon have an impact on drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWz180tOlaLVg90H21EOLACvtfcHk0lhNKoXuZGTLzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjur7M&md5=6666a45786be0a081b452ab139a279de</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1080%2F17460441.2019.1653850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2019.1653850%26sid%3Dliteratum%253Aachs%26aulast%3DMoir%26aufirst%3DM.%26aulast%3DDanon%26aufirst%3DJ.%2BJ.%26aulast%3DReekie%26aufirst%3DT.%2BA.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DAn%2520overview%2520of%2520late-stage%2520functionalization%2520in%2520today%25E2%2580%2599s%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2019%26volume%3D14%26spage%3D1137%26epage%3D1149%26doi%3D10.1080%2F17460441.2019.1653850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szpera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moseley, D. F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span> <span> </span><span class="NLM_article-title">The fluorination of CâH bonds: developments and perspectives</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">14824</span>â <span class="NLM_lpage">14848</span>, <span class="refDoi">Â DOI: 10.1002/anie.201814457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201814457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2lsbfL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=14824-14848&author=R.+Szperaauthor=D.+F.+J.+Moseleyauthor=L.+B.+Smithauthor=A.+J.+Sterlingauthor=V.+Gouverneur&title=The+fluorination+of+C%E2%80%93H+bonds%3A+developments+and+perspectives&doi=10.1002%2Fanie.201814457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">The Fluorination of C-H Bonds: Developments and Perspectives</span></div><div class="casAuthors">Szpera, Robert; Moseley, Daniel F. J.; Smith, Lewis B.; Sterling, Alistair J.; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14824-14848</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review discusses fluorination reactions at C-H bonds, including metal-catalyzed directed fluorination reactions, and directed and undirected radical-mediated fluorination reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFPTwsJa2oc7Vg90H21EOLACvtfcHk0lhNKoXuZGTLzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2lsbfL&md5=2295219ba91a3d67ae3e89b014b7bb84</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201814457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201814457%26sid%3Dliteratum%253Aachs%26aulast%3DSzpera%26aufirst%3DR.%26aulast%3DMoseley%26aufirst%3DD.%2BF.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BB.%26aulast%3DSterling%26aufirst%3DA.%2BJ.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3DThe%2520fluorination%2520of%2520C%25E2%2580%2593H%2520bonds%253A%2520developments%2520and%2520perspectives%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D14824%26epage%3D14848%26doi%3D10.1002%2Fanie.201814457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Champagne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroches, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandamme, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquin, J.-F.</span></span> <span> </span><span class="NLM_article-title">Monofluorination of organic compounds: 10 years of innovation</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9073</span>â <span class="NLM_lpage">9174</span>, <span class="refDoi">Â DOI: 10.1021/cr500706a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500706a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2ntrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=9073-9174&author=P.+A.+Champagneauthor=J.+Desrochesauthor=J.-D.+Hamelauthor=M.+Vandammeauthor=J.-F.+Paquin&title=Monofluorination+of+organic+compounds%3A+10+years+of+innovation&doi=10.1021%2Fcr500706a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Monofluorination of Organic Compounds: 10 Years of Innovation</span></div><div class="casAuthors">Champagne, Pier Alexandre; Desroches, Justine; Hamel, Jean-Denys; Vandamme, Mathilde; Paquin, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9073-9174</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review is regarding the monofluorination of org. compds., i.e., synthetic methods allowing the introduction of a single C-F bond.  It emphasizes developments that occurred within the last 10 years.  After a brief survey of the approaches for the creation of single C-F bonds, the recent synthetic methods will be classified and reviewed according to the hybridization of the carbon atom bearing the fluorine atom.  Within each section, further subclassification according to the targeted fluorinated motif has been used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQEf8H1PdwwrVg90H21EOLACvtfcHk0lhNKoXuZGTLzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2ntrg%253D&md5=20781b11dc1f14c2547e20e2b07d1be9</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Fcr500706a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500706a%26sid%3Dliteratum%253Aachs%26aulast%3DChampagne%26aufirst%3DP.%2BA.%26aulast%3DDesroches%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DJ.-D.%26aulast%3DVandamme%26aufirst%3DM.%26aulast%3DPaquin%26aufirst%3DJ.-F.%26atitle%3DMonofluorination%2520of%2520organic%2520compounds%253A%252010%2520years%2520of%2520innovation%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D9073%26epage%3D9174%26doi%3D10.1021%2Fcr500706a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span> <span> </span><span class="NLM_article-title">Fluorination in medicinal chemistry: methods, strategies, and recent developments</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">305</span>â <span class="NLM_lpage">321</span>, <span class="refDoi">Â DOI: 10.1021/op700134j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op700134j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFShurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=305-321&author=K.+L.+Kirk&title=Fluorination+in+medicinal+chemistry%3A+methods%2C+strategies%2C+and+recent+developments&doi=10.1021%2Fop700134j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments</span></div><div class="casAuthors">Kirk, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-321</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Methods for introducing fluorine into org. mols. are reviewed, with an emphasis on prepn. of compds. designed for biomedicinal applications.  Electrophilic fluorination, nucleophilic fluorination, and enantioselective monofluorination procedures are discussed.  This is followed by a review of the development of nucleophilic and electrophilic trifluoromethylation procedures.  The final sections highlight recent applications of fluorine chem. in drug development with selected examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8akVjV2KOCLVg90H21EOLACvtfcHk0lhNKoXuZGTLzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFShurw%253D&md5=a711891a5ddcec38304baab1dbc79282</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fop700134j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop700134j%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DFluorination%2520in%2520medicinal%2520chemistry%253A%2520methods%252C%2520strategies%252C%2520and%2520recent%2520developments%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D305%26epage%3D321%26doi%3D10.1021%2Fop700134j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Modern carbonâfluorine bond forming reactions for aryl fluoride synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">612</span>â <span class="NLM_lpage">633</span>, <span class="refDoi">Â DOI: 10.1021/cr500366b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500366b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegtbzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=612-633&author=M.+G.+Campbellauthor=T.+Ritter&title=Modern+carbon%E2%80%93fluorine+bond+forming+reactions+for+aryl+fluoride+synthesis&doi=10.1021%2Fcr500366b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">Modern Carbon-Fluorine Bond Forming Reactions for Aryl Fluoride Synthesis</span></div><div class="casAuthors">Campbell, Michael G.; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">612-633</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on modern carbon-fluorine bond forming reactions for aryl fluoride synthesis.  Topics discussed include: nucleophilic arene fluorination; nucleophilic deoxyfluorination of phenols; electrophilic arene fluorination; oxidative fluorination with fluoride; arene 18F-fluorination for positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEuoUOGSbs7Vg90H21EOLACvtfcHk0lhv7pmw7IlSgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegtbzF&md5=080f9c9f181a05850dc6cc0978c0b6fa</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1021%2Fcr500366b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500366b%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DM.%2BG.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DModern%2520carbon%25E2%2580%2593fluorine%2520bond%2520forming%2520reactions%2520for%2520aryl%2520fluoride%2520synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D612%26epage%3D633%26doi%3D10.1021%2Fcr500366b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Selective CâH bond fluorination of phenols with a removable directing group: late-stage fluorination of 2-phenoxyl nicotinate derivatives</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2846</span>â <span class="NLM_lpage">2849</span>, <span class="refDoi">Â DOI: 10.1021/acscatal.5b00306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.5b00306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtVWrsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=2846-2849&author=S.-J.+Louauthor=Q.+Chenauthor=Y.-F.+Wangauthor=D.-Q.+Xuauthor=X.-H.+Duauthor=J.-Q.+Heauthor=Y.-J.+Maoauthor=Z.-Y.+Xu&title=Selective+C%E2%80%93H+bond+fluorination+of+phenols+with+a+removable+directing+group%3A+late-stage+fluorination+of+2-phenoxyl+nicotinate+derivatives&doi=10.1021%2Facscatal.5b00306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25eR"><div class="casContent"><span class="casTitleNuber">25e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective C-H Bond Fluorination of Phenols with a Removable Directing Group: Late-Stage Fluorination of 2-Phenoxyl Nicotinate Derivatives</span></div><div class="casAuthors">Lou, Shao-Jie; Chen, Qi; Wang, Yi-Feng; Xu, Dan-Qian; Du, Xiao-Hua; He, Jiang-Qi; Mao, Yang-Jie; Xu, Zhen-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2846-2849</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile and site-selective C-H bond fluorination of phenols using removable 2-pyridyloxy group as an auxiliary was developed.  E.g., in presence of Pd(dba)2 and N-fluorobenzenesulfonimide, fluorination of 2-phenoxypyridine gave 81% I.  Alternatively, late-stage C-H bond fluorination of bioactive 2-phenoxyl nicotinate derivs. and diflufenican were also feasible under the present strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobqvI_frHh0rVg90H21EOLACvtfcHk0lhv7pmw7IlSgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtVWrsrs%253D&md5=bff95c9d6d9a33fa72ec23584f84398b</span></div><a href="/servlet/linkout?suffix=cit25e&amp;dbid=16384&amp;doi=10.1021%2Facscatal.5b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.5b00306%26sid%3Dliteratum%253Aachs%26aulast%3DLou%26aufirst%3DS.-J.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DXu%26aufirst%3DD.-Q.%26aulast%3DDu%26aufirst%3DX.-H.%26aulast%3DHe%26aufirst%3DJ.-Q.%26aulast%3DMao%26aufirst%3DY.-J.%26aulast%3DXu%26aufirst%3DZ.-Y.%26atitle%3DSelective%2520C%25E2%2580%2593H%2520bond%2520fluorination%2520of%2520phenols%2520with%2520a%2520removable%2520directing%2520group%253A%2520late-stage%2520fluorination%2520of%25202-phenoxyl%2520nicotinate%2520derivatives%26jtitle%3DACS%2520Catal.%26date%3D2015%26volume%3D5%26spage%3D2846%26epage%3D2849%26doi%3D10.1021%2Facscatal.5b00306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, J. A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolfes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursalian, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghs, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genicot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gastel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalysed electrophilic aromatic CâH fluorination</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>554</i></span>,  <span class="NLM_fpage">511</span>â <span class="NLM_lpage">514</span>, <span class="refDoi">Â DOI: 10.1038/nature25749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnature25749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29469096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFCrtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=554&publication_year=2018&pages=511-514&author=K.+Yamamotoauthor=J.+Liauthor=J.+A.+O.+Garberauthor=J.+D.+Rolfesauthor=G.+B.+Boursalianauthor=J.+C.+Borghsauthor=C.+Genicotauthor=J.+Jacqauthor=M.+van+Gastelauthor=F.+Neeseauthor=T.+Ritter&title=Palladium-catalysed+electrophilic+aromatic+C%E2%80%93H+fluorination&doi=10.1038%2Fnature25749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25fR"><div class="casContent"><span class="casTitleNuber">25f</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalysed electrophilic aromatic C-H fluorination</span></div><div class="casAuthors">Yamamoto, Kumiko; Li, Jiakun; Garber, Jeffrey A. O.; Rolfes, Julian D.; Boursalian, Gregory B.; Borghs, Jannik C.; Genicot, Christophe; Jacq, Jerome; van Gastel, Maurice; Neese, Frank; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">554</span>
        (<span class="NLM_cas:issue">7693</span>),
    <span class="NLM_cas:pages">511-514</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Aryl fluorides are widely used in the pharmaceutical and agrochem. industries, and recent advances have enabled their synthesis through the conversion of various functional groups.  However, there is a lack of general methods for direct arom. carbon-hydrogen (C-H) fluorination.  Conventional methods require the use of either strong fluorinating reagents, which are often unselective and difficult to handle, such as elemental fluorine, or less reactive reagents that attack only the most activated arenes, which reduces the substrate scope.  A method for the direct fluorination of arom. C-H bonds could facilitate access to fluorinated derivs. of functional mols. that would otherwise be difficult to produce.  For example, drug candidates with improved properties, such as increased metabolic stability or better blood-brain-barrier penetration, may become available.  Here we describe an approach to catalysis and the resulting development of an undirected, palladium-catalyzed method for arom. C-H fluorination using mild electrophilic fluorinating reagents.  The reaction involves a mode of catalysis that is unusual in arom. C-H functionalization because no organometallic intermediate is formed; instead, a reactive transition-metal-fluoride electrophile is generated catalytically for the fluorination of arenes that do not otherwise react with mild fluorinating reagents.  The scope and functional-group tolerance of this reaction could provide access to functional fluorinated mols. in pharmaceutical and agrochem. development that would otherwise not be readily accessible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2db4Fz5yE_LVg90H21EOLACvtfcHk0lhv7pmw7IlSgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFCrtr8%253D&md5=b0324d3f6b466ea3b86a38801a744485</span></div><a href="/servlet/linkout?suffix=cit25f&amp;dbid=16384&amp;doi=10.1038%2Fnature25749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25749%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGarber%26aufirst%3DJ.%2BA.%2BO.%26aulast%3DRolfes%26aufirst%3DJ.%2BD.%26aulast%3DBoursalian%26aufirst%3DG.%2BB.%26aulast%3DBorghs%26aufirst%3DJ.%2BC.%26aulast%3DGenicot%26aufirst%3DC.%26aulast%3DJacq%26aufirst%3DJ.%26aulast%3Dvan%2BGastel%26aufirst%3DM.%26aulast%3DNeese%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DPalladium-catalysed%2520electrophilic%2520aromatic%2520C%25E2%2580%2593H%2520fluorination%26jtitle%3DNature%26date%3D2018%26volume%3D554%26spage%3D511%26epage%3D514%26doi%3D10.1038%2Fnature25749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">PhenoFluorMix: practical chemoselective deoxyfluorination of phenols</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">544</span>â <span class="NLM_lpage">547</span>, <span class="refDoi">Â DOI: 10.1021/ol5035518</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5035518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=544-547&author=T.+Fujimotoauthor=T.+Ritter&title=PhenoFluorMix%3A+practical+chemoselective+deoxyfluorination+of+phenols&doi=10.1021%2Fol5035518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25gR"><div class="casContent"><span class="casTitleNuber">25g</span><div class="casTitle"><span class="NLM_cas:atitle">PhenoFluorMix: Practical Chemoselective Deoxyfluorination of Phenols</span></div><div class="casAuthors">Fujimoto, Teppei; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">544-547</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical deoxyfluorination with novel deoxyfluorinating reagent PhenoFluorMix, a mixt. of N,N'-1,3-bis(2,6-diisopropylphenyl)chloroimidazolium chloride and CsF, is presented.  PhenoFluorMix overcomes the challenges assocd. with hydrolysis of PhenoFluor.  PhenoFluorMix does not hydrolyze, is readily available on decagram scale, and is storable in air.  In this paper, we demonstrate the practicality of the reagent and exhibit the deoxyfluorination of a variety of phenols and heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJw6tRFylga7Vg90H21EOLACvtfcHk0lhv7pmw7IlSgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWns7g%253D&md5=02ed1484e06fa21d5b92ce6aa485d292</span></div><a href="/servlet/linkout?suffix=cit25g&amp;dbid=16384&amp;doi=10.1021%2Fol5035518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5035518%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DPhenoFluorMix%253A%2520practical%2520chemoselective%2520deoxyfluorination%2520of%2520phenols%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D544%26epage%3D547%26doi%3D10.1021%2Fol5035518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiRocco, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudge, M.</span></span> <span> </span><span class="NLM_article-title">Late-stage functionalization of biologically active heterocycles through photoredox catalysis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4802</span>â <span class="NLM_lpage">4806</span>, <span class="refDoi">Â DOI: 10.1002/anie.201402023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201402023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4802-4806&author=D.+A.+DiRoccoauthor=K.+Dykstraauthor=S.+Krskaauthor=P.+Vachalauthor=D.+V.+Conwayauthor=M.+Tudge&title=Late-stage+functionalization+of+biologically+active+heterocycles+through+photoredox+catalysis&doi=10.1002%2Fanie.201402023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Late-stage functionalization of biologically active heterocycles through photoredox catalysis</span></div><div class="casAuthors">Dirocco Daniel A; Dykstra Kevin; Krska Shane; Vachal Petr; Conway Donald V; Tudge Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4802-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The direct C H functionalization of heterocycles has become an increasingly valuable tool in modern drug discovery.  However, the introduction of small alkyl groups, such as methyl, by this method has not been realized in the context of complex molecule synthesis since existing methods rely on the use of strong oxidants and elevated temperatures to generate the requisite radical species.  Herein, we report the use of stable organic peroxides activated by visible-light photoredox catalysis to achieve the direct methyl-, ethyl-, and cyclopropylation of a variety of biologically active heterocycles.  The simple protocol, mild reaction conditions, and unique tolerability of this method make it an important tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmAsN0YQNtXD69zv1FsJFMfW6udTcc2eZu_LTBGk-8Urntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D&md5=ca31296d61c97e944eaaf326a8190458</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402023%26sid%3Dliteratum%253Aachs%26aulast%3DDiRocco%26aufirst%3DD.%2BA.%26aulast%3DDykstra%26aufirst%3DK.%26aulast%3DKrska%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DConway%26aufirst%3DD.%2BV.%26aulast%3DTudge%26aufirst%3DM.%26atitle%3DLate-stage%2520functionalization%2520of%2520biologically%2520active%2520heterocycles%2520through%2520photoredox%2520catalysis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4802%26epage%3D4806%26doi%3D10.1002%2Fanie.201402023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteker, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Trimethylphosphate as a methylating agent for cross coupling: a slow-release mechanism for the methylation of arylboronic esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">17197</span>â <span class="NLM_lpage">17202</span>, <span class="refDoi">Â DOI: 10.1021/jacs.8b10076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b10076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKnur3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=17197-17202&author=Z.-T.+Heauthor=H.+Liauthor=A.+M.+Haydlauthor=G.+T.+Whitekerauthor=J.+F.+Hartwig&title=Trimethylphosphate+as+a+methylating+agent+for+cross+coupling%3A+a+slow-release+mechanism+for+the+methylation+of+arylboronic+esters&doi=10.1021%2Fjacs.8b10076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Trimethylphosphate as a Methylating Agent for Cross Coupling: A Slow-Release Mechanism for the Methylation of Arylboronic Esters</span></div><div class="casAuthors">He, Zhi-Tao; Li, Haoquan; Haydl, Alexander M.; Whiteker, Gregory T.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17197-17202</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tri-Me phosphate acted as an effective source of Me groups; in the presence of CuI, and LiI, (MeO)3P(:O) underwent chemoselective coupling with arylpinacolboronates mediated by LiOt-Bu in 1,3-dimethylimidazolidin-2-one (DMI) to yield methylarenes in higher yields than related coupling reactions using either Me iodide or Me tosylate.  The methylation reaction was used in tandem with iridium-catalyzed regioselective borylation with bis(pinacolato)diboron to provide a one-pot methylation reaction for arenes, and for trideuteromethylation of arylpinacoboronates using tris(trideuteromethyl) phosphate.  The chemoselectivity of the reaction was tested using additives possessing various functional groups (robustness screen); unprotected amines, alcs., and amides and terminal alkynes were not tolerated.  The methylation of 1-naphthylpinacolboronate was demonstrated on a 200 mmol scale.  The kinetics of the methylation and its dependence on Li+ and I- ions was detd. and a mechanism suggested.  Me iodide is released slowly upon reaction of tri-Me phosphate with iodide; the low concn. of MeI enables selective reaction with arylcopper intermediates generated from the arylboronate rather than with other nucleophiles, while binding of tert-butoxide to the pinacolboronate reactants inhibits reaction of MeI with tert-butoxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsXA5OuLeJhLVg90H21EOLACvtfcHk0ljJ0fpwbXno8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKnur3K&md5=966a6f09464d464c9d7da2af5a8ed881</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b10076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b10076%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DZ.-T.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHaydl%26aufirst%3DA.%2BM.%26aulast%3DWhiteker%26aufirst%3DG.%2BT.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DTrimethylphosphate%2520as%2520a%2520methylating%2520agent%2520for%2520cross%2520coupling%253A%2520a%2520slow-release%2520mechanism%2520for%2520the%2520methylation%2520of%2520arylboronic%2520esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D17197%26epage%3D17202%26doi%3D10.1021%2Fjacs.8b10076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Haydl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed methylation of aryl, heteroaryl, and vinyl boronate esters</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1337</span>â <span class="NLM_lpage">1341</span>, <span class="refDoi">Â DOI: 10.1021/acs.orglett.9b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.9b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVWjtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=1337-1341&author=A.+M.+Haydlauthor=J.+F.+Hartwig&title=Palladium-catalyzed+methylation+of+aryl%2C+heteroaryl%2C+and+vinyl+boronate+esters&doi=10.1021%2Facs.orglett.9b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Methylation of Aryl, Heteroaryl, and Vinyl Boronate Esters</span></div><div class="casAuthors">Haydl, Alexander M.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1337-1341</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method for the direct methylation of aryl, heteroaryl, and vinyl boronate esters is reported, involving the reaction of iodomethane with aryl-, heteroaryl-, and vinylboronate esters catalyzed by palladium and PtBu2Me.  This transformation occurs with a remarkably broad scope and is suitable for late-stage derivatization of biol. active compds. via the boronate esters.  The unique capabilities of this method are demonstrated by combining carbon-boron bond-forming reactions with palladium-catalyzed methylation in a tandem transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomscu9ZdlbErVg90H21EOLACvtfcHk0ljJ0fpwbXno8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVWjtLw%253D&md5=033fcba7d30179e8e622332347c52ba1</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.9b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.9b00025%26sid%3Dliteratum%253Aachs%26aulast%3DHaydl%26aufirst%3DA.%2BM.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520methylation%2520of%2520aryl%252C%2520heteroaryl%252C%2520and%2520vinyl%2520boronate%2520esters%26jtitle%3DOrg.%2520Lett.%26date%3D2019%26volume%3D21%26spage%3D1337%26epage%3D1341%26doi%3D10.1021%2Facs.orglett.9b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-Q.</span></span> <span> </span><span class="NLM_article-title">Divergent CâH functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discovery</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">7222</span>â <span class="NLM_lpage">7228</span>, <span class="refDoi">Â DOI: 10.1021/ja201708f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja201708f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=7222-7228&author=H.-X.+Daiauthor=A.+F.+Stepanauthor=M.+S.+Plummerauthor=Y.-H.+Zhangauthor=J.-Q.+Yu&title=Divergent+C%E2%80%93H+functionalizations+directed+by+sulfonamide+pharmacophores%3A+late-stage+diversification+as+a+tool+for+drug+discovery&doi=10.1021%2Fja201708f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26dR"><div class="casContent"><span class="casTitleNuber">26d</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent C-H Functionalizations Directed by Sulfonamide Pharmacophores: Late-Stage Diversification as a Tool for Drug Discovery</span></div><div class="casAuthors">Dai, Hui-Xiong; Stepan, Antonia F.; Plummer, Mark S.; Zhang, Yang-Hui; Yu, Jin-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7222-7228</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modern drug discovery is contingent on identifying lead compds. and rapidly synthesizing analogs.  The use of a common pharmacophore to direct multiple and divergent C-H functionalizations of lead compds. is a particularly attractive approach.  Herein, we demonstrate the viability of late-stage diversification through the divergent C-H functionalization of sulfonamides, an important class of pharmacophores found in nearly 200 drugs currently on the market, including the non-steroidal anti-inflammatory blockbuster drug celecoxib.  We developed a set of six categorically different sulfonamide C-H functionalization reactions (olefination, arylation, alkylation, halogenation, carboxylation, and carbonylation), each representing a distinct handle for further diversification to reach a large no. of analogs.  We then performed late-stage, site-selective diversification of a sulfonamide drug candidate contg. multiple potentially reactive C-H bonds to synthesize directly novel celecoxib analogs as potential cyclooxygenase-II (COX-2)-specific inhibitors.  Together with other recently developed practical directing groups, such as CONHOMe and CONHC6F5, sulfonamide directing groups demonstrate that the auxiliary approach established in asym. catalysis can be equally effective in developing broadly useful C-H activation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXYAuyvgct5LVg90H21EOLACvtfcHk0lgW1nc71FsoQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSqtbY%253D&md5=a5fd5362c557b527c52dd12327572c6e</span></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=10.1021%2Fja201708f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja201708f%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DH.-X.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DZhang%26aufirst%3DY.-H.%26aulast%3DYu%26aufirst%3DJ.-Q.%26atitle%3DDivergent%2520C%25E2%2580%2593H%2520functionalizations%2520directed%2520by%2520sulfonamide%2520pharmacophores%253A%2520late-stage%2520diversification%2520as%2520a%2520tool%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D7222%26epage%3D7228%26doi%3D10.1021%2Fja201708f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Serpier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genicot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Selective methylation of arenes: a radical CâH functionalization/cross-coupling sequence</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10697</span>â <span class="NLM_lpage">10701</span>, <span class="refDoi">Â DOI: 10.1002/anie.201804628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201804628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1ykurjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=10697-10701&author=F.+Serpierauthor=F.+Panauthor=W.+S.+Hamauthor=J.+Jacqauthor=C.+Genicotauthor=T.+Ritter&title=Selective+methylation+of+arenes%3A+a+radical+C%E2%80%93H+functionalization%2Fcross-coupling+sequence&doi=10.1002%2Fanie.201804628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26eR"><div class="casContent"><span class="casTitleNuber">26e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Methylation of Arenes: A Radical C-H Functionalization/Cross-Coupling Sequence</span></div><div class="casAuthors">Serpier, Fabien; Pan, Fei; Ham, Won Seok; Jacq, Jerome; Genicot, Christophe; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10697-10701</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A selective, nonchelation-assisted methylation of arenes has been developed.  The overall transformation, which combines a C-H functionalization reaction with a nickel-catalyzed cross-coupling, offers rapid access to methylated arenes with high para selectivity.  The reaction is amenable to late-stage methylation of small-mol. pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVJSHAvYGov7Vg90H21EOLACvtfcHk0lgW1nc71FsoQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1ykurjN&md5=4db5782909c8909827a690953fe42238</span></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.1002%2Fanie.201804628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201804628%26sid%3Dliteratum%253Aachs%26aulast%3DSerpier%26aufirst%3DF.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DHam%26aufirst%3DW.%2BS.%26aulast%3DJacq%26aufirst%3DJ.%26aulast%3DGenicot%26aufirst%3DC.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DSelective%2520methylation%2520of%2520arenes%253A%2520a%2520radical%2520C%25E2%2580%2593H%2520functionalization%252Fcross-coupling%2520sequence%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D10697%26epage%3D10701%26doi%3D10.1002%2Fanie.201804628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">CâH methylation of heteroarenes inspired by radical SAM methyl transferase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">4853</span>â <span class="NLM_lpage">4856</span>, <span class="refDoi">Â DOI: 10.1021/ja5007838</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5007838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVOntbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4853-4856&author=J.+Guiauthor=Q.+Zhouauthor=C.-M.+Panauthor=Y.+Yabeauthor=A.+C.+Burnsauthor=M.+R.+Collinsauthor=M.+A.+Ornelasauthor=Y.+Ishiharaauthor=P.+S.+Baran&title=C%E2%80%93H+methylation+of+heteroarenes+inspired+by+radical+SAM+methyl+transferase&doi=10.1021%2Fja5007838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26fR"><div class="casContent"><span class="casTitleNuber">26f</span><div class="casTitle"><span class="NLM_cas:atitle">C-H Methylation of Heteroarenes Inspired by Radical SAM Methyl Transferase</span></div><div class="casAuthors">Gui, Jinghan; Zhou, Qianghui; Pan, Chung-Mao; Yabe, Yuki; Burns, Aaron C.; Collins, Michael R.; Ornelas, Martha A.; Ishihara, Yoshihiro; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4853-4856</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A variety of nitrogen heterocycles such as caffeine I (R = H) reacted with the (phenylsulfonyl)methylating agent zinc bis(phenylsulfonylmethylsulfinate) (PhSO2CH2SO2)2Zn (II) with tert-Bu hydroperoxide in PhCF3/H2O to yield phenylsulfonylmethylated nitrogen heterocycles such as I (R = PhSO2CH2) in 41-99% yields and in most cases as single regioisomers; the method is tolerant of air and moisture, did not racemize nonracemic amino acid derivs., and tolerated various functional groups such as bromo and nitro groups.  Using one of three different sets of reagents (either activated Mg in MeOH, SmI2 in THF/H2O, or Raney nickel in EtOH), phenylsulfonylmethylated products such as I (R = PhSO2CH2) were desulfonylated in 75-99% yields to yield methylated products such as I (R = Me); thus, the two-step procedure constitutes a method for radical methylation of nitrogen heterocycles.  The phenylsulfonylmethylated product was readily sepd. from the unmethylated heterocycles, while the corresponding methylated products were not always separable from starting material.  Deuteration and fluorination of I (R = PhSO2CH2) followed by dephenylsulfonylation yielded I (R = D3C, F2HC); the phenylsulfonylmethyl group was also converted to a methylthiothiocarbonyl group and underwent stereoselective Julia coupling to benzaldehyde to yield I [R = MeS2C, (E)-PhCH:CH].  The structures of a phenylsulfonylated pyridazinamine and of [Zn(H2O)62+](PhSO2CH2SO2-)2 (IIâ¢6 H2O) were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGsSdyPD-gtbVg90H21EOLACvtfcHk0lgW1nc71FsoQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVOntbk%253D&md5=fb7aedc04d994e8c59ff033f7b5f636d</span></div><a href="/servlet/linkout?suffix=cit26f&amp;dbid=16384&amp;doi=10.1021%2Fja5007838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5007838%26sid%3Dliteratum%253Aachs%26aulast%3DGui%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DC.-M.%26aulast%3DYabe%26aufirst%3DY.%26aulast%3DBurns%26aufirst%3DA.%2BC.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DOrnelas%26aufirst%3DM.%2BA.%26aulast%3DIshihara%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DC%25E2%2580%2593H%2520methylation%2520of%2520heteroarenes%2520inspired%2520by%2520radical%2520SAM%2520methyl%2520transferase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4853%26epage%3D4856%26doi%3D10.1021%2Fja5007838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkis, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engl, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Site-selective CâH oxygenation via aryl sulfonium salts</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">16161</span>â <span class="NLM_lpage">16166</span>, <span class="refDoi">Â DOI: 10.1002/anie.201908718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201908718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVCmsLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=16161-16166&author=R.+Sangauthor=S.+E.+Korkisauthor=W.+Suauthor=F.+Yeauthor=P.+S.+Englauthor=F.+Bergerauthor=T.+Ritter&title=Site-selective+C%E2%80%93H+oxygenation+via+aryl+sulfonium+salts&doi=10.1002%2Fanie.201908718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Site-selective C-H Oxygenation via Aryl Sulfonium Salts</span></div><div class="casAuthors">Sang, Ruocheng; Korkis, Stamatis E.; Su, Wanqi; Ye, Fei; Engl, Pascal S.; Berger, Florian; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16161-16166</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein, we report a two-step process forming arene C-O bonds in excellent site-selectivity at a late-stage.  The C-O bond formation is achieved by selective introduction of a thianthrenium group, which is then converted into C-O bonds using photoredox chem.  Electron-rich, -poor and -neutral arenes as well as complex drug-like small mols. are successfully transformed into both phenols and various ethers.  The sequence differs conceptually from all previous arene oxygenation reactions in that oxygen functionality can be incorporated into complex small mols. at a late stage site-selectively, which has not been shown via aryl halides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMin99-Ep3dLVg90H21EOLACvtfcHk0lj1qqQwcnju5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVCmsLnM&md5=1048889cdd5a451cca4102495997c545</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201908718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201908718%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DR.%26aulast%3DKorkis%26aufirst%3DS.%2BE.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DEngl%26aufirst%3DP.%2BS.%26aulast%3DBerger%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DSite-selective%2520C%25E2%2580%2593H%2520oxygenation%2520via%2520aryl%2520sulfonium%2520salts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D16161%26epage%3D16166%26doi%3D10.1002%2Fanie.201908718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¶rgel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanwar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Late-stage aromatic CâH oxygenation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">16026</span>â <span class="NLM_lpage">16031</span>, <span class="refDoi">Â DOI: 10.1021/jacs.8b09208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b09208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BB3cvptlOksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=16026-16031&author=J.+B%C3%B6rgelauthor=L.+Tanwarauthor=F.+Bergerauthor=T.+Ritter&title=Late-stage+aromatic+C%E2%80%93H+oxygenation&doi=10.1021%2Fjacs.8b09208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Late-Stage Aromatic C-H Oxygenation</span></div><div class="casAuthors">Borgel Jonas; Tanwar Lalita; Berger Florian; Ritter Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">16026-16031</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Synthetic methods for oxidative aromatic C-O bond formation are sparse, despite their demand in metabolite synthesis for drug discovery and development.  We report a novel methodology for late-stage C-O bond formation of arenes.  The reaction proceeds with excellent functional group tolerance even for highly functionalized substrates.  The resulting aryl mesylates provide access to potential human metabolites of pharmaceuticals, and may be used directly to install a C-F bond to block metabolic hotspots.  A charge-transfer interaction between the reagent bis(methanesulfonyl) peroxide and the substrate arenes may be relevant for the chemoselective functionalization of arenes over other functional groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQw9mgpRiLb9JcXNb62YGmbfW6udTcc2eackpghIaY5-7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvptlOksg%253D%253D&md5=80478bc5ba1bfd921147f3fc7cffeafb</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b09208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b09208%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6rgel%26aufirst%3DJ.%26aulast%3DTanwar%26aufirst%3DL.%26aulast%3DBerger%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DLate-stage%2520aromatic%2520C%25E2%2580%2593H%2520oxygenation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D16026%26epage%3D16031%26doi%3D10.1021%2Fjacs.8b09208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wanke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novais, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harjivan, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, A. M. M.</span></span> <span> </span><span class="NLM_article-title">Biomimetic oxidation of aromatic xenobiotics: synthesis of the phenolic metabolites from the anti-HIV drug efavirenz</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4554</span>â <span class="NLM_lpage">4561</span>, <span class="refDoi">Â DOI: 10.1039/c2ob25212k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1039%2Fc2ob25212k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=22569890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFGms7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=4554-4561&author=R.+Wankeauthor=D.+A.+Novaisauthor=S.+G.+Harjivanauthor=M.+Marquesauthor=A.+M.+M.+Antunes&title=Biomimetic+oxidation+of+aromatic+xenobiotics%3A+synthesis+of+the+phenolic+metabolites+from+the+anti-HIV+drug+efavirenz&doi=10.1039%2Fc2ob25212k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic oxidation of aromatic xenobiotics: synthesis of the phenolic metabolites from the anti-HIV drug efavirenz</span></div><div class="casAuthors">Wanke, Riccardo; Novais, David A.; Harjivan, Shrika G.; Marques, M. Matilde; Antunes, Alexandra M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4554-4561</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report the oxidn. of the first line anti-HIV drug efavirenz (EFV), mediated by a bio-inspired nonheme Fe-complex.  Depending upon the exptl. conditions this system can be tuned either to yield the major EFV metabolite, 8-hydroxy-EFV, in enantiomerically pure form or to mimic cytochrome P 450 (CYP) activity, yielding 8-hydroxy-EFV and 7-hydroxy-EFV, the two phenolic EFV metabolites reported to be formed in vivo.  The successful oxidn. of the anti-estrogen tamoxifen and the equine estrogen equilin into their CYP-mediated metabolites supports the general application of bio-inspired nonheme Fe-complexes in mirroring CYP activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqddwRH2X8nOLVg90H21EOLACvtfcHk0lj1qqQwcnju5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFGms7s%253D&md5=4df5aa640e140bb1ad6467344816e64e</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25212k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25212k%26sid%3Dliteratum%253Aachs%26aulast%3DWanke%26aufirst%3DR.%26aulast%3DNovais%26aufirst%3DD.%2BA.%26aulast%3DHarjivan%26aufirst%3DS.%2BG.%26aulast%3DMarques%26aufirst%3DM.%26aulast%3DAntunes%26aufirst%3DA.%2BM.%2BM.%26atitle%3DBiomimetic%2520oxidation%2520of%2520aromatic%2520xenobiotics%253A%2520synthesis%2520of%2520the%2520phenolic%2520metabolites%2520from%2520the%2520anti-HIV%2520drug%2520efavirenz%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D4554%26epage%3D4561%26doi%3D10.1039%2Fc2ob25212k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beshore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciolek, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajkovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, I. J.</span></span> <span> </span><span class="NLM_article-title">Microbial biotransformation â an important tool for the study of drug metabolism</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">877</span>â <span class="NLM_lpage">886</span>, <span class="refDoi">Â DOI: 10.1080/00498254.2018.1512018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1080%2F00498254.2018.1512018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30118378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKju7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2019&pages=877-886&author=R.+Salterauthor=D.+C.+Beshoreauthor=S.+L.+Collettiauthor=L.+Evansauthor=Y.+Gongauthor=R.+Helmyauthor=Y.+Liuauthor=C.+M.+Maciolekauthor=G.+Martinauthor=N.+Pajkovicauthor=R.+Phippsauthor=J.+Smallauthor=J.+Steeleauthor=R.+de+Vriesauthor=H.+Williamsauthor=I.+J.+Martin&title=Microbial+biotransformation+%E2%80%93+an+important+tool+for+the+study+of+drug+metabolism&doi=10.1080%2F00498254.2018.1512018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27dR"><div class="casContent"><span class="casTitleNuber">27d</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial biotransformation - an important tool for the study of drug metabolism</span></div><div class="casAuthors">Salter, Rhys; Beshore, Douglas C.; Colletti, Steven L.; Evans, Liam; Gong, Yong; Helmy, Roy; Liu, Yong; Maciolek, Cheri M.; Martin, Gary; Pajkovic, Natasa; Phipps, Richard; Small, James; Steele, Jonathan; de Vries, Ronald; Williams, Headley; Martin, Iain J.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">877-886</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Metabolite identification is an integral part of both preclin. and clin. drug discovery and development.  Synthesis of drug metabolites is often required to support definitive identification, preclin. safety studies and clin. trials.  Here we describe the use of microbial biotransformation as a tool to produce drug metabolites, complementing traditional chem. synthesis and other biosynthetic methods such as hepatocytes, liver microsomes and recombinant human drug metabolizing enzymes.  A workflow is discussed whereby microbial strains are initially screened for their ability to form the putative metabolites of interest, followed by a scale-up to afford quantities sufficient to perform definitive identification and further studies.  Examples of the microbial synthesis of several difficult-to-synthesize hydroxylated metabolites and three difficult-to-synthesize glucuronidated metabolites are described, and the use of microbial biotransformation in drug discovery and development is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocObzDiaKijbVg90H21EOLACvtfcHk0lj1qqQwcnju5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKju7%252FN&md5=34d70ef745aa3c945205b4ac819ba720</span></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=10.1080%2F00498254.2018.1512018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2018.1512018%26sid%3Dliteratum%253Aachs%26aulast%3DSalter%26aufirst%3DR.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DEvans%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DHelmy%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaciolek%26aufirst%3DC.%2BM.%26aulast%3DMartin%26aufirst%3DG.%26aulast%3DPajkovic%26aufirst%3DN.%26aulast%3DPhipps%26aufirst%3DR.%26aulast%3DSmall%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3Dde%2BVries%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DH.%26aulast%3DMartin%26aufirst%3DI.%2BJ.%26atitle%3DMicrobial%2520biotransformation%2520%25E2%2580%2593%2520an%2520important%2520tool%2520for%2520the%2520study%2520of%2520drug%2520metabolism%26jtitle%3DXenobiotica%26date%3D2019%26volume%3D49%26spage%3D877%26epage%3D886%26doi%3D10.1080%2F00498254.2018.1512018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Minisci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perchinummo, M.</span></span> <span> </span><span class="NLM_article-title">Nucleophilic character of alkyl radicalsâVI: a new convenient selective alkylation of heteroaromatic bases</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3575</span>â <span class="NLM_lpage">3579</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4020(01)97768-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2FS0040-4020%2801%2997768-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFyns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=3575-3579&author=F.+Minisciauthor=R.+Bernardiauthor=F.+Bertiniauthor=R.+Galliauthor=M.+Perchinummo&title=Nucleophilic+character+of+alkyl+radicals%E2%80%94VI%3A+a+new+convenient+selective+alkylation+of+heteroaromatic+bases&doi=10.1016%2FS0040-4020%2801%2997768-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleophilic character of alkyl radicals.  VI.  New convenient selective alkylation of heteroaromatic bases</span></div><div class="casAuthors">Minisci, F.; Bernardi, R.; Bertini, F.; Galli, R.; Perchinummo, M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3575-80</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">A new method of homolytic alkylation of heteroaromatic bases, such as pyridines, quinolines, and isoquinolines, is described, in which the silver-catalyzed oxidative decarboxylation of acids by peroxydisulfate is used as a source of alkyl radicals.  The method is esp. noteworthy because of the good yields and the high selectivity obtained, due to the nucleophilic character of the alkyl radicals; for synthetic interest it is comparable to electrophilic alkylation in the homocyclic series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDy822OWvBPbVg90H21EOLACvtfcHk0lj8d6hj4WA6ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFyns7g%253D&md5=7df59f61bffc344fd37eb0c0ea01baac</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2997768-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252997768-3%26sid%3Dliteratum%253Aachs%26aulast%3DMinisci%26aufirst%3DF.%26aulast%3DBernardi%26aufirst%3DR.%26aulast%3DBertini%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DR.%26aulast%3DPerchinummo%26aufirst%3DM.%26atitle%3DNucleophilic%2520character%2520of%2520alkyl%2520radicals%25E2%2580%2594VI%253A%2520a%2520new%2520convenient%2520selective%2520alkylation%2520of%2520heteroaromatic%2520bases%26jtitle%3DTetrahedron%26date%3D1971%26volume%3D27%26spage%3D3575%26epage%3D3579%26doi%3D10.1016%2FS0040-4020%2801%2997768-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, R. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, R. J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in Minisci-type reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">13666</span>â <span class="NLM_lpage">13699</span>, <span class="refDoi">Â DOI: 10.1002/anie.201900977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201900977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFSrtL%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=13666-13699&author=R.+S.+J.+Proctorauthor=R.+J.+Phipps&title=Recent+advances+in+Minisci-type+reactions&doi=10.1002%2Fanie.201900977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in Minisci-Type Reactions</span></div><div class="casAuthors">Proctor, Rupert S. J.; Phipps, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13666-13699</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Reactions that involve the addn. of carbon-centered radicals to basic heteroarenes, followed by formal hydrogen atom loss, have become widely known as Minisci-type reactions.  First developed into a useful synthetic tool in the late 1960s by Minisci, this reaction type has been in const. use over the last half century by chemists seeking to functionalize heterocycles in a rapid and direct manner, avoiding the need for de novo heterocycle synthesis.  While the originally developed protocols for radical generation remain in active use today, they have been joined in recent years by a new array of radical generation strategies that allow use of a wider variety of radical precursors that often operate under milder and more benign conditions.  The recent surge of interest in new transformations based on free radical reactivity has meant that numerous choices are now available to a synthetic chemist looking to utilize a Minisci-type reaction.  Radical-generation methods based on photoredox catalysis and electrochem. have joined approaches which utilize thermal cleavage or the in situ generation of reactive radical precursors.  This review will cover the remarkably large body of literature that has appeared on this topic over the last decade in an attempt to provide guidance to the synthetic chemist, as well as a perspective on both the challenges that have been overcome and those that still remain.  As well as the logical classification of advances based on the nature of the radical precursor, with which most advances have been concerned, recent advances in control of various selectivity aspects assocd. with Minisci-type reactions will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5HR0V-arVd7Vg90H21EOLACvtfcHk0lj8d6hj4WA6ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFSrtL%252FN&md5=bd06587b8508f32ad764c55ac0f29cd9</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201900977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201900977%26sid%3Dliteratum%253Aachs%26aulast%3DProctor%26aufirst%3DR.%2BS.%2BJ.%26aulast%3DPhipps%26aufirst%3DR.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520Minisci-type%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D13666%26epage%3D13699%26doi%3D10.1002%2Fanie.201900977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span>; <span class="NLM_string-name">Rarey, M.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Docking and Scoring.</span> In  <i>Reviews in Computational Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowitz, K. B.</span>, <span class="NLM_string-name">Boyd, E. B.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>; Vol.  <span class="NLM_volume">17</span>, pp  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">60</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2F0471224413.ch1" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1-60&author=I.+Muegge&author=M.+Rareyauthor=K.+B.+Lipkowitz&author=E.+B.+Boyd&title=Reviews+in+Computational+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F0471224413.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471224413.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DMuegge%26aufirst%3DI.%26atitle%3DSmall%2520Molecule%2520Docking%2520and%2520Scoring.%26btitle%3DReviews%2520in%2520Computational%2520Chemistry%26aulast%3DLipkowitz%26aufirst%3DK.%2BB.%26pub%3DWiley-VCH%26date%3D2001%26volume%3D17%26spage%3D1%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sushko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novotarskyi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶rner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelaziz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetko, I. V.</span></span> <span> </span><span class="NLM_article-title">Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi">Â DOI: 10.1186/s13321-014-0048-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1186%2Fs13321-014-0048-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislWhtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=48&author=Y.+Sushkoauthor=S.+Novotarskyiauthor=R.+K%C3%B6rnerauthor=J.+Vogtauthor=A.+Abdelazizauthor=I.+V.+Tetko&title=Prediction-driven+matched+molecular+pairs+to+interpret+QSARs+and+aid+the+molecular+optimization+process&doi=10.1186%2Fs13321-014-0048-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process</span></div><div class="casAuthors">Sushko, Yurii; Novotarskyi, Sergii; Koerner, Robert; Vogt, Joachim; Abdelaziz, Ahmed; Tetko, Igor V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48/1-48/39, 39 pp.</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background QSAR is an established and powerful method for cheap in silico assessment of physicochem. properties and biol. activities of chem. compds.  However, QSAR models are rather complex math. constructs that cannot easily be interpreted.  Medicinal chemists would benefit from practical guidance regarding which mols. to synthesize.  Another possible approach is anal. of pairs of very similar mols., so-called matched mol. pairs (MMPs).  Such an approach allows identification of mol. transformations that affect particular activities (e.g. toxicity).  In contrast to QSAR, chem. interpretation of these transformations is straightforward.  Furthermore, such transformations can give medicinal chemists useful hints for the hit-to-lead optimization process.  Results The current study suggests a combination of QSAR and MMP approaches by finding MMP transformations based on QSAR predictions for large chem. datasets.  The study shows that such an approach, referred to as prediction-driven MMP anal., is a useful tool for medicinal chemists, allowing identification of large nos. of "interesting" transformations that can be used to drive the mol. optimization process.  All the methodol. developments have been implemented as software products available online as part of OCHEM.  Conclusions The prediction-driven MMPs methodol. was exemplified by two use cases: modeling of aquatic toxicity and CYP3A4 inhibition.  This approach helped us to interpret QSAR models and allowed identification of a no. of "significant" mol. transformations that affect the desired properties.  This can facilitate drug design as a part of mol. optimization process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTzctKLS8vxrVg90H21EOLACvtfcHk0lhZRQrTtbyHDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislWhtLw%253D&md5=837bda80de79a7621c887de1fed0375a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1186%2Fs13321-014-0048-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-014-0048-0%26sid%3Dliteratum%253Aachs%26aulast%3DSushko%26aufirst%3DY.%26aulast%3DNovotarskyi%26aufirst%3DS.%26aulast%3DK%25C3%25B6rner%26aufirst%3DR.%26aulast%3DVogt%26aufirst%3DJ.%26aulast%3DAbdelaziz%26aufirst%3DA.%26aulast%3DTetko%26aufirst%3DI.%2BV.%26atitle%3DPrediction-driven%2520matched%2520molecular%2520pairs%2520to%2520interpret%2520QSARs%2520and%2520aid%2520the%2520molecular%2520optimization%2520process%26jtitle%3DJ.%2520Cheminf.%26date%3D2014%26volume%3D6%26spage%3D48%26doi%3D10.1186%2Fs13321-014-0048-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voitovich, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derviaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amouric, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collette, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, X.</span></span> <span> </span><span class="NLM_article-title">Integrated strategy for lead optimization based on fragment growing: the diversity-oriented-target-focused-synthesis approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5719</span>â <span class="NLM_lpage">5732</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00653</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5719-5732&author=L.+Hofferauthor=Y.+V.+Voitovichauthor=B.+Rauxauthor=K.+Carrascoauthor=C.+Mullerauthor=A.+Y.+Fedorovauthor=C.+Derviauxauthor=A.+Amouricauthor=S.+Betziauthor=D.+Horvathauthor=A.+Varnekauthor=Y.+Colletteauthor=S.+Combesauthor=P.+Rocheauthor=X.+Morelli&title=Integrated+strategy+for+lead+optimization+based+on+fragment+growing%3A+the+diversity-oriented-target-focused-synthesis+approach&doi=10.1021%2Facs.jmedchem.8b00653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach</span></div><div class="casAuthors">Hoffer, Laurent; Voitovich, Yuliia V.; Raux, Brigitt; Carrasco, Kendall; Muller, Christophe; Fedorov, Aleksey Y.; Derviaux, Carine; Amouric, Agnes; Betzi, Stephane; Horvath, Dragos; Varnek, Alexandre; Collette, Yves; Combes, Sebastien; Roche, Philippe; Morelli, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5719-5732</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past few decades, hit identification has been greatly facilitated by advances in high-throughput and fragment-based screenings.  One major hurdle remaining in drug discovery is process automation of hit-to-lead (H2L) optimization.  Here, we report a time- and cost-efficient integrated strategy for H2L optimization as well as a partially automated design of potent chem. probes consisting of a focused-chem.-library design and virtual screening coupled with robotic diversity-oriented de novo synthesis and automated in vitro evaluation.  The virtual library is generated by combining an activated fragment, corresponding to the substructure binding to the target, with a collection of functionalized building blocks using in silico encoded chem. reactions carefully chosen from a list of one-step org. transformations relevant in medicinal chem.  The proof of concept was demonstrated using the optimization of bromodomain inhibitors as a test case, leading to the validation of several compds. with improved affinity by several orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrocVtdmg7D67Vg90H21EOLACvtfcHk0lhZRQrTtbyHDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK&md5=0e5f18636e2b1df24314efa81e67e2b5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00653%26sid%3Dliteratum%253Aachs%26aulast%3DHoffer%26aufirst%3DL.%26aulast%3DVoitovich%26aufirst%3DY.%2BV.%26aulast%3DRaux%26aufirst%3DB.%26aulast%3DCarrasco%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26aulast%3DDerviaux%26aufirst%3DC.%26aulast%3DAmouric%26aufirst%3DA.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DVarnek%26aufirst%3DA.%26aulast%3DCollette%26aufirst%3DY.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DMorelli%26aufirst%3DX.%26atitle%3DIntegrated%2520strategy%2520for%2520lead%2520optimization%2520based%2520on%2520fragment%2520growing%253A%2520the%2520diversity-oriented-target-focused-synthesis%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5719%26epage%3D5732%26doi%3D10.1021%2Facs.jmedchem.8b00653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutowo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CibriÃ¡n-Uhalte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MagariÃ±os, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span> <span> </span><span class="NLM_article-title">The ChEMBL database in 2017</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D945</span>â <span class="NLM_lpage">D954</span>, <span class="refDoi">Â DOI: 10.1093/nar/gkw1074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1093%2Fnar%2Fgkw1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=27899562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D945-D954&author=A.+Gaultonauthor=A.+Herseyauthor=M.+Nowotkaauthor=A.+P.+Bentoauthor=J.+Chambersauthor=D.+Mendezauthor=P.+Mutowoauthor=F.+Atkinsonauthor=L.+J.+Bellisauthor=E.+Cibri%C3%A1n-Uhalteauthor=M.+Daviesauthor=N.+Dedmanauthor=A.+Karlssonauthor=M.+P.+Magari%C3%B1osauthor=J.+P.+Overingtonauthor=G.+Papadatosauthor=I.+Smitauthor=A.+R.+Leach&title=The+ChEMBL+database+in+2017&doi=10.1093%2Fnar%2Fgkw1074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL database in 2017</span></div><div class="casAuthors">Gaulton, Anna; Hersey, Anne; Nowotka, Micha-l; Bento, A. Patricia; Chambers, Jon; Mendez, David; Mutowo, Prudence; Atkinson, Francis; Bellis, Louisa J.; Cibrian-Uhalte, Elena; Davies, Mark; Dedman, Nathan; Karlsson, Anneli; Magarinos, Maria Paula; Overington, John P.; Papadatos, George; Smit, Ines; Leach, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D945-D954</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues.  Since then, alongside the continued extn. of data from the medicinal chem. literature, new sources of bioactivity data have also been added to the database.  These include: deposited data sets from neglected disease screening; crop protection data; drug metab. and disposition data and bioactivity data from patents.  A no. of improvements and new features have also been incorporated.  These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clin. candidates, addn. of metabolic pathways for drugs and calcn. of structural alerts.  The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0IuNShSHIrVg90H21EOLACvtfcHk0lhZRQrTtbyHDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D&md5=1dcbb641f8c2d11410663f97505a4911</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1074%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DMendez%26aufirst%3DD.%26aulast%3DMutowo%26aufirst%3DP.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DCibri%25C3%25A1n-Uhalte%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DDedman%26aufirst%3DN.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DMagari%25C3%25B1os%26aufirst%3DM.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSmit%26aufirst%3DI.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26atitle%3DThe%2520ChEMBL%2520database%2520in%25202017%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD945%26epage%3DD954%26doi%3D10.1093%2Fnar%2Fgkw1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span>ChEMBL24_1 downloaded October 11, <span class="NLM_year">2018</span>, from <a href="ftp://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_24_1/" class="extLink">ftp://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_24_1/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ChEMBL24_1+downloaded+October+11%2C+2018%2C+from+ftp%3A%2F%2Fftp.ebi.ac.uk%2Fpub%2Fdatabases%2Fchembl%2FChEMBLdb%2Freleases%2Fchembl_24_1%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, K. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR study of pyrrolo[3,4-<i>b</i>]pyridin-7(6<i>H</i>)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1736</span>â <span class="NLM_lpage">1739</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.01.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmcl.2013.01.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=23411080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Sju7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1736-1739&author=C.+J.+Limauthor=J.+Y.+Kimauthor=B.+H.+Leeauthor=K.+S.+Ohauthor=K.+Y.+Yi&title=Synthesis+and+SAR+study+of+pyrrolo%5B3%2C4-b%5Dpyridin-7%286H%29-one+derivatives+as+melanin+concentrating+hormone+receptor+1+%28MCH-R1%29+antagonists&doi=10.1016%2Fj.bmcl.2013.01.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists</span></div><div class="casAuthors">Lim, Chae Jo; Kim, Ji Young; Lee, Byung Ho; Oh, Kwang-Seok; Yi, Kyu Yang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1736-1739</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of novel pyrrolo[3,4-b]pyridin-7(6H)-one MCH-R1 antagonists are described.  A systematic SAR study probing the effects of aryl-, benzyl- and arylthio-substituents at the 2-position of the pyrrolo[3,4-b]pyridin-7(6H)-ones led to identification of the 2-[(4-fluorophenyl)thio] deriv. 7b as a highly potent MCH-R1 antagonist.  This compd. also has favorable pharmacokinetic properties along with a high metabolic stability and a minimal impact on CYP isoforms and hERG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptvrvVkR3bNrVg90H21EOLACvtfcHk0lhRBIM7fRuUcA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Sju7w%253D&md5=21259ebb9ef6d0a7d1b4628d2dc26db6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.053%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DC.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DOh%26aufirst%3DK.%2BS.%26aulast%3DYi%26aufirst%3DK.%2BY.%26atitle%3DSynthesis%2520and%2520SAR%2520study%2520of%2520pyrrolo%255B3%252C4-b%255Dpyridin-7%25286H%2529-one%2520derivatives%2520as%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCH-R1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1736%26epage%3D1739%26doi%3D10.1016%2Fj.bmcl.2013.01.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ©zina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benakli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaubien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Louis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinault, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaseshan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchemin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BhÃ©rer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, G. L.</span></span> <span> </span><span class="NLM_article-title">Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of ulimorelin (TZP-101) from hit to clinic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8305</span>â <span class="NLM_lpage">8320</span>, <span class="refDoi">Â DOI: 10.1021/jm2007062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fms1antg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8305-8320&author=H.+R.+Hoveydaauthor=E.+Marsaultauthor=R.+Gagnonauthor=A.+P.+Mathieuauthor=M.+V%C3%A9zinaauthor=A.+Landryauthor=Z.+Wangauthor=K.+Benakliauthor=S.+Beaubienauthor=C.+Saint-Louisauthor=M.+Brassardauthor=J.+F.+Pinaultauthor=L.+Ouelletauthor=S.+Bhatauthor=M.+Ramaseshanauthor=X.+Pengauthor=L.+Foucherauthor=S.+Beaucheminauthor=P.+Bh%C3%A9rerauthor=D.+F.+Veberauthor=M.+L.+Petersonauthor=G.+L.+Fraser&title=Optimization+of+the+potency+and+pharmacokinetic+properties+of+a+macrocyclic+ghrelin+receptor+agonist+%28Part+I%29%3A+development+of+ulimorelin+%28TZP-101%29+from+hit+to+clinic&doi=10.1021%2Fjm2007062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic</span></div><div class="casAuthors">Hoveyda Hamid R; Marsault Eric; Gagnon Rene; Mathieu Axel P; Vezina Martin; Landry Annick; Wang Zhigang; Benakli Kamel; Beaubien Sylvie; Saint-Louis Carl; Brassard Martin; Pinault Jean-Francois; Ouellet Luc; Bhat Shridhar; Ramaseshan Mahesh; Peng Xiaowen; Foucher Laurence; Beauchemin Sophie; Bherer Patrick; Veber Daniel F; Peterson Mark L; Fraser Graeme L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8305-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-throughput screening of Tranzyme Pharma's proprietary macrocycle library using the aequorin Ca2+-bioluminescence assay against the human ghrelin receptor (GRLN) led to the discovery of novel agonists against this G-protein coupled receptor.  Early hits such as 1 (Ki=86 nM, EC50=134 nM) though potent in vitro displayed poor pharmacokinetic properties that required optimization.  While such macrocycles are not fully rule-of-five compliant, principally due to their molecular weight and clogP, optimization of their pharmacokinetic properties proved feasible largely through conformational rigidification.  Extensive SAR led to the identification of 2 (Ki=16 nM, EC50=29 nM), also known as ulimorelin or TZP-101, which has progressed to phase III human clinical trials for the treatment of postoperative ileus.  X-ray structure and detailed NMR studies indicated a rigid peptidomimetic portion in 2 that is best defined as a nonideal type-I' Î²-turn.  Compound 2 is 24% orally bioavailable in both rats and monkeys.  Despite its potency, in vitro and in gastric emptying studies, 2 did not induce growth hormone (GH) release in rats, thus demarcating the GH versus GI pharmacology of GRLN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREoes2wBiC73y-c-E1v-fmfW6udTcc2eYLW5SOMTqtcbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fms1antg%253D%253D&md5=bdc3b14ed821c61c4fecea50c60f0b07</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm2007062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007062%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%2BR.%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DGagnon%26aufirst%3DR.%26aulast%3DMathieu%26aufirst%3DA.%2BP.%26aulast%3DV%25C3%25A9zina%26aufirst%3DM.%26aulast%3DLandry%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBenakli%26aufirst%3DK.%26aulast%3DBeaubien%26aufirst%3DS.%26aulast%3DSaint-Louis%26aufirst%3DC.%26aulast%3DBrassard%26aufirst%3DM.%26aulast%3DPinault%26aufirst%3DJ.%2BF.%26aulast%3DOuellet%26aufirst%3DL.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DRamaseshan%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFoucher%26aufirst%3DL.%26aulast%3DBeauchemin%26aufirst%3DS.%26aulast%3DBh%25C3%25A9rer%26aufirst%3DP.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DFraser%26aufirst%3DG.%2BL.%26atitle%3DOptimization%2520of%2520the%2520potency%2520and%2520pharmacokinetic%2520properties%2520of%2520a%2520macrocyclic%2520ghrelin%2520receptor%2520agonist%2520%2528Part%2520I%2529%253A%2520development%2520of%2520ulimorelin%2520%2528TZP-101%2529%2520from%2520hit%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8305%26epage%3D8320%26doi%3D10.1021%2Fjm2007062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâBrien, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axford, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmaster, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hoosear, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivasankaran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of small molecule splicing modulators of survival motor neuron-2 (SMN2) for the treatment of spinal muscular atrophy (SMA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11021</span>â <span class="NLM_lpage">11036</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01291</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFeju7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11021-11036&author=A.+K.+Cheungauthor=B.+Hurleyauthor=R.+Kerriganauthor=L.+Shuauthor=D.+N.+Chinauthor=Y.+Shenauthor=G.+O%E2%80%99Brienauthor=M.+J.+Sungauthor=Y.+Houauthor=J.+Axfordauthor=E.+Codyauthor=R.+Sunauthor=A.+Fazalauthor=C.+Fridrichauthor=C.+C.+Sanchezauthor=R.+C.+Tomlinsonauthor=M.+Jainauthor=L.+Dengauthor=K.+Hoffmasterauthor=C.+Songauthor=M.+Van+Hoosearauthor=Y.+Shinauthor=R.+Servaisauthor=C.+Towlerauthor=M.+Hildauthor=D.+Curtisauthor=W.+F.+Dietrichauthor=L.+G.+Hamannauthor=K.+Brinerauthor=K.+S.+Chenauthor=D.+Kobayashiauthor=R.+Sivasankaranauthor=N.+A.+Dales&title=Discovery+of+small+molecule+splicing+modulators+of+survival+motor+neuron-2+%28SMN2%29+for+the+treatment+of+spinal+muscular+atrophy+%28SMA%29&doi=10.1021%2Facs.jmedchem.8b01291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)</span></div><div class="casAuthors">Cheung, Atwood K.; Hurley, Brian; Kerrigan, Ryan; Shu, Lei; Chin, Donovan N.; Shen, Yiping; OBrien, Gary; Sung, Moo Je; Hou, Ying; Axford, Jake; Cody, Emma; Sun, Robert; Fazal, Aleem; Tomlinson, Ronald C.; Jain, Monish; Deng, Lin; Hoffmaster, Keith; Song, Cheng; Van Hoosear, Mailin; Shin, Youngah; Servais, Rebecca; Towler, Christopher; Hild, Marc; Curtis, Daniel; Dietrich, William F.; Hamann, Lawrence G.; Briner, Karin; Chen, Karen S.; Kobayashi, Dione; Sivasankaran, Rajeev; Dales, Natalie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11021-11036</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spinal muscular atrophy (SMA), a rare neuromuscular disorder, is the leading genetic cause of death in infants and toddlers.  SMA is caused by the deletion or a loss of function mutation of the survival motor neuron 1 (SMN1) gene.  In humans, a second closely related gene SMN2 exists, however it codes for a less stable SMN protein.  In recent years, significant progress has been made toward disease modifying treatments for SMA by modulating SMN2 pre-mRNA splicing.  Herein, we describe the discovery of LMI070/branaplam, a small mol. that stabilizes the interaction between the spliceosome and SMN2 pre-mRNA.  Branaplam (1) originated from a high-throughput phenotypic screening hit, pyridazine 2, and evolved via multi-parameter lead optimization.  In a severe mouse SMA model, branaplam treatment increased full-length SMN RNA and protein levels, and extended survival.  Currently, branaplam is in clin. studies for SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprrHPkSEhGhrVg90H21EOLACvtfcHk0ljbofjvqQyiBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFeju7nL&md5=c564332b680a6ef0ad06bc9e5a4db16e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01291%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DHurley%26aufirst%3DB.%26aulast%3DKerrigan%26aufirst%3DR.%26aulast%3DShu%26aufirst%3DL.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DG.%26aulast%3DSung%26aufirst%3DM.%2BJ.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DAxford%26aufirst%3DJ.%26aulast%3DCody%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DSanchez%26aufirst%3DC.%2BC.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DHoffmaster%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DVan%2BHoosear%26aufirst%3DM.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DServais%26aufirst%3DR.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DDietrich%26aufirst%3DW.%2BF.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DBriner%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DKobayashi%26aufirst%3DD.%26aulast%3DSivasankaran%26aufirst%3DR.%26aulast%3DDales%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520splicing%2520modulators%2520of%2520survival%2520motor%2520neuron-2%2520%2528SMN2%2529%2520for%2520the%2520treatment%2520of%2520spinal%2520muscular%2520atrophy%2520%2528SMA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11021%26epage%3D11036%26doi%3D10.1021%2Facs.jmedchem.8b01291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">A survey of the role of noncovalent sulfur interactions in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4383</span>â <span class="NLM_lpage">4438</span>, <span class="refDoi">Â DOI: 10.1021/jm501853m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501853m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4383-4438&author=B.+R.+Benoauthor=K.-S.+Yeungauthor=M.+D.+Bartbergerauthor=L.+D.+Penningtonauthor=N.+A.+Meanwell&title=A+survey+of+the+role+of+noncovalent+sulfur+interactions+in+drug+design&doi=10.1021%2Fjm501853m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span></div><div class="casAuthors">Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D.; Pennington, Lewis D.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4383-4438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Electron deficient, bivalent sulfur atoms have two areas of pos. electrostatic potential, a consequence of the low-lying Ï* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, Ï-systems.  Intramol. interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a mol.  Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramol. hydrogen-bonding interaction, appears to be underappreciated by the medicinal chem. community.  In this Perspective, we discuss the theor. basis for sulfur Ï* orbital interactions and illustrate their importance in the context of drug design and org. synthesis.  The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermol. interactions between ligand C-S Ï* orbitals and proteins are illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKXRsl4BQYrVg90H21EOLACvtfcHk0ljbofjvqQyiBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D&md5=d12f53eb3271c161cfc833fb9f7c02b3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501853m%26sid%3Dliteratum%253Aachs%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520survey%2520of%2520the%2520role%2520of%2520noncovalent%2520sulfur%2520interactions%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4383%26epage%3D4438%26doi%3D10.1021%2Fjm501853m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¶schke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9337</span>â <span class="NLM_lpage">9349</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9337-9349&author=P.+Czodrowskiauthor=A.+Mallingerauthor=D.+Wienkeauthor=C.+Esdarauthor=O.+P%C3%B6schkeauthor=M.+Buschauthor=F.+Rohdichauthor=S.+A.+Ecclesauthor=M.-J.+Ortiz-Ruizauthor=R.+Schneiderauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=D.+Musilauthor=D.+Schwarzauthor=T.+Daleauthor=K.+Urbahnsauthor=J.+Blaggauthor=K.+Schiemann&title=Structure-based+optimization+of+potent%2C+selective%2C+and+orally+bioavailable+CDK8+inhibitors+discovered+by+high-throughput+screening&doi=10.1021%2Facs.jmedchem.6b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening</span></div><div class="casAuthors">Czodrowski, Paul; Mallinger, Aurelie; Wienke, Dirk; Esdar, Christina; Poeschke, Oliver; Busch, Michael; Rohdich, Felix; Eccles, Suzanne A.; Ortiz-Ruiz, Maria-Jesus; Schneider, Richard; Raynaud, Florence I.; Clarke, Paul A.; Musil, Djordje; Schwarz, Daniel; Dale, Trevor; Urbahns, Klaus; Blagg, Julian; Schiemann, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9337-9349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Mediator complex-assocd. cyclin dependent kinase CDK8 regulates beta-catenin-dependent transcription following activation of WNT signaling.  Multiple lines of evidence suggest CDK8 may act as an oncogene in the development of colorectal cancer.  Here the authors describe the successful optimization of an imidazo-thiadiazole series of CDK8 inhibitors that was identified in a high-throughput screening campaign and further progressed by structure-based design.  In several optimization cycles, the authors improved the microsomal stability, potency and kinase selectivity.  The initial imidazo-thiadiazole scaffold was replaced by a 3-methyl-1H-pyrazolo[3,4-b]-pyridine which resulted in compd. MSC2530818 that displayed excellent kinase selectivity, biochem. and cellular potency, microsomal stability and is orally bioavailable.  Furthermore, the authors demonstrated modulation of phospho-STAT1, a pharmacodynamic biomarker of CDK8 activity, and tumor growth inhibition in an APC-mutant SW620 human colorectal carcinoma xenograft model after oral administration.  Compd. MSC2530818 demonstrated suitable potency and selectivity to progress into preclin. in vivo efficacy and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoP_Ycv9Xj97Vg90H21EOLACvtfcHk0liYNEL1d9PvUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF&md5=9ab270aed38647f9bafe213cf9d75171</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00597%26sid%3Dliteratum%253Aachs%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DP%25C3%25B6schke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.-J.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DSchiemann%26aufirst%3DK.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520CDK8%2520inhibitors%2520discovered%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9337%26epage%3D9349%26doi%3D10.1021%2Facs.jmedchem.6b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parcella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant-Young, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjanappa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bora, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanumegowda, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colston, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raybon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santone, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4369</span>â <span class="NLM_lpage">4385</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4369-4385&author=K.-S.+Yeungauthor=B.+R.+Benoauthor=K.+Parcellaauthor=J.+A.+Benderauthor=K.+A.+Grant-Youngauthor=A.+Nickelauthor=P.+Gunagaauthor=P.+Anjanappaauthor=R.+O.+Boraauthor=K.+Selvakumarauthor=K.+Rigatauthor=Y.-K.+Wangauthor=M.+Liuauthor=J.+Lemmauthor=K.+Mosureauthor=S.+Sheriffauthor=C.+Wanauthor=M.+Witmerauthor=K.+Kishauthor=U.+Hanumegowdaauthor=X.+Zhuoauthor=Y.-Z.+Shuauthor=D.+Parkerauthor=R.+Haskellauthor=A.+Ngauthor=Q.+Gaoauthor=E.+Colstonauthor=J.+Raybonauthor=D.+M.+Graselaauthor=K.+Santoneauthor=M.+Gaoauthor=N.+A.+Meanwellauthor=M.+Sinzauthor=M.+G.+Soarsauthor=J.+O.+Knipeauthor=S.+B.+Robertsauthor=J.+F.+Kadow&title=Discovery+of+a+hepatitis+C+virus+NS5B+replicase+palm+site+allosteric+inhibitor+%28BMS-929075%29+advanced+to+phase+1+clinical+studies&doi=10.1021%2Facs.jmedchem.7b00328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies</span></div><div class="casAuthors">Yeung, Kap-Sun; Beno, Brett R.; Parcella, Kyle; Bender, John A.; Grant-Young, Katherine A.; Nickel, Andrew; Gunaga, Prashantha; Anjanappa, Prakash; Bora, Rajesh Onkardas; Selvakumar, Kumaravel; Rigat, Karen; Wang, Ying-Kai; Liu, Mengping; Lemm, Julie; Mosure, Kathy; Sheriff, Steven; Wan, Changhong; Witmer, Mark; Kish, Kevin; Hanumegowda, Umesh; Zhuo, Xiaoliang; Shu, Yue-Zhong; Parker, Dawn; Haskell, Roy; Ng, Alicia; Gao, Qi; Colston, Elizabeth; Raybon, Joseph; Grasela, Dennis M.; Santone, Kenneth; Gao, Min; Meanwell, Nicholas A.; Sinz, Michael; Soars, Matthew G.; Knipe, Jay O.; Roberts, Susan B.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4369-4385</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection.  Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid 4, the known benzofuran analog 5, and the benzothiadiazine deriv. 6, an optimization process utilizing the simple benzofuran template 7 as a starting point for a fragment growing approach was pursued.  A delicate balance of mol. properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metab., and excretion profile.  These efforts led to the discovery of BMS-929075 (37), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic parameters across preclin. animal species.  The human PK properties from the Phase I clin. studies of 37 were better than anticipated and suggest promising potential for QD administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0KsD9y5uorVg90H21EOLACvtfcHk0ljNtZOwhVJ_ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D&md5=354b41a850bfa225b52baeddb1cb59b0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00328%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DGrant-Young%26aufirst%3DK.%2BA.%26aulast%3DNickel%26aufirst%3DA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DAnjanappa%26aufirst%3DP.%26aulast%3DBora%26aufirst%3DR.%2BO.%26aulast%3DSelvakumar%26aufirst%3DK.%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DHanumegowda%26aufirst%3DU.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DHaskell%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DColston%26aufirst%3DE.%26aulast%3DRaybon%26aufirst%3DJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DSantone%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520hepatitis%2520C%2520virus%2520NS5B%2520replicase%2520palm%2520site%2520allosteric%2520inhibitor%2520%2528BMS-929075%2529%2520advanced%2520to%2520phase%25201%2520clinical%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4369%26epage%3D4385%26doi%3D10.1021%2Facs.jmedchem.7b00328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Autry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzillo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacci-Tobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briere, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubczak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzzio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span> <span> </span><span class="NLM_article-title">Design of selective, ATP-competitive inhibitors of Akt</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4615</span>â <span class="NLM_lpage">4622</span>, <span class="refDoi">Â DOI: 10.1021/jm1003842</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1003842" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt12ku78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4615-4622&author=K.+D.+Freeman-Cookauthor=C.+Autryauthor=G.+Borzilloauthor=D.+Gordonauthor=E.+Barbacci-Tobinauthor=V.+Bernardoauthor=D.+Briereauthor=T.+Clarkauthor=M.+Corbettauthor=J.+Jakubczakauthor=S.+Kakarauthor=E.+Knauthauthor=B.+Lippaauthor=M.+J.+Luzzioauthor=M.+Mansourauthor=G.+Martinelliauthor=M.+Marxauthor=K.+Nelsonauthor=J.+Panditauthor=F.+Rajamohanauthor=S.+Robinsonauthor=C.+Subramanyamauthor=L.+Weiauthor=M.+Wythesauthor=J.+Morris&title=Design+of+selective%2C+ATP-competitive+inhibitors+of+Akt&doi=10.1021%2Fjm1003842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Selective, ATP-Competitive Inhibitors of Akt</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Autry, Christopher; Borzillo, Gary; Gordon, Deborah; Barbacci-Tobin, Elsa; Bernardo, Vincent; Briere, David; Clark, Tracey; Corbett, Matthew; Jakubczak, John; Kakar, Shefali; Knauth, Elizabeth; Lippa, Blaise; Luzzio, Michael J.; Mansour, Mahmoud; Martinelli, Gary; Marx, Matthew; Nelson, Kendra; Pandit, Jayvardhan; Rajamohan, Francis; Robinson, Shaughnessy; Subramanyam, Chakrapani; Wei, Liuqing; Wythes, Martin; Morris, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4615-4622</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the design and synthesis of novel, ATP-competitive Akt inhibitors from an elaborated 3-aminopyrrolidine scaffold.  Key findings include the discovery of an initial lead that was modestly selective and medicinal chem. optimization of that lead to provide more selective analogs.  Anal. of the data suggested that highly lipophilic analogs would likely suffer from poor overall properties.  Central to the discussion is the concept of optimization of lipophilic efficiency and the ability to balance overall druglike properties with the careful control of lipophilicity in the lead series.  Discovery of the nonracemic amide series and subsequent modification produced an advanced analog that performed well in advancedaminopyrrolidine substituted pyrrolopyrimidine preclin. assays, including xenograft tumor growth inhibition studies, and this analog was nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqLbzBekJF5LVg90H21EOLACvtfcHk0ljNtZOwhVJ_ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt12ku78%253D&md5=e45372a44f93072f7152a0a2600d7be4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm1003842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1003842%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DBorzillo%26aufirst%3DG.%26aulast%3DGordon%26aufirst%3DD.%26aulast%3DBarbacci-Tobin%26aufirst%3DE.%26aulast%3DBernardo%26aufirst%3DV.%26aulast%3DBriere%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DT.%26aulast%3DCorbett%26aufirst%3DM.%26aulast%3DJakubczak%26aufirst%3DJ.%26aulast%3DKakar%26aufirst%3DS.%26aulast%3DKnauth%26aufirst%3DE.%26aulast%3DLippa%26aufirst%3DB.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DMansour%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DMarx%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DK.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520Akt%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4615%26epage%3D4622%26doi%3D10.1021%2Fjm1003842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>â <span class="NLM_lpage">1164</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0ljNtZOwhVJ_ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugovic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepomuceno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzolio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shireman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, S.</span></span> <span> </span><span class="NLM_article-title">Novel octahydropyrrolo[3,4-<i>c</i>]pyrroles are selective orexin-2 antagonists: SAR leading to a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5620</span>â <span class="NLM_lpage">5636</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5620-5636&author=M.+A.+Letavicauthor=P.+Bonaventureauthor=N.+I.+Carruthersauthor=C.+Dugovicauthor=T.+Koudriakovaauthor=B.+Lordauthor=T.+W.+Lovenbergauthor=K.+S.+Lyauthor=N.+S.+Maniauthor=D.+Nepomucenoauthor=D.+J.+Pippelauthor=M.+Rizzolioauthor=J.+E.+Sheltonauthor=C.+R.+Shahauthor=B.+T.+Shiremanauthor=L.+K.+Youngauthor=S.+Yun&title=Novel+octahydropyrrolo%5B3%2C4-c%5Dpyrroles+are+selective+orexin-2+antagonists%3A+SAR+leading+to+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.5b00742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Bonaventure, Pascal; Carruthers, Nicholas I.; Dugovic, Christine; Koudriakova, Tatiana; Lord, Brian; Lovenberg, Timothy W.; Ly, Kiev S.; Mani, Neelakandha S.; Nepomuceno, Diane; Pippel, Daniel J.; Rizzolio, Michele; Shelton, Jonathan E.; Shah, Chandra R.; Shireman, Brock T.; Young, Lana K.; Yun, Sujin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5620-5636</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The preclin. characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described.  Optimization of physicochem. and DMPK properties led to the discovery of compds. with tissue distribution and duration of action suitable for evaluation in the treatment of primary insomnia.  These selective orexin-2 antagonists are proven to promote sleep in rats, and this work ultimately led to the identification of a compd. that progressed into human clin. trials for the treatment of primary insomnia.  The synthesis, SAR, and optimization of the pharmacokinetic properties of this series of compds. as well as the identification of the clin. candidate I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruHSY6-Pv5L7Vg90H21EOLACvtfcHk0ljFRSW5noGtDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansL%252FP&md5=6d8785a362aab57c84f6a6db0775d84e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00742%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DLy%26aufirst%3DK.%2BS.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DPippel%26aufirst%3DD.%2BJ.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DShah%26aufirst%3DC.%2BR.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26aulast%3DYoung%26aufirst%3DL.%2BK.%26aulast%3DYun%26aufirst%3DS.%26atitle%3DNovel%2520octahydropyrrolo%255B3%252C4-c%255Dpyrroles%2520are%2520selective%2520orexin-2%2520antagonists%253A%2520SAR%2520leading%2520to%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5620%26epage%3D5636%26doi%3D10.1021%2Facs.jmedchem.5b00742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matiskella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of the human immunodeficiency virus type 1 (HIV-1) attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6308</span>â <span class="NLM_lpage">6327</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00759</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00759" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFGgsrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6308-6327&author=T.+Wangauthor=Y.+Uedaauthor=Z.+Zhangauthor=Z.+Yinauthor=J.+Matiskellaauthor=B.+C.+Pearceauthor=Z.+Yangauthor=M.+Zhengauthor=D.+D.+Parkerauthor=G.+A.+Yamanakaauthor=Y.-F.+Gongauthor=H.-T.+Hoauthor=R.+J.+Colonnoauthor=D.+R.+Langleyauthor=P.-F.+Linauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Discovery+of+the+human+immunodeficiency+virus+type+1+%28HIV-1%29+attachment+inhibitor+temsavir+and+its+phosphonooxymethyl+prodrug+fostemsavir&doi=10.1021%2Facs.jmedchem.8b00759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir</span></div><div class="casAuthors">Wang, Tao; Ueda, Yasu; Zhang, Zhongxing; Yin, Zhiwei; Matiskella, John; Pearce, Bradley C.; Yang, Zheng; Zheng, Ming; Parker, Dawn D.; Yamanaka, Gregory A.; Gong, Yi-Fei; Ho, Hsu-Tso; Colonno, Richard J.; Langley, David R.; Lin, Pin-Fang; Meanwell, Nicholas A.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6308-6327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The optimization of the 4-methoxy-6-azaindole series of HIV-1 attachment inhibitors (AIs) that originated with 1 to deliver temsavir (3, BMS-626529) is described.  The most beneficial increases in potency and pharmacokinetic (PK) properties were attained by incorporating N-linked, sp2-hybridized heteroaryl rings at the 7-position of the heterocyclic nucleus.  Compds. that adhered to a coplanarity model afforded targeted antiviral potency, leading to the identification of 3 with characteristics that provided for targeted exposure and PK properties in three preclin. species.  However, the phys. properties of 3 limited plasma exposure at higher doses, both in preclin. studies and in clin. trials as the result of dissoln.- and/or soly.-limited absorption, a deficiency addressed by the prepn. of the phosphonooxymethyl prodrug 4 (BMS-663068, fostemsavir).  An extended-release formulation of 4 is currently in phase III clin. trials where it has shown promise as part of a drug combination therapy in highly treatment-experienced HIV-1 infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqufpirYoyNPrVg90H21EOLACvtfcHk0ljFRSW5noGtDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFGgsrfE&md5=e14780f89a22152c7506d225e4e9b5c9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00759%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DMatiskella%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DB.%2BC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DD.%2BD.%26aulast%3DYamanaka%26aufirst%3DG.%2BA.%26aulast%3DGong%26aufirst%3DY.-F.%26aulast%3DHo%26aufirst%3DH.-T.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DLin%26aufirst%3DP.-F.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520attachment%2520inhibitor%2520temsavir%2520and%2520its%2520phosphonooxymethyl%2520prodrug%2520fostemsavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6308%26epage%3D6327%26doi%3D10.1021%2Facs.jmedchem.8b00759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shinozuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokumaru, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsumi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of DS-6930, a potent selective PPARÎ³ modulator. Part II: lead optimization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5099</span>â <span class="NLM_lpage">5117</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2018.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmc.2018.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30220602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslahs7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5099-5117&author=T.+Shinozukaauthor=T.+Tsukadaauthor=K.+Fujiiauthor=E.+Tokumaruauthor=K.+Shimadaauthor=Y.+Onishiauthor=Y.+Matsuiauthor=S.+Wakimotoauthor=M.+Kurohaauthor=T.+Ogataauthor=K.+Arakiauthor=J.+Ohsumiauthor=R.+Sawamuraauthor=N.+Watanabeauthor=H.+Yamamotoauthor=K.+Fujimotoauthor=Y.+Taniauthor=M.+Moriauthor=J.+Tanaka&title=Discovery+of+DS-6930%2C+a+potent+selective+PPAR%CE%B3+modulator.+Part+II%3A+lead+optimization&doi=10.1016%2Fj.bmc.2018.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of DS-6930, a potent selective PPARÎ³ modulator. Part II: Lead optimization</span></div><div class="casAuthors">Shinozuka, Tsuyoshi; Tsukada, Tomoharu; Fujii, Kunihiko; Tokumaru, Eri; Shimada, Kousei; Onishi, Yoshiyuki; Matsui, Yumi; Wakimoto, Satoko; Kuroha, Masanori; Ogata, Tsuneaki; Araki, Kazushi; Ohsumi, Jun; Sawamura, Ryoko; Watanabe, Nobuaki; Yamamoto, Hideki; Fujimoto, Kazunori; Tani, Yoshiro; Mori, Makoto; Tanaka, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5099-5117</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Attempts were made to reduce the lipophilicity of previously synthesized compd. (II) for the avoidance of hepatotoxicity.  The replacement of the left-hand side benzene with 2-pyridine resulted in the substantial loss of potency.  Because poor membrane permeability was responsible for poor potency in vitro, the adjustment of lipophilicity was examd., which resulted in the discovery of di-Me pyridine deriv. (I, DS-6930).  In preclin. studies, DS-6930 demonstrated high PPARÎ³ agonist potency with robust plasma glucose redn.  DS-6930 maintained diminished PPARÎ³-related adverse effects upon toxicol. evaluation in vivo, and demonstrated no hepatotoxicity.  Cofactor recruitment assay showed that several cofactors, such as RIP140 and PGC1, were significantly recruited, whereas several canonical factors was not affected.  This selective cofactor recruitment was caused due to the distinct binding mode of DS-6930.  The calcium salt, DS-6930b, which is expected to be an effective inducer of insulin sensitization without edema, could be evaluated clin. in T2DM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAh_sdwZr3XLVg90H21EOLACvtfcHk0li2PTSRzaTRSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslahs7rP&md5=0608dcb7a15699727dff137b65f3b81b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DShinozuka%26aufirst%3DT.%26aulast%3DTsukada%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DK.%26aulast%3DTokumaru%26aufirst%3DE.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DOnishi%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DY.%26aulast%3DWakimoto%26aufirst%3DS.%26aulast%3DKuroha%26aufirst%3DM.%26aulast%3DOgata%26aufirst%3DT.%26aulast%3DAraki%26aufirst%3DK.%26aulast%3DOhsumi%26aufirst%3DJ.%26aulast%3DSawamura%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DTani%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520DS-6930%252C%2520a%2520potent%2520selective%2520PPAR%25CE%25B3%2520modulator.%2520Part%2520II%253A%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D5099%26epage%3D5117%26doi%3D10.1016%2Fj.bmc.2018.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Procopiou, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, M. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowedder, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saklatvala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollis, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorp, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>S</i>)-3-(3-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((<i>R</i>)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic acid, a nonpeptidic Î±<sub>v</sub>Î²<sub>6</sub> integrin inhibitor for the inhaled treatment of idiopathic pulmonary fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8417</span>â <span class="NLM_lpage">8443</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00959</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00959" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSmtbjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8417-8443&author=P.+A.+Procopiouauthor=N.+A.+Andersonauthor=J.+Barrettauthor=T.+N.+Barrettauthor=M.+H.+J.+Crawfordauthor=B.+J.+Fallonauthor=A.+P.+Hancockauthor=J.+Leauthor=S.+Lemmaauthor=R.+P.+Marshallauthor=J.+Morrellauthor=J.+M.+Pritchardauthor=J.+E.+Rowedderauthor=P.+Saklatvalaauthor=R.+J.+Slackauthor=S.+L.+Sollisauthor=C.+J.+Sucklingauthor=L.+R.+Thorpauthor=G.+Vitulliauthor=S.+J.+F.+Macdonald&title=Discovery+of+%28S%29-3-%283-%283%2C5-dimethyl-1H-pyrazol-1-yl%29phenyl%29-4-%28%28R%29-3-%282-%285%2C6%2C7%2C8-tetrahydro-1%2C8-naphthyridin-2-yl%29ethyl%29pyrrolidin-1-yl%29butanoic+acid%2C+a+nonpeptidic+%CE%B1v%CE%B26+integrin+inhibitor+for+the+inhaled+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.8b00959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic Î±vÎ²6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Procopiou, Panayiotis A.; Anderson, Niall A.; Barrett, John; Barrett, Tim N.; Crawford, Matthew H. J.; Fallon, Brendan J.; Hancock, Ashley P.; Le, Joelle; Lemma, Seble; Marshall, Richard P.; Morrell, Josie; Pritchard, John M.; Rowedder, James E.; Saklatvala, Paula; Slack, Robert J.; Sollis, Steven L.; Suckling, Colin J.; Thorp, Lee R.; Vitulli, Giovanni; Macdonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8417-8443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3-aryl-(pyrrolidin-1-yl)butanoic acids were synthesized using a diastereoselective route, which involved rhodium catalyzed asym. 1,4-addn. of arylboronic acids in the presence of (R)-BINAP to a crotonate ester to provide the (S) abs. configuration for the major product.  A variety of aryl substituents including morpholine, pyrazole, triazole, imidazole and cyclic ether were screened in cell adhesion assays for affinity against Î±vÎ²1, Î±vÎ²3, Î±vÎ²5, Î±vÎ²6 and Î±vÎ²8 integrins.  Several analogs with high affinity and selectivity for the Î±vÎ²6 integrin were identified.  The analog IÂ·HCl was found to have high affinity for Î±vÎ²6 integrin in a radioligand binding assay (pKi = 11), a long dissocn. half-life (7 h) , high soly. in saline at pH 7 (>71 mg/mL) and pharmacokinetic properties commensurate with inhaled dosing by nebulization.  It was selected for further investigation as a potential therapeutic agent for the treatment of idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeicNqg-TYWbVg90H21EOLACvtfcHk0li2PTSRzaTRSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSmtbjE&md5=6d19e081fe06edb14912ac58a16e2c50</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00959%26sid%3Dliteratum%253Aachs%26aulast%3DProcopiou%26aufirst%3DP.%2BA.%26aulast%3DAnderson%26aufirst%3DN.%2BA.%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DT.%2BN.%26aulast%3DCrawford%26aufirst%3DM.%2BH.%2BJ.%26aulast%3DFallon%26aufirst%3DB.%2BJ.%26aulast%3DHancock%26aufirst%3DA.%2BP.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DLemma%26aufirst%3DS.%26aulast%3DMarshall%26aufirst%3DR.%2BP.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DRowedder%26aufirst%3DJ.%2BE.%26aulast%3DSaklatvala%26aufirst%3DP.%26aulast%3DSlack%26aufirst%3DR.%2BJ.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DSuckling%26aufirst%3DC.%2BJ.%26aulast%3DThorp%26aufirst%3DL.%2BR.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DDiscovery%2520of%2520%2528S%2529-3-%25283-%25283%252C5-dimethyl-1H-pyrazol-1-yl%2529phenyl%2529-4-%2528%2528R%2529-3-%25282-%25285%252C6%252C7%252C8-tetrahydro-1%252C8-naphthyridin-2-yl%2529ethyl%2529pyrrolidin-1-yl%2529butanoic%2520acid%252C%2520a%2520nonpeptidic%2520%25CE%25B1v%25CE%25B26%2520integrin%2520inhibitor%2520for%2520the%2520inhaled%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8417%26epage%3D8443%26doi%3D10.1021%2Facs.jmedchem.8b00959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimerâs disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8616</span>â <span class="NLM_lpage">8637</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8616-8637&author=Z.+Wangauthor=Y.+Wangauthor=B.+Wangauthor=W.+Liauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+evaluation+of+orally+available+clioquinol-moracin+M+hybrids+as+multitarget-directed+ligands+for+cognitive+improvement+in+a+rat+model+of+neurodegeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b01222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease</span></div><div class="casAuthors">Wang, Zhiren; Wang, Yali; Wang, Bo; Li, Wenrui; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8616-8637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of clioquinol-moracin hybrids were designed and synthesized by fusing the pharmacophores of clioquinol and moracin M, and their activities as multitarget-directed ligands against Alzheimer's disease were evaluated.  Biol. activity results demonstrated that these hybrids possessed significant inhibitory activities against phosphodiesterase 4D (PDE4D) and AÎ² aggregation as well as remarkable antioxidant effects and excellent blood-brain barrier permeability.  The optimal compd., I (WBQ5187), exhibited excellent PDE4D inhibitory potency (IC50 = 0.32 Î¼M), significant antioxidant effects, appropriate biometal chelating functions, and interesting properties that modulated self- and metal-induced AÎ² aggregation.  Two-dimensional NMR studies revealed that I had significant interactions with AÎ²1-42 at the R5, H6, H14, Q15, and F20 residues.  Furthermore, this typical hybrid possessed preeminent neuroprotective effects against inflammation in microglial cells.  Most importantly, oral administration of IÂ·HCl demonstrated marked improvements in cognitive and spatial memory in a rat model of Alzheimer's disease and protected hippocampal neurons from necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcLe7jrheic7Vg90H21EOLACvtfcHk0li2PTSRzaTRSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI&md5=1230163c53dc646777185602d9fa9643</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01222%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520available%2520clioquinol-moracin%2520M%2520hybrids%2520as%2520multitarget-directed%2520ligands%2520for%2520cognitive%2520improvement%2520in%2520a%2520rat%2520model%2520of%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8616%26epage%3D8637%26doi%3D10.1021%2Facs.jmedchem.5b01222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Bourdonnec, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windh, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajello, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiant, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feschenko, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogdon, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derelanko, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, R. E.</span></span> <span> </span><span class="NLM_article-title">Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of <i>N,N</i>-diethyl-4-(5-hydroxyspiro[chromene-2,4â²-piperidine]-4-yl)benzamide (ADL5859)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5893</span>â <span class="NLM_lpage">5896</span>, <span class="refDoi">Â DOI: 10.1021/jm8008986</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8008986" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFeltL7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5893-5896&author=B.+Le%0ABourdonnecauthor=R.+T.+Windhauthor=C.+W.+Ajelloauthor=L.+K.+Leisterauthor=M.+Guauthor=G.-H.+Chuauthor=P.+A.+Tuthillauthor=W.+M.+Barkerauthor=M.+Koblishauthor=D.+D.+Wiantauthor=T.+M.+Graczykauthor=S.+Belangerauthor=J.+A.+Casselauthor=M.+S.+Feschenkoauthor=B.+L.+Brogdonauthor=S.+A.+Smithauthor=D.+D.+Christauthor=M.+J.+Derelankoauthor=S.+Kutzauthor=P.+J.+Littleauthor=R.+N.+DeHavenauthor=D.+L.+DeHaven-Hudkinsauthor=R.+E.+Dolle&title=Potent%2C+orally+bioavailable+delta+opioid+receptor+agonists+for+the+treatment+of+pain%3A+discovery+of+N%2CN-diethyl-4-%285-hydroxyspiro%5Bchromene-2%2C4%E2%80%B2-piperidine%5D-4-yl%29benzamide+%28ADL5859%29&doi=10.1021%2Fjm8008986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)</span></div><div class="casAuthors">Le Bourdonnec, Bertrand; Windh, Rolf T.; Ajello, Christopher W.; Leister, Lara K.; Gu, Minghua; Chu, Guo-Hua; Tuthill, Paul A.; Barker, William M.; Koblish, Michael; Wiant, Daniel D.; Graczyk, Thomas M.; Belanger, Serge; Cassel, Joel A.; Feschenko, Marina S.; Brogdon, Bernice L.; Smith, Steven A.; Christ, David D.; Derelanko, Michael J.; Kutz, Steve; Little, Patrick J.; DeHaven, Robert N.; DeHaven-Hudkins, Diane L.; Dolle, Roland E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5893-5896</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective Î´ opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions.  A spirocyclic deriv. was identified as a promising hit through screening.  Subsequent lead optimization identified compd. 20 (ADL5859) as a potent, selective, and orally bioavailable Î´ agonist.  Compd. 20 was selected as a clin. candidate for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoncECgkLuz4rVg90H21EOLACvtfcHk0ljfdGlyx6EPQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFeltL7K&md5=a38e21537b5b13dac20974940eec4375</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm8008986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008986%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DWindh%26aufirst%3DR.%2BT.%26aulast%3DAjello%26aufirst%3DC.%2BW.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DGu%26aufirst%3DM.%26aulast%3DChu%26aufirst%3DG.-H.%26aulast%3DTuthill%26aufirst%3DP.%2BA.%26aulast%3DBarker%26aufirst%3DW.%2BM.%26aulast%3DKoblish%26aufirst%3DM.%26aulast%3DWiant%26aufirst%3DD.%2BD.%26aulast%3DGraczyk%26aufirst%3DT.%2BM.%26aulast%3DBelanger%26aufirst%3DS.%26aulast%3DCassel%26aufirst%3DJ.%2BA.%26aulast%3DFeschenko%26aufirst%3DM.%2BS.%26aulast%3DBrogdon%26aufirst%3DB.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DDerelanko%26aufirst%3DM.%2BJ.%26aulast%3DKutz%26aufirst%3DS.%26aulast%3DLittle%26aufirst%3DP.%2BJ.%26aulast%3DDeHaven%26aufirst%3DR.%2BN.%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26atitle%3DPotent%252C%2520orally%2520bioavailable%2520delta%2520opioid%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520pain%253A%2520discovery%2520of%2520N%252CN-diethyl-4-%25285-hydroxyspiro%255Bchromene-2%252C4%25E2%2580%25B2-piperidine%255D-4-yl%2529benzamide%2520%2528ADL5859%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5893%26epage%3D5896%26doi%3D10.1021%2Fjm8008986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Bourdonnec, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windh, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajello, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiant, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feschenko, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogdon, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derelanko, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, R. E.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of <i>N,N</i>-diethyl-3-hydroxy-4-(spiro[chromene-2,4â²-piperidine]-4-yl) benzamide (ADL5747)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5685</span>â <span class="NLM_lpage">5702</span>, <span class="refDoi">Â DOI: 10.1021/jm900773n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900773n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWkurvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5685-5702&author=B.+Le%0ABourdonnecauthor=R.+T.+Windhauthor=L.+K.+Leisterauthor=Q.+J.+Zhouauthor=C.+W.+Ajelloauthor=M.+Guauthor=G.-H.+Chuauthor=P.+A.+Tuthillauthor=W.+M.+Barkerauthor=M.+Koblishauthor=D.+D.+Wiantauthor=T.+M.+Graczykauthor=S.+Belangerauthor=J.+A.+Casselauthor=M.+S.+Feschenkoauthor=B.+L.+Brogdonauthor=S.+A.+Smithauthor=M.+J.+Derelankoauthor=S.+Kutzauthor=P.+J.+Littleauthor=R.+N.+DeHavenauthor=D.+L.+DeHaven-Hudkinsauthor=R.+E.+Dolle&title=Spirocyclic+delta+opioid+receptor+agonists+for+the+treatment+of+pain%3A+discovery+of+N%2CN-diethyl-3-hydroxy-4-%28spiro%5Bchromene-2%2C4%E2%80%B2-piperidine%5D-4-yl%29+benzamide+%28ADL5747%29&doi=10.1021%2Fjm900773n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) Benzamide (ADL5747)</span></div><div class="casAuthors">Le Bourdonnec, Bertrand; Windh, Rolf T.; Leister, Lara K.; Zhou, Q. Jean; Ajello, Christopher W.; Gu, Minghua; Chu, Guo-Hua; Tuthill, Paul A.; Barker, William M.; Koblish, Michael; Wiant, Daniel D.; Graczyk, Thomas M.; Belanger, Serge; Cassel, Joel A.; Feschenko, Marina S.; Brogdon, Bernice L.; Smith, Steven A.; Derelanko, Michael J.; Kutz, Steve; Little, Patrick J.; De Haven, Robert N.; De Haven-Hudkins, Diane L.; Dolle, Roland E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5685-5702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective, nonpeptidic Î´ opioid receptor agonists have been the subject of great interest as potential novel analgesic agents.  The discoveries of BW373U86 (I) and SNC80 (II) contributed to the rapid expansion of research in this field.  However, poor drug-like properties and low therapeutic indexes have prevented clin. evaluation of these agents.  Doses of I and II similar to those required for analgesic activity produce convulsions in rodents and nonhuman primates.  Recently, a novel series of potent, selective, and orally bioavailable delta opioid receptor agonists was described.  The lead deriv., ADL5859 (III), is currently in phase II proof-of-concept studies for the management of pain.  Further structure activity relationship exploration has led to the discovery of ADL5747 (IV), which is approx. 50-fold more potent than III in an animal model of inflammatory pain.  On the basis of its favorable efficacy, safety, and pharmacokinetic profile, IV was selected as a clin. candidate for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0gbucCvC4DLVg90H21EOLACvtfcHk0ljfdGlyx6EPQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWkurvP&md5=ac08eaad9f032e9d2ef50b7d03b48d3e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900773n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900773n%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DWindh%26aufirst%3DR.%2BT.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DZhou%26aufirst%3DQ.%2BJ.%26aulast%3DAjello%26aufirst%3DC.%2BW.%26aulast%3DGu%26aufirst%3DM.%26aulast%3DChu%26aufirst%3DG.-H.%26aulast%3DTuthill%26aufirst%3DP.%2BA.%26aulast%3DBarker%26aufirst%3DW.%2BM.%26aulast%3DKoblish%26aufirst%3DM.%26aulast%3DWiant%26aufirst%3DD.%2BD.%26aulast%3DGraczyk%26aufirst%3DT.%2BM.%26aulast%3DBelanger%26aufirst%3DS.%26aulast%3DCassel%26aufirst%3DJ.%2BA.%26aulast%3DFeschenko%26aufirst%3DM.%2BS.%26aulast%3DBrogdon%26aufirst%3DB.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DDerelanko%26aufirst%3DM.%2BJ.%26aulast%3DKutz%26aufirst%3DS.%26aulast%3DLittle%26aufirst%3DP.%2BJ.%26aulast%3DDeHaven%26aufirst%3DR.%2BN.%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26atitle%3DSpirocyclic%2520delta%2520opioid%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520pain%253A%2520discovery%2520of%2520N%252CN-diethyl-3-hydroxy-4-%2528spiro%255Bchromene-2%252C4%25E2%2580%25B2-piperidine%255D-4-yl%2529%2520benzamide%2520%2528ADL5747%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5685%26epage%3D5702%26doi%3D10.1021%2Fjm900773n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongsted, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannecouque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span> <span> </span><span class="NLM_article-title">Overview of recent strategic advances in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9375</span>â <span class="NLM_lpage">9414</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVKgsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9375-9414&author=G.+Wuauthor=T.+Zhaoauthor=D.+Kangauthor=J.+Zhangauthor=Y.+Songauthor=V.+Namasivayamauthor=J.+Kongstedauthor=C.+Pannecouqueauthor=E.+De+Clercqauthor=V.+Poongavanamauthor=X.+Liuauthor=P.+Zhan&title=Overview+of+recent+strategic+advances+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.9b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of Recent Strategic Advances in Medicinal Chemistry</span></div><div class="casAuthors">Wu, Gaochan; Zhao, Tong; Kang, Dongwei; Zhang, Jian; Song, Yuning; Namasivayam, Vigneshwaran; Kongsted, Jacob; Pannecouque, Christophe; De Clercq, Erik; Poongavanam, Vasanthanathan; Liu, Xinyong; Zhan, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9375-9414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Introducing novel strategies, concepts and technologies that speed up drug discovery and the drug development cycle is of great importance both in the highly competitive pharmaceutical industry as well as in academia.  This review aims to present a "big-picture" overview of recent strategic innovations in medicinal chem. and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQnxCWBy2AJLVg90H21EOLACvtfcHk0lhii1V2LqmHfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVKgsrk%253D&md5=0012d1386ecf4e84e1caf5e90837d708</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DKongsted%26aufirst%3DJ.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DP.%26atitle%3DOverview%2520of%2520recent%2520strategic%2520advances%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9375%26epage%3D9414%26doi%3D10.1021%2Facs.jmedchem.9b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18a','cit18b','cit18c','cit18d'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b'],'ref21':['cit21a','cit21b','cit21c','cit21d'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b','cit25c','cit25d','cit25e','cit25f','cit25g'],'ref26':['cit26a','cit26b','cit26c','cit26d','cit26e','cit26f'],'ref27':['cit27a','cit27b','cit27c','cit27d'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Palak Babbar, Pronay Das, Yogavel Manickam, Yash Mankad, Swati Yadav, Suhel Parvez, Amit Sharma, <span class="NLM_string-name hlFld-ContribAuthor">D. Srinivasa Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structural Analysis of Cladosporin-Based Inhibitors of Malaria Parasites. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1777-1794. <a href="https://doi.org/10.1021/acsinfecdis.1c00092" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00092%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructural%252BAnalysis%252Bof%252BCladosporin-Based%252BInhibitors%252Bof%252BMalaria%252BParasites%26aulast%3DBabbar%26aufirst%3DPalak%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23022021%26date%3D12042021%26volume%3D7%26issue%3D6%26spage%3D1777%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Derun Li, Yongqi Deng, Abdelghani Achab, Indu Bharathan, Brett Andrew Hopkins, Wensheng Yu, Hongjun Zhang, Sulagna Sanyal, Qinglin Pu, Hua Zhou, Kun Liu, Jongwon Lim, Xavier Fradera, Charles A. Lesburg, Alfred Lammens, Theodore A. Martinot, Ryan D. Cohen, Amy C. Doty, Heidi Ferguson, Elliott B. Nickbarg, Mangeng Cheng, Peter Spacciapoli, Prasanthi Geda, Xuelei Song, Nadya Smotrov, Pravien Abeywickrema, Christine Andrews, Chad Chamberlin, Omar Mabrouk, Patrick Curran, Matthew Richards, Peter Saradjian, J. Richard Miller, Ian Knemeyer, Karin M. Otte, Stella Vincent, Nunzio Sciammetta, Alexander Pasternak, David Jonathan Bennett, <span class="NLM_string-name hlFld-ContribAuthor">Yongxin Han</span>. </span><span class="cited-content_cbyCitation_article-title">Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 389-396. <a href="https://doi.org/10.1021/acsmedchemlett.0c00525" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00525%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCarbamate%252Band%252BN-Pyrimidine%252BMitigate%252BAmide%252BHydrolysis%25253A%252BStructure-Based%252BDrug%252BDesign%252Bof%252BTetrahydroquinoline%252BIDO1%252BInhibitors%26aulast%3DLi%26aufirst%3DDerun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D23022021%26date%3D26022021%26volume%3D12%26issue%3D3%26spage%3D389%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang-Dong  Zuo</span>, <span class="hlFld-ContribAuthor ">Xiao-Shuang  Ji</span>, <span class="hlFld-ContribAuthor ">Cheng  Guo</span>, <span class="hlFld-ContribAuthor ">Shu-Jiang  Tu</span>, <span class="hlFld-ContribAuthor ">Wen-Juan  Hao</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Cu-Catalyzed radical-triggered spirotricyclization of enediynes and enyne-nitriles for the synthesis of pentacyclic spiroindenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (7)
                                     , 1496-1502. <a href="https://doi.org/10.1039/D0QO01640C" title="DOI URL">https://doi.org/10.1039/D0QO01640C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01640C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01640C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DCu-Catalyzed%252Bradical-triggered%252Bspirotricyclization%252Bof%252Benediynes%252Band%252Benyne-nitriles%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpentacyclic%252Bspiroindenes%26aulast%3DZuo%26aufirst%3DHang-Dong%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D7%26spage%3D1496%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Ingo  Muegge</span>. </span><span class="cited-content_cbyCitation_article-title">Holistic Drug Design for Multiparameter Optimization in Modern Small Molecule Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>10 </em>, 128003. <a href="https://doi.org/10.1016/j.bmcl.2021.128003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHolistic%252BDrug%252BDesign%252Bfor%252BMultiparameter%252BOptimization%252Bin%252BModern%252BSmall%252BMolecule%252BDrug%252BDiscovery%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2021%26volume%3D10%26spage%3D128003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Oebbeke</span>, <span class="hlFld-ContribAuthor ">Christof  Siefker</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  Wagner</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>. </span><span class="cited-content_cbyCitation_article-title">FragmentâBindung an die KinaseâScharnierâRegion: Wenn Ladungsverteilung und lokale p
              K
              a
              âVerschiebungen etablierte BioisosterieâKonzepte fehlleiten. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (1)
                                     , 256-262. <a href="https://doi.org/10.1002/ange.202011295" title="DOI URL">https://doi.org/10.1002/ange.202011295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202011295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202011295%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DFragment%2525E2%252580%252590Bindung%252Ban%252Bdie%252BKinase%2525E2%252580%252590Scharnier%2525E2%252580%252590Region%25253A%252BWenn%252BLadungsverteilung%252Bund%252Blokale%252Bp%252BK%252Ba%252B%2525E2%252580%252590Verschiebungen%252Betablierte%252BBioisosterie%2525E2%252580%252590Konzepte%252Bfehlleiten%26aulast%3DOebbeke%26aufirst%3DMatthias%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D1%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Oebbeke</span>, <span class="hlFld-ContribAuthor ">Christof  Siefker</span>, <span class="hlFld-ContribAuthor ">BjÃ¶rn  Wagner</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment Binding to Kinase Hinge: If Charge Distribution and Local p
              K
              a
              Shifts Mislead Popular Bioisosterism Concepts. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (1)
                                     , 252-258. <a href="https://doi.org/10.1002/anie.202011295" title="DOI URL">https://doi.org/10.1002/anie.202011295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202011295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202011295%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DFragment%252BBinding%252Bto%252BKinase%252BHinge%25253A%252BIf%252BCharge%252BDistribution%252Band%252BLocal%252Bp%252BK%252Ba%252BShifts%252BMislead%252BPopular%252BBioisosterism%252BConcepts%26aulast%3DOebbeke%26aufirst%3DMatthias%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D1%26spage%3D252%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huabin  Hu</span>, <span class="hlFld-ContribAuthor ">JÃ¼rgen  Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Activity cliffs produced by single-atom modification of active compounds: Systematic identification and rationalization based on X-ray structures. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112846. <a href="https://doi.org/10.1016/j.ejmech.2020.112846" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112846%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DActivity%252Bcliffs%252Bproduced%252Bby%252Bsingle-atom%252Bmodification%252Bof%252Bactive%252Bcompounds%25253A%252BSystematic%252Bidentification%252Band%252Brationalization%252Bbased%252Bon%252BX-ray%252Bstructures%26aulast%3DHu%26aufirst%3DHuabin%26date%3D2020%26volume%3D207%26spage%3D112846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonas  Verhellen</span>, <span class="hlFld-ContribAuthor ">Jeriek  Van den Abeele</span>. </span><span class="cited-content_cbyCitation_article-title">Illuminating elite patches of chemical space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (42)
                                     , 11485-11491. <a href="https://doi.org/10.1039/D0SC03544K" title="DOI URL">https://doi.org/10.1039/D0SC03544K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC03544K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC03544K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DIlluminating%252Belite%252Bpatches%252Bof%252Bchemical%252Bspace%26aulast%3DVerhellen%26aufirst%3DJonas%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D42%26spage%3D11485%26epage%3D11491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0019.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Positional analogue scanning for multiparameter optimization of aromatic or heteroaromatic ring-containing hit or lead compounds leverages the beneficial effects that minor structure modifications can have on molecular and physicochemical properties and intra- and intermolecular interactions (CH â X: exchange of aromatic or heteroaromatic CH groups with N atoms or CF, CMe, or COH groups, etc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The Topliss method for potency optimization of aromatic ring-containing hit or lead compounds considers effects on hydrophobic (Ï), electronic (Ï), and steric (<i>E</i><sub>s</sub>) Hansch parameters (L = less active, E = equiactive, M = more active; descending lines indicate sequence; square brackets indicate alternates; â , compared to 4-H compound). Figure is adapted from J. G. Topliss.<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. An example of full, iterative nitrogen scanning, which contributed to the identification of a lead compound (<b>13</b>) with an improved pharmacological profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. An example of partial, tandem fluorine and nitrogen scanning, which contributed to the identification of clinical candidate <b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MMP analyses. The percentages of MMPs derived from ChEMBL24 with â¥3-fold decreases (blue), <3-fold changes (gray), and â¥3-fold increases (orange) are depicted. For exact values, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Tables S1âS4)</a>. The number of MMP occurrences is noted in the upper left corner for each graph. The statistical significances of the differences between the â¥3-fold decrease and â¥3-fold increase bins are indicated by one, two, or three asterisks corresponding to Ï<sup>2</sup><i>p</i>-values of <0.05, <0.01, and <0.001, respectively. The number of MMPs represents the total number of MMPs associated with unique assay data extracted from ChEMBL24. The number of unique MMPs lists the number of structurally unique MMPs. The number of assays refers to the number of unique ChEMBL24 assays associated with the respective MMPs. Interpretations of property increases for each parameter are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S5)</a>. A list of measures and units associated with the assays for each property for CH group â N atom exchanges is given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S6)</a>. The statistics for ring diversity among unique MMPs for CH group â N atom exchanges is provided as <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Table S7)</a>. An overview of targets associated with ChEMBL24 assays is also available in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf" class="ext-link">Supporting Information (Figure S1)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Positional analogue analyses. MMP statistics presented in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> are dissected here by positional analogues. Positional analogue designations are assigned relative to the nearest ring substituent or ring fusion. The percentages of MMPs with â¥3-fold decreases (blue), <3-fold changes (gray), or â¥3-fold increases (orange) are depicted. The number of MMP occurrences is noted in the upper left corner for each graph. The statistical significances of the differences between the â¥3-fold decrease and â¥3-fold increase bins are indicated by one, two, or three asterisks corresponding to Ï<sup>2</sup><i>p</i>-values of <0.05, <0.01, and <0.001, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. An example of nitrogen scanning to improve potency, which contributed to the identification of clinical candidate <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. An example of nitrogen scanning to increase microsomal stability, which contributed to the identification of preclinical candidate <b>34</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0018.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. An example of iterative nitrogen scanning to increase microsomal stability, reduce CYP 3A4 inhibition, and ablate PXR activity, which contributed to the identification of clinical candidate <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. An example of fluorine scanning to improve potency, which contributed to the identification of clinical candidate <b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. An example of fluorine scanning to increase microsomal stability and improve PK and neuroPK profiles, which contributed to the identification of clinical candidate <b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. An example of fluorine scanning to increase oral bioavailability and avoid hERG and CYP 1A2 inhibition, which contributed to the identification of clinical candidate <b>55</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. An example of methyl scanning to improve potency and cellular permeability, which contributed to the identification of clinical candidate <b>63</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0006.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. An example of methyl scanning to improve potency and membrane permeability, which contributed to the identification of clinical candidate <b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0007.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. An example of methyl scanning to reduce hERG inhibition, which contributed to the identification of clinical candidate <b>74</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0008.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. An example of hydroxyl scanning to improve potency and membrane permeability, which contributed to the identification of advanced lead <b>79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0009.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. An example of hydroxyl scanning to reduce inhibition of hERG and CYP 2D6, which contributed to the identification of clinical candidates <b>81</b> and <b>85</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/medium/jm9b02092_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0010.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. General guidance for leveraging positional analogue scanning for multiparameter optimization in drug design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02092/20200903/images/large/jm9b02092_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02092&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E. R.</span></span> <span> </span><span class="NLM_article-title">The impact of chemical probes in drug discovery: a pharmaceutical industry perspective</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">10</span>â <span class="NLM_lpage">16</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2015.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.chembiol.2015.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=26933732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=10-16&author=R.+M.+Garbaccioauthor=E.+R.+Parmee&title=The+impact+of+chemical+probes+in+drug+discovery%3A+a+pharmaceutical+industry+perspective&doi=10.1016%2Fj.chembiol.2015.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective</span></div><div class="casAuthors">Garbaccio, Robert M.; Parmee, Emma R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-17</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Chem. probes represent an important component of both academic and pharmaceutical drug discovery research.  As a complement to prior reviews that have defined this scientific field, we aim to provide an industry perspective on the value of having high-quality chem. probes throughout the course of preclin. research.  By studying examples from the internal Merck pipeline, we recognize that these probes require significant collaborative investment to realize their potential impact in clarifying the tractability and translation of a given therapeutic target.  This perspective concludes with recommendations for chem. probe discovery aimed toward maximizing their potential to identify targets that result in the successful delivery of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwf2z0pWI1rVg90H21EOLACvtfcHk0lgM7hE3jkFXtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqsLk%253D&md5=7cb4cb2533a5f52281d34fa51c684105</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DThe%2520impact%2520of%2520chemical%2520probes%2520in%2520drug%2520discovery%253A%2520a%2520pharmaceutical%2520industry%2520perspective%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D10%26epage%3D16%26doi%3D10.1016%2Fj.chembiol.2015.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâHagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SundstrÃ¶m, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%99Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0ljBjlLQbHdMHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug design: an update on recent applications of efficiency metrics, strategies for replacing problematic elements, and compounds in nontraditional drug space</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">564</span>â <span class="NLM_lpage">616</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrestox.6b00043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=564-616&author=N.+A.+Meanwell&title=Improving+drug+design%3A+an+update+on+recent+applications+of+efficiency+metrics%2C+strategies+for+replacing+problematic+elements%2C+and+compounds+in+nontraditional+drug+space&doi=10.1021%2Facs.chemrestox.6b00043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-616</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery and development is a complex and lengthy enterprise that suffers from high rates of candidate attrition at all stages of the process.  The phys., biol., and toxicol. properties of a drug candidate are inextricably linked to its structure, and once a mol. has been synthesized, all subsequent studies along the development path are focused only on assessing and understanding its properties in greater detail.  Unfortunately, a full prediction of the biol. properties of a mol. from an anal. of its 2- or 3-dimensional structure is currently beyond our expertise.  This backdrop mandates that considerable care be taken at the design stage if a mol. is to be successful in testing a mechanistic concept underlying a disease process and to progress into late stage clin. trials and, ultimately, marketing approval.  While there are multiple potential causes of candidate attrition, an introspective anal. of drug design practices over the past decade has focused attention on the perception that contemporary mols. are unnecessarily obese, burdened by high mol. wt. and excessive lipophilicity.  This practice is believed to have its roots in the singular pursuit of enhancing potency during lead optimization rather than adopting a more holistic approach to drug design that gives broader consideration to how structural features affect developability properties.  In an effort to provide the medicinal chem. community with practical guideposts to enhancing compd. quality in the drug design phase and which can readily be applied, a series of efficiency indexes have been proposed that attempt to define aspects of compd. quality in the context of a series of physicochem. parameters.  Of these metrics, lipophilic ligand efficiency (LLE or LipE), which provides an index of the dependence of the potency of a mol. on its intrinsic lipophilicity, has been characterized as the most robust metric that has potential for broad-based application.  In this review, after describing the background literature behind the derivation of efficiency metrics and approaches to assessing compd. aesthetics, synopses of some recent practical application in lead optimization campaigns are presented.  However, mols. that fall into space beyond that assocd. with traditional drug-like properties are an important part of the current and future landscape, exemplified by the summary of direct acting hepatitis C virus NS3 and NS5A inhibitors that have transformed clin. therapy for this chronic disease.  While drug development in nontraditional drug-like space is more challenging and the rules for compd. quality will be different with much still to be understood, careful and disciplined drug design practices will be an essential element of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotJb_EhGoW7Vg90H21EOLACvtfcHk0ljBjlLQbHdMHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D&md5=aef48399fb698b5f958c1cc11e1d25aa</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520design%253A%2520an%2520update%2520on%2520recent%2520applications%2520of%2520efficiency%2520metrics%252C%2520strategies%2520for%2520replacing%2520problematic%2520elements%252C%2520and%2520compounds%2520in%2520nontraditional%2520drug%2520space%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2016%26volume%3D29%26spage%3D564%26epage%3D616%26doi%3D10.1021%2Facs.chemrestox.6b00043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abou-Gharbia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childers, W. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of innovative therapeutics: todayâs realities and tomorrowâs vision. 2. Pharmaâs challenges and their commitment to innovation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5525</span>â <span class="NLM_lpage">5553</span>, <span class="refDoi">Â DOI: 10.1021/jm401564r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401564r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5525-5553&author=M.+Abou-Gharbiaauthor=W.+E.+Childers&title=Discovery+of+innovative+therapeutics%3A+today%E2%80%99s+realities+and+tomorrow%E2%80%99s+vision.+2.+Pharma%E2%80%99s+challenges+and+their+commitment+to+innovation&doi=10.1021%2Fjm401564r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision. 2. Pharma's Challenges and Their Commitment to Innovation</span></div><div class="casAuthors">Abou-Gharbia, Magid; Childers, Wayne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is facing enormous challenges, including reduced efficiency, stagnant success rate, patent expirations for key drugs, fierce price competition from generics, high regulatory hurdles, and the industry's perceived tarnished image.  Pharma has responded by embarking on a range of initiatives.  Other sectors, including NIH, have also responded.  Academic drug discovery groups have appeared to support the transition of innovative academic discoveries and ideas into attractive drug discovery opportunities.  Part 1 of this two-part series discussed the criticisms that have been leveled at the pharmaceutical industry over the past 3 decades and summarized the supporting data for and against these criticisms.  This second installment will focus on the current challenges facing the pharmaceutical industry and Pharma's responses, focusing on the industry's changing perspective and new business models for coping with the loss of talent and declining clin. pipelines as well as presenting some examples of recent drug discovery successes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4lpJv0KTwLVg90H21EOLACvtfcHk0lhKwTcWpihDTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D&md5=81598458e7db3879f2e5bb67d5b40eb3</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fjm401564r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401564r%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26atitle%3DDiscovery%2520of%2520innovative%2520therapeutics%253A%2520today%25E2%2580%2599s%2520realities%2520and%2520tomorrow%25E2%2580%2599s%2520vision.%25202.%2520Pharma%25E2%2580%2599s%2520challenges%2520and%2520their%2520commitment%2520to%2520innovation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5525%26epage%3D5553%26doi%3D10.1021%2Fjm401564r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mytelka, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunwiddie, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persinger, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munos, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindborg, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schacht, A. L.</span></span> <span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industryâs grand challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">203</span>â <span class="NLM_lpage">214</span>, <span class="refDoi">Â DOI: 10.1038/nrd3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge&doi=10.1038%2Fnrd3078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lhKwTcWpihDTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214%26doi%3D10.1038%2Fnrd3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D. R.</span></span> <span> </span><span class="NLM_article-title">Statistical analysis of the effects of common chemical substituents on ligand potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">564</span>, <span class="refDoi">Â DOI: 10.1021/jm070838y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070838y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ejtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=553-564&author=P.+J.+Hajdukauthor=D.+R.+Sauer&title=Statistical+analysis+of+the+effects+of+common+chemical+substituents+on+ligand+potency&doi=10.1021%2Fjm070838y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Statistical Analysis of the Effects of Common Chemical Substituents on Ligand Potency</span></div><div class="casAuthors">Hajduk, Philip J.; Sauer, Daryl R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The results of a statistical anal. of more than 84000 compds. from lead optimization programs against 30 different protein targets is presented, with a focus on the effects that different chem. substituents have on compd. potency.  It is obsd. that the potency changes induced by most chem. groups follows a nearly normal distribution centered near zero (i.e., no effect on potency).  However, the widths of the distributions vary significantly between different substituents, and these effects cannot be rationalized by simple physicochem. parameters.  In addn., certain substituents consistently bias the distribution toward higher or lower potency, suggesting the existence of preferred and nonpreferred chem. groups for lead optimization.  The implications of these results for understanding protein-ligand recognition and for enhancing the efficiency and speed of lead optimization will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9sbNYA_Mzl7Vg90H21EOLACvtfcHk0lhKwTcWpihDTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ejtQ%253D%253D&md5=396d02789aece9be31fe3508fbabca7d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm070838y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070838y%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DSauer%26aufirst%3DD.%2BR.%26atitle%3DStatistical%2520analysis%2520of%2520the%2520effects%2520of%2520common%2520chemical%2520substituents%2520on%2520ligand%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D553%26epage%3D564%26doi%3D10.1021%2Fjm070838y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Leveraging the Necessary Nitrogen Atom in Chemical Biology and Drug Discovery</span>. Presented at the 258th National Meeting of the American Chemical Society, San Diego Convention Center, San Diego, CA, August 27, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=L.+D.+Pennington&title=Leveraging+the+Necessary+Nitrogen+Atom+in+Chemical+Biology+and+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DLeveraging%2520the%2520Necessary%2520Nitrogen%2520Atom%2520in%2520Chemical%2520Biology%2520and%2520Drug%2520Discovery%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3552</span>â <span class="NLM_lpage">3579</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+necessary+nitrogen+atom%3A+a+versatile+high-impact+design+element+for+multiparameter+optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein â¥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0liwrfGrlsjRhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520necessary%2520nitrogen%2520atom%253A%2520a%2520versatile%2520high-impact%2520design%2520element%2520for%2520multiparameter%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span> <span> </span><span class="NLM_article-title">The difference a single atom can make: synthesis and design at the chemistryâbiology interface</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">11961</span>â <span class="NLM_lpage">11980</span>, <span class="refDoi">Â DOI: 10.1021/acs.joc.7b02088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b02088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGhs7%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=11961-11980&author=D.+L.+Boger&title=The+difference+a+single+atom+can+make%3A+synthesis+and+design+at+the+chemistry%E2%80%93biology+interface&doi=10.1021%2Facs.joc.7b02088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface</span></div><div class="casAuthors">Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11961-11980</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A Perspective of work in our lab. on the examn. of biol. active compds., esp. natural products, is presented.  In the context of individual programs and along with a summary of our work, selected cases are presented that illustrate the impact single atom changes can have on the biol. properties of the compds.  The examples were chosen to highlight single heavy atom changes that improve activity, rather than those that involve informative alterations that reduce or abolish activity.  The examples were also chosen to illustrate that the impact of such single-atom changes can originate from steric, electronic, conformational, or H-bonding effects, from changes in functional reactivity, from fundamental intermol. interactions with a biol. target, from introduction of a new or altered functionalization site, or from features as simple as improvements in stability or phys. properties.  Nearly all the examples highlighted represent not only unusual instances of productive deep-seated natural product modifications and were introduced through total synthesis but are also remarkable in that they are derived from only a single heavy atom change in the structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX_eF-VHK7ZbVg90H21EOLACvtfcHk0liwrfGrlsjRhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGhs7%252FE&md5=1ed0b2ee9315842d41e6efec8f97ed2c</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b02088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b02088%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DThe%2520difference%2520a%2520single%2520atom%2520can%2520make%253A%2520synthesis%2520and%2520design%2520at%2520the%2520chemistry%25E2%2580%2593biology%2520interface%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D11961%26epage%3D11980%26doi%3D10.1021%2Facs.joc.7b02088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">SchÃ¶nherr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Profound methyl effects in drug discovery and a call for new CâH methylation reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12256</span>â <span class="NLM_lpage">12267</span>, <span class="refDoi">Â DOI: 10.1002/anie.201303207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201303207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12256-12267&author=H.+Sch%C3%B6nherrauthor=T.+Cernak&title=Profound+methyl+effects+in+drug+discovery+and+a+call+for+new+C%E2%80%93H+methylation+reactions&doi=10.1002%2Fanie.201303207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Profound methyl effects in drug discovery and a call for new C-H methylation reactions</span></div><div class="casAuthors">Schonherr Heike; Cernak Tim</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12256-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The methyl group is one of the most commonly occurring carbon fragments in small-molecule drugs.  This simplest alkyl fragment appears in more than 67 % of the top-selling drugs of 2011 and can modulate both the biological and physical properties of a molecule.  This Review focuses on so-called magic methyl effects on binding potency, where the seemingly mundane change of C H to C Me improves the IC50  value of a drug candidate more than 100-fold.  This discussion is followed by a survey of recent advances in synthetic chemistry that allow the direct methylation of C(sp(2) ) H and C(sp(3) ) H bonds.  It is our hope that the relevance of the meager methyl group to drug discovery as presented herein will inspire reports on new C H methylation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyoLZDDgvsMh0LsK7uFuY7fW6udTcc2eYcsp2-jB01sbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D&md5=ef08f80e55b2c530b49e4306da024902</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303207%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DH.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DProfound%2520methyl%2520effects%2520in%2520drug%2520discovery%2520and%2520a%2520call%2520for%2520new%2520C%25E2%2580%2593H%2520methylation%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12256%26epage%3D12267%26doi%3D10.1002%2Fanie.201303207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Methyl effects on proteinâligand binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4489</span>â <span class="NLM_lpage">4500</span>, <span class="refDoi">Â DOI: 10.1021/jm3003697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4489-4500&author=C.+S.+Leungauthor=S.+S.+F.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Methyl+effects+on+protein%E2%80%93ligand+binding&doi=10.1021%2Fjm3003697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Effects on Protein-Ligand Binding</span></div><div class="casAuthors">Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4489-4500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of addn. of a Me group to a lead compd. on biol. activity are examd.  A literature anal. of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event.  Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water mols., and changes in conformational energetics.  The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calcns. for Me replacements in inhibitor series for p38Î± MAP kinase, ACK1, PTP1B, and thrombin.  Me substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change.  The greatest improvements in activity arise from coupling the conformational gain with the burial of the Me group in a hydrophobic region of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0Czyhgy6KbVg90H21EOLACvtfcHk0liwrfGrlsjRhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D&md5=0ea58d9c1bf845d383931b6a017f9b37</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm3003697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003697%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BS.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DMethyl%2520effects%2520on%2520protein%25E2%2580%2593ligand%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4489%26epage%3D4500%26doi%3D10.1021%2Fjm3003697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5822</span>â <span class="NLM_lpage">5880</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5822-5880&author=N.+A.+Meanwell&title=Fluorine+and+fluorinated+motifs+in+the+design+and+application+of+bioisosteres+for+drug+design&doi=10.1021%2Facs.jmedchem.7b01788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5822-5880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the Me group while also acting as a functional mimetic of the carbonyl, carbinol, andnitrile moieties.  In this context, fluorine substitution can influence the potency, conformation, metab., membrane permeability, and P-gp recognition of a mol. and temper inhibition of the hERG channel by basic amines.  However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated mol. construction that broadens biol. mimesis.  In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a mol. are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsoQvY950L3LVg90H21EOLACvtfcHk0lipAsWqBKgdLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7w%253D&md5=2d0ce3326c7ff932da8d7d26972ced14</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DFluorine%2520and%2520fluorinated%2520motifs%2520in%2520the%2520design%2520and%2520application%2520of%2520bioisosteres%2520for%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5822%26epage%3D5880%26doi%3D10.1021%2Facs.jmedchem.7b01788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span> <span> </span><span class="NLM_article-title">A survey of the role of nitrile groups in proteinâligand interactions</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2713</span>â <span class="NLM_lpage">2728</span>, <span class="refDoi">Â DOI: 10.4155/fmc-2018-0252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.4155%2Ffmc-2018-0252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30518255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWrt7nE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=2713-2728&author=Y.+Wangauthor=Y.+Duauthor=N.+Huang&title=A+survey+of+the+role+of+nitrile+groups+in+protein%E2%80%93ligand+interactions&doi=10.4155%2Ffmc-2018-0252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">A survey of the role of nitrile groups in protein-ligand interactions</span></div><div class="casAuthors">Wang, Yuanxun; Du, Yunfei; Huang, Niu</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2713-2728</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In classical medicinal chem., nitrile groups were commonly considered as bioisosteres of carbonyl, hydroxyl and carboxyl groups, as well as halogen atoms.  However, there is a lack of in-depth understanding about the structural and energetic characteristics of nitrile groups in protein-ligand interactions.  Here, we have surveyed the Protein Data Bank and ChEMBL databases with the goal of characterizing such protein-ligand interactions for nitrile-contg. compds.  We discuss the versatile roles of nitrile groups in improving binding affinities, and give special attention to examples of displacing and mimicking binding-site waters by nitrile groups.  We expect that this review article will further inspire medicinal chemists to exploit nitrile groups rationally in structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWBvAO21DSLVg90H21EOLACvtfcHk0lipAsWqBKgdLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWrt7nE&md5=0317a874050467a6f60b5134aa909d8f</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0252%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DN.%26atitle%3DA%2520survey%2520of%2520the%2520role%2520of%2520nitrile%2520groups%2520in%2520protein%25E2%2580%2593ligand%2520interactions%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D2713%26epage%3D2728%26doi%3D10.4155%2Ffmc-2018-0252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sager, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">Hydroxyl groups in synthetic and natural-product-derived therapeutics: a perspective on a common functional group</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8915</span>â <span class="NLM_lpage">8930</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOjsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8915-8930&author=J.+Cramerauthor=C.+P.+Sagerauthor=B.+Ernst&title=Hydroxyl+groups+in+synthetic+and+natural-product-derived+therapeutics%3A+a+perspective+on+a+common+functional+group&doi=10.1021%2Facs.jmedchem.9b00179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group</span></div><div class="casAuthors">Cramer, Jonathan; Sager, Christoph P.; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8915-8930</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  By forming extended hydrogen bond networks, the contribution of hydroxyl groups to affinity can reach several orders of magnitude.  However, because of the high directionality of their interactions, a maximal affinity gain can only be achieved when the ligand scaffold allows a perfect spatial fit with the binding site.  In contrast to the broad potential of hydroxyl groups for mol. recognition is their exceptionally high desolvation penalty, which can equally reduce binding affinity.  As a consequence, alcs. are rarely present in synthetic drugs, but predominantly found in therapeutics derived directly or inspired from natural products, which were shaped under evolutionary pressure.  In this perspective, advantages as well as drawbacks influencing the use of OH groups in medicinal chem. are discussed and illustrated with four exemplary case studies.  Addnl., guidelines for drug design are derived from common features found in existing therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Ay8IcfLbF7Vg90H21EOLACvtfcHk0lipAsWqBKgdLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOjsLY%253D&md5=5fff184a72d160ae211d4bc3d8dfba47</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00179%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DJ.%26aulast%3DSager%26aufirst%3DC.%2BP.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DHydroxyl%2520groups%2520in%2520synthetic%2520and%2520natural-product-derived%2520therapeutics%253A%2520a%2520perspective%2520on%2520a%2520common%2520functional%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8915%26epage%3D8930%26doi%3D10.1021%2Facs.jmedchem.9b00179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency as an important metric in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6401</span>â <span class="NLM_lpage">6420</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6401-6420&author=T.+W.+Johnsonauthor=R.+A.+Gallegoauthor=M.+P.+Edwards&title=Lipophilic+efficiency+as+an+important+metric+in+drug+design&doi=10.1021%2Facs.jmedchem.8b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic Efficiency as an Important Metric in Drug Design</span></div><div class="casAuthors">Johnson, Ted W.; Gallego, Rebecca A.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6401-6420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chem. lead optimization programs.  In this perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chem. lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, esp. when guided by physiochem. property-based optimization (PPBO).  Also highlighted are examples of small structural modifications such as addn. of single atoms, small functional groups, and cyclizations that produce large increases in LipE.  Understanding the factors that may contribute to LipE changes through anal. of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed.  Herein we advocate for use of LipE anal. coupled with PPBO and SBDD as an efficient mechanism for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ8DOcOj6GrVg90H21EOLACvtfcHk0lj3avnY-OxwZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D&md5=29f38880914fa75c33be3a640ace4309</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DGallego%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DLipophilic%2520efficiency%2520as%2520an%2520important%2520metric%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6401%26epage%3D6420%26doi%3D10.1021%2Facs.jmedchem.8b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the efficiency and physicochemical trajectories of successful optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6421</span>â <span class="NLM_lpage">6467</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6421-6467&author=R.+J.+Youngauthor=P.+D.+Leeson&title=Mapping+the+efficiency+and+physicochemical+trajectories+of+successful+optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></div><div class="casAuthors">Young, Robert J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6421-6467</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The practices and tactics employed in successful optimizations are examd., judged from the trajectories of ligand efficiency and property evolution.  A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technol.) and types of mols., including those beyond the rule of five.  The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable.  What is clear is that while targets are different, successful mols. are almost invariably among the most efficient for their target, even at the extremes.  Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQtcLKSk7q7Vg90H21EOLACvtfcHk0lj3avnY-OxwZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D&md5=f040ef02d161e070bb5021fde1585e66</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMapping%2520the%2520efficiency%2520and%2520physicochemical%2520trajectories%2520of%2520successful%2520optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6421%26epage%3D6467%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Practical application of ligand efficiency metrics in lead optimization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3006</span>â <span class="NLM_lpage">3015</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2018.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmc.2018.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29655612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVent7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3006-3015&author=J.+S.+Scottauthor=M.+J.+Waring&title=Practical+application+of+ligand+efficiency+metrics+in+lead+optimization&doi=10.1016%2Fj.bmc.2018.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Practical application of ligand efficiency metrics in lead optimisation</span></div><div class="casAuthors">Scott, James S.; Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3006-3015</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The use of composite metrics that normalize biol. potency values in relation to markers of physicochem. properties, such as size or lipophilicity, has gained a significant amt. of traction with many medicinal chemists in recent years.  However, there is no consensus on best practice in the area and their application has attracted some criticism.  Here we present our approach to their application in lead optimization projects, provide an objective discussion of the principles we consider important and illustrate how our use of lipophilic ligand efficiency enabled the progression of a no. of our successful drug discovery projects.  We derive, from this and some recent literature highlights, a set of heuristic guidelines for lipophilicity based optimization that we believe are generally applicable across chem. series and protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNrcXUmwxG8rVg90H21EOLACvtfcHk0lj3avnY-OxwZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVent7g%253D&md5=50bba76316f6f2ec3c89e06f6717c388</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DPractical%2520application%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3006%26epage%3D3015%26doi%3D10.1016%2Fj.bmc.2018.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, Y. C.</span></span> <i>Quantitative Drug Design: A Critical Introduction</i>; <span class="NLM_publisher-name">CRC Press/Taylor & Francis Group</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1201%2F9781420071009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+C.+Martin&title=Quantitative+Drug+Design%3A+A+Critical+Introduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1201%2F9781420071009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420071009%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DY.%2BC.%26btitle%3DQuantitative%2520Drug%2520Design%253A%2520A%2520Critical%2520Introduction%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%2520Group%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">The many roles of computation in drug discovery</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1813</span>â <span class="NLM_lpage">1818</span>, <span class="refDoi">Â DOI: 10.1126/science.1096361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1126%2Fscience.1096361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=15031495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFehu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1813-1818&author=W.+L.+Jorgensen&title=The+many+roles+of+computation+in+drug+discovery&doi=10.1126%2Fscience.1096361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles of Computation in Drug Discovery</span></div><div class="casAuthors">Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5665</span>),
    <span class="NLM_cas:pages">1813-1818</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  An overview is given on the diverse uses of computational chem. in drug discovery.  Particular emphasis is placed on virtual screening, de novo design, evaluation of drug-likeness, and advanced methods for detg. protein-ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPr2xRlx_bxbVg90H21EOLACvtfcHk0lj3avnY-OxwZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFehu7w%253D&md5=77b2fac63e750ca7cdc7e4f35654549a</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096361%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DThe%2520many%2520roles%2520of%2520computation%2520in%2520drug%2520discovery%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1813%26epage%3D1818%26doi%3D10.1126%2Fscience.1096361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Van Drie, J. H.</span></span> <span> </span><span class="NLM_article-title">Computer-aided drug design: the next 20 years</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">591</span>â <span class="NLM_lpage">601</span>, <span class="refDoi">Â DOI: 10.1007/s10822-007-9142-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1007%2Fs10822-007-9142-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=17989929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BD2sjitVWntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=591-601&author=J.+H.+Van+Drie&title=Computer-aided+drug+design%3A+the+next+20+years&doi=10.1007%2Fs10822-007-9142-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided drug design: the next 20 years</span></div><div class="casAuthors">Van Drie John H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10-11</span>),
    <span class="NLM_cas:pages">591-601</span>
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    </div><div class="casAbstract">This perspectives article has been taken from a talk the author gave at the symposium in honor of Yvonne C.  Martin's retirement, held at the American Chemical Society spring meeting in Chicago on March 25, 2007.  The talk was intended as a somewhat lighthearted attempt to gaze into the future; inevitably, in print, things will come across more seriously than was intended.  As we all know-the past is rarely predictive of the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1OlneT5VFUBOk4JA3soTqfW6udTcc2ealnmytIKMvCrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjitVWntw%253D%253D&md5=01bb0b716a58f96beb7dc0fd525abe3e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1007%2Fs10822-007-9142-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-007-9142-y%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26atitle%3DComputer-aided%2520drug%2520design%253A%2520the%2520next%252020%2520years%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2007%26volume%3D21%26spage%3D591%26epage%3D601%26doi%3D10.1007%2Fs10822-007-9142-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Computer-aided drug discovery</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">630</span>, (F1000 Faculty Rev) <span class="refDoi">Â DOI: 10.12688/f1000research.6653.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.12688%2Ff1000research.6653.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=630&author=J.+Bajorath&title=Computer-aided+drug+discovery&doi=10.12688%2Ff1000research.6653.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided drug discovery [version 1; referees: 3 approved]</span></div><div class="casAuthors">Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">630/1-630/8</span>CODEN:
                <span class="NLM_cas:coden">FRESJL</span>;
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    
            (<span class="NLM_cas:orgname">F1000 Research Ltd.</span>)
        </div><div class="casAbstract">Computational approaches are an integral part of interdisciplinary drug discovery research.  Understanding the science behind computational tools, their opportunities, and limitations is essential to make a true impact on drug discovery at different levels.  If applied in a scientifically meaningful way, computational methods improve the ability to identify and evaluate potential drug mols., but there remain weaknesses in the methods that preclude na.ovrddot.ive applications.  Herein, current trends in computer-aided drug discovery are reviewed, and selected computational areas are discussed.  Approaches are highlighted that aid in the identification and optimization of new drug candidates.  Emphasis is put on the presentation and discussion of computational concepts and methods, rather than case studies or application examples.  As such, this contribution aims to provide an overview of the current methodol. spectrum of computational drug discovery for a broad audience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8_WWMna927Vg90H21EOLACvtfcHk0lgg3EC8bYNsqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D&md5=8766cd816d41aa01356ffce757026720</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.6653.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.6653.1%26sid%3Dliteratum%253Aachs%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputer-aided%2520drug%2520discovery%26jtitle%3DF1000Research%26date%3D2015%26volume%3D4%26spage%3D630%26doi%3D10.12688%2Ff1000research.6653.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Segall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusof, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champness, E. J.</span></span> <span> </span><span class="NLM_article-title">Avoiding missed opportunities by analyzing the sensitivity of our decisions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4267</span>â <span class="NLM_lpage">4277</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01921</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01921" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFGmu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4267-4277&author=M.+D.+Segallauthor=I.+Yusofauthor=E.+J.+Champness&title=Avoiding+missed+opportunities+by+analyzing+the+sensitivity+of+our+decisions&doi=10.1021%2Facs.jmedchem.5b01921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Avoiding Missed Opportunities by Analyzing the Sensitivity of Our Decisions</span></div><div class="casAuthors">Segall, Matthew D.; Yusof, Iskander; Champness, Edmund J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4267-4277</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery is a multiparameter optimization process in which the goal of a project is to identify compds. that meet multiple property criteria required to achieve a therapeutic objective.  However, once a profile of property criteria has been chosen, the impact of these criteria on the decisions made regarding progression of compds. or chem. series should be carefully considered.  In some cases the decision is very sensitive to a specific property criterion, and such a criterion may artificially distort the direction of the project; any uncertainty in the "correct" value or the importance of this criterion may lead to valuable opportunities being missed.  In this paper, we describe a method for analyzing the sensitivity of the prioritization of compds. to a multiparameter profile of property criteria.  We show how the results can be easily interpreted and illustrate how this anal. can highlight new avenues for exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUZozwQLjSAbVg90H21EOLACvtfcHk0lgg3EC8bYNsqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFGmu7c%253D&md5=ee3d2630efd9eb85c1a576a9dc70bbff</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01921%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26aulast%3DYusof%26aufirst%3DI.%26aulast%3DChampness%26aufirst%3DE.%2BJ.%26atitle%3DAvoiding%2520missed%2520opportunities%2520by%2520analyzing%2520the%2520sensitivity%2520of%2520our%2520decisions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4267%26epage%3D4277%26doi%3D10.1021%2Facs.jmedchem.5b01921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissantz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶rner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidhart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz-Gasch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">A real-world perspective on molecular design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4087</span>â <span class="NLM_lpage">4102</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyjtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4087-4102&author=B.+Kuhnauthor=W.+Gubaauthor=J.+Hertauthor=D.+W.+Bannerauthor=C.+Bissantzauthor=S.+M.+Ceccarelliauthor=W.+Haapauthor=M.+K%C3%B6rnerauthor=A.+Kuglstatterauthor=C.+D.+Lernerauthor=P.+Matteiauthor=W.+Neidhartauthor=E.+Pinardauthor=M.+G.+Rudolphauthor=T.+Schulz-Gaschauthor=T.+J.+Wolteringauthor=M.+Stahl&title=A+real-world+perspective+on+molecular+design&doi=10.1021%2Facs.jmedchem.5b01875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A Real-World Perspective on Molecular Design</span></div><div class="casAuthors">Kuhn, Bernd; Guba, Wolfgang; Hert, Jerome; Banner, David; Bissantz, Caterina; Ceccarelli, Simona; Haap, Wolfgang; Korner, Matthias; Kuglstatter, Andreas; Lerner, Christian; Mattei, Patrizio; Neidhart, Werner; Pinard, Emmanuel; Rudolph, Markus G.; Schulz-Gasch, Tanja; Woltering, Thomas; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4087-4102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a series of small mol. drug discovery case studies where computational methods were prospectively employed to impact Roche research projects, with the aim of highlighting those methods that provide real added value.  Our brief accounts encompass a broad range of methods and techniques applied to a variety of enzymes and receptors.  Most of these are based on judicious application of knowledge about mol. conformations and interactions: filling of lipophilic pockets to gain affinity or selectivity, addn. of polar substituents, scaffold hopping, transfer of SAR, conformation anal., and mol. overlays.  A case study of sequence-driven focused screening is presented to illustrate how appropriate preprocessing of information enables effective exploitation of prior knowledge.  We conclude that qual. statements enabling chemists to focus on promising regions of chem. space are often more impactful than quant. prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxOLDuNAX5U7Vg90H21EOLACvtfcHk0ljjxLREMv8LMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyjtb0%253D&md5=0b81f2a0e9996c5dae44e61e5488ba79</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01875%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DK%25C3%25B6rner%26aufirst%3DM.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLerner%26aufirst%3DC.%2BD.%26aulast%3DMattei%26aufirst%3DP.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520real-world%2520perspective%2520on%2520molecular%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4087%26epage%3D4102%26doi%3D10.1021%2Facs.jmedchem.5b01875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muresan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Chemical predictive modeling to improve compound quality</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">948</span>â <span class="NLM_lpage">962</span>, <span class="refDoi">Â DOI: 10.1038/nrd4128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnrd4128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=24287782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=948-962&author=J.+G.+Cummingauthor=A.+M.+Davisauthor=S.+Muresanauthor=M.+Haeberleinauthor=H.+Chen&title=Chemical+predictive+modeling+to+improve+compound+quality&doi=10.1038%2Fnrd4128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical predictive modelling to improve compound quality</span></div><div class="casAuthors">Cumming, John G.; Davis, Andrew M.; Muresan, Sorel; Haeberlein, Markus; Chen, Hongming</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">948-962</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'quality' of small-mol. drug candidates, encompassing aspects including their potency, selectivity and ADMET (absorption, distribution, metab., excretion and toxicity) characteristics, is a key factor influencing the chances of success in clin. trials.  Importantly, such characteristics are under the control of chemists during the identification and optimization of lead compds.  Here, we discuss the application of computational methods, particularly quant. structure-activity relationships (QSARs), in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their use and impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XwzW0wcxYbVg90H21EOLACvtfcHk0ljjxLREMv8LMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF&md5=e0a4265bb306ae5544d00f3c9e3e4050</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1038%2Fnrd4128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4128%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DHaeberlein%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DChemical%2520predictive%2520modeling%2520to%2520improve%2520compound%2520quality%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D948%26epage%3D962%26doi%3D10.1038%2Fnrd4128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BostrÃ¶m, J.</span></span> <span> </span><span class="NLM_article-title">Understanding our love affair with <i>p</i>-chlorophenyl: present day implications from historical biases of reagent selection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2390</span>â <span class="NLM_lpage">2405</span>, <span class="refDoi">Â DOI: 10.1021/jm501894t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501894t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Snsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2390-2405&author=D.+G.+Brownauthor=M.+M.+Gagnonauthor=J.+Bostr%C3%B6m&title=Understanding+our+love+affair+with+p-chlorophenyl%3A+present+day+implications+from+historical+biases+of+reagent+selection&doi=10.1021%2Fjm501894t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Our Love Affair with p-Chlorophenyl: Present Day Implications from Historical Biases of Reagent Selection</span></div><div class="casAuthors">Brown, Dean G.; Gagnon, Moriah M.; Bostrom, Jonas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2390-2405</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with further theor. anal. We report here an unexpectedly strong preference toward para substitution in Ph rings within drug discovery programs.  A population anal. of arom. rings in various drug databases demonstrated that para substitution is favored over meta and ortho regioisomers, with p-chlorophenyl (p-ClPh) being one of the most predominant examples.  We speculate that the frequency of p-ClPh is traced back to historical models of medicinal chem. where para-substituted regioisomers were perhaps more easily accessed, and further reinforced by Topliss in 1972 that if Ph was active, the p-ClPh should be made because of ease of synthesis and hydrophobicity driven potency effects.  On the basis of our anal., the para bias has become useful conventional wisdom but perhaps so much so that a perception has been created that druglike space favors a linear arom. structure.  It is hoped this anal. will catalyze a new look at design of reagent databases and screening collections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZxc2KY5KeHrVg90H21EOLACvtfcHk0ljjxLREMv8LMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Snsr0%253D&md5=7f8a3a4eff01600299e04d59341a34dd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501894t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501894t%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DGagnon%26aufirst%3DM.%2BM.%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26atitle%3DUnderstanding%2520our%2520love%2520affair%2520with%2520p-chlorophenyl%253A%2520present%2520day%2520implications%2520from%2520historical%2520biases%2520of%2520reagent%2520selection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2390%26epage%3D2405%26doi%3D10.1021%2Fjm501894t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Segall, M. D.</span></span> <span> </span><span class="NLM_article-title">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1292</span>â <span class="NLM_lpage">1310</span>, <span class="refDoi">Â DOI: 10.2174/138161212799436430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.2174%2F138161212799436430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=22316157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1292-1310&author=M.+D.+Segall&title=Multi-parameter+optimization%3A+identifying+high+quality+compounds+with+a+balance+of+properties&doi=10.2174%2F138161212799436430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span></div><div class="casAuthors">Segall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1292-1310</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metab., and elimination (ADME) properties and an acceptable safety profile.  Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery.  Approaches to simultaneously optimizing many factors in a design are broadly described under the term "multi-parameter optimization" (MPO).  In this review, we will describe how MPO can be applied to efficiently design and select high quality compds. and describe the range of methods that have been employed in drug discovery, including; simple "rules of thumb" such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and exptl. variability.  We will explore how these methods have been applied to predicted and exptl. data to reduce attrition and improve the productivity of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPFOVyg2ehWbVg90H21EOLACvtfcHk0liJ8YZAu03cbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D&md5=43f90ad751fd2c0bc47715f465ef31b3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161212799436430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436430%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26atitle%3DMulti-parameter%2520optimization%253A%2520identifying%2520high%2520quality%2520compounds%2520with%2520a%2520balance%2520of%2520properties%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1292%26epage%3D1310%26doi%3D10.2174%2F138161212799436430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">Utilization of operational schemes for analog synthesis in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1006</span>â <span class="NLM_lpage">1011</span>, <span class="refDoi">Â DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006-1011&author=J.+G.+Topliss&title=Utilization+of+operational+schemes+for+analog+synthesis+in+drug+design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0liJ8YZAu03cbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520operational%2520schemes%2520for%2520analog%2520synthesis%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26epage%3D1011%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">A manual method for applying the Hansch approach to drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">463</span>â <span class="NLM_lpage">469</span>, <span class="refDoi">Â DOI: 10.1021/jm00214a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00214a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=463-469&author=J.+G.+Topliss&title=A+manual+method+for+applying+the+Hansch+approach+to+drug+design&doi=10.1021%2Fjm00214a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">A manual method for applying the Hansch approach to drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A procedure is described in which an initial small group of compds. is selected, tested, and ordered according to potency.  The potency order in the group is then compared to the tabulated potency order calcd. for various parameter dependencies relating to hydrophobic, electronic, and steric effects.  From this activity pattern anal. the probable operative parameters can be deduced and a new substituent selection made for the synthesis of potentially more potent analogs.  Application of the method is illustrated with a series of examples.  It differs from a previously described decision tree, single compd. stepwise approach in that it involves the batchwise anal. of small groups of compds., usually the preferred procedure for logistical reasons if the compds. are relatively easy to synthesize.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpILt0RoFSjlbVg90H21EOLACvtfcHk0liJ8YZAu03cbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D&md5=74658b807e3e45cbee88855eda203bdb</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm00214a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00214a001%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DA%2520manual%2520method%2520for%2520applying%2520the%2520Hansch%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D463%26epage%3D469%26doi%3D10.1021%2Fjm00214a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span></span> <span> </span><span class="NLM_article-title">A quantitative approach to biochemical structureâactivity relationships</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">232</span>â <span class="NLM_lpage">239</span>, <span class="refDoi">Â DOI: 10.1021/ar50020a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar50020a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOnu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1969&pages=232-239&author=C.+Hansch&title=A+quantitative+approach+to+biochemical+structure%E2%80%93activity+relationships&doi=10.1021%2Far50020a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative approach to biochemical structure-activity relationships</span></div><div class="casAuthors">Hansch, Corwin</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">232-9</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    </div><div class="casAbstract">The quant. approach to the biochem.-structure-activity relation has been discussed and reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6L7IpLGnFLVg90H21EOLACvtfcHk0liJ8YZAu03cbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOnu74%253D&md5=1516684273e1f31a590fa3ab6ddee4d1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Far50020a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far50020a002%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520approach%2520to%2520biochemical%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1969%26volume%3D2%26spage%3D232%26epage%3D239%26doi%3D10.1021%2Far50020a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obst Sander, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâArcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¼ller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for CâFÂ·Â·Â·C = O interactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2507</span>â <span class="NLM_lpage">2511</span>, <span class="refDoi">Â DOI: 10.1002/anie.200351268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.200351268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2507-2511&author=J.+A.+Olsenauthor=D.+W.+Bannerauthor=P.+Seilerauthor=U.+Obst+Sanderauthor=A.+D%E2%80%99Arcyauthor=M.+Stihleauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=A+fluorine+scan+of+thrombin+inhibitors+to+map+the+fluorophilicity%2Ffluorophobicity+of+an+enzyme+active+site%3A+evidence+for+C%E2%80%93F%C2%B7%C2%B7%C2%B7C+%3D+O+interactions&doi=10.1002%2Fanie.200351268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: Evidence for C-FÂ·Â·Â·C=O interactions</span></div><div class="casAuthors">Olsen, Jacob A.; Banner, David W.; Seiler, Paul; Sander, Ulrike Obst; D'Arcy, Allan; Stihle, Martine; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2507-2511</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly fluorophilic environment comprising the H-CÎ±-C=O unit of Asn 98 in the active site of thrombin was identified by X-ray crystallog. of a complex formed between the enzyme and a synthetic inhibitor (see partial X-ray structure, distances are in Angstroms).  Short C-FÂ·Â·Â·H-CÎ± and C-FÂ·Â·Â·C=O contacts involving H-CÎ±-C=O fragments were also frequently obsd. in small-mol. X-ray crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojeeRuEw83aLVg90H21EOLACvtfcHk0lj1U4v8un652g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFCrt7k%253D&md5=f9851cb27f3e9d10152ad10abcd5c965</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351268%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DJ.%2BA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DObst%2BSander%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DA%2520fluorine%2520scan%2520of%2520thrombin%2520inhibitors%2520to%2520map%2520the%2520fluorophilicity%252Ffluorophobicity%2520of%2520an%2520enzyme%2520active%2520site%253A%2520evidence%2520for%2520C%25E2%2580%2593F%25C2%25B7%25C2%25B7%25C2%25B7C%2520%253D%2520O%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2507%26epage%3D2511%26doi%3D10.1002%2Fanie.200351268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pirrung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halstead, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, N. J. G.</span></span> <span> </span><span class="NLM_article-title">Methyl scanning: total synthesis of demethylasterriquinone B1 and derivatives for identification of sites of interaction with and isolation of its receptor(s)</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">4609</span>â <span class="NLM_lpage">4626</span>, <span class="refDoi">Â DOI: 10.1021/ja044325h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja044325h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Krtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=4609-4626&author=M.+Pirrungauthor=Y.+Liuauthor=L.+Dengauthor=D.+K.+Halsteadauthor=Z.+Liauthor=J.+F.+Mayauthor=M.+Wedelauthor=D.+A.+Austinauthor=N.+J.+G.+Webster&title=Methyl+scanning%3A+total+synthesis+of+demethylasterriquinone+B1+and+derivatives+for+identification+of+sites+of+interaction+with+and+isolation+of+its+receptor%28s%29&doi=10.1021%2Fja044325h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Scanning: Total Synthesis of Demethylasterriquinone B1 and Derivatives for Identification of Sites of Interaction with and Isolation of Its Receptor(s)</span></div><div class="casAuthors">Pirrung, Michael C.; Liu, Yufa; Deng, Liu; Halstead, Diana K.; Li, Zhitao; May, John F.; Wedel, Michael; Austin, Darrell A.; Webster, Nicholas J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4609-4624</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The principle of Me scanning is proposed for detn. of the sites of interaction between biol. active small mols. and their macromol. target(s).  It involves the systematic prepn. of a family of methylated derivs. of a compd. and their biol. testing.  As a functional assay, the method can identify the regions of a mol. that are important (and unimportant) for biol. activity against even unknown targets, and thus provides an excellent complement to structural biol.  Me scanning was applied to demethylasterriquinone B1, a small-mol. mimetic of insulin.  A new, optimal total synthesis of this natural product was developed that enables the family of Me scan derivs. to be concisely prepd. for evaluation in a cellular assay.  The results of this expt. were used to design a biotin-demethylasterriquinone conjugate for use as an affinity reagent.  This compd. was prepd. in tens of milligram quantities in a four-step synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFivtvsdHSBLVg90H21EOLACvtfcHk0lj1U4v8un652g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Krtrw%253D&md5=0556ce71c359790203c641280d133dbf</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja044325h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja044325h%26sid%3Dliteratum%253Aachs%26aulast%3DPirrung%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DHalstead%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMay%26aufirst%3DJ.%2BF.%26aulast%3DWedel%26aufirst%3DM.%26aulast%3DAustin%26aufirst%3DD.%2BA.%26aulast%3DWebster%26aufirst%3DN.%2BJ.%2BG.%26atitle%3DMethyl%2520scanning%253A%2520total%2520synthesis%2520of%2520demethylasterriquinone%2520B1%2520and%2520derivatives%2520for%2520identification%2520of%2520sites%2520of%2520interaction%2520with%2520and%2520isolation%2520of%2520its%2520receptor%2528s%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D4609%26epage%3D4626%26doi%3D10.1021%2Fja044325h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">In praise of remarkably powerful centamolecular therapeutic agents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1094</span>â <span class="NLM_lpage">1097</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.9b00286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1094-1097&author=N.+A.+Meanwellauthor=W.+R.+Ewing&title=In+praise+of+remarkably+powerful+centamolecular+therapeutic+agents&doi=10.1021%2Facsmedchemlett.9b00286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In Praise of Remarkably Powerful Centamolecular Therapeutic Agents</span></div><div class="casAuthors">Meanwell, Nicholas A.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1094-1097</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  While biol. medications have addressed many challenging therapeutic targets, the pharmacopeia is still dominated by centamols.  In this viewpoint, we illustrate the impact of centamol. drugs on mortality and morbidity due to chronic viral infections and present select examples from other disease areas that highlight some of their remarkably powerful biochem. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofRNASt4Snv7Vg90H21EOLACvtfcHk0lj1U4v8un652g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlylsL3F&md5=16a78cfdc956392783a087a86bec8888</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00286%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DIn%2520praise%2520of%2520remarkably%2520powerful%2520centamolecular%2520therapeutic%2520agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D1094%26epage%3D1097%26doi%3D10.1021%2Facsmedchemlett.9b00286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">1081</span>â <span class="NLM_lpage">1085</span>, <span class="refDoi">Â DOI: 10.1126/science.2471267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1126%2Fscience.2471267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=2471267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=1081-1085&author=B.+C.+Cunninghamauthor=J.+A.+Wells&title=High-resolution+epitope+mapping+of+hGH-receptor+interactions+by+alanine-scanning+mutagenesis&doi=10.1126%2Fscience.2471267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis</span></div><div class="casAuthors">Cunningham, Brian C.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4908</span>),
    <span class="NLM_cas:pages">1081-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A strategy, called alanine-scanning mutagenesis, was used to identify specific side chains in human growth hormone (hGH) that strongly modulate binding to the hGH receptor cloned from human liver.  Single alanine mutations (62 in total) were introduced at every residue contained within the 3 discontinuous segments of hGH (residues 2-19, 54-74, and 167-191) that have been implicated in receptor recognition.  The alanine scan revealed a cluster of a dozen large side chains that when mutated to alanine each showed >4-fold lower binding affinity to the hGH receptor.  Many of these residues that promote binding to the hGH receptor are altered in homologs of hGH (such as placental lactogens and prolactins) that do not bind tightly to the hGH receptor.  The overall folding of these mutant proteins was indistinguishable from that of the wild-type hGH, as detd. by strong cross-reactivities with 7 different conformationally sensitive monoclonal antibodies.  The alanine scan also identified at least one side chain, Glu174, that hindered binding because when it was mutated to alanine the receptor affinity increased by >4-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zoDe8YESIrVg90H21EOLACvtfcHk0lj1U4v8un652g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D&md5=b88aa28886f1716c85f8beb76e7e7100</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.2471267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2471267%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DB.%2BC.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DHigh-resolution%2520epitope%2520mapping%2520of%2520hGH-receptor%2520interactions%2520by%2520alanine-scanning%2520mutagenesis%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D1081%26epage%3D1085%26doi%3D10.1126%2Fscience.2471267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montague, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossetter, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, E. J.</span></span> <span> </span><span class="NLM_article-title">Learning medicinal chemistry absorption, distribution, metabolism, excretion, and toxicity (ADMET) rules from cross-company matched molecular pairs analysis (MMPA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3277</span>â <span class="NLM_lpage">3292</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKmsbvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3277-3292&author=C.+Kramerauthor=A.+Tingauthor=H.+Zhengauthor=J.+Hertauthor=T.+Schindlerauthor=M.+Stahlauthor=G.+Robbauthor=J.+J.+Crawfordauthor=J.+Blaneyauthor=S.+Montagueauthor=A.+G.+Leachauthor=A.+G.+Dossetterauthor=E.+J.+Griffen&title=Learning+medicinal+chemistry+absorption%2C+distribution%2C+metabolism%2C+excretion%2C+and+toxicity+%28ADMET%29+rules+from+cross-company+matched+molecular+pairs+analysis+%28MMPA%29&doi=10.1021%2Facs.jmedchem.7b00935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA)</span></div><div class="casAuthors">Kramer, Christian; Ting, Attilla; Zheng, Hao; Hert, Jerome; Schindler, Torsten; Stahl, Martin; Robb, Graeme; Crawford, James J.; Blaney, Jeff; Montague, Shane; Leach, Andrew G.; Dossetter, Al G.; Griffen, Ed J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3277-3292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The first large scale anal. of in vitro absorption, distribution, metab., excretion, and toxicity (ADMET) data shared across multiple major pharma has been performed.  Using advanced matched mol. pair anal. (MMPA), the authors combined data from three pharmaceutical companies and generated ADMET rules, avoiding the need to disclose the full chem. structures.  On top of the very large exchange of knowledge, all companies involved synergistically gained approx. 20% more rules from the shared transformations.  There is good quant. agreement between the rules based on shared data compared to both individual companies' rules and rules published in the literature.  Known correlations between log D, soly., in vitro clearance, and plasma protein binding also hold in transformation space, but there are also interesting exceptions.  Data pools such as this allow focusing on particular functional groups and characterizing their ADMET profile.  Finally the role of a corpus of robustly tested medicinal chem. knowledge in the training of medicinal chem. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGR-l9JlU2p7Vg90H21EOLACvtfcHk0lh6wDRtVvB86Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKmsbvK&md5=5c17d88815192fd481e84e24921095ac</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00935%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DTing%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DRobb%26aufirst%3DG.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DBlaney%26aufirst%3DJ.%26aulast%3DMontague%26aufirst%3DS.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DLearning%2520medicinal%2520chemistry%2520absorption%252C%2520distribution%252C%2520metabolism%252C%2520excretion%252C%2520and%2520toxicity%2520%2528ADMET%2529%2520rules%2520from%2520cross-company%2520matched%2520molecular%2520pairs%2520analysis%2520%2528MMPA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3277%26epage%3D3292%26doi%3D10.1021%2Facs.jmedchem.7b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, C. E.</span></span> <span> </span><span class="NLM_article-title">A multi-endpoint matched molecular pair (MMP) analysis of 6-membered heterocycles</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">381</span>â <span class="NLM_lpage">388</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2016.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmc.2016.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=27840138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=381-388&author=G.+Changauthor=K.+Huardauthor=G.+W.+Kauffmanauthor=A.+F.+Stepanauthor=C.+E.+Keefer&title=A+multi-endpoint+matched+molecular+pair+%28MMP%29+analysis+of+6-membered+heterocycles&doi=10.1016%2Fj.bmc.2016.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">A multi-endpoint matched molecular pair (MMP) analysis of 6-membered heterocycles</span></div><div class="casAuthors">Chang, George; Huard, Kim; Kauffman, Gregory W.; Stepan, Antonia F.; Keefer, Christopher E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-388</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Arom. rings, ubiquitous in pharmaceutical compds., are often exchanged with another ring during the optimization process of drug discovery.  Inevitably, the preferred ring system for one endpoint may prove detrimental to another, thus necessitating a holistic, multiple endpoint optimization approach for finding the ideal replacement.  Accordingly, we conducted an extensive matched mol. pair (MMP) anal. of common 6-membered arom. rings across 4 endpoints crit. for drug discovery (log D lipophilicity, microsomal metab., P-gp efflux and passive permeability).  We also investigated the effect of context by considering the connecting atom.  Heat maps were created as a simple yet comprehensive way to view and analyze the vast amt. of interrelated data.  Paired difference statistical tests were used to identify transforms with changes that were significantly different from zero.  We conclude that the heat maps of transforms provide a unique and powerful approach for multiparameter optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4S5NvQKzOjLVg90H21EOLACvtfcHk0lh6wDRtVvB86Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL7J&md5=88d8b910b84e6d40388885cc28d336c8</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuard%26aufirst%3DK.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKeefer%26aufirst%3DC.%2BE.%26atitle%3DA%2520multi-endpoint%2520matched%2520molecular%2520pair%2520%2528MMP%2529%2520analysis%2520of%25206-membered%2520heterocycles%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D381%26epage%3D388%26doi%3D10.1016%2Fj.bmc.2016.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic replacements for benzene: maximising ADME benefits by considering individual ring isomers</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">1057</span>â <span class="NLM_lpage">1068</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.ejmech.2016.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=27783976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=1057-1068&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=Heterocyclic+replacements+for+benzene%3A+maximising+ADME+benefits+by+considering+individual+ring+isomers&doi=10.1016%2Fj.ejmech.2016.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic replacements for benzene: Maximizing ADME benefits by considering individual ring isomers</span></div><div class="casAuthors">Ritchie, Timothy J.; Macdonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1057-1068</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The impact of replacing a monosubstituted benzene (phenyl) ring with thirty three arom. and nine aliph. heterocycles on nine ADME-related screens (soly., lipophilicity, permeability, protein binding CYP450 inhibition and metabolic clearance) was assessed using matched mol. pair anal.  The results indicate that the influence on the ADME profile can differ significantly depending on the ring identity and importantly on the individual regioisomers that are possible for some rings.  This information enables the medicinal chemist to make an informed choice about which rings and regioisomers to employ as monosubstituted benzene replacements, based upon the knowledge of how such replacements are likely to influence ADME-related parameters, for example to target higher soly. while avoiding CYP450 liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWSOM3yUz8kbVg90H21EOLACvtfcHk0lh6wDRtVvB86Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgu7bP&md5=127e1316b7bff0db030226548f96045c</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DHeterocyclic%2520replacements%2520for%2520benzene%253A%2520maximising%2520ADME%2520benefits%2520by%2520considering%2520individual%2520ring%2520isomers%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D1057%26epage%3D1068%26doi%3D10.1016%2Fj.ejmech.2016.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpfe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Evolving concept of activity cliffs</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">14360</span>â <span class="NLM_lpage">14368</span>, <span class="refDoi">Â DOI: 10.1021/acsomega.9b02221</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b02221" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1aksb%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=14360-14368&author=D.+Stumpfeauthor=H.+Huauthor=J.+Bajorath&title=Evolving+concept+of+activity+cliffs&doi=10.1021%2Facsomega.9b02221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving Concept of Activity Cliffs</span></div><div class="casAuthors">Stumpfe, Dagmar; Hu, Huabin; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">14360-14368</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Activity cliffs (ACs) are generally defined as pairs or groups of structurally similar compds. that are active against the same target but have large differences in potency.  Accordingly, ACs capture chem. modifications that strongly influence biol. activity.  Therefore, they are of particular interest in structure-activity relationship (SAR) anal. and compd. optimization.  The AC concept is much more complex than it may appear at a first glance, esp. if one aims to represent ACs computationally and identify them systematically.  To these ends, mol. similarity and potency difference criteria must be carefully considered for AC assessment.  Furthermore, ACs are often perceived differently in medicinal and computational chem., depending on whether they are studied on a case-by-case basis or systematically.  For practical applications, intuitive access to AC information plays a major role.  Over the years, the AC concept has been further refined and extended.  Herein, we review the evolution of the AC concept, emphasizing new anal. schemes and findings that help to better understand ACs and ext. SAR knowledge from them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47Gyaq-vbgbVg90H21EOLACvtfcHk0lgifQlxrrBCsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1aksb%252FL&md5=1c25c816cfe3ca0b3ad61023d2bd8a3f</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b02221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b02221%26sid%3Dliteratum%253Aachs%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DEvolving%2520concept%2520of%2520activity%2520cliffs%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26spage%3D14360%26epage%3D14368%26doi%3D10.1021%2Facsomega.9b02221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, C.</span></span> <span> </span><span class="NLM_article-title">Nonadditivity analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4034</span>â <span class="NLM_lpage">4042</span>, <span class="refDoi">Â DOI: 10.1021/acs.jcim.9b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.9b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslektr%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=4034-4042&author=C.+Kramer&title=Nonadditivity+analysis&doi=10.1021%2Facs.jcim.9b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonadditivity Analysis</span></div><div class="casAuthors">Kramer, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4034-4042</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We introduce the statistics behind a novel type of SAR anal. named "nonadditivity anal.".  On the basis of all pairs of matched pairs within a given data set, the approach analyzes whether the same transformations between related mols. have the same effect, i.e., whether they are additive.  Assuming that the exptl. uncertainty is normally distributed, the additivities can be analyzed with statistical rigor and sets of compds. can be found that show significant nonadditivity.  Nonadditivity anal. can not only detect nonadditivity, potential SAR outliers, and sets of key compds. but also allow estg. an upper limit of the exptl. uncertainty in the data set.  We demonstrate how complex SAR features that inform medicinal chem. can be found in large SAR data sets.  Finally, we show how the upper limit of exptl. uncertainty for a given biochem. assay can be estd. without the need for repeated measurements of the same protein-ligand system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnH9UtiNjinrVg90H21EOLACvtfcHk0lgifQlxrrBCsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslektr%252FF&md5=af972caed1cdca9dda8f58f2f64340b4</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.9b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.9b00631%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26atitle%3DNonadditivity%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D4034%26epage%3D4042%26doi%3D10.1021%2Facs.jcim.9b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span> <span> </span><span class="NLM_article-title">Decision making in medicinal chemistry: the power of our intuition</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">956</span>â <span class="NLM_lpage">958</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Orur7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=956-958&author=L.+Gomez&title=Decision+making+in+medicinal+chemistry%3A+the+power+of+our+intuition&doi=10.1021%2Facsmedchemlett.8b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Decision Making in Medicinal Chemistry: The Power of Our Intuition</span></div><div class="casAuthors">Gomez, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">956-958</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Medicinal chemists rely on their intuition to make decisions regarding the course of a medicinal chem. program.  Our ability to accurately and efficiently process large data sets routinely requires that we reduce the vol. of information to manageable proportions.  This prioritization process, however, can be affected by intuitive biases.  One such situation is structure-activity relationship (SAR) anal. in nonadditive data sets in which attempts to intuitively predict the activity of compds. based on preliminary data can lead to erroneous conclusions.  Matrix anal. can be a useful tool to accurately det. the nature of the SAR and to improve our decision-making process during an analoging campaign.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNYEcXQuaZhrVg90H21EOLACvtfcHk0lgifQlxrrBCsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Orur7N&md5=e37470769559afca2691e0a0ee15bae2</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00359%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DL.%26atitle%3DDecision%2520making%2520in%2520medicinal%2520chemistry%253A%2520the%2520power%2520of%2520our%2520intuition%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D956%26epage%3D958%26doi%3D10.1021%2Facsmedchemlett.8b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wienen-Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, H.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Surprising non-additivity of methyl groups in drugâkinase interaction</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2585â</span>â <span class="NLM_lpage">2594</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00476</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00476" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVSqs73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=2585%E2%88%92-2594&author=B.+Wienen-Schmidtauthor=D.+Schmidtauthor=H.-D.+Gerberauthor=A.+Heineauthor=H.+Gohlkeauthor=G.+Klebe&title=Surprising+non-additivity+of+methyl+groups+in+drug%E2%80%93kinase+interaction&doi=10.1021%2Facschembio.9b00476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Surprising Non-Additivity of Methyl Groups in Drug-Kinase Interaction</span></div><div class="casAuthors">Wienen-Schmidt, Barbara; Schmidt, Denis; Gerber, Hans-Dieter; Heine, Andreas; Gohlke, Holger; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2585-2594</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug optimization is guided by biophys. methods with increasing popularity.  In the context of lead structure modifications, the introduction of Me groups is a simple but potentially powerful approach.  Hence, it is crucial to systematically investigate the influence of ligand methylation on biophys. characteristics such as thermodn.  Here, we investigate the influence of ligand methylation in different positions and combinations on the drug-kinase interaction.  Binding modes and complex structures were analyzed using protein crystallog.  Thermodn. signatures were measured via isothermal titrn. calorimetry (ITC).  An extensive computational anal. supported the understanding of the underlying mechanisms.  We found that not only position but also stereochem. of the Me group has an influence on binding potency as well as the thermodn. signature of ligand binding to the protein.  Strikingly, the combination of single Me groups does not lead to additive effects.  In our case, the merger of two Me groups in one ligand leads to an entirely new alternative ligand binding mode in the protein ligand complex.  Moreover, the combination of the two Me groups also resulted in a nonadditive thermodn. profile of ligand binding.  Mol. dynamics (MD) simulations revealed distinguished characteristic motions of the ligands in soln. explaining the pronounced thermodn. changes.  The unexpected drastic change in protein ligand interaction highlights the importance of crystallog. control even for minor modifications such as the introduction of a Me group.  For an in-depth understanding of ligand binding behavior, MD simulations have shown to be a powerful tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4CmV2t7zeK7Vg90H21EOLACvtfcHk0lhdMCR16TtDqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVSqs73M&md5=40a57540d8979628a9a8dae2ff0d0896</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00476%26sid%3Dliteratum%253Aachs%26aulast%3DWienen-Schmidt%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DGerber%26aufirst%3DH.-D.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DSurprising%2520non-additivity%2520of%2520methyl%2520groups%2520in%2520drug%25E2%2580%2593kinase%2520interaction%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26spage%3D2585%25E2%2588%2592%26epage%3D2594%26doi%3D10.1021%2Facschembio.9b00476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croghan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, K. K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickrell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnett, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span> <span> </span><span class="NLM_article-title">Quinolinone-based agonists of S1P<sub>1</sub>: use of a N-scan SAR strategy to optimize in vitro and in vivo activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">527</span>â <span class="NLM_lpage">531</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.10.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmcl.2011.10.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=22104144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVyksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=527-531&author=L.+D.+Penningtonauthor=M.+D.+Croghanauthor=K.+K.+C.+Shamauthor=A.+J.+Pickrellauthor=P.+E.+Harringtonauthor=M.+J.+Frohnauthor=B.+A.+Lanmanauthor=A.+B.+Reedauthor=M.+R.+Leeauthor=H.+Xuauthor=M.+McElvainauthor=Y.+Xuauthor=X.+Zhangauthor=M.+Fiorinoauthor=M.+Hornerauthor=H.+G.+Morrisonauthor=H.+A.+Arnettauthor=C.+Fotschauthor=A.+S.+Taskerauthor=M.+Wongauthor=V.+J.+Cee&title=Quinolinone-based+agonists+of+S1P1%3A+use+of+a+N-scan+SAR+strategy+to+optimize+in+vitro+and+in+vivo+activity&doi=10.1016%2Fj.bmcl.2011.10.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolinone-based agonists of S1P1: Use of a N-scan SAR strategy to optimize in vitro and in vivo activity</span></div><div class="casAuthors">Pennington, Lewis D.; Croghan, Michael D.; Sham, Kelvin K. C.; Pickrell, Alexander J.; Harrington, Paul E.; Frohn, Michael J.; Lanman, Brian A.; Reed, Anthony B.; Lee, Matthew R.; Xu, Han; McElvain, Michele; Xu, Yang; Zhang, Xuxia; Fiorino, Michael; Horner, Michelle; Morrison, Henry G.; Arnett, Heather A.; Fotsch, Christopher; Tasker, Andrew S.; Wong, Min; Cee, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">527-531</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We reveal how a N-scan SAR strategy (systematic substitution of each CH group with a N atom) was employed for quinolinone-based S1P1 agonist (I) to modulate physicochem. properties and optimize in vitro and in vivo activity.  The diaza-analog (II) displays improved potency (hS1P1 RI; II: EC50 = 0.020 Î¼M, 120% efficacy; I: EC50 = 0.070 Î¼M, 110% efficacy) and selectivity (hS1P3 Ca2+ flux; II: EC50 >25 Î¼M; I: EC50 = 1.5 Î¼M, 92% efficacy), as well as enhanced pharmacokinetics (II: CL = 0.15 L/h/kg, Vdss = 5.1 L/kg, T1/2 = 24 h, %F = 110; I: CL = 0.93 L/h/kg, Vdss = 11 L/kg, T1/2 = 15 h, %F = 60) and pharmacodynamics (II: 1.0 mg/kg po, 24 h PLC POC = -67%; I: 3 mg/kg po, 24 h PLC POC = -51%) in rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPwWWOfAvgLVg90H21EOLACvtfcHk0lhdMCR16TtDqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVyksg%253D%253D&md5=819b9bdc99ca598ac65dcdf34370bfde</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.085%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DSham%26aufirst%3DK.%2BK.%2BC.%26aulast%3DPickrell%26aufirst%3DA.%2BJ.%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DFrohn%26aufirst%3DM.%2BJ.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFiorino%26aufirst%3DM.%26aulast%3DHorner%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DH.%2BG.%26aulast%3DArnett%26aufirst%3DH.%2BA.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3DQuinolinone-based%2520agonists%2520of%2520S1P1%253A%2520use%2520of%2520a%2520N-scan%2520SAR%2520strategy%2520to%2520optimize%2520in%2520vitro%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D527%26epage%3D531%26doi%3D10.1016%2Fj.bmcl.2011.10.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Strategic Use of the N Atom in Novel Agonists of S1P<sub>1</sub></span>. Presented at the Overman Symposium, Eli Lilly & Co., Indianapolis, IN, September 12, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+D.+Pennington&title=Strategic+Use+of+the+N+Atom+in+Novel+Agonists+of+S1P1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStrategic%2520Use%2520of%2520the%2520N%2520Atom%2520in%2520Novel%2520Agonists%2520of%2520S1P1%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Molecular Design in Ligand- and Structure-Based Drug Discovery</span>. Presented at the University of Michigan Department of Chemistry Seminar Series, University of Michigan, Ann Arbor, MI, November 25, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+D.+Pennington&title=Molecular+Design+in+Ligand-+and+Structure-Based+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DMolecular%2520Design%2520in%2520Ligand-%2520and%2520Structure-Based%2520Drug%2520Discovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hyohdoh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itezono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takanashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iikura, H.</span></span> <span> </span><span class="NLM_article-title">Fluorine scanning by nonselective fluorination: enhancing Raf/MEK inhibition while keeping physicochemical properties</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1059</span>â <span class="NLM_lpage">1063</span>, <span class="refDoi">Â DOI: 10.1021/ml4002419</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyrtLnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1059-1063&author=I.+Hyohdohauthor=N.+Furuichiauthor=T.+Aokiauthor=Y.+Itezonoauthor=H.+Shiraiauthor=S.+Ozawaauthor=F.+Watanabeauthor=M.+Matsushitaauthor=M.+Sakaitaniauthor=P.-S.+Hoauthor=K.+Takanashiauthor=N.+Haradaauthor=Y.+Tomiiauthor=K.+Yoshinariauthor=K.+Oriauthor=M.+Taboauthor=Y.+Aokiauthor=N.+Shimmaauthor=H.+Iikura&title=Fluorine+scanning+by+nonselective+fluorination%3A+enhancing+Raf%2FMEK+inhibition+while+keeping+physicochemical+properties&doi=10.1021%2Fml4002419"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties</span></div><div class="casAuthors">Hyohdoh, Ikumi; Furuichi, Noriyuki; Aoki, Toshihiro; Itezono, Yoshiko; Shirai, Haruyoshi; Ozawa, Sawako; Watanabe, Fumio; Matsushita, Masayuki; Sakaitani, Masahiro; Ho, Pil-Su; Takanashi, Kenji; Harada, Naoki; Tomii, Yasushi; Yoshinari, Kiyoshi; Ori, Kazutomo; Tabo, Mitsuyasu; Aoki, Yuko; Shimma, Nobuo; Iikura, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1059-1063</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile methodol. effective in obtaining a set of compds. monofluorinated at various positions (fluorine scan) by chem. synthesis is reported.  Direct and nonselective fluorination reactions of our lead compd. I and key intermediate II worked efficiently to afford a total of six monofluorinated derivs.  All of the derivs. kept their physicochem. properties compared with the lead I and one of them had enhanced Raf/MEK inhibitory activity.  Keeping physicochem. properties could be considered a benefit of monofluorinated derivs. compared with chlorinated derivs., iodinated derivs., methylated derivs., etc.  This key finding led to the identification of compd. III, which had potent tumor growth inhibition in a xenograft model, excellent PK profiles in three animal species, and no crit. toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQO4W5X_AfQLVg90H21EOLACvtfcHk0lhdMCR16TtDqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyrtLnK&md5=c2da121b1a697eeff67786f88225b811</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fml4002419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002419%26sid%3Dliteratum%253Aachs%26aulast%3DHyohdoh%26aufirst%3DI.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DItezono%26aufirst%3DY.%26aulast%3DShirai%26aufirst%3DH.%26aulast%3DOzawa%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DP.-S.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DTomii%26aufirst%3DY.%26aulast%3DYoshinari%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DK.%26aulast%3DTabo%26aufirst%3DM.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DIikura%26aufirst%3DH.%26atitle%3DFluorine%2520scanning%2520by%2520nonselective%2520fluorination%253A%2520enhancing%2520Raf%252FMEK%2520inhibition%2520while%2520keeping%2520physicochemical%2520properties%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1059%26epage%3D1063%26doi%3D10.1021%2Fml4002419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyohdoh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takanashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iikura, H.</span></span> <span> </span><span class="NLM_article-title">Optimizing the physicochemical properties of Raf/MEK inhibitors by nitrogen scanning</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">309</span>â <span class="NLM_lpage">314</span>, <span class="refDoi">Â DOI: 10.1021/ml400379x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400379x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eitLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=309-314&author=T.+Aokiauthor=I.+Hyohdohauthor=N.+Furuichiauthor=S.+Ozawaauthor=F.+Watanabeauthor=M.+Matsushitaauthor=M.+Sakaitaniauthor=K.+Morikamiauthor=K.+Takanashiauthor=N.+Haradaauthor=Y.+Tomiiauthor=K.+Shirakiauthor=K.+Furumotoauthor=M.+Taboauthor=K.+Yoshinariauthor=K.+Oriauthor=Y.+Aokiauthor=N.+Shimmaauthor=H.+Iikura&title=Optimizing+the+physicochemical+properties+of+Raf%2FMEK+inhibitors+by+nitrogen+scanning&doi=10.1021%2Fml400379x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning</span></div><div class="casAuthors">Aoki, Toshihiro; Hyohdoh, Ikumi; Furuichi, Noriyuki; Ozawa, Sawako; Watanabe, Fumio; Matsushita, Masayuki; Sakaitani, Masahiro; Morikami, Kenji; Takanashi, Kenji; Harada, Naoki; Tomii, Yasushi; Shiraki, Koji; Furumoto, Kentaro; Tabo, Mitsuyasu; Yoshinari, Kiyoshi; Ori, Kazutomo; Aoki, Yuko; Shimma, Nobuo; Iikura, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-314</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituting a carbon atom with a nitrogen atom (nitrogen substitution) on an arom. ring in our leads I and II (X8 = X9 = CH) by applying nitrogen scanning afforded a set of compds. that improved not only the soly. but also the metabolic stability.  The impact after nitrogen substitution on interactions between a deriv. and its on- and off-target proteins (Raf/MEK, CYPs, and hERG channel) was also detected with most of them contributing to weaker interactions.  After identifying the positions that kept inhibitory activity on HCT116 cell growth and Raf/MEK, compd. II (X8 = X9 = N) (CH5126766/RO5126766) was selected as a clin. compd.  A phase I clin. trial is ongoing for solid cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNIlM5ZKpyzLVg90H21EOLACvtfcHk0lg__1rX1Uh2RA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eitLc%253D&md5=0f69b4f9da08754bff72823f6455a7c5</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fml400379x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400379x%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DHyohdoh%26aufirst%3DI.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DOzawa%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DSakaitani%26aufirst%3DM.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DTomii%26aufirst%3DY.%26aulast%3DShiraki%26aufirst%3DK.%26aulast%3DFurumoto%26aufirst%3DK.%26aulast%3DTabo%26aufirst%3DM.%26aulast%3DYoshinari%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DIikura%26aufirst%3DH.%26atitle%3DOptimizing%2520the%2520physicochemical%2520properties%2520of%2520Raf%252FMEK%2520inhibitors%2520by%2520nitrogen%2520scanning%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D309%26epage%3D314%26doi%3D10.1021%2Fml400379x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmstrom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klug-McLeod, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakaryants, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S.</span></span> <span> </span><span class="NLM_article-title">Quick building blocks (QBB): an innovative and efficient business model to speed medicinal chemistry analog synthesis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1104</span>â <span class="NLM_lpage">1109</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.9b00205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlams7fM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1104-1109&author=C.+J.+Helalauthor=M.+Bundesmannauthor=S.+Hammondauthor=M.+Holmstromauthor=J.+Klug-McLeodauthor=B.+A.+Lefkerauthor=D.+McLeodauthor=C.+Subramanyamauthor=O.+Zakaryantsauthor=S.+Sakata&title=Quick+building+blocks+%28QBB%29%3A+an+innovative+and+efficient+business+model+to+speed+medicinal+chemistry+analog+synthesis&doi=10.1021%2Facsmedchemlett.9b00205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis</span></div><div class="casAuthors">Helal, Christopher J.; Bundesmann, Mark; Hammond, Susan; Holmstrom, Melissa; Klug-McLeod, Jacquelyn; Lefker, Bruce A.; McLeod, Dale; Subramanyam, Chakrapani; Zakaryants, Oleg; Sakata, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1104-1109</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many pharmaceutical companies have invested millions of dollars in establishing internal chem. stores to provide reliable access to large nos. of building blocks (BB) for the synthesis of new mols., esp. for the timely design and execution of parallel (library) synthesis.  Recognizing budget and logistical limitations, we required a more economically scalable process to provide diverse BB.  We disclose a novel business partnership that achieves the goals of just-in-time, economical access to com. BB that increases chem. space coverage and accelerates the synthesis of new drug candidates.  We believe that this model can be of benefit to companies of all sizes that are engaged in drug discovery by reducing cost, increasing diversity of analog mols. in a time-conscious manner, and reducing BB inventory.  More efficient use of BB by customers may allow com. vendors to devote a greater portion of their resources to prepg. novel BB that increase chem. diversity as opposed to resynthesizing out-of-stock compds. that are inaccessible within company compd. collections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4oiMXHzQZrbVg90H21EOLACvtfcHk0lg__1rX1Uh2RA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlams7fM&md5=5d1b97e977d63c8cdf51ad26257d15f3</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00205%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBundesmann%26aufirst%3DM.%26aulast%3DHammond%26aufirst%3DS.%26aulast%3DHolmstrom%26aufirst%3DM.%26aulast%3DKlug-McLeod%26aufirst%3DJ.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DMcLeod%26aufirst%3DD.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DZakaryants%26aufirst%3DO.%26aulast%3DSakata%26aufirst%3DS.%26atitle%3DQuick%2520building%2520blocks%2520%2528QBB%2529%253A%2520an%2520innovative%2520and%2520efficient%2520business%2520model%2520to%2520speed%2520medicinal%2520chemistry%2520analog%2520synthesis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D1104%26epage%3D1109%26doi%3D10.1021%2Facsmedchemlett.9b00205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span> <span> </span><span class="NLM_article-title">The next level in chemical space navigation: going far beyond enumerable compound libraries</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1148</span>â <span class="NLM_lpage">1156</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2019.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.drudis.2019.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30851414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslaksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=1148-1156&author=T.+Hoffmannauthor=M.+Gastreich&title=The+next+level+in+chemical+space+navigation%3A+going+far+beyond+enumerable+compound+libraries&doi=10.1016%2Fj.drudis.2019.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">The next level in chemical space navigation: going far beyond enumerable compound libraries</span></div><div class="casAuthors">Hoffmann, Torsten; Gastreich, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1148-1156</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Recent innovations have brought pharmacophore-driven methods for navigating virtual chem. spaces, the size of which can reach into the billions of mols., to the fingertips of every chemist.  There has been a paradigm shift in the underlying computational chem. that drives chem. space search applications, incorporating intelligent reaction knowledge into their core so that they can readily deliver com. available mols. as nearest neighbor hits from within giant virtual spaces.  These vast resources enable medicinal chemists to execute rapid scaffold-hopping expts., rapid hit expansion, and structure-activity relationship (SAR) exploitation in largely intellectual property (IP)-free territory and at unparalleled low cost.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodA_WnK9Z3jbVg90H21EOLACvtfcHk0li-jDV0F0GyMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslaksb4%253D&md5=d707299b8c6e0ace79f27172147517e3</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DGastreich%26aufirst%3DM.%26atitle%3DThe%2520next%2520level%2520in%2520chemical%2520space%2520navigation%253A%2520going%2520far%2520beyond%2520enumerable%2520compound%2520libraries%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2019%26volume%3D24%26spage%3D1148%26epage%3D1156%26doi%3D10.1016%2Fj.drudis.2019.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goble, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohri, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span> <span> </span><span class="NLM_article-title">Increased building block access through collaboration</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1458</span>â <span class="NLM_lpage">1462</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2018.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.drudis.2018.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29571837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC1MnktlOgug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1458-1462&author=C.+J.+Helalauthor=A.+Bartolozziauthor=S.+D.+Gobleauthor=N.+S.+Maniauthor=A.+Guzman-Perezauthor=A.+K.+Ohriauthor=Z.-C.+Shiauthor=C.+Subramanyam&title=Increased+building+block+access+through+collaboration&doi=10.1016%2Fj.drudis.2018.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Increased building block access through collaboration</span></div><div class="casAuthors">Helal Christopher J; Bartolozzi Alessandra; Goble Steven D; Shi Zhi-Cai; Mani Neelakanda S; Guzman-Perez Angel; Ohri Ajay K; Subramanyam Chakrapani</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1458-1462</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgt4Gd6-WlAP69nzq6467DfW6udTcc2ebFwBCJQcnaHbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnktlOgug%253D%253D&md5=f91f621ad61ce13c503c38c7e3959ac1</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBartolozzi%26aufirst%3DA.%26aulast%3DGoble%26aufirst%3DS.%2BD.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DOhri%26aufirst%3DA.%2BK.%26aulast%3DShi%26aufirst%3DZ.-C.%26aulast%3DSubramanyam%26aufirst%3DC.%26atitle%3DIncreased%2520building%2520block%2520access%2520through%2520collaboration%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D1458%26epage%3D1462%26doi%3D10.1016%2Fj.drudis.2018.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogej, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomkinson, N. P.</span></span> <span> </span><span class="NLM_article-title">Designing novel building blocks is an overlooked strategy to improve compound quality</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">11</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2014.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.drudis.2014.09.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=25281855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC2M7nt1aksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=11-17&author=F.+W.+Goldbergauthor=J.+G.+Kettleauthor=T.+Kogejauthor=M.+W.+D.+Perryauthor=N.+P.+Tomkinson&title=Designing+novel+building+blocks+is+an+overlooked+strategy+to+improve+compound+quality&doi=10.1016%2Fj.drudis.2014.09.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21dR"><div class="casContent"><span class="casTitleNuber">21d</span><div class="casTitle"><span class="NLM_cas:atitle">Designing novel building blocks is an overlooked strategy to improve compound quality</span></div><div class="casAuthors">Goldberg Frederick W; Kettle Jason G; Tomkinson Nick P; Kogej Thierry; Perry Matthew W D</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">One pragmatic way to improve compound quality, while enhancing and accelerating drug discovery projects, is the ability to access a high quality, novel, diverse building block collection.  Here, we outline general principles that should be applied to ensure that a building block collection has the greatest impact on drug discovery projects, by discussing design principles for novel reagents and what types of reagents are popular with medicinal chemists in general.  We initiated a program in 2009 to address this, which has already delivered three candidate drugs, and the success of that program provides evidence that focussing on building block design is a useful strategy for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPdgCfKmtVe0g6wdEZmT2rfW6udTcc2ebFwBCJQcnaHbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7nt1aksA%253D%253D&md5=6abab9b017e3d115c1ac7ac6b0483bb9</span></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DKogej%26aufirst%3DT.%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DTomkinson%26aufirst%3DN.%2BP.%26atitle%3DDesigning%2520novel%2520building%2520blocks%2520is%2520an%2520overlooked%2520strategy%2520to%2520improve%2520compound%2520quality%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.drudis.2014.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Grygorenko, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volochnyuk, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabukhin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, D. B.</span></span> <span> </span><span class="NLM_article-title">The symbiotic relationship between drug discovery and organic chemistry</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1196â</span>â <span class="NLM_lpage">1237</span>, <span class="refDoi">Â DOI: 10.1002/chem.201903232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fchem.201903232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=31429510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVOhu73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=1196%E2%88%92-1237&author=O.+O.+Grygorenkoauthor=D.+M.+Volochnyukauthor=S.+V.+Ryabukhinauthor=D.+B.+Judd&title=The+symbiotic+relationship+between+drug+discovery+and+organic+chemistry&doi=10.1002%2Fchem.201903232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">The Symbiotic Relationship Between Drug Discovery and Organic Chemistry</span></div><div class="casAuthors">Grygorenko, Oleksandr O.; Volochnyuk, Dmitriy M.; Ryabukhin, Sergey V.; Judd, Duncan B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1196-1237</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  All pharmaceutical products contain org. mols.; the source may be a natural product or a fully synthetic mol., or a combination of both.  Thus, it follows that org. chem. underpins both existing and upcoming pharmaceutical products.  The reverse relationship has also affected org. synthesis, changing its landscape towards increasingly complex targets.  This Review article sets out to give a concise appraisal of this symbiotic relationship between org. chem. and drug discovery, along with a discussion of the design concepts and highlighting key milestones along the journey.  In particular, criteria for a high-quality compd. library design enabling efficient virtual navigation of chem. space, as well as rise and fall of concepts for its synthetic exploration (such as combinatorial chem.; diversity-, biol.-, lead-, or fragment-oriented syntheses; and DNA-encoded libraries) are critically surveyed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Fk5uC_3_C7Vg90H21EOLACvtfcHk0li-jDV0F0GyMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVOhu73M&md5=595516bf7865e5b1024348d426521d25</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201903232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201903232%26sid%3Dliteratum%253Aachs%26aulast%3DGrygorenko%26aufirst%3DO.%2BO.%26aulast%3DVolochnyuk%26aufirst%3DD.%2BM.%26aulast%3DRyabukhin%26aufirst%3DS.%2BV.%26aulast%3DJudd%26aufirst%3DD.%2BB.%26atitle%3DThe%2520symbiotic%2520relationship%2520between%2520drug%2520discovery%2520and%2520organic%2520chemistry%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2020%26volume%3D26%26spage%3D1196%25E2%2588%2592%26epage%3D1237%26doi%3D10.1002%2Fchem.201903232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreher, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillyer, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truppo, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E. R.</span></span> <span> </span><span class="NLM_article-title">The importance of synthetic chemistry in the pharmaceutical industry</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">eaat0805</span>, <span class="refDoi">Â DOI: 10.1126/science.aat0805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1126%2Fscience.aat0805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30655413" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2019&pages=eaat0805&author=K.+R.+Camposauthor=P.+J.+Colemanauthor=J.+C.+Alvarezauthor=S.+D.+Dreherauthor=R.+M.+Garbaccioauthor=N.+K.+Terrettauthor=R.+D.+Tillyerauthor=M.+D.+Truppoauthor=E.+R.+Parmee&title=The+importance+of+synthetic+chemistry+in+the+pharmaceutical+industry&doi=10.1126%2Fscience.aat0805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1126%2Fscience.aat0805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aat0805%26sid%3Dliteratum%253Aachs%26aulast%3DCampos%26aufirst%3DK.%2BR.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DAlvarez%26aufirst%3DJ.%2BC.%26aulast%3DDreher%26aufirst%3DS.%2BD.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26aulast%3DTillyer%26aufirst%3DR.%2BD.%26aulast%3DTruppo%26aufirst%3DM.%2BD.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DThe%2520importance%2520of%2520synthetic%2520chemistry%2520in%2520the%2520pharmaceutical%2520industry%26jtitle%3DScience%26date%3D2019%26volume%3D363%26spage%3Deaat0805%26doi%3D10.1126%2Fscience.aat0805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">BostrÃ¶m, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KeserÃ¼, G. M.</span></span> <span> </span><span class="NLM_article-title">Expanding the medicinal chemistry synthetic toolbox</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">709</span>â <span class="NLM_lpage">727</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2018.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnrd.2018.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30140018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=709-727&author=J.+Bostr%C3%B6mauthor=D.+G.+Brownauthor=R.+J.+Youngauthor=G.+M.+Keser%C3%BC&title=Expanding+the+medicinal+chemistry+synthetic+toolbox&doi=10.1038%2Fnrd.2018.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the medicinal chemistry synthetic toolbox</span></div><div class="casAuthors">Bostrom Jonas; Brown Dean G; Young Robert J; Keseru Gyorgy M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">709-727</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The key objectives of medicinal chemistry are to efficiently design and synthesize bioactive compounds that have the potential to become safe and efficacious drugs.  Most medicinal chemistry programmes rely on screening compound collections populated by a range of molecules derived from a set of known and robust chemistry reactions.  Analysis of the role of synthetic organic chemistry in subsequent hit and lead optimization efforts suggests that only a few reactions dominate.  Thus, the uptake of new synthetic methodologies in drug discovery is limited.  Starting from the known limitations of reaction parameters, synthesis design tools, synthetic strategies and innovative chemistries, here we highlight opportunities for the expansion of the medicinal chemists' synthetic toolbox.  More intense crosstalk between synthetic and medicinal chemists in industry and academia should enable enhanced impact of new methodologies in future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy8c_ueHSwcYMcDoIzZtNkfW6udTcc2eatcCW5cGpwFLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D&md5=d87e988602808139597576ced56faa88</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.116%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DExpanding%2520the%2520medicinal%2520chemistry%2520synthetic%2520toolbox%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D709%26epage%3D727%26doi%3D10.1038%2Fnrd.2018.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Organic synthesis provides opportunities to transform drug discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">394</span>, <span class="refDoi">Â DOI: 10.1038/s41557-018-0021-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fs41557-018-0021-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29568051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=383-394&author=D.+C.+Blakemoreauthor=L.+Castroauthor=I.+Churcherauthor=D.+C.+Reesauthor=A.+W.+Thomasauthor=D.+M.+Wilsonauthor=A.+Wood&title=Organic+synthesis+provides+opportunities+to+transform+drug+discovery&doi=10.1038%2Fs41557-018-0021-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis provides opportunities to transform drug discovery</span></div><div class="casAuthors">Blakemore, David C.; Castro, Luis; Churcher, Ian; Rees, David C.; Thomas, Andrew W.; Wilson, David M.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite decades of ground-breaking research in academia, org. synthesis is still a rate-limiting factor in drug-discovery projects.  Here we present some current challenges in synthetic org. chem. from the perspective of the pharmaceutical industry and highlight problematic steps that, if overcome, would find extensive application in the discovery of transformational medicines.  Significant synthesis challenges arise from the fact that drug mols. typically contain amines and N-heterocycles, as well as unprotected polar groups.  There is also a need for new reactions that enable non-traditional disconnections, more C-H bond activation and late-stage functionalization, as well as stereoselectively substituted aliph. heterocyclic ring synthesis, C-X or C-C bond formation.  We also emphasize that syntheses compatible with biomacromols. will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.  We believe that increasing collaboration between academic and industrial chemists is crucial to address the challenges outlined here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqR_RxjClS7Vg90H21EOLACvtfcHk0lg0K0WJyaLVbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D&md5=f6269ea8193e28416fd86fe8afbcea3f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0021-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0021-z%26sid%3Dliteratum%253Aachs%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOrganic%2520synthesis%2520provides%2520opportunities%2520to%2520transform%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D383%26epage%3D394%26doi%3D10.1038%2Fs41557-018-0021-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The medicinal chemistâs toolbox for late stage functionalization of drug-like molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">546</span>â <span class="NLM_lpage">576</span>, <span class="refDoi">Â DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=26507237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+medicinal+chemist%E2%80%99s+toolbox+for+late+stage+functionalization+of+drug-like+molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span></div><div class="casAuthors">Cernak, Tim; Dykstra, Kevin D.; Tyagarajan, Sriram; Vachal, Petr; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">546-576</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs.  LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the prepn. of biol. probes.  This review details a toolbox of intermol. C-H functionalization chemistries with proven applicability to drug-like mols., classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations.  In addn., a no. of examples illustrate how LSF approaches have been used to impact actual drug discovery and chem. biol. efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7N9sPaaVAQbVg90H21EOLACvtfcHk0lhq9gbYlsnRtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN&md5=a52fc5692f5515e5cadab0f2746fd6f7</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520medicinal%2520chemist%25E2%2580%2599s%2520toolbox%2520for%2520late%2520stage%2520functionalization%2520of%2520drug-like%2520molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danon, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reekie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">An overview of late-stage functionalization in todayâs drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1137</span>â <span class="NLM_lpage">1149</span>, <span class="refDoi">Â DOI: 10.1080/17460441.2019.1653850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1080%2F17460441.2019.1653850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=31411499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjur7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1137-1149&author=M.+Moirauthor=J.+J.+Danonauthor=T.+A.+Reekieauthor=M.+Kassiou&title=An+overview+of+late-stage+functionalization+in+today%E2%80%99s+drug+discovery&doi=10.1080%2F17460441.2019.1653850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of late-stage functionalization in today's drug discovery</span></div><div class="casAuthors">Moir, Michael; Danon, Jonathon J.; Reekie, Tristan A.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1137-1149</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Late-stage functionalization (LSF) can introduce important chem. groups in the very last steps of the synthesis.  LSF has the potential to speed up the prepn. of novel chem. entities and diverse chem. libraries and have a major impact on drug discovery.  Functional group tolerance and mild conditions allows access to new mols. not easily accessible by conventional approaches without the need for laborious de novo chem. synthesis.: A historical overview of late-stage functionalization and its applicability to drug discovery is provided.  Pioneering methodologies that laid the foundations for the field are briefly covered and archetypal examples of their application to drug discovery are discussed.  Novel methodologies reported in the past few years mainly stemming from the recent renaissances of photoredox catalysis and radical chem. are reviewed and their application to drug discovery considered.: It is envisioned that late-stage functionalization will improve the efficiency and efficacy of drug discovery.  There is evidence of the widespread uptake of LSF by the medicinal chem. community and it is expected that the recent and continuing endeavors of many academic labs. and pharmaceutical companies will soon have an impact on drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWz180tOlaLVg90H21EOLACvtfcHk0lhq9gbYlsnRtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjur7M&md5=6666a45786be0a081b452ab139a279de</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1080%2F17460441.2019.1653850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2019.1653850%26sid%3Dliteratum%253Aachs%26aulast%3DMoir%26aufirst%3DM.%26aulast%3DDanon%26aufirst%3DJ.%2BJ.%26aulast%3DReekie%26aufirst%3DT.%2BA.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DAn%2520overview%2520of%2520late-stage%2520functionalization%2520in%2520today%25E2%2580%2599s%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2019%26volume%3D14%26spage%3D1137%26epage%3D1149%26doi%3D10.1080%2F17460441.2019.1653850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szpera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moseley, D. F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span> <span> </span><span class="NLM_article-title">The fluorination of CâH bonds: developments and perspectives</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">14824</span>â <span class="NLM_lpage">14848</span>, <span class="refDoi">Â DOI: 10.1002/anie.201814457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201814457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2lsbfL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=14824-14848&author=R.+Szperaauthor=D.+F.+J.+Moseleyauthor=L.+B.+Smithauthor=A.+J.+Sterlingauthor=V.+Gouverneur&title=The+fluorination+of+C%E2%80%93H+bonds%3A+developments+and+perspectives&doi=10.1002%2Fanie.201814457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">The Fluorination of C-H Bonds: Developments and Perspectives</span></div><div class="casAuthors">Szpera, Robert; Moseley, Daniel F. J.; Smith, Lewis B.; Sterling, Alistair J.; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14824-14848</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review discusses fluorination reactions at C-H bonds, including metal-catalyzed directed fluorination reactions, and directed and undirected radical-mediated fluorination reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFPTwsJa2oc7Vg90H21EOLACvtfcHk0lhq9gbYlsnRtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2lsbfL&md5=2295219ba91a3d67ae3e89b014b7bb84</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201814457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201814457%26sid%3Dliteratum%253Aachs%26aulast%3DSzpera%26aufirst%3DR.%26aulast%3DMoseley%26aufirst%3DD.%2BF.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BB.%26aulast%3DSterling%26aufirst%3DA.%2BJ.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3DThe%2520fluorination%2520of%2520C%25E2%2580%2593H%2520bonds%253A%2520developments%2520and%2520perspectives%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D14824%26epage%3D14848%26doi%3D10.1002%2Fanie.201814457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Champagne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroches, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandamme, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquin, J.-F.</span></span> <span> </span><span class="NLM_article-title">Monofluorination of organic compounds: 10 years of innovation</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9073</span>â <span class="NLM_lpage">9174</span>, <span class="refDoi">Â DOI: 10.1021/cr500706a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500706a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtF2ntrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=9073-9174&author=P.+A.+Champagneauthor=J.+Desrochesauthor=J.-D.+Hamelauthor=M.+Vandammeauthor=J.-F.+Paquin&title=Monofluorination+of+organic+compounds%3A+10+years+of+innovation&doi=10.1021%2Fcr500706a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Monofluorination of Organic Compounds: 10 Years of Innovation</span></div><div class="casAuthors">Champagne, Pier Alexandre; Desroches, Justine; Hamel, Jean-Denys; Vandamme, Mathilde; Paquin, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9073-9174</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review is regarding the monofluorination of org. compds., i.e., synthetic methods allowing the introduction of a single C-F bond.  It emphasizes developments that occurred within the last 10 years.  After a brief survey of the approaches for the creation of single C-F bonds, the recent synthetic methods will be classified and reviewed according to the hybridization of the carbon atom bearing the fluorine atom.  Within each section, further subclassification according to the targeted fluorinated motif has been used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQEf8H1PdwwrVg90H21EOLACvtfcHk0lhq9gbYlsnRtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtF2ntrg%253D&md5=20781b11dc1f14c2547e20e2b07d1be9</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Fcr500706a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500706a%26sid%3Dliteratum%253Aachs%26aulast%3DChampagne%26aufirst%3DP.%2BA.%26aulast%3DDesroches%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DJ.-D.%26aulast%3DVandamme%26aufirst%3DM.%26aulast%3DPaquin%26aufirst%3DJ.-F.%26atitle%3DMonofluorination%2520of%2520organic%2520compounds%253A%252010%2520years%2520of%2520innovation%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D9073%26epage%3D9174%26doi%3D10.1021%2Fcr500706a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span> <span> </span><span class="NLM_article-title">Fluorination in medicinal chemistry: methods, strategies, and recent developments</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">305</span>â <span class="NLM_lpage">321</span>, <span class="refDoi">Â DOI: 10.1021/op700134j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op700134j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFShurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=305-321&author=K.+L.+Kirk&title=Fluorination+in+medicinal+chemistry%3A+methods%2C+strategies%2C+and+recent+developments&doi=10.1021%2Fop700134j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments</span></div><div class="casAuthors">Kirk, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-321</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Methods for introducing fluorine into org. mols. are reviewed, with an emphasis on prepn. of compds. designed for biomedicinal applications.  Electrophilic fluorination, nucleophilic fluorination, and enantioselective monofluorination procedures are discussed.  This is followed by a review of the development of nucleophilic and electrophilic trifluoromethylation procedures.  The final sections highlight recent applications of fluorine chem. in drug development with selected examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8akVjV2KOCLVg90H21EOLACvtfcHk0ljBjW_KYQDUZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFShurw%253D&md5=a711891a5ddcec38304baab1dbc79282</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fop700134j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop700134j%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DFluorination%2520in%2520medicinal%2520chemistry%253A%2520methods%252C%2520strategies%252C%2520and%2520recent%2520developments%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D305%26epage%3D321%26doi%3D10.1021%2Fop700134j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Modern carbonâfluorine bond forming reactions for aryl fluoride synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">612</span>â <span class="NLM_lpage">633</span>, <span class="refDoi">Â DOI: 10.1021/cr500366b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500366b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegtbzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=612-633&author=M.+G.+Campbellauthor=T.+Ritter&title=Modern+carbon%E2%80%93fluorine+bond+forming+reactions+for+aryl+fluoride+synthesis&doi=10.1021%2Fcr500366b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">Modern Carbon-Fluorine Bond Forming Reactions for Aryl Fluoride Synthesis</span></div><div class="casAuthors">Campbell, Michael G.; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">612-633</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on modern carbon-fluorine bond forming reactions for aryl fluoride synthesis.  Topics discussed include: nucleophilic arene fluorination; nucleophilic deoxyfluorination of phenols; electrophilic arene fluorination; oxidative fluorination with fluoride; arene 18F-fluorination for positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEuoUOGSbs7Vg90H21EOLACvtfcHk0ljBjW_KYQDUZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegtbzF&md5=080f9c9f181a05850dc6cc0978c0b6fa</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1021%2Fcr500366b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500366b%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DM.%2BG.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DModern%2520carbon%25E2%2580%2593fluorine%2520bond%2520forming%2520reactions%2520for%2520aryl%2520fluoride%2520synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D612%26epage%3D633%26doi%3D10.1021%2Fcr500366b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.-Y.</span></span> <span> </span><span class="NLM_article-title">Selective CâH bond fluorination of phenols with a removable directing group: late-stage fluorination of 2-phenoxyl nicotinate derivatives</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2846</span>â <span class="NLM_lpage">2849</span>, <span class="refDoi">Â DOI: 10.1021/acscatal.5b00306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.5b00306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtVWrsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=2846-2849&author=S.-J.+Louauthor=Q.+Chenauthor=Y.-F.+Wangauthor=D.-Q.+Xuauthor=X.-H.+Duauthor=J.-Q.+Heauthor=Y.-J.+Maoauthor=Z.-Y.+Xu&title=Selective+C%E2%80%93H+bond+fluorination+of+phenols+with+a+removable+directing+group%3A+late-stage+fluorination+of+2-phenoxyl+nicotinate+derivatives&doi=10.1021%2Facscatal.5b00306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25eR"><div class="casContent"><span class="casTitleNuber">25e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective C-H Bond Fluorination of Phenols with a Removable Directing Group: Late-Stage Fluorination of 2-Phenoxyl Nicotinate Derivatives</span></div><div class="casAuthors">Lou, Shao-Jie; Chen, Qi; Wang, Yi-Feng; Xu, Dan-Qian; Du, Xiao-Hua; He, Jiang-Qi; Mao, Yang-Jie; Xu, Zhen-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2846-2849</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A facile and site-selective C-H bond fluorination of phenols using removable 2-pyridyloxy group as an auxiliary was developed.  E.g., in presence of Pd(dba)2 and N-fluorobenzenesulfonimide, fluorination of 2-phenoxypyridine gave 81% I.  Alternatively, late-stage C-H bond fluorination of bioactive 2-phenoxyl nicotinate derivs. and diflufenican were also feasible under the present strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobqvI_frHh0rVg90H21EOLACvtfcHk0ljBjW_KYQDUZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtVWrsrs%253D&md5=bff95c9d6d9a33fa72ec23584f84398b</span></div><a href="/servlet/linkout?suffix=cit25e&amp;dbid=16384&amp;doi=10.1021%2Facscatal.5b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.5b00306%26sid%3Dliteratum%253Aachs%26aulast%3DLou%26aufirst%3DS.-J.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DXu%26aufirst%3DD.-Q.%26aulast%3DDu%26aufirst%3DX.-H.%26aulast%3DHe%26aufirst%3DJ.-Q.%26aulast%3DMao%26aufirst%3DY.-J.%26aulast%3DXu%26aufirst%3DZ.-Y.%26atitle%3DSelective%2520C%25E2%2580%2593H%2520bond%2520fluorination%2520of%2520phenols%2520with%2520a%2520removable%2520directing%2520group%253A%2520late-stage%2520fluorination%2520of%25202-phenoxyl%2520nicotinate%2520derivatives%26jtitle%3DACS%2520Catal.%26date%3D2015%26volume%3D5%26spage%3D2846%26epage%3D2849%26doi%3D10.1021%2Facscatal.5b00306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garber, J. A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolfes, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursalian, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghs, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genicot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gastel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalysed electrophilic aromatic CâH fluorination</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>554</i></span>,  <span class="NLM_fpage">511</span>â <span class="NLM_lpage">514</span>, <span class="refDoi">Â DOI: 10.1038/nature25749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1038%2Fnature25749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=29469096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFCrtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=554&publication_year=2018&pages=511-514&author=K.+Yamamotoauthor=J.+Liauthor=J.+A.+O.+Garberauthor=J.+D.+Rolfesauthor=G.+B.+Boursalianauthor=J.+C.+Borghsauthor=C.+Genicotauthor=J.+Jacqauthor=M.+van+Gastelauthor=F.+Neeseauthor=T.+Ritter&title=Palladium-catalysed+electrophilic+aromatic+C%E2%80%93H+fluorination&doi=10.1038%2Fnature25749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25fR"><div class="casContent"><span class="casTitleNuber">25f</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalysed electrophilic aromatic C-H fluorination</span></div><div class="casAuthors">Yamamoto, Kumiko; Li, Jiakun; Garber, Jeffrey A. O.; Rolfes, Julian D.; Boursalian, Gregory B.; Borghs, Jannik C.; Genicot, Christophe; Jacq, Jerome; van Gastel, Maurice; Neese, Frank; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">554</span>
        (<span class="NLM_cas:issue">7693</span>),
    <span class="NLM_cas:pages">511-514</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Aryl fluorides are widely used in the pharmaceutical and agrochem. industries, and recent advances have enabled their synthesis through the conversion of various functional groups.  However, there is a lack of general methods for direct arom. carbon-hydrogen (C-H) fluorination.  Conventional methods require the use of either strong fluorinating reagents, which are often unselective and difficult to handle, such as elemental fluorine, or less reactive reagents that attack only the most activated arenes, which reduces the substrate scope.  A method for the direct fluorination of arom. C-H bonds could facilitate access to fluorinated derivs. of functional mols. that would otherwise be difficult to produce.  For example, drug candidates with improved properties, such as increased metabolic stability or better blood-brain-barrier penetration, may become available.  Here we describe an approach to catalysis and the resulting development of an undirected, palladium-catalyzed method for arom. C-H fluorination using mild electrophilic fluorinating reagents.  The reaction involves a mode of catalysis that is unusual in arom. C-H functionalization because no organometallic intermediate is formed; instead, a reactive transition-metal-fluoride electrophile is generated catalytically for the fluorination of arenes that do not otherwise react with mild fluorinating reagents.  The scope and functional-group tolerance of this reaction could provide access to functional fluorinated mols. in pharmaceutical and agrochem. development that would otherwise not be readily accessible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2db4Fz5yE_LVg90H21EOLACvtfcHk0lgthpXuVClxlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFCrtr8%253D&md5=b0324d3f6b466ea3b86a38801a744485</span></div><a href="/servlet/linkout?suffix=cit25f&amp;dbid=16384&amp;doi=10.1038%2Fnature25749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25749%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGarber%26aufirst%3DJ.%2BA.%2BO.%26aulast%3DRolfes%26aufirst%3DJ.%2BD.%26aulast%3DBoursalian%26aufirst%3DG.%2BB.%26aulast%3DBorghs%26aufirst%3DJ.%2BC.%26aulast%3DGenicot%26aufirst%3DC.%26aulast%3DJacq%26aufirst%3DJ.%26aulast%3Dvan%2BGastel%26aufirst%3DM.%26aulast%3DNeese%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DPalladium-catalysed%2520electrophilic%2520aromatic%2520C%25E2%2580%2593H%2520fluorination%26jtitle%3DNature%26date%3D2018%26volume%3D554%26spage%3D511%26epage%3D514%26doi%3D10.1038%2Fnature25749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">PhenoFluorMix: practical chemoselective deoxyfluorination of phenols</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">544</span>â <span class="NLM_lpage">547</span>, <span class="refDoi">Â DOI: 10.1021/ol5035518</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5035518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=544-547&author=T.+Fujimotoauthor=T.+Ritter&title=PhenoFluorMix%3A+practical+chemoselective+deoxyfluorination+of+phenols&doi=10.1021%2Fol5035518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25gR"><div class="casContent"><span class="casTitleNuber">25g</span><div class="casTitle"><span class="NLM_cas:atitle">PhenoFluorMix: Practical Chemoselective Deoxyfluorination of Phenols</span></div><div class="casAuthors">Fujimoto, Teppei; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">544-547</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical deoxyfluorination with novel deoxyfluorinating reagent PhenoFluorMix, a mixt. of N,N'-1,3-bis(2,6-diisopropylphenyl)chloroimidazolium chloride and CsF, is presented.  PhenoFluorMix overcomes the challenges assocd. with hydrolysis of PhenoFluor.  PhenoFluorMix does not hydrolyze, is readily available on decagram scale, and is storable in air.  In this paper, we demonstrate the practicality of the reagent and exhibit the deoxyfluorination of a variety of phenols and heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJw6tRFylga7Vg90H21EOLACvtfcHk0lgthpXuVClxlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWns7g%253D&md5=02ed1484e06fa21d5b92ce6aa485d292</span></div><a href="/servlet/linkout?suffix=cit25g&amp;dbid=16384&amp;doi=10.1021%2Fol5035518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5035518%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DPhenoFluorMix%253A%2520practical%2520chemoselective%2520deoxyfluorination%2520of%2520phenols%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D544%26epage%3D547%26doi%3D10.1021%2Fol5035518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiRocco, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudge, M.</span></span> <span> </span><span class="NLM_article-title">Late-stage functionalization of biologically active heterocycles through photoredox catalysis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4802</span>â <span class="NLM_lpage">4806</span>, <span class="refDoi">Â DOI: 10.1002/anie.201402023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201402023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4802-4806&author=D.+A.+DiRoccoauthor=K.+Dykstraauthor=S.+Krskaauthor=P.+Vachalauthor=D.+V.+Conwayauthor=M.+Tudge&title=Late-stage+functionalization+of+biologically+active+heterocycles+through+photoredox+catalysis&doi=10.1002%2Fanie.201402023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Late-stage functionalization of biologically active heterocycles through photoredox catalysis</span></div><div class="casAuthors">Dirocco Daniel A; Dykstra Kevin; Krska Shane; Vachal Petr; Conway Donald V; Tudge Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4802-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The direct C H functionalization of heterocycles has become an increasingly valuable tool in modern drug discovery.  However, the introduction of small alkyl groups, such as methyl, by this method has not been realized in the context of complex molecule synthesis since existing methods rely on the use of strong oxidants and elevated temperatures to generate the requisite radical species.  Herein, we report the use of stable organic peroxides activated by visible-light photoredox catalysis to achieve the direct methyl-, ethyl-, and cyclopropylation of a variety of biologically active heterocycles.  The simple protocol, mild reaction conditions, and unique tolerability of this method make it an important tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmAsN0YQNtXD69zv1FsJFMfW6udTcc2eZdgwhWbPmR0bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D&md5=ca31296d61c97e944eaaf326a8190458</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402023%26sid%3Dliteratum%253Aachs%26aulast%3DDiRocco%26aufirst%3DD.%2BA.%26aulast%3DDykstra%26aufirst%3DK.%26aulast%3DKrska%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DConway%26aufirst%3DD.%2BV.%26aulast%3DTudge%26aufirst%3DM.%26atitle%3DLate-stage%2520functionalization%2520of%2520biologically%2520active%2520heterocycles%2520through%2520photoredox%2520catalysis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4802%26epage%3D4806%26doi%3D10.1002%2Fanie.201402023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteker, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Trimethylphosphate as a methylating agent for cross coupling: a slow-release mechanism for the methylation of arylboronic esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">17197</span>â <span class="NLM_lpage">17202</span>, <span class="refDoi">Â DOI: 10.1021/jacs.8b10076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b10076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKnur3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=17197-17202&author=Z.-T.+Heauthor=H.+Liauthor=A.+M.+Haydlauthor=G.+T.+Whitekerauthor=J.+F.+Hartwig&title=Trimethylphosphate+as+a+methylating+agent+for+cross+coupling%3A+a+slow-release+mechanism+for+the+methylation+of+arylboronic+esters&doi=10.1021%2Fjacs.8b10076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Trimethylphosphate as a Methylating Agent for Cross Coupling: A Slow-Release Mechanism for the Methylation of Arylboronic Esters</span></div><div class="casAuthors">He, Zhi-Tao; Li, Haoquan; Haydl, Alexander M.; Whiteker, Gregory T.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17197-17202</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tri-Me phosphate acted as an effective source of Me groups; in the presence of CuI, and LiI, (MeO)3P(:O) underwent chemoselective coupling with arylpinacolboronates mediated by LiOt-Bu in 1,3-dimethylimidazolidin-2-one (DMI) to yield methylarenes in higher yields than related coupling reactions using either Me iodide or Me tosylate.  The methylation reaction was used in tandem with iridium-catalyzed regioselective borylation with bis(pinacolato)diboron to provide a one-pot methylation reaction for arenes, and for trideuteromethylation of arylpinacoboronates using tris(trideuteromethyl) phosphate.  The chemoselectivity of the reaction was tested using additives possessing various functional groups (robustness screen); unprotected amines, alcs., and amides and terminal alkynes were not tolerated.  The methylation of 1-naphthylpinacolboronate was demonstrated on a 200 mmol scale.  The kinetics of the methylation and its dependence on Li+ and I- ions was detd. and a mechanism suggested.  Me iodide is released slowly upon reaction of tri-Me phosphate with iodide; the low concn. of MeI enables selective reaction with arylcopper intermediates generated from the arylboronate rather than with other nucleophiles, while binding of tert-butoxide to the pinacolboronate reactants inhibits reaction of MeI with tert-butoxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsXA5OuLeJhLVg90H21EOLACvtfcHk0lj7XLi4699E7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKnur3K&md5=966a6f09464d464c9d7da2af5a8ed881</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b10076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b10076%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DZ.-T.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHaydl%26aufirst%3DA.%2BM.%26aulast%3DWhiteker%26aufirst%3DG.%2BT.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DTrimethylphosphate%2520as%2520a%2520methylating%2520agent%2520for%2520cross%2520coupling%253A%2520a%2520slow-release%2520mechanism%2520for%2520the%2520methylation%2520of%2520arylboronic%2520esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D17197%26epage%3D17202%26doi%3D10.1021%2Fjacs.8b10076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Haydl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwig, J. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed methylation of aryl, heteroaryl, and vinyl boronate esters</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1337</span>â <span class="NLM_lpage">1341</span>, <span class="refDoi">Â DOI: 10.1021/acs.orglett.9b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.9b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVWjtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=1337-1341&author=A.+M.+Haydlauthor=J.+F.+Hartwig&title=Palladium-catalyzed+methylation+of+aryl%2C+heteroaryl%2C+and+vinyl+boronate+esters&doi=10.1021%2Facs.orglett.9b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Methylation of Aryl, Heteroaryl, and Vinyl Boronate Esters</span></div><div class="casAuthors">Haydl, Alexander M.; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1337-1341</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A method for the direct methylation of aryl, heteroaryl, and vinyl boronate esters is reported, involving the reaction of iodomethane with aryl-, heteroaryl-, and vinylboronate esters catalyzed by palladium and PtBu2Me.  This transformation occurs with a remarkably broad scope and is suitable for late-stage derivatization of biol. active compds. via the boronate esters.  The unique capabilities of this method are demonstrated by combining carbon-boron bond-forming reactions with palladium-catalyzed methylation in a tandem transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomscu9ZdlbErVg90H21EOLACvtfcHk0lj7XLi4699E7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVWjtLw%253D&md5=033fcba7d30179e8e622332347c52ba1</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.9b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.9b00025%26sid%3Dliteratum%253Aachs%26aulast%3DHaydl%26aufirst%3DA.%2BM.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520methylation%2520of%2520aryl%252C%2520heteroaryl%252C%2520and%2520vinyl%2520boronate%2520esters%26jtitle%3DOrg.%2520Lett.%26date%3D2019%26volume%3D21%26spage%3D1337%26epage%3D1341%26doi%3D10.1021%2Facs.orglett.9b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plummer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-Q.</span></span> <span> </span><span class="NLM_article-title">Divergent CâH functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discovery</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">7222</span>â <span class="NLM_lpage">7228</span>, <span class="refDoi">Â DOI: 10.1021/ja201708f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja201708f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=7222-7228&author=H.-X.+Daiauthor=A.+F.+Stepanauthor=M.+S.+Plummerauthor=Y.-H.+Zhangauthor=J.-Q.+Yu&title=Divergent+C%E2%80%93H+functionalizations+directed+by+sulfonamide+pharmacophores%3A+late-stage+diversification+as+a+tool+for+drug+discovery&doi=10.1021%2Fja201708f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26dR"><div class="casContent"><span class="casTitleNuber">26d</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent C-H Functionalizations Directed by Sulfonamide Pharmacophores: Late-Stage Diversification as a Tool for Drug Discovery</span></div><div class="casAuthors">Dai, Hui-Xiong; Stepan, Antonia F.; Plummer, Mark S.; Zhang, Yang-Hui; Yu, Jin-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7222-7228</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modern drug discovery is contingent on identifying lead compds. and rapidly synthesizing analogs.  The use of a common pharmacophore to direct multiple and divergent C-H functionalizations of lead compds. is a particularly attractive approach.  Herein, we demonstrate the viability of late-stage diversification through the divergent C-H functionalization of sulfonamides, an important class of pharmacophores found in nearly 200 drugs currently on the market, including the non-steroidal anti-inflammatory blockbuster drug celecoxib.  We developed a set of six categorically different sulfonamide C-H functionalization reactions (olefination, arylation, alkylation, halogenation, carboxylation, and carbonylation), each representing a distinct handle for further diversification to reach a large no. of analogs.  We then performed late-stage, site-selective diversification of a sulfonamide drug candidate contg. multiple potentially reactive C-H bonds to synthesize directly novel celecoxib analogs as potential cyclooxygenase-II (COX-2)-specific inhibitors.  Together with other recently developed practical directing groups, such as CONHOMe and CONHC6F5, sulfonamide directing groups demonstrate that the auxiliary approach established in asym. catalysis can be equally effective in developing broadly useful C-H activation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXYAuyvgct5LVg90H21EOLACvtfcHk0lj7XLi4699E7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSqtbY%253D&md5=a5fd5362c557b527c52dd12327572c6e</span></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=10.1021%2Fja201708f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja201708f%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DH.-X.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DPlummer%26aufirst%3DM.%2BS.%26aulast%3DZhang%26aufirst%3DY.-H.%26aulast%3DYu%26aufirst%3DJ.-Q.%26atitle%3DDivergent%2520C%25E2%2580%2593H%2520functionalizations%2520directed%2520by%2520sulfonamide%2520pharmacophores%253A%2520late-stage%2520diversification%2520as%2520a%2520tool%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D7222%26epage%3D7228%26doi%3D10.1021%2Fja201708f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Serpier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genicot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Selective methylation of arenes: a radical CâH functionalization/cross-coupling sequence</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10697</span>â <span class="NLM_lpage">10701</span>, <span class="refDoi">Â DOI: 10.1002/anie.201804628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201804628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1ykurjN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=10697-10701&author=F.+Serpierauthor=F.+Panauthor=W.+S.+Hamauthor=J.+Jacqauthor=C.+Genicotauthor=T.+Ritter&title=Selective+methylation+of+arenes%3A+a+radical+C%E2%80%93H+functionalization%2Fcross-coupling+sequence&doi=10.1002%2Fanie.201804628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26eR"><div class="casContent"><span class="casTitleNuber">26e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Methylation of Arenes: A Radical C-H Functionalization/Cross-Coupling Sequence</span></div><div class="casAuthors">Serpier, Fabien; Pan, Fei; Ham, Won Seok; Jacq, Jerome; Genicot, Christophe; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10697-10701</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A selective, nonchelation-assisted methylation of arenes has been developed.  The overall transformation, which combines a C-H functionalization reaction with a nickel-catalyzed cross-coupling, offers rapid access to methylated arenes with high para selectivity.  The reaction is amenable to late-stage methylation of small-mol. pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVJSHAvYGov7Vg90H21EOLACvtfcHk0lj7XLi4699E7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1ykurjN&md5=4db5782909c8909827a690953fe42238</span></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.1002%2Fanie.201804628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201804628%26sid%3Dliteratum%253Aachs%26aulast%3DSerpier%26aufirst%3DF.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DHam%26aufirst%3DW.%2BS.%26aulast%3DJacq%26aufirst%3DJ.%26aulast%3DGenicot%26aufirst%3DC.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DSelective%2520methylation%2520of%2520arenes%253A%2520a%2520radical%2520C%25E2%2580%2593H%2520functionalization%252Fcross-coupling%2520sequence%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D10697%26epage%3D10701%26doi%3D10.1002%2Fanie.201804628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">CâH methylation of heteroarenes inspired by radical SAM methyl transferase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">4853</span>â <span class="NLM_lpage">4856</span>, <span class="refDoi">Â DOI: 10.1021/ja5007838</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5007838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVOntbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=4853-4856&author=J.+Guiauthor=Q.+Zhouauthor=C.-M.+Panauthor=Y.+Yabeauthor=A.+C.+Burnsauthor=M.+R.+Collinsauthor=M.+A.+Ornelasauthor=Y.+Ishiharaauthor=P.+S.+Baran&title=C%E2%80%93H+methylation+of+heteroarenes+inspired+by+radical+SAM+methyl+transferase&doi=10.1021%2Fja5007838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26fR"><div class="casContent"><span class="casTitleNuber">26f</span><div class="casTitle"><span class="NLM_cas:atitle">C-H Methylation of Heteroarenes Inspired by Radical SAM Methyl Transferase</span></div><div class="casAuthors">Gui, Jinghan; Zhou, Qianghui; Pan, Chung-Mao; Yabe, Yuki; Burns, Aaron C.; Collins, Michael R.; Ornelas, Martha A.; Ishihara, Yoshihiro; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4853-4856</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A variety of nitrogen heterocycles such as caffeine I (R = H) reacted with the (phenylsulfonyl)methylating agent zinc bis(phenylsulfonylmethylsulfinate) (PhSO2CH2SO2)2Zn (II) with tert-Bu hydroperoxide in PhCF3/H2O to yield phenylsulfonylmethylated nitrogen heterocycles such as I (R = PhSO2CH2) in 41-99% yields and in most cases as single regioisomers; the method is tolerant of air and moisture, did not racemize nonracemic amino acid derivs., and tolerated various functional groups such as bromo and nitro groups.  Using one of three different sets of reagents (either activated Mg in MeOH, SmI2 in THF/H2O, or Raney nickel in EtOH), phenylsulfonylmethylated products such as I (R = PhSO2CH2) were desulfonylated in 75-99% yields to yield methylated products such as I (R = Me); thus, the two-step procedure constitutes a method for radical methylation of nitrogen heterocycles.  The phenylsulfonylmethylated product was readily sepd. from the unmethylated heterocycles, while the corresponding methylated products were not always separable from starting material.  Deuteration and fluorination of I (R = PhSO2CH2) followed by dephenylsulfonylation yielded I (R = D3C, F2HC); the phenylsulfonylmethyl group was also converted to a methylthiothiocarbonyl group and underwent stereoselective Julia coupling to benzaldehyde to yield I [R = MeS2C, (E)-PhCH:CH].  The structures of a phenylsulfonylated pyridazinamine and of [Zn(H2O)62+](PhSO2CH2SO2-)2 (IIâ¢6 H2O) were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGsSdyPD-gtbVg90H21EOLACvtfcHk0lhLgAnyMDlCBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVOntbk%253D&md5=fb7aedc04d994e8c59ff033f7b5f636d</span></div><a href="/servlet/linkout?suffix=cit26f&amp;dbid=16384&amp;doi=10.1021%2Fja5007838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5007838%26sid%3Dliteratum%253Aachs%26aulast%3DGui%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DC.-M.%26aulast%3DYabe%26aufirst%3DY.%26aulast%3DBurns%26aufirst%3DA.%2BC.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DOrnelas%26aufirst%3DM.%2BA.%26aulast%3DIshihara%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DC%25E2%2580%2593H%2520methylation%2520of%2520heteroarenes%2520inspired%2520by%2520radical%2520SAM%2520methyl%2520transferase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D4853%26epage%3D4856%26doi%3D10.1021%2Fja5007838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkis, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engl, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Site-selective CâH oxygenation via aryl sulfonium salts</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">16161</span>â <span class="NLM_lpage">16166</span>, <span class="refDoi">Â DOI: 10.1002/anie.201908718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201908718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVCmsLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=16161-16166&author=R.+Sangauthor=S.+E.+Korkisauthor=W.+Suauthor=F.+Yeauthor=P.+S.+Englauthor=F.+Bergerauthor=T.+Ritter&title=Site-selective+C%E2%80%93H+oxygenation+via+aryl+sulfonium+salts&doi=10.1002%2Fanie.201908718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Site-selective C-H Oxygenation via Aryl Sulfonium Salts</span></div><div class="casAuthors">Sang, Ruocheng; Korkis, Stamatis E.; Su, Wanqi; Ye, Fei; Engl, Pascal S.; Berger, Florian; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16161-16166</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein, we report a two-step process forming arene C-O bonds in excellent site-selectivity at a late-stage.  The C-O bond formation is achieved by selective introduction of a thianthrenium group, which is then converted into C-O bonds using photoredox chem.  Electron-rich, -poor and -neutral arenes as well as complex drug-like small mols. are successfully transformed into both phenols and various ethers.  The sequence differs conceptually from all previous arene oxygenation reactions in that oxygen functionality can be incorporated into complex small mols. at a late stage site-selectively, which has not been shown via aryl halides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMin99-Ep3dLVg90H21EOLACvtfcHk0lhLgAnyMDlCBg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVCmsLnM&md5=1048889cdd5a451cca4102495997c545</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201908718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201908718%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DR.%26aulast%3DKorkis%26aufirst%3DS.%2BE.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DEngl%26aufirst%3DP.%2BS.%26aulast%3DBerger%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DSite-selective%2520C%25E2%2580%2593H%2520oxygenation%2520via%2520aryl%2520sulfonium%2520salts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D16161%26epage%3D16166%26doi%3D10.1002%2Fanie.201908718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¶rgel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanwar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Late-stage aromatic CâH oxygenation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">16026</span>â <span class="NLM_lpage">16031</span>, <span class="refDoi">Â DOI: 10.1021/jacs.8b09208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b09208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BB3cvptlOksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=16026-16031&author=J.+B%C3%B6rgelauthor=L.+Tanwarauthor=F.+Bergerauthor=T.+Ritter&title=Late-stage+aromatic+C%E2%80%93H+oxygenation&doi=10.1021%2Fjacs.8b09208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Late-Stage Aromatic C-H Oxygenation</span></div><div class="casAuthors">Borgel Jonas; Tanwar Lalita; Berger Florian; Ritter Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">16026-16031</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Synthetic methods for oxidative aromatic C-O bond formation are sparse, despite their demand in metabolite synthesis for drug discovery and development.  We report a novel methodology for late-stage C-O bond formation of arenes.  The reaction proceeds with excellent functional group tolerance even for highly functionalized substrates.  The resulting aryl mesylates provide access to potential human metabolites of pharmaceuticals, and may be used directly to install a C-F bond to block metabolic hotspots.  A charge-transfer interaction between the reagent bis(methanesulfonyl) peroxide and the substrate arenes may be relevant for the chemoselective functionalization of arenes over other functional groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQw9mgpRiLb9JcXNb62YGmbfW6udTcc2eaeNnilLv1hurntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvptlOksg%253D%253D&md5=80478bc5ba1bfd921147f3fc7cffeafb</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b09208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b09208%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6rgel%26aufirst%3DJ.%26aulast%3DTanwar%26aufirst%3DL.%26aulast%3DBerger%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DLate-stage%2520aromatic%2520C%25E2%2580%2593H%2520oxygenation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D16026%26epage%3D16031%26doi%3D10.1021%2Fjacs.8b09208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wanke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novais, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harjivan, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, A. M. M.</span></span> <span> </span><span class="NLM_article-title">Biomimetic oxidation of aromatic xenobiotics: synthesis of the phenolic metabolites from the anti-HIV drug efavirenz</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4554</span>â <span class="NLM_lpage">4561</span>, <span class="refDoi">Â DOI: 10.1039/c2ob25212k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1039%2Fc2ob25212k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=22569890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFGms7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=4554-4561&author=R.+Wankeauthor=D.+A.+Novaisauthor=S.+G.+Harjivanauthor=M.+Marquesauthor=A.+M.+M.+Antunes&title=Biomimetic+oxidation+of+aromatic+xenobiotics%3A+synthesis+of+the+phenolic+metabolites+from+the+anti-HIV+drug+efavirenz&doi=10.1039%2Fc2ob25212k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic oxidation of aromatic xenobiotics: synthesis of the phenolic metabolites from the anti-HIV drug efavirenz</span></div><div class="casAuthors">Wanke, Riccardo; Novais, David A.; Harjivan, Shrika G.; Marques, M. Matilde; Antunes, Alexandra M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4554-4561</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report the oxidn. of the first line anti-HIV drug efavirenz (EFV), mediated by a bio-inspired nonheme Fe-complex.  Depending upon the exptl. conditions this system can be tuned either to yield the major EFV metabolite, 8-hydroxy-EFV, in enantiomerically pure form or to mimic cytochrome P 450 (CYP) activity, yielding 8-hydroxy-EFV and 7-hydroxy-EFV, the two phenolic EFV metabolites reported to be formed in vivo.  The successful oxidn. of the anti-estrogen tamoxifen and the equine estrogen equilin into their CYP-mediated metabolites supports the general application of bio-inspired nonheme Fe-complexes in mirroring CYP activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqddwRH2X8nOLVg90H21EOLACvtfcHk0lhT1AFzDf226g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFGms7s%253D&md5=4df5aa640e140bb1ad6467344816e64e</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25212k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25212k%26sid%3Dliteratum%253Aachs%26aulast%3DWanke%26aufirst%3DR.%26aulast%3DNovais%26aufirst%3DD.%2BA.%26aulast%3DHarjivan%26aufirst%3DS.%2BG.%26aulast%3DMarques%26aufirst%3DM.%26aulast%3DAntunes%26aufirst%3DA.%2BM.%2BM.%26atitle%3DBiomimetic%2520oxidation%2520of%2520aromatic%2520xenobiotics%253A%2520synthesis%2520of%2520the%2520phenolic%2520metabolites%2520from%2520the%2520anti-HIV%2520drug%2520efavirenz%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D4554%26epage%3D4561%26doi%3D10.1039%2Fc2ob25212k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beshore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciolek, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajkovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, I. J.</span></span> <span> </span><span class="NLM_article-title">Microbial biotransformation â an important tool for the study of drug metabolism</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">877</span>â <span class="NLM_lpage">886</span>, <span class="refDoi">Â DOI: 10.1080/00498254.2018.1512018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1080%2F00498254.2018.1512018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30118378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKju7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2019&pages=877-886&author=R.+Salterauthor=D.+C.+Beshoreauthor=S.+L.+Collettiauthor=L.+Evansauthor=Y.+Gongauthor=R.+Helmyauthor=Y.+Liuauthor=C.+M.+Maciolekauthor=G.+Martinauthor=N.+Pajkovicauthor=R.+Phippsauthor=J.+Smallauthor=J.+Steeleauthor=R.+de+Vriesauthor=H.+Williamsauthor=I.+J.+Martin&title=Microbial+biotransformation+%E2%80%93+an+important+tool+for+the+study+of+drug+metabolism&doi=10.1080%2F00498254.2018.1512018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27dR"><div class="casContent"><span class="casTitleNuber">27d</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial biotransformation - an important tool for the study of drug metabolism</span></div><div class="casAuthors">Salter, Rhys; Beshore, Douglas C.; Colletti, Steven L.; Evans, Liam; Gong, Yong; Helmy, Roy; Liu, Yong; Maciolek, Cheri M.; Martin, Gary; Pajkovic, Natasa; Phipps, Richard; Small, James; Steele, Jonathan; de Vries, Ronald; Williams, Headley; Martin, Iain J.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">877-886</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Metabolite identification is an integral part of both preclin. and clin. drug discovery and development.  Synthesis of drug metabolites is often required to support definitive identification, preclin. safety studies and clin. trials.  Here we describe the use of microbial biotransformation as a tool to produce drug metabolites, complementing traditional chem. synthesis and other biosynthetic methods such as hepatocytes, liver microsomes and recombinant human drug metabolizing enzymes.  A workflow is discussed whereby microbial strains are initially screened for their ability to form the putative metabolites of interest, followed by a scale-up to afford quantities sufficient to perform definitive identification and further studies.  Examples of the microbial synthesis of several difficult-to-synthesize hydroxylated metabolites and three difficult-to-synthesize glucuronidated metabolites are described, and the use of microbial biotransformation in drug discovery and development is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocObzDiaKijbVg90H21EOLACvtfcHk0lhT1AFzDf226g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKju7%252FN&md5=34d70ef745aa3c945205b4ac819ba720</span></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=10.1080%2F00498254.2018.1512018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2018.1512018%26sid%3Dliteratum%253Aachs%26aulast%3DSalter%26aufirst%3DR.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26aulast%3DEvans%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DHelmy%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaciolek%26aufirst%3DC.%2BM.%26aulast%3DMartin%26aufirst%3DG.%26aulast%3DPajkovic%26aufirst%3DN.%26aulast%3DPhipps%26aufirst%3DR.%26aulast%3DSmall%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3Dde%2BVries%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DH.%26aulast%3DMartin%26aufirst%3DI.%2BJ.%26atitle%3DMicrobial%2520biotransformation%2520%25E2%2580%2593%2520an%2520important%2520tool%2520for%2520the%2520study%2520of%2520drug%2520metabolism%26jtitle%3DXenobiotica%26date%3D2019%26volume%3D49%26spage%3D877%26epage%3D886%26doi%3D10.1080%2F00498254.2018.1512018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Minisci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perchinummo, M.</span></span> <span> </span><span class="NLM_article-title">Nucleophilic character of alkyl radicalsâVI: a new convenient selective alkylation of heteroaromatic bases</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3575</span>â <span class="NLM_lpage">3579</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4020(01)97768-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2FS0040-4020%2801%2997768-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFyns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=3575-3579&author=F.+Minisciauthor=R.+Bernardiauthor=F.+Bertiniauthor=R.+Galliauthor=M.+Perchinummo&title=Nucleophilic+character+of+alkyl+radicals%E2%80%94VI%3A+a+new+convenient+selective+alkylation+of+heteroaromatic+bases&doi=10.1016%2FS0040-4020%2801%2997768-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleophilic character of alkyl radicals.  VI.  New convenient selective alkylation of heteroaromatic bases</span></div><div class="casAuthors">Minisci, F.; Bernardi, R.; Bertini, F.; Galli, R.; Perchinummo, M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3575-80</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">A new method of homolytic alkylation of heteroaromatic bases, such as pyridines, quinolines, and isoquinolines, is described, in which the silver-catalyzed oxidative decarboxylation of acids by peroxydisulfate is used as a source of alkyl radicals.  The method is esp. noteworthy because of the good yields and the high selectivity obtained, due to the nucleophilic character of the alkyl radicals; for synthetic interest it is comparable to electrophilic alkylation in the homocyclic series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDy822OWvBPbVg90H21EOLACvtfcHk0lhT1AFzDf226g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFyns7g%253D&md5=7df59f61bffc344fd37eb0c0ea01baac</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2997768-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252997768-3%26sid%3Dliteratum%253Aachs%26aulast%3DMinisci%26aufirst%3DF.%26aulast%3DBernardi%26aufirst%3DR.%26aulast%3DBertini%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DR.%26aulast%3DPerchinummo%26aufirst%3DM.%26atitle%3DNucleophilic%2520character%2520of%2520alkyl%2520radicals%25E2%2580%2594VI%253A%2520a%2520new%2520convenient%2520selective%2520alkylation%2520of%2520heteroaromatic%2520bases%26jtitle%3DTetrahedron%26date%3D1971%26volume%3D27%26spage%3D3575%26epage%3D3579%26doi%3D10.1016%2FS0040-4020%2801%2997768-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, R. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, R. J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in Minisci-type reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">13666</span>â <span class="NLM_lpage">13699</span>, <span class="refDoi">Â DOI: 10.1002/anie.201900977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2Fanie.201900977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFSrtL%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=13666-13699&author=R.+S.+J.+Proctorauthor=R.+J.+Phipps&title=Recent+advances+in+Minisci-type+reactions&doi=10.1002%2Fanie.201900977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in Minisci-Type Reactions</span></div><div class="casAuthors">Proctor, Rupert S. J.; Phipps, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13666-13699</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Reactions that involve the addn. of carbon-centered radicals to basic heteroarenes, followed by formal hydrogen atom loss, have become widely known as Minisci-type reactions.  First developed into a useful synthetic tool in the late 1960s by Minisci, this reaction type has been in const. use over the last half century by chemists seeking to functionalize heterocycles in a rapid and direct manner, avoiding the need for de novo heterocycle synthesis.  While the originally developed protocols for radical generation remain in active use today, they have been joined in recent years by a new array of radical generation strategies that allow use of a wider variety of radical precursors that often operate under milder and more benign conditions.  The recent surge of interest in new transformations based on free radical reactivity has meant that numerous choices are now available to a synthetic chemist looking to utilize a Minisci-type reaction.  Radical-generation methods based on photoredox catalysis and electrochem. have joined approaches which utilize thermal cleavage or the in situ generation of reactive radical precursors.  This review will cover the remarkably large body of literature that has appeared on this topic over the last decade in an attempt to provide guidance to the synthetic chemist, as well as a perspective on both the challenges that have been overcome and those that still remain.  As well as the logical classification of advances based on the nature of the radical precursor, with which most advances have been concerned, recent advances in control of various selectivity aspects assocd. with Minisci-type reactions will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5HR0V-arVd7Vg90H21EOLACvtfcHk0li4PjdQAXFrQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFSrtL%252FN&md5=bd06587b8508f32ad764c55ac0f29cd9</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201900977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201900977%26sid%3Dliteratum%253Aachs%26aulast%3DProctor%26aufirst%3DR.%2BS.%2BJ.%26aulast%3DPhipps%26aufirst%3DR.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520Minisci-type%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D13666%26epage%3D13699%26doi%3D10.1002%2Fanie.201900977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span>; <span class="NLM_string-name">Rarey, M.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Docking and Scoring.</span> In  <i>Reviews in Computational Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowitz, K. B.</span>, <span class="NLM_string-name">Boyd, E. B.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>; Vol.  <span class="NLM_volume">17</span>, pp  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">60</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1002%2F0471224413.ch1" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1-60&author=I.+Muegge&author=M.+Rareyauthor=K.+B.+Lipkowitz&author=E.+B.+Boyd&title=Reviews+in+Computational+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F0471224413.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471224413.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DMuegge%26aufirst%3DI.%26atitle%3DSmall%2520Molecule%2520Docking%2520and%2520Scoring.%26btitle%3DReviews%2520in%2520Computational%2520Chemistry%26aulast%3DLipkowitz%26aufirst%3DK.%2BB.%26pub%3DWiley-VCH%26date%3D2001%26volume%3D17%26spage%3D1%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sushko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novotarskyi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶rner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelaziz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetko, I. V.</span></span> <span> </span><span class="NLM_article-title">Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi">Â DOI: 10.1186/s13321-014-0048-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1186%2Fs13321-014-0048-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislWhtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=48&author=Y.+Sushkoauthor=S.+Novotarskyiauthor=R.+K%C3%B6rnerauthor=J.+Vogtauthor=A.+Abdelazizauthor=I.+V.+Tetko&title=Prediction-driven+matched+molecular+pairs+to+interpret+QSARs+and+aid+the+molecular+optimization+process&doi=10.1186%2Fs13321-014-0048-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process</span></div><div class="casAuthors">Sushko, Yurii; Novotarskyi, Sergii; Koerner, Robert; Vogt, Joachim; Abdelaziz, Ahmed; Tetko, Igor V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48/1-48/39, 39 pp.</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background QSAR is an established and powerful method for cheap in silico assessment of physicochem. properties and biol. activities of chem. compds.  However, QSAR models are rather complex math. constructs that cannot easily be interpreted.  Medicinal chemists would benefit from practical guidance regarding which mols. to synthesize.  Another possible approach is anal. of pairs of very similar mols., so-called matched mol. pairs (MMPs).  Such an approach allows identification of mol. transformations that affect particular activities (e.g. toxicity).  In contrast to QSAR, chem. interpretation of these transformations is straightforward.  Furthermore, such transformations can give medicinal chemists useful hints for the hit-to-lead optimization process.  Results The current study suggests a combination of QSAR and MMP approaches by finding MMP transformations based on QSAR predictions for large chem. datasets.  The study shows that such an approach, referred to as prediction-driven MMP anal., is a useful tool for medicinal chemists, allowing identification of large nos. of "interesting" transformations that can be used to drive the mol. optimization process.  All the methodol. developments have been implemented as software products available online as part of OCHEM.  Conclusions The prediction-driven MMPs methodol. was exemplified by two use cases: modeling of aquatic toxicity and CYP3A4 inhibition.  This approach helped us to interpret QSAR models and allowed identification of a no. of "significant" mol. transformations that affect the desired properties.  This can facilitate drug design as a part of mol. optimization process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTzctKLS8vxrVg90H21EOLACvtfcHk0li4PjdQAXFrQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislWhtLw%253D&md5=837bda80de79a7621c887de1fed0375a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1186%2Fs13321-014-0048-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-014-0048-0%26sid%3Dliteratum%253Aachs%26aulast%3DSushko%26aufirst%3DY.%26aulast%3DNovotarskyi%26aufirst%3DS.%26aulast%3DK%25C3%25B6rner%26aufirst%3DR.%26aulast%3DVogt%26aufirst%3DJ.%26aulast%3DAbdelaziz%26aufirst%3DA.%26aulast%3DTetko%26aufirst%3DI.%2BV.%26atitle%3DPrediction-driven%2520matched%2520molecular%2520pairs%2520to%2520interpret%2520QSARs%2520and%2520aid%2520the%2520molecular%2520optimization%2520process%26jtitle%3DJ.%2520Cheminf.%26date%3D2014%26volume%3D6%26spage%3D48%26doi%3D10.1186%2Fs13321-014-0048-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voitovich, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derviaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amouric, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collette, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morelli, X.</span></span> <span> </span><span class="NLM_article-title">Integrated strategy for lead optimization based on fragment growing: the diversity-oriented-target-focused-synthesis approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5719</span>â <span class="NLM_lpage">5732</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00653</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5719-5732&author=L.+Hofferauthor=Y.+V.+Voitovichauthor=B.+Rauxauthor=K.+Carrascoauthor=C.+Mullerauthor=A.+Y.+Fedorovauthor=C.+Derviauxauthor=A.+Amouricauthor=S.+Betziauthor=D.+Horvathauthor=A.+Varnekauthor=Y.+Colletteauthor=S.+Combesauthor=P.+Rocheauthor=X.+Morelli&title=Integrated+strategy+for+lead+optimization+based+on+fragment+growing%3A+the+diversity-oriented-target-focused-synthesis+approach&doi=10.1021%2Facs.jmedchem.8b00653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach</span></div><div class="casAuthors">Hoffer, Laurent; Voitovich, Yuliia V.; Raux, Brigitt; Carrasco, Kendall; Muller, Christophe; Fedorov, Aleksey Y.; Derviaux, Carine; Amouric, Agnes; Betzi, Stephane; Horvath, Dragos; Varnek, Alexandre; Collette, Yves; Combes, Sebastien; Roche, Philippe; Morelli, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5719-5732</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past few decades, hit identification has been greatly facilitated by advances in high-throughput and fragment-based screenings.  One major hurdle remaining in drug discovery is process automation of hit-to-lead (H2L) optimization.  Here, we report a time- and cost-efficient integrated strategy for H2L optimization as well as a partially automated design of potent chem. probes consisting of a focused-chem.-library design and virtual screening coupled with robotic diversity-oriented de novo synthesis and automated in vitro evaluation.  The virtual library is generated by combining an activated fragment, corresponding to the substructure binding to the target, with a collection of functionalized building blocks using in silico encoded chem. reactions carefully chosen from a list of one-step org. transformations relevant in medicinal chem.  The proof of concept was demonstrated using the optimization of bromodomain inhibitors as a test case, leading to the validation of several compds. with improved affinity by several orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrocVtdmg7D67Vg90H21EOLACvtfcHk0li4PjdQAXFrQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSrtLrK&md5=0e5f18636e2b1df24314efa81e67e2b5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00653%26sid%3Dliteratum%253Aachs%26aulast%3DHoffer%26aufirst%3DL.%26aulast%3DVoitovich%26aufirst%3DY.%2BV.%26aulast%3DRaux%26aufirst%3DB.%26aulast%3DCarrasco%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26aulast%3DDerviaux%26aufirst%3DC.%26aulast%3DAmouric%26aufirst%3DA.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DVarnek%26aufirst%3DA.%26aulast%3DCollette%26aufirst%3DY.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DRoche%26aufirst%3DP.%26aulast%3DMorelli%26aufirst%3DX.%26atitle%3DIntegrated%2520strategy%2520for%2520lead%2520optimization%2520based%2520on%2520fragment%2520growing%253A%2520the%2520diversity-oriented-target-focused-synthesis%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5719%26epage%3D5732%26doi%3D10.1021%2Facs.jmedchem.8b00653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutowo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CibriÃ¡n-Uhalte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MagariÃ±os, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadatos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span> <span> </span><span class="NLM_article-title">The ChEMBL database in 2017</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D945</span>â <span class="NLM_lpage">D954</span>, <span class="refDoi">Â DOI: 10.1093/nar/gkw1074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1093%2Fnar%2Fgkw1074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=27899562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D945-D954&author=A.+Gaultonauthor=A.+Herseyauthor=M.+Nowotkaauthor=A.+P.+Bentoauthor=J.+Chambersauthor=D.+Mendezauthor=P.+Mutowoauthor=F.+Atkinsonauthor=L.+J.+Bellisauthor=E.+Cibri%C3%A1n-Uhalteauthor=M.+Daviesauthor=N.+Dedmanauthor=A.+Karlssonauthor=M.+P.+Magari%C3%B1osauthor=J.+P.+Overingtonauthor=G.+Papadatosauthor=I.+Smitauthor=A.+R.+Leach&title=The+ChEMBL+database+in+2017&doi=10.1093%2Fnar%2Fgkw1074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">The ChEMBL database in 2017</span></div><div class="casAuthors">Gaulton, Anna; Hersey, Anne; Nowotka, Micha-l; Bento, A. Patricia; Chambers, Jon; Mendez, David; Mutowo, Prudence; Atkinson, Francis; Bellis, Louisa J.; Cibrian-Uhalte, Elena; Davies, Mark; Dedman, Nathan; Karlsson, Anneli; Magarinos, Maria Paula; Overington, John P.; Papadatos, George; Smit, Ines; Leach, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D945-D954</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an open large-scale bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012 and 2014 Nucleic Acids Research Database Issues.  Since then, alongside the continued extn. of data from the medicinal chem. literature, new sources of bioactivity data have also been added to the database.  These include: deposited data sets from neglected disease screening; crop protection data; drug metab. and disposition data and bioactivity data from patents.  A no. of improvements and new features have also been incorporated.  These include the annotation of assays and targets using ontologies, the inclusion of targets and indications for clin. candidates, addn. of metabolic pathways for drugs and calcn. of structural alerts.  The ChEMBL data can be accessed via a web-interface, RDF distribution, data downloads and RESTful web-services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0IuNShSHIrVg90H21EOLACvtfcHk0lgzay0mPbRw2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWhurs%253D&md5=1dcbb641f8c2d11410663f97505a4911</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1074%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNowotka%26aufirst%3DM.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DMendez%26aufirst%3DD.%26aulast%3DMutowo%26aufirst%3DP.%26aulast%3DAtkinson%26aufirst%3DF.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DCibri%25C3%25A1n-Uhalte%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DDedman%26aufirst%3DN.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DMagari%25C3%25B1os%26aufirst%3DM.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DPapadatos%26aufirst%3DG.%26aulast%3DSmit%26aufirst%3DI.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26atitle%3DThe%2520ChEMBL%2520database%2520in%25202017%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD945%26epage%3DD954%26doi%3D10.1093%2Fnar%2Fgkw1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span>ChEMBL24_1 downloaded October 11, <span class="NLM_year">2018</span>, from <a href="ftp://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_24_1/" class="extLink">ftp://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_24_1/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ChEMBL24_1+downloaded+October+11%2C+2018%2C+from+ftp%3A%2F%2Fftp.ebi.ac.uk%2Fpub%2Fdatabases%2Fchembl%2FChEMBLdb%2Freleases%2Fchembl_24_1%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, K. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR study of pyrrolo[3,4-<i>b</i>]pyridin-7(6<i>H</i>)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1736</span>â <span class="NLM_lpage">1739</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2013.01.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmcl.2013.01.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=23411080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Sju7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1736-1739&author=C.+J.+Limauthor=J.+Y.+Kimauthor=B.+H.+Leeauthor=K.+S.+Ohauthor=K.+Y.+Yi&title=Synthesis+and+SAR+study+of+pyrrolo%5B3%2C4-b%5Dpyridin-7%286H%29-one+derivatives+as+melanin+concentrating+hormone+receptor+1+%28MCH-R1%29+antagonists&doi=10.1016%2Fj.bmcl.2013.01.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists</span></div><div class="casAuthors">Lim, Chae Jo; Kim, Ji Young; Lee, Byung Ho; Oh, Kwang-Seok; Yi, Kyu Yang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1736-1739</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of novel pyrrolo[3,4-b]pyridin-7(6H)-one MCH-R1 antagonists are described.  A systematic SAR study probing the effects of aryl-, benzyl- and arylthio-substituents at the 2-position of the pyrrolo[3,4-b]pyridin-7(6H)-ones led to identification of the 2-[(4-fluorophenyl)thio] deriv. 7b as a highly potent MCH-R1 antagonist.  This compd. also has favorable pharmacokinetic properties along with a high metabolic stability and a minimal impact on CYP isoforms and hERG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptvrvVkR3bNrVg90H21EOLACvtfcHk0lgzay0mPbRw2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Sju7w%253D&md5=21259ebb9ef6d0a7d1b4628d2dc26db6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.053%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DC.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DOh%26aufirst%3DK.%2BS.%26aulast%3DYi%26aufirst%3DK.%2BY.%26atitle%3DSynthesis%2520and%2520SAR%2520study%2520of%2520pyrrolo%255B3%252C4-b%255Dpyridin-7%25286H%2529-one%2520derivatives%2520as%2520melanin%2520concentrating%2520hormone%2520receptor%25201%2520%2528MCH-R1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1736%26epage%3D1739%26doi%3D10.1016%2Fj.bmcl.2013.01.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VÃ©zina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benakli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaubien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Louis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinault, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaseshan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchemin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BhÃ©rer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, G. L.</span></span> <span> </span><span class="NLM_article-title">Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of ulimorelin (TZP-101) from hit to clinic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8305</span>â <span class="NLM_lpage">8320</span>, <span class="refDoi">Â DOI: 10.1021/jm2007062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fms1antg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8305-8320&author=H.+R.+Hoveydaauthor=E.+Marsaultauthor=R.+Gagnonauthor=A.+P.+Mathieuauthor=M.+V%C3%A9zinaauthor=A.+Landryauthor=Z.+Wangauthor=K.+Benakliauthor=S.+Beaubienauthor=C.+Saint-Louisauthor=M.+Brassardauthor=J.+F.+Pinaultauthor=L.+Ouelletauthor=S.+Bhatauthor=M.+Ramaseshanauthor=X.+Pengauthor=L.+Foucherauthor=S.+Beaucheminauthor=P.+Bh%C3%A9rerauthor=D.+F.+Veberauthor=M.+L.+Petersonauthor=G.+L.+Fraser&title=Optimization+of+the+potency+and+pharmacokinetic+properties+of+a+macrocyclic+ghrelin+receptor+agonist+%28Part+I%29%3A+development+of+ulimorelin+%28TZP-101%29+from+hit+to+clinic&doi=10.1021%2Fjm2007062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic</span></div><div class="casAuthors">Hoveyda Hamid R; Marsault Eric; Gagnon Rene; Mathieu Axel P; Vezina Martin; Landry Annick; Wang Zhigang; Benakli Kamel; Beaubien Sylvie; Saint-Louis Carl; Brassard Martin; Pinault Jean-Francois; Ouellet Luc; Bhat Shridhar; Ramaseshan Mahesh; Peng Xiaowen; Foucher Laurence; Beauchemin Sophie; Bherer Patrick; Veber Daniel F; Peterson Mark L; Fraser Graeme L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8305-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">High-throughput screening of Tranzyme Pharma's proprietary macrocycle library using the aequorin Ca2+-bioluminescence assay against the human ghrelin receptor (GRLN) led to the discovery of novel agonists against this G-protein coupled receptor.  Early hits such as 1 (Ki=86 nM, EC50=134 nM) though potent in vitro displayed poor pharmacokinetic properties that required optimization.  While such macrocycles are not fully rule-of-five compliant, principally due to their molecular weight and clogP, optimization of their pharmacokinetic properties proved feasible largely through conformational rigidification.  Extensive SAR led to the identification of 2 (Ki=16 nM, EC50=29 nM), also known as ulimorelin or TZP-101, which has progressed to phase III human clinical trials for the treatment of postoperative ileus.  X-ray structure and detailed NMR studies indicated a rigid peptidomimetic portion in 2 that is best defined as a nonideal type-I' Î²-turn.  Compound 2 is 24% orally bioavailable in both rats and monkeys.  Despite its potency, in vitro and in gastric emptying studies, 2 did not induce growth hormone (GH) release in rats, thus demarcating the GH versus GI pharmacology of GRLN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREoes2wBiC73y-c-E1v-fmfW6udTcc2eZ8FF7lViRye7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fms1antg%253D%253D&md5=bdc3b14ed821c61c4fecea50c60f0b07</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm2007062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007062%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%2BR.%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DGagnon%26aufirst%3DR.%26aulast%3DMathieu%26aufirst%3DA.%2BP.%26aulast%3DV%25C3%25A9zina%26aufirst%3DM.%26aulast%3DLandry%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBenakli%26aufirst%3DK.%26aulast%3DBeaubien%26aufirst%3DS.%26aulast%3DSaint-Louis%26aufirst%3DC.%26aulast%3DBrassard%26aufirst%3DM.%26aulast%3DPinault%26aufirst%3DJ.%2BF.%26aulast%3DOuellet%26aufirst%3DL.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DRamaseshan%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFoucher%26aufirst%3DL.%26aulast%3DBeauchemin%26aufirst%3DS.%26aulast%3DBh%25C3%25A9rer%26aufirst%3DP.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DFraser%26aufirst%3DG.%2BL.%26atitle%3DOptimization%2520of%2520the%2520potency%2520and%2520pharmacokinetic%2520properties%2520of%2520a%2520macrocyclic%2520ghrelin%2520receptor%2520agonist%2520%2528Part%2520I%2529%253A%2520development%2520of%2520ulimorelin%2520%2528TZP-101%2529%2520from%2520hit%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8305%26epage%3D8320%26doi%3D10.1021%2Fjm2007062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâBrien, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axford, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmaster, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hoosear, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivasankaran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of small molecule splicing modulators of survival motor neuron-2 (SMN2) for the treatment of spinal muscular atrophy (SMA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11021</span>â <span class="NLM_lpage">11036</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01291</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFeju7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11021-11036&author=A.+K.+Cheungauthor=B.+Hurleyauthor=R.+Kerriganauthor=L.+Shuauthor=D.+N.+Chinauthor=Y.+Shenauthor=G.+O%E2%80%99Brienauthor=M.+J.+Sungauthor=Y.+Houauthor=J.+Axfordauthor=E.+Codyauthor=R.+Sunauthor=A.+Fazalauthor=C.+Fridrichauthor=C.+C.+Sanchezauthor=R.+C.+Tomlinsonauthor=M.+Jainauthor=L.+Dengauthor=K.+Hoffmasterauthor=C.+Songauthor=M.+Van+Hoosearauthor=Y.+Shinauthor=R.+Servaisauthor=C.+Towlerauthor=M.+Hildauthor=D.+Curtisauthor=W.+F.+Dietrichauthor=L.+G.+Hamannauthor=K.+Brinerauthor=K.+S.+Chenauthor=D.+Kobayashiauthor=R.+Sivasankaranauthor=N.+A.+Dales&title=Discovery+of+small+molecule+splicing+modulators+of+survival+motor+neuron-2+%28SMN2%29+for+the+treatment+of+spinal+muscular+atrophy+%28SMA%29&doi=10.1021%2Facs.jmedchem.8b01291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)</span></div><div class="casAuthors">Cheung, Atwood K.; Hurley, Brian; Kerrigan, Ryan; Shu, Lei; Chin, Donovan N.; Shen, Yiping; OBrien, Gary; Sung, Moo Je; Hou, Ying; Axford, Jake; Cody, Emma; Sun, Robert; Fazal, Aleem; Tomlinson, Ronald C.; Jain, Monish; Deng, Lin; Hoffmaster, Keith; Song, Cheng; Van Hoosear, Mailin; Shin, Youngah; Servais, Rebecca; Towler, Christopher; Hild, Marc; Curtis, Daniel; Dietrich, William F.; Hamann, Lawrence G.; Briner, Karin; Chen, Karen S.; Kobayashi, Dione; Sivasankaran, Rajeev; Dales, Natalie A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11021-11036</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spinal muscular atrophy (SMA), a rare neuromuscular disorder, is the leading genetic cause of death in infants and toddlers.  SMA is caused by the deletion or a loss of function mutation of the survival motor neuron 1 (SMN1) gene.  In humans, a second closely related gene SMN2 exists, however it codes for a less stable SMN protein.  In recent years, significant progress has been made toward disease modifying treatments for SMA by modulating SMN2 pre-mRNA splicing.  Herein, we describe the discovery of LMI070/branaplam, a small mol. that stabilizes the interaction between the spliceosome and SMN2 pre-mRNA.  Branaplam (1) originated from a high-throughput phenotypic screening hit, pyridazine 2, and evolved via multi-parameter lead optimization.  In a severe mouse SMA model, branaplam treatment increased full-length SMN RNA and protein levels, and extended survival.  Currently, branaplam is in clin. studies for SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprrHPkSEhGhrVg90H21EOLACvtfcHk0lga82ivE5-gwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFeju7nL&md5=c564332b680a6ef0ad06bc9e5a4db16e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01291%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DHurley%26aufirst%3DB.%26aulast%3DKerrigan%26aufirst%3DR.%26aulast%3DShu%26aufirst%3DL.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DG.%26aulast%3DSung%26aufirst%3DM.%2BJ.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DAxford%26aufirst%3DJ.%26aulast%3DCody%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DSanchez%26aufirst%3DC.%2BC.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DHoffmaster%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DVan%2BHoosear%26aufirst%3DM.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DServais%26aufirst%3DR.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DDietrich%26aufirst%3DW.%2BF.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DBriner%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DKobayashi%26aufirst%3DD.%26aulast%3DSivasankaran%26aufirst%3DR.%26aulast%3DDales%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520splicing%2520modulators%2520of%2520survival%2520motor%2520neuron-2%2520%2528SMN2%2529%2520for%2520the%2520treatment%2520of%2520spinal%2520muscular%2520atrophy%2520%2528SMA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11021%26epage%3D11036%26doi%3D10.1021%2Facs.jmedchem.8b01291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">A survey of the role of noncovalent sulfur interactions in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4383</span>â <span class="NLM_lpage">4438</span>, <span class="refDoi">Â DOI: 10.1021/jm501853m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501853m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4383-4438&author=B.+R.+Benoauthor=K.-S.+Yeungauthor=M.+D.+Bartbergerauthor=L.+D.+Penningtonauthor=N.+A.+Meanwell&title=A+survey+of+the+role+of+noncovalent+sulfur+interactions+in+drug+design&doi=10.1021%2Fjm501853m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span></div><div class="casAuthors">Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D.; Pennington, Lewis D.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4383-4438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Electron deficient, bivalent sulfur atoms have two areas of pos. electrostatic potential, a consequence of the low-lying Ï* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, Ï-systems.  Intramol. interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a mol.  Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramol. hydrogen-bonding interaction, appears to be underappreciated by the medicinal chem. community.  In this Perspective, we discuss the theor. basis for sulfur Ï* orbital interactions and illustrate their importance in the context of drug design and org. synthesis.  The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermol. interactions between ligand C-S Ï* orbitals and proteins are illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKXRsl4BQYrVg90H21EOLACvtfcHk0lga82ivE5-gwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D&md5=d12f53eb3271c161cfc833fb9f7c02b3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501853m%26sid%3Dliteratum%253Aachs%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520survey%2520of%2520the%2520role%2520of%2520noncovalent%2520sulfur%2520interactions%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4383%26epage%3D4438%26doi%3D10.1021%2Fjm501853m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¶schke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9337</span>â <span class="NLM_lpage">9349</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9337-9349&author=P.+Czodrowskiauthor=A.+Mallingerauthor=D.+Wienkeauthor=C.+Esdarauthor=O.+P%C3%B6schkeauthor=M.+Buschauthor=F.+Rohdichauthor=S.+A.+Ecclesauthor=M.-J.+Ortiz-Ruizauthor=R.+Schneiderauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=D.+Musilauthor=D.+Schwarzauthor=T.+Daleauthor=K.+Urbahnsauthor=J.+Blaggauthor=K.+Schiemann&title=Structure-based+optimization+of+potent%2C+selective%2C+and+orally+bioavailable+CDK8+inhibitors+discovered+by+high-throughput+screening&doi=10.1021%2Facs.jmedchem.6b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening</span></div><div class="casAuthors">Czodrowski, Paul; Mallinger, Aurelie; Wienke, Dirk; Esdar, Christina; Poeschke, Oliver; Busch, Michael; Rohdich, Felix; Eccles, Suzanne A.; Ortiz-Ruiz, Maria-Jesus; Schneider, Richard; Raynaud, Florence I.; Clarke, Paul A.; Musil, Djordje; Schwarz, Daniel; Dale, Trevor; Urbahns, Klaus; Blagg, Julian; Schiemann, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9337-9349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Mediator complex-assocd. cyclin dependent kinase CDK8 regulates beta-catenin-dependent transcription following activation of WNT signaling.  Multiple lines of evidence suggest CDK8 may act as an oncogene in the development of colorectal cancer.  Here the authors describe the successful optimization of an imidazo-thiadiazole series of CDK8 inhibitors that was identified in a high-throughput screening campaign and further progressed by structure-based design.  In several optimization cycles, the authors improved the microsomal stability, potency and kinase selectivity.  The initial imidazo-thiadiazole scaffold was replaced by a 3-methyl-1H-pyrazolo[3,4-b]-pyridine which resulted in compd. MSC2530818 that displayed excellent kinase selectivity, biochem. and cellular potency, microsomal stability and is orally bioavailable.  Furthermore, the authors demonstrated modulation of phospho-STAT1, a pharmacodynamic biomarker of CDK8 activity, and tumor growth inhibition in an APC-mutant SW620 human colorectal carcinoma xenograft model after oral administration.  Compd. MSC2530818 demonstrated suitable potency and selectivity to progress into preclin. in vivo efficacy and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoP_Ycv9Xj97Vg90H21EOLACvtfcHk0li11xyVCG37dA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF&md5=9ab270aed38647f9bafe213cf9d75171</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00597%26sid%3Dliteratum%253Aachs%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DP%25C3%25B6schke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.-J.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DSchiemann%26aufirst%3DK.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520CDK8%2520inhibitors%2520discovered%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9337%26epage%3D9349%26doi%3D10.1021%2Facs.jmedchem.6b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parcella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant-Young, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjanappa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bora, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanumegowda, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colston, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raybon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santone, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4369</span>â <span class="NLM_lpage">4385</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4369-4385&author=K.-S.+Yeungauthor=B.+R.+Benoauthor=K.+Parcellaauthor=J.+A.+Benderauthor=K.+A.+Grant-Youngauthor=A.+Nickelauthor=P.+Gunagaauthor=P.+Anjanappaauthor=R.+O.+Boraauthor=K.+Selvakumarauthor=K.+Rigatauthor=Y.-K.+Wangauthor=M.+Liuauthor=J.+Lemmauthor=K.+Mosureauthor=S.+Sheriffauthor=C.+Wanauthor=M.+Witmerauthor=K.+Kishauthor=U.+Hanumegowdaauthor=X.+Zhuoauthor=Y.-Z.+Shuauthor=D.+Parkerauthor=R.+Haskellauthor=A.+Ngauthor=Q.+Gaoauthor=E.+Colstonauthor=J.+Raybonauthor=D.+M.+Graselaauthor=K.+Santoneauthor=M.+Gaoauthor=N.+A.+Meanwellauthor=M.+Sinzauthor=M.+G.+Soarsauthor=J.+O.+Knipeauthor=S.+B.+Robertsauthor=J.+F.+Kadow&title=Discovery+of+a+hepatitis+C+virus+NS5B+replicase+palm+site+allosteric+inhibitor+%28BMS-929075%29+advanced+to+phase+1+clinical+studies&doi=10.1021%2Facs.jmedchem.7b00328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies</span></div><div class="casAuthors">Yeung, Kap-Sun; Beno, Brett R.; Parcella, Kyle; Bender, John A.; Grant-Young, Katherine A.; Nickel, Andrew; Gunaga, Prashantha; Anjanappa, Prakash; Bora, Rajesh Onkardas; Selvakumar, Kumaravel; Rigat, Karen; Wang, Ying-Kai; Liu, Mengping; Lemm, Julie; Mosure, Kathy; Sheriff, Steven; Wan, Changhong; Witmer, Mark; Kish, Kevin; Hanumegowda, Umesh; Zhuo, Xiaoliang; Shu, Yue-Zhong; Parker, Dawn; Haskell, Roy; Ng, Alicia; Gao, Qi; Colston, Elizabeth; Raybon, Joseph; Grasela, Dennis M.; Santone, Kenneth; Gao, Min; Meanwell, Nicholas A.; Sinz, Michael; Soars, Matthew G.; Knipe, Jay O.; Roberts, Susan B.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4369-4385</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection.  Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid 4, the known benzofuran analog 5, and the benzothiadiazine deriv. 6, an optimization process utilizing the simple benzofuran template 7 as a starting point for a fragment growing approach was pursued.  A delicate balance of mol. properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metab., and excretion profile.  These efforts led to the discovery of BMS-929075 (37), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic parameters across preclin. animal species.  The human PK properties from the Phase I clin. studies of 37 were better than anticipated and suggest promising potential for QD administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0KsD9y5uorVg90H21EOLACvtfcHk0liqEUEjCE9RSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D&md5=354b41a850bfa225b52baeddb1cb59b0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00328%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DGrant-Young%26aufirst%3DK.%2BA.%26aulast%3DNickel%26aufirst%3DA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DAnjanappa%26aufirst%3DP.%26aulast%3DBora%26aufirst%3DR.%2BO.%26aulast%3DSelvakumar%26aufirst%3DK.%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DHanumegowda%26aufirst%3DU.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DHaskell%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DColston%26aufirst%3DE.%26aulast%3DRaybon%26aufirst%3DJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DSantone%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520hepatitis%2520C%2520virus%2520NS5B%2520replicase%2520palm%2520site%2520allosteric%2520inhibitor%2520%2528BMS-929075%2529%2520advanced%2520to%2520phase%25201%2520clinical%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4369%26epage%3D4385%26doi%3D10.1021%2Facs.jmedchem.7b00328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Autry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzillo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacci-Tobin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briere, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubczak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzzio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span> <span> </span><span class="NLM_article-title">Design of selective, ATP-competitive inhibitors of Akt</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4615</span>â <span class="NLM_lpage">4622</span>, <span class="refDoi">Â DOI: 10.1021/jm1003842</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1003842" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt12ku78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4615-4622&author=K.+D.+Freeman-Cookauthor=C.+Autryauthor=G.+Borzilloauthor=D.+Gordonauthor=E.+Barbacci-Tobinauthor=V.+Bernardoauthor=D.+Briereauthor=T.+Clarkauthor=M.+Corbettauthor=J.+Jakubczakauthor=S.+Kakarauthor=E.+Knauthauthor=B.+Lippaauthor=M.+J.+Luzzioauthor=M.+Mansourauthor=G.+Martinelliauthor=M.+Marxauthor=K.+Nelsonauthor=J.+Panditauthor=F.+Rajamohanauthor=S.+Robinsonauthor=C.+Subramanyamauthor=L.+Weiauthor=M.+Wythesauthor=J.+Morris&title=Design+of+selective%2C+ATP-competitive+inhibitors+of+Akt&doi=10.1021%2Fjm1003842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Selective, ATP-Competitive Inhibitors of Akt</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Autry, Christopher; Borzillo, Gary; Gordon, Deborah; Barbacci-Tobin, Elsa; Bernardo, Vincent; Briere, David; Clark, Tracey; Corbett, Matthew; Jakubczak, John; Kakar, Shefali; Knauth, Elizabeth; Lippa, Blaise; Luzzio, Michael J.; Mansour, Mahmoud; Martinelli, Gary; Marx, Matthew; Nelson, Kendra; Pandit, Jayvardhan; Rajamohan, Francis; Robinson, Shaughnessy; Subramanyam, Chakrapani; Wei, Liuqing; Wythes, Martin; Morris, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4615-4622</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the design and synthesis of novel, ATP-competitive Akt inhibitors from an elaborated 3-aminopyrrolidine scaffold.  Key findings include the discovery of an initial lead that was modestly selective and medicinal chem. optimization of that lead to provide more selective analogs.  Anal. of the data suggested that highly lipophilic analogs would likely suffer from poor overall properties.  Central to the discussion is the concept of optimization of lipophilic efficiency and the ability to balance overall druglike properties with the careful control of lipophilicity in the lead series.  Discovery of the nonracemic amide series and subsequent modification produced an advanced analog that performed well in advancedaminopyrrolidine substituted pyrrolopyrimidine preclin. assays, including xenograft tumor growth inhibition studies, and this analog was nominated for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqLbzBekJF5LVg90H21EOLACvtfcHk0liBueFSQLtL7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt12ku78%253D&md5=e45372a44f93072f7152a0a2600d7be4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm1003842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1003842%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DBorzillo%26aufirst%3DG.%26aulast%3DGordon%26aufirst%3DD.%26aulast%3DBarbacci-Tobin%26aufirst%3DE.%26aulast%3DBernardo%26aufirst%3DV.%26aulast%3DBriere%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DT.%26aulast%3DCorbett%26aufirst%3DM.%26aulast%3DJakubczak%26aufirst%3DJ.%26aulast%3DKakar%26aufirst%3DS.%26aulast%3DKnauth%26aufirst%3DE.%26aulast%3DLippa%26aufirst%3DB.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DMansour%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DMarx%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DK.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520Akt%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4615%26epage%3D4622%26doi%3D10.1021%2Fjm1003842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>â <span class="NLM_lpage">1164</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0liBueFSQLtL7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugovic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepomuceno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzolio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shireman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, S.</span></span> <span> </span><span class="NLM_article-title">Novel octahydropyrrolo[3,4-<i>c</i>]pyrroles are selective orexin-2 antagonists: SAR leading to a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5620</span>â <span class="NLM_lpage">5636</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5620-5636&author=M.+A.+Letavicauthor=P.+Bonaventureauthor=N.+I.+Carruthersauthor=C.+Dugovicauthor=T.+Koudriakovaauthor=B.+Lordauthor=T.+W.+Lovenbergauthor=K.+S.+Lyauthor=N.+S.+Maniauthor=D.+Nepomucenoauthor=D.+J.+Pippelauthor=M.+Rizzolioauthor=J.+E.+Sheltonauthor=C.+R.+Shahauthor=B.+T.+Shiremanauthor=L.+K.+Youngauthor=S.+Yun&title=Novel+octahydropyrrolo%5B3%2C4-c%5Dpyrroles+are+selective+orexin-2+antagonists%3A+SAR+leading+to+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.5b00742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Bonaventure, Pascal; Carruthers, Nicholas I.; Dugovic, Christine; Koudriakova, Tatiana; Lord, Brian; Lovenberg, Timothy W.; Ly, Kiev S.; Mani, Neelakandha S.; Nepomuceno, Diane; Pippel, Daniel J.; Rizzolio, Michele; Shelton, Jonathan E.; Shah, Chandra R.; Shireman, Brock T.; Young, Lana K.; Yun, Sujin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5620-5636</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The preclin. characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described.  Optimization of physicochem. and DMPK properties led to the discovery of compds. with tissue distribution and duration of action suitable for evaluation in the treatment of primary insomnia.  These selective orexin-2 antagonists are proven to promote sleep in rats, and this work ultimately led to the identification of a compd. that progressed into human clin. trials for the treatment of primary insomnia.  The synthesis, SAR, and optimization of the pharmacokinetic properties of this series of compds. as well as the identification of the clin. candidate I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruHSY6-Pv5L7Vg90H21EOLACvtfcHk0lgZdkAYxQk_cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansL%252FP&md5=6d8785a362aab57c84f6a6db0775d84e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00742%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DDugovic%26aufirst%3DC.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DLy%26aufirst%3DK.%2BS.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DPippel%26aufirst%3DD.%2BJ.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DShelton%26aufirst%3DJ.%2BE.%26aulast%3DShah%26aufirst%3DC.%2BR.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26aulast%3DYoung%26aufirst%3DL.%2BK.%26aulast%3DYun%26aufirst%3DS.%26atitle%3DNovel%2520octahydropyrrolo%255B3%252C4-c%255Dpyrroles%2520are%2520selective%2520orexin-2%2520antagonists%253A%2520SAR%2520leading%2520to%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5620%26epage%3D5636%26doi%3D10.1021%2Facs.jmedchem.5b00742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matiskella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of the human immunodeficiency virus type 1 (HIV-1) attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6308</span>â <span class="NLM_lpage">6327</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00759</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00759" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFGgsrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6308-6327&author=T.+Wangauthor=Y.+Uedaauthor=Z.+Zhangauthor=Z.+Yinauthor=J.+Matiskellaauthor=B.+C.+Pearceauthor=Z.+Yangauthor=M.+Zhengauthor=D.+D.+Parkerauthor=G.+A.+Yamanakaauthor=Y.-F.+Gongauthor=H.-T.+Hoauthor=R.+J.+Colonnoauthor=D.+R.+Langleyauthor=P.-F.+Linauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Discovery+of+the+human+immunodeficiency+virus+type+1+%28HIV-1%29+attachment+inhibitor+temsavir+and+its+phosphonooxymethyl+prodrug+fostemsavir&doi=10.1021%2Facs.jmedchem.8b00759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir</span></div><div class="casAuthors">Wang, Tao; Ueda, Yasu; Zhang, Zhongxing; Yin, Zhiwei; Matiskella, John; Pearce, Bradley C.; Yang, Zheng; Zheng, Ming; Parker, Dawn D.; Yamanaka, Gregory A.; Gong, Yi-Fei; Ho, Hsu-Tso; Colonno, Richard J.; Langley, David R.; Lin, Pin-Fang; Meanwell, Nicholas A.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6308-6327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The optimization of the 4-methoxy-6-azaindole series of HIV-1 attachment inhibitors (AIs) that originated with 1 to deliver temsavir (3, BMS-626529) is described.  The most beneficial increases in potency and pharmacokinetic (PK) properties were attained by incorporating N-linked, sp2-hybridized heteroaryl rings at the 7-position of the heterocyclic nucleus.  Compds. that adhered to a coplanarity model afforded targeted antiviral potency, leading to the identification of 3 with characteristics that provided for targeted exposure and PK properties in three preclin. species.  However, the phys. properties of 3 limited plasma exposure at higher doses, both in preclin. studies and in clin. trials as the result of dissoln.- and/or soly.-limited absorption, a deficiency addressed by the prepn. of the phosphonooxymethyl prodrug 4 (BMS-663068, fostemsavir).  An extended-release formulation of 4 is currently in phase III clin. trials where it has shown promise as part of a drug combination therapy in highly treatment-experienced HIV-1 infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqufpirYoyNPrVg90H21EOLACvtfcHk0lgZdkAYxQk_cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFGgsrfE&md5=e14780f89a22152c7506d225e4e9b5c9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00759%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DMatiskella%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DB.%2BC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DD.%2BD.%26aulast%3DYamanaka%26aufirst%3DG.%2BA.%26aulast%3DGong%26aufirst%3DY.-F.%26aulast%3DHo%26aufirst%3DH.-T.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DLin%26aufirst%3DP.-F.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520attachment%2520inhibitor%2520temsavir%2520and%2520its%2520phosphonooxymethyl%2520prodrug%2520fostemsavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6308%26epage%3D6327%26doi%3D10.1021%2Facs.jmedchem.8b00759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shinozuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokumaru, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsumi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawamura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of DS-6930, a potent selective PPARÎ³ modulator. Part II: lead optimization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5099</span>â <span class="NLM_lpage">5117</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2018.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=10.1016%2Fj.bmc.2018.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=30220602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslahs7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5099-5117&author=T.+Shinozukaauthor=T.+Tsukadaauthor=K.+Fujiiauthor=E.+Tokumaruauthor=K.+Shimadaauthor=Y.+Onishiauthor=Y.+Matsuiauthor=S.+Wakimotoauthor=M.+Kurohaauthor=T.+Ogataauthor=K.+Arakiauthor=J.+Ohsumiauthor=R.+Sawamuraauthor=N.+Watanabeauthor=H.+Yamamotoauthor=K.+Fujimotoauthor=Y.+Taniauthor=M.+Moriauthor=J.+Tanaka&title=Discovery+of+DS-6930%2C+a+potent+selective+PPAR%CE%B3+modulator.+Part+II%3A+lead+optimization&doi=10.1016%2Fj.bmc.2018.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of DS-6930, a potent selective PPARÎ³ modulator. Part II: Lead optimization</span></div><div class="casAuthors">Shinozuka, Tsuyoshi; Tsukada, Tomoharu; Fujii, Kunihiko; Tokumaru, Eri; Shimada, Kousei; Onishi, Yoshiyuki; Matsui, Yumi; Wakimoto, Satoko; Kuroha, Masanori; Ogata, Tsuneaki; Araki, Kazushi; Ohsumi, Jun; Sawamura, Ryoko; Watanabe, Nobuaki; Yamamoto, Hideki; Fujimoto, Kazunori; Tani, Yoshiro; Mori, Makoto; Tanaka, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5099-5117</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Attempts were made to reduce the lipophilicity of previously synthesized compd. (II) for the avoidance of hepatotoxicity.  The replacement of the left-hand side benzene with 2-pyridine resulted in the substantial loss of potency.  Because poor membrane permeability was responsible for poor potency in vitro, the adjustment of lipophilicity was examd., which resulted in the discovery of di-Me pyridine deriv. (I, DS-6930).  In preclin. studies, DS-6930 demonstrated high PPARÎ³ agonist potency with robust plasma glucose redn.  DS-6930 maintained diminished PPARÎ³-related adverse effects upon toxicol. evaluation in vivo, and demonstrated no hepatotoxicity.  Cofactor recruitment assay showed that several cofactors, such as RIP140 and PGC1, were significantly recruited, whereas several canonical factors was not affected.  This selective cofactor recruitment was caused due to the distinct binding mode of DS-6930.  The calcium salt, DS-6930b, which is expected to be an effective inducer of insulin sensitization without edema, could be evaluated clin. in T2DM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAh_sdwZr3XLVg90H21EOLACvtfcHk0lgZdkAYxQk_cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslahs7rP&md5=0608dcb7a15699727dff137b65f3b81b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DShinozuka%26aufirst%3DT.%26aulast%3DTsukada%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DK.%26aulast%3DTokumaru%26aufirst%3DE.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DOnishi%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DY.%26aulast%3DWakimoto%26aufirst%3DS.%26aulast%3DKuroha%26aufirst%3DM.%26aulast%3DOgata%26aufirst%3DT.%26aulast%3DAraki%26aufirst%3DK.%26aulast%3DOhsumi%26aufirst%3DJ.%26aulast%3DSawamura%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DTani%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520DS-6930%252C%2520a%2520potent%2520selective%2520PPAR%25CE%25B3%2520modulator.%2520Part%2520II%253A%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D5099%26epage%3D5117%26doi%3D10.1016%2Fj.bmc.2018.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Procopiou, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, M. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowedder, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saklatvala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollis, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorp, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>S</i>)-3-(3-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((<i>R</i>)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic acid, a nonpeptidic Î±<sub>v</sub>Î²<sub>6</sub> integrin inhibitor for the inhaled treatment of idiopathic pulmonary fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8417</span>â <span class="NLM_lpage">8443</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00959</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00959" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSmtbjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8417-8443&author=P.+A.+Procopiouauthor=N.+A.+Andersonauthor=J.+Barrettauthor=T.+N.+Barrettauthor=M.+H.+J.+Crawfordauthor=B.+J.+Fallonauthor=A.+P.+Hancockauthor=J.+Leauthor=S.+Lemmaauthor=R.+P.+Marshallauthor=J.+Morrellauthor=J.+M.+Pritchardauthor=J.+E.+Rowedderauthor=P.+Saklatvalaauthor=R.+J.+Slackauthor=S.+L.+Sollisauthor=C.+J.+Sucklingauthor=L.+R.+Thorpauthor=G.+Vitulliauthor=S.+J.+F.+Macdonald&title=Discovery+of+%28S%29-3-%283-%283%2C5-dimethyl-1H-pyrazol-1-yl%29phenyl%29-4-%28%28R%29-3-%282-%285%2C6%2C7%2C8-tetrahydro-1%2C8-naphthyridin-2-yl%29ethyl%29pyrrolidin-1-yl%29butanoic+acid%2C+a+nonpeptidic+%CE%B1v%CE%B26+integrin+inhibitor+for+the+inhaled+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.8b00959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic Î±vÎ²6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Procopiou, Panayiotis A.; Anderson, Niall A.; Barrett, John; Barrett, Tim N.; Crawford, Matthew H. J.; Fallon, Brendan J.; Hancock, Ashley P.; Le, Joelle; Lemma, Seble; Marshall, Richard P.; Morrell, Josie; Pritchard, John M.; Rowedder, James E.; Saklatvala, Paula; Slack, Robert J.; Sollis, Steven L.; Suckling, Colin J.; Thorp, Lee R.; Vitulli, Giovanni; Macdonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8417-8443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3-aryl-(pyrrolidin-1-yl)butanoic acids were synthesized using a diastereoselective route, which involved rhodium catalyzed asym. 1,4-addn. of arylboronic acids in the presence of (R)-BINAP to a crotonate ester to provide the (S) abs. configuration for the major product.  A variety of aryl substituents including morpholine, pyrazole, triazole, imidazole and cyclic ether were screened in cell adhesion assays for affinity against Î±vÎ²1, Î±vÎ²3, Î±vÎ²5, Î±vÎ²6 and Î±vÎ²8 integrins.  Several analogs with high affinity and selectivity for the Î±vÎ²6 integrin were identified.  The analog IÂ·HCl was found to have high affinity for Î±vÎ²6 integrin in a radioligand binding assay (pKi = 11), a long dissocn. half-life (7 h) , high soly. in saline at pH 7 (>71 mg/mL) and pharmacokinetic properties commensurate with inhaled dosing by nebulization.  It was selected for further investigation as a potential therapeutic agent for the treatment of idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeicNqg-TYWbVg90H21EOLACvtfcHk0lj1HsoI2cGZYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSmtbjE&md5=6d19e081fe06edb14912ac58a16e2c50</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00959%26sid%3Dliteratum%253Aachs%26aulast%3DProcopiou%26aufirst%3DP.%2BA.%26aulast%3DAnderson%26aufirst%3DN.%2BA.%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DT.%2BN.%26aulast%3DCrawford%26aufirst%3DM.%2BH.%2BJ.%26aulast%3DFallon%26aufirst%3DB.%2BJ.%26aulast%3DHancock%26aufirst%3DA.%2BP.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DLemma%26aufirst%3DS.%26aulast%3DMarshall%26aufirst%3DR.%2BP.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DRowedder%26aufirst%3DJ.%2BE.%26aulast%3DSaklatvala%26aufirst%3DP.%26aulast%3DSlack%26aufirst%3DR.%2BJ.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DSuckling%26aufirst%3DC.%2BJ.%26aulast%3DThorp%26aufirst%3DL.%2BR.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DDiscovery%2520of%2520%2528S%2529-3-%25283-%25283%252C5-dimethyl-1H-pyrazol-1-yl%2529phenyl%2529-4-%2528%2528R%2529-3-%25282-%25285%252C6%252C7%252C8-tetrahydro-1%252C8-naphthyridin-2-yl%2529ethyl%2529pyrrolidin-1-yl%2529butanoic%2520acid%252C%2520a%2520nonpeptidic%2520%25CE%25B1v%25CE%25B26%2520integrin%2520inhibitor%2520for%2520the%2520inhaled%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8417%26epage%3D8443%26doi%3D10.1021%2Facs.jmedchem.8b00959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimerâs disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8616</span>â <span class="NLM_lpage">8637</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8616-8637&author=Z.+Wangauthor=Y.+Wangauthor=B.+Wangauthor=W.+Liauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+evaluation+of+orally+available+clioquinol-moracin+M+hybrids+as+multitarget-directed+ligands+for+cognitive+improvement+in+a+rat+model+of+neurodegeneration+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b01222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease</span></div><div class="casAuthors">Wang, Zhiren; Wang, Yali; Wang, Bo; Li, Wenrui; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8616-8637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of clioquinol-moracin hybrids were designed and synthesized by fusing the pharmacophores of clioquinol and moracin M, and their activities as multitarget-directed ligands against Alzheimer's disease were evaluated.  Biol. activity results demonstrated that these hybrids possessed significant inhibitory activities against phosphodiesterase 4D (PDE4D) and AÎ² aggregation as well as remarkable antioxidant effects and excellent blood-brain barrier permeability.  The optimal compd., I (WBQ5187), exhibited excellent PDE4D inhibitory potency (IC50 = 0.32 Î¼M), significant antioxidant effects, appropriate biometal chelating functions, and interesting properties that modulated self- and metal-induced AÎ² aggregation.  Two-dimensional NMR studies revealed that I had significant interactions with AÎ²1-42 at the R5, H6, H14, Q15, and F20 residues.  Furthermore, this typical hybrid possessed preeminent neuroprotective effects against inflammation in microglial cells.  Most importantly, oral administration of IÂ·HCl demonstrated marked improvements in cognitive and spatial memory in a rat model of Alzheimer's disease and protected hippocampal neurons from necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcLe7jrheic7Vg90H21EOLACvtfcHk0lj1HsoI2cGZYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kgt7nI&md5=1230163c53dc646777185602d9fa9643</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01222%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520available%2520clioquinol-moracin%2520M%2520hybrids%2520as%2520multitarget-directed%2520ligands%2520for%2520cognitive%2520improvement%2520in%2520a%2520rat%2520model%2520of%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8616%26epage%3D8637%26doi%3D10.1021%2Facs.jmedchem.5b01222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Bourdonnec, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windh, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajello, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiant, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feschenko, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogdon, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derelanko, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, R. E.</span></span> <span> </span><span class="NLM_article-title">Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of <i>N,N</i>-diethyl-4-(5-hydroxyspiro[chromene-2,4â²-piperidine]-4-yl)benzamide (ADL5859)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5893</span>â <span class="NLM_lpage">5896</span>, <span class="refDoi">Â DOI: 10.1021/jm8008986</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8008986" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFeltL7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5893-5896&author=B.+Le%0ABourdonnecauthor=R.+T.+Windhauthor=C.+W.+Ajelloauthor=L.+K.+Leisterauthor=M.+Guauthor=G.-H.+Chuauthor=P.+A.+Tuthillauthor=W.+M.+Barkerauthor=M.+Koblishauthor=D.+D.+Wiantauthor=T.+M.+Graczykauthor=S.+Belangerauthor=J.+A.+Casselauthor=M.+S.+Feschenkoauthor=B.+L.+Brogdonauthor=S.+A.+Smithauthor=D.+D.+Christauthor=M.+J.+Derelankoauthor=S.+Kutzauthor=P.+J.+Littleauthor=R.+N.+DeHavenauthor=D.+L.+DeHaven-Hudkinsauthor=R.+E.+Dolle&title=Potent%2C+orally+bioavailable+delta+opioid+receptor+agonists+for+the+treatment+of+pain%3A+discovery+of+N%2CN-diethyl-4-%285-hydroxyspiro%5Bchromene-2%2C4%E2%80%B2-piperidine%5D-4-yl%29benzamide+%28ADL5859%29&doi=10.1021%2Fjm8008986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)</span></div><div class="casAuthors">Le Bourdonnec, Bertrand; Windh, Rolf T.; Ajello, Christopher W.; Leister, Lara K.; Gu, Minghua; Chu, Guo-Hua; Tuthill, Paul A.; Barker, William M.; Koblish, Michael; Wiant, Daniel D.; Graczyk, Thomas M.; Belanger, Serge; Cassel, Joel A.; Feschenko, Marina S.; Brogdon, Bernice L.; Smith, Steven A.; Christ, David D.; Derelanko, Michael J.; Kutz, Steve; Little, Patrick J.; DeHaven, Robert N.; DeHaven-Hudkins, Diane L.; Dolle, Roland E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5893-5896</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective Î´ opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions.  A spirocyclic deriv. was identified as a promising hit through screening.  Subsequent lead optimization identified compd. 20 (ADL5859) as a potent, selective, and orally bioavailable Î´ agonist.  Compd. 20 was selected as a clin. candidate for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoncECgkLuz4rVg90H21EOLACvtfcHk0ljsJ-OSgk3dEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFeltL7K&md5=a38e21537b5b13dac20974940eec4375</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm8008986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008986%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DWindh%26aufirst%3DR.%2BT.%26aulast%3DAjello%26aufirst%3DC.%2BW.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DGu%26aufirst%3DM.%26aulast%3DChu%26aufirst%3DG.-H.%26aulast%3DTuthill%26aufirst%3DP.%2BA.%26aulast%3DBarker%26aufirst%3DW.%2BM.%26aulast%3DKoblish%26aufirst%3DM.%26aulast%3DWiant%26aufirst%3DD.%2BD.%26aulast%3DGraczyk%26aufirst%3DT.%2BM.%26aulast%3DBelanger%26aufirst%3DS.%26aulast%3DCassel%26aufirst%3DJ.%2BA.%26aulast%3DFeschenko%26aufirst%3DM.%2BS.%26aulast%3DBrogdon%26aufirst%3DB.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DDerelanko%26aufirst%3DM.%2BJ.%26aulast%3DKutz%26aufirst%3DS.%26aulast%3DLittle%26aufirst%3DP.%2BJ.%26aulast%3DDeHaven%26aufirst%3DR.%2BN.%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26atitle%3DPotent%252C%2520orally%2520bioavailable%2520delta%2520opioid%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520pain%253A%2520discovery%2520of%2520N%252CN-diethyl-4-%25285-hydroxyspiro%255Bchromene-2%252C4%25E2%2580%25B2-piperidine%255D-4-yl%2529benzamide%2520%2528ADL5859%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5893%26epage%3D5896%26doi%3D10.1021%2Fjm8008986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Bourdonnec, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windh, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajello, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiant, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassel, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feschenko, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogdon, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derelanko, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeHaven-Hudkins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, R. E.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of <i>N,N</i>-diethyl-3-hydroxy-4-(spiro[chromene-2,4â²-piperidine]-4-yl) benzamide (ADL5747)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5685</span>â <span class="NLM_lpage">5702</span>, <span class="refDoi">Â DOI: 10.1021/jm900773n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900773n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWkurvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5685-5702&author=B.+Le%0ABourdonnecauthor=R.+T.+Windhauthor=L.+K.+Leisterauthor=Q.+J.+Zhouauthor=C.+W.+Ajelloauthor=M.+Guauthor=G.-H.+Chuauthor=P.+A.+Tuthillauthor=W.+M.+Barkerauthor=M.+Koblishauthor=D.+D.+Wiantauthor=T.+M.+Graczykauthor=S.+Belangerauthor=J.+A.+Casselauthor=M.+S.+Feschenkoauthor=B.+L.+Brogdonauthor=S.+A.+Smithauthor=M.+J.+Derelankoauthor=S.+Kutzauthor=P.+J.+Littleauthor=R.+N.+DeHavenauthor=D.+L.+DeHaven-Hudkinsauthor=R.+E.+Dolle&title=Spirocyclic+delta+opioid+receptor+agonists+for+the+treatment+of+pain%3A+discovery+of+N%2CN-diethyl-3-hydroxy-4-%28spiro%5Bchromene-2%2C4%E2%80%B2-piperidine%5D-4-yl%29+benzamide+%28ADL5747%29&doi=10.1021%2Fjm900773n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) Benzamide (ADL5747)</span></div><div class="casAuthors">Le Bourdonnec, Bertrand; Windh, Rolf T.; Leister, Lara K.; Zhou, Q. Jean; Ajello, Christopher W.; Gu, Minghua; Chu, Guo-Hua; Tuthill, Paul A.; Barker, William M.; Koblish, Michael; Wiant, Daniel D.; Graczyk, Thomas M.; Belanger, Serge; Cassel, Joel A.; Feschenko, Marina S.; Brogdon, Bernice L.; Smith, Steven A.; Derelanko, Michael J.; Kutz, Steve; Little, Patrick J.; De Haven, Robert N.; De Haven-Hudkins, Diane L.; Dolle, Roland E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5685-5702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective, nonpeptidic Î´ opioid receptor agonists have been the subject of great interest as potential novel analgesic agents.  The discoveries of BW373U86 (I) and SNC80 (II) contributed to the rapid expansion of research in this field.  However, poor drug-like properties and low therapeutic indexes have prevented clin. evaluation of these agents.  Doses of I and II similar to those required for analgesic activity produce convulsions in rodents and nonhuman primates.  Recently, a novel series of potent, selective, and orally bioavailable delta opioid receptor agonists was described.  The lead deriv., ADL5859 (III), is currently in phase II proof-of-concept studies for the management of pain.  Further structure activity relationship exploration has led to the discovery of ADL5747 (IV), which is approx. 50-fold more potent than III in an animal model of inflammatory pain.  On the basis of its favorable efficacy, safety, and pharmacokinetic profile, IV was selected as a clin. candidate for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0gbucCvC4DLVg90H21EOLACvtfcHk0ljsJ-OSgk3dEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWkurvP&md5=ac08eaad9f032e9d2ef50b7d03b48d3e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900773n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900773n%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DWindh%26aufirst%3DR.%2BT.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DZhou%26aufirst%3DQ.%2BJ.%26aulast%3DAjello%26aufirst%3DC.%2BW.%26aulast%3DGu%26aufirst%3DM.%26aulast%3DChu%26aufirst%3DG.-H.%26aulast%3DTuthill%26aufirst%3DP.%2BA.%26aulast%3DBarker%26aufirst%3DW.%2BM.%26aulast%3DKoblish%26aufirst%3DM.%26aulast%3DWiant%26aufirst%3DD.%2BD.%26aulast%3DGraczyk%26aufirst%3DT.%2BM.%26aulast%3DBelanger%26aufirst%3DS.%26aulast%3DCassel%26aufirst%3DJ.%2BA.%26aulast%3DFeschenko%26aufirst%3DM.%2BS.%26aulast%3DBrogdon%26aufirst%3DB.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DDerelanko%26aufirst%3DM.%2BJ.%26aulast%3DKutz%26aufirst%3DS.%26aulast%3DLittle%26aufirst%3DP.%2BJ.%26aulast%3DDeHaven%26aufirst%3DR.%2BN.%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26atitle%3DSpirocyclic%2520delta%2520opioid%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520pain%253A%2520discovery%2520of%2520N%252CN-diethyl-3-hydroxy-4-%2528spiro%255Bchromene-2%252C4%25E2%2580%25B2-piperidine%255D-4-yl%2529%2520benzamide%2520%2528ADL5747%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5685%26epage%3D5702%26doi%3D10.1021%2Fjm900773n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongsted, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannecouque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span> <span> </span><span class="NLM_article-title">Overview of recent strategic advances in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9375</span>â <span class="NLM_lpage">9414</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVKgsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9375-9414&author=G.+Wuauthor=T.+Zhaoauthor=D.+Kangauthor=J.+Zhangauthor=Y.+Songauthor=V.+Namasivayamauthor=J.+Kongstedauthor=C.+Pannecouqueauthor=E.+De+Clercqauthor=V.+Poongavanamauthor=X.+Liuauthor=P.+Zhan&title=Overview+of+recent+strategic+advances+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.9b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of Recent Strategic Advances in Medicinal Chemistry</span></div><div class="casAuthors">Wu, Gaochan; Zhao, Tong; Kang, Dongwei; Zhang, Jian; Song, Yuning; Namasivayam, Vigneshwaran; Kongsted, Jacob; Pannecouque, Christophe; De Clercq, Erik; Poongavanam, Vasanthanathan; Liu, Xinyong; Zhan, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9375-9414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Introducing novel strategies, concepts and technologies that speed up drug discovery and the drug development cycle is of great importance both in the highly competitive pharmaceutical industry as well as in academia.  This review aims to present a "big-picture" overview of recent strategic innovations in medicinal chem. and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQnxCWBy2AJLVg90H21EOLACvtfcHk0ljsJ-OSgk3dEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVKgsrk%253D&md5=0012d1386ecf4e84e1caf5e90837d708</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DKongsted%26aufirst%3DJ.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DP.%26atitle%3DOverview%2520of%2520recent%2520strategic%2520advances%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9375%26epage%3D9414%26doi%3D10.1021%2Facs.jmedchem.9b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i12"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02092">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41713"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02092?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02092</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Statistics for MMPs from CH group â N atom or CF, CMe, or COH group exchanges, property increase definitions, diversity of assay data for MMPs from CH group â N atom exchanges, statistics for ring diversity among unique MMPs in ChEMBL24 from CH group â N atom exchanges, relative positional analogue designation examples, medicinal chemistry strategies, target distribution in the ChEMBL24 database, distribution of fold-increases and fold-decreases in rat clearance for 4-fluoro analogues from CH group â CF group exchanges, and distribution of functional activities for all CH group â N atom exchanges and for a subset of antiproliferative assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02092/suppl_file/jm9b02092_si_001.pdf">jm9b02092_si_001.pdf (319.83 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02092&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02092" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02092" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a7140ff513c16","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
